AFFINITY INTERACTIONS OF ACTIN WITH HSl AND Annexin I, II, IV, V AND VI IN RAW264.7 MACRO PHAGES

\

IN VITRO AND IN THE Fe-RECEPTOR COMPLEX
by

Angelica Kirsten Florentinus Bachelor of Applied Science, Master of Science (Ryerson University , 2008)

A thesis
presented to Ryerson University in partial fulfillment of the requirements for the degree of Master in the program of Molecular Science

Toronto, Ontario, Canada, 2008

© Angelica Kirsten Florentinus, 2008

PFUlPEflTY Of
RVERSOt~ UNWERSUYLIBRARY

AUTHOR'S DECLARATION

"I~

Angelica Kirsten Florentinus~ hereby declare that I am the sole author of this thesis that is comprised entirely of my original scholarly work.

I authorize Ryerson University to lend this thesis to other institutions or individuals for the purpose of scholarly research.

I further authorize Ryerson University to reproduce this thesis by photocopying or by other means, in total or in part, at the request of other institutions for the purpose of scholarly research

Signature:

Affinity Interactions of Actin with HS1 and. Annexin I, II, IV, V and. VI in RAW264 . 7 Macrophages in vitro and. in the Fe. .Receptor Contplex
© Angelica Kirsten Florentinus, B SC, M Sc, 2008, l\1olecular Science, Ryerson University

ABSTRACT
Actin binding proteins HS 1 and Annexin I, U, IV, V and VI proteins were exan1ined in RAW macrophages in vitro using affinity chron1atography, LC-MS/MS, western blot, cell staining and expression of fluorescent proteins. Actins and many related actin isoforn1s were observed in the phagosotne. However, actins were also observed on polystyrene beads incubated with crude extracts readily bound to NHS affinity chromatography beads in the absence of anti.. actin antibodies. Annexin II and V and the haematopoietic specific proteins HSl (also called Lyn substrate) were prominently observed in isolated phagosomes and not observed in control beads incubated with crude extracts ofRAW macrophages. Annexin II and Vas well as G3BP, FLTl, FARP2, STARD13, RAB25 and FRAPl were observed to bind actin in affinity chromatography experiments using LC-MS/MS and western blot. Cell staining and/or

expression of GFP constructs showed that actin, HSl and Annexin V prominently accumulate at the nascent Fc-receptor complex ofRAW macrophages.

iv

ACKNOWLEDGEMENTS
I would like to take this oppot1unity to express n1y sincere gratitude and appreciation to a variety of people who made this 1naster' s thesis possible.

Firstly, I would like to thank my supervisor Dr John Marshall for his knowledge, continued support and encouragen1ent throughout my thesis project. I atn grateful for the tnany opportunities that he has provided me to complete n1y undergraduate career in the Netherlands and during my graduate studies at Ryerson University.

Many thanks go to alltny colleagues in the Protein Biochen1istry laboratory at Ryerson University for their advice and support

I am indebted to the School of Graduate Studies at Ryerson University for scholarship funding, vvhich made my thesis financially possible.

Finally, special thanks go to Tommy, my friends and family for their strong support and understanding throughout all these years.

v

TABLE OF CONTENTS
AUTHOR'S D ECLARATl ON eoooooooeee~oooos&oo~eeoeoeooesssoeeoeee~scceooooooeeeeooooootoo·eeoooooooeeeeeeoos&sooo.ooooeefleoo II ABSTRACT
··e eoo oooo &eo oe e eeos s

e~ooo e <&eoee ooooocae eos cooooo ooooeeeeoo oo oos oeeeeooo ooosso o o e oeoeeeoooooooofloeooo o ooeoeee oooo

G

ooeee eoeoeeos

IV
V

A CI(N 0 WL E DGEMENTS

oo o · soo e oo oeoos oso o ooeeees sssooooooo ··· eee oo ooo oo so ooo ooo oseooooooooe es ooo ooeo ···· oooo oooeeeoooooeoose

LIST 0 F FIGURES Ll ST 0 F TABLES

ee e oooooooeeeo ooo o o o oo oooo oosooee oo ooooooo ooeoo ooo oooeeeoo oooooso ooo ooo s sooooo0ooeo SGoooooooeeG oooo0ooeeeeoe oo

VIII VIII

eo ·e eooo o oooeeooo o G oooe eo oo ooo c;ooooeoe ooo oooo oeo ooeoe·oeeooooooo» o ··· eooo oo.,oo e ooe eo oosoS»

eee~ ~&&& sso eooQt·· &&~ooo oo

AB BREVIATI 0 N S ·ssoooo~··ee~ooo ooot~
. I NTR0 D U CTI 0 N HYPOTHESIS

eeeG Cl

oooo~·eeeee ooo sssoseeooe411ee-sssoooooooo · ···" GOO oo·oseeeoooo ~·eeeee eo&& sso o o ~eee&sesoo oo· o · IX

ee·seooo······ooooeoo···oooooooooeeeeoooossooseooooeeeessoooooeoee······etooee··eoooooooeeeoooessseeei!>O&e····oooooo····l

oooG o -aee· se oooo o ooeeeoo o o

~··eeeeooooosoe eeoooooss~S~ssoo ooo ··· sssoooo~ ···· eee~ Goo oo·o oeeeooooooee eeoooos seooooeee·s·ooooooooo 10

0 BJECTJ\TES "oe GoG ····ooo o oooo oeee oooo oooeeeoooo oe ooliee· eo eee&eeee oo oo· ·····c ooo ooo· ····o oooooo···~oooooo~eeeoooo eesooooo···Cisooooo oooo 10

MATERIALS AND METH0 n· s eoOOS$$$9ee~e~eeoeiiiiii$00000e··· Cie~ oooooooo···ooooooo3~~eeeooooo~&eeeeeoo&IIIIIIOOOeeeeiiiCIIIIOOOOOOOOOe12
Cell culture .......................................... ............................................................................. 12 Antibodies ........................................................................................................................ 12 DNA constructs ................................................................................................................ 12 Itnmuno flttorescence staining .......................................................................................... 13 Competent cells (RbCl) .................................................................................................... 15 Transformation of cotnpetent DH5a with GFP constructs ............................................... IS GFP transfections ............ ........ ........ .. ....... ........................................................................ 16 Affinity chromatography .................................................................................................. 17 -Protein G/ Sepharose, Fast Flow colutnn (1) ........................................................... 17 -N-hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow ............................ 18 SDS-PAGE and Westen1 Blotting......................................................... ........ ................... 19 Blue Silver Stain ................................................................................................................ 21 Silver Stain (Hahn's lab protocols) .................................................................................. 21 Capturing of the Fc-receptor complex (LARC) ............................................................. .. 22 Liquid Chromatography Mass Spectron1etry (LC-MS/MS) ............................................ 22 Peptide correlation ............................................................................................................ 23 Generation of protein-protein interaction model using iHOP ....................... ................... 24

RESULTS

eeee eee oe s

sseoeo·4tllle·sooooo<~···· eooooo&o · eeeoooo cP&Iieeeeeeeooo osoeeaeeeeeos&~tPooooot~ eos111 ss .ooo0 ot~····ooo o oo oeeeeeoo ooooeeeeeeeos · sse o 25

Capturing the Fc-receptor complex (LARC) .................................................................... 26 Mass spectrometry of captured Fc-receptor con1plexes ................................................... 27 Affinity Chron1atography ................................................................................................. 31 -Protein G/ Sepharose, Fast Flow column ................................................................. 31 -N-hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow ............................ 31 LC-MS/MS of proteins observed in affinity chrmnatography pull downs ...................... 3 8 Confocal microscopy ........................................................................................................ 41

Vl

-Imn1uno f1 uorescent staining .................................................................................... 41 -GFP transfection ....................................................................................................... 42 Protein-protein interaction n1odels (iHOP) ...................................................................... 43

Capturing the Fc-receptor conlplex .................................................................................. 48 Mass spectrometry of captured Fc-receptor complexes ................................................... 48 Affinity Chromatography ................................................................................................. 50 LC-MS/MS of proteins observed in affinity chromatography pull downs ...................... 50 Confocal microscopy ........................................................................................................ 51 -Itnmuno fluorescent stai11ing .................................................................................... 51 -GFP transfection ........................................ ............................................................... 51 Protein-protein interaction tnodels (iHOP) ...................................................................... 52

vii

List of figures
FIGURE 1. PC-RECEPTOR MEDIATED PHAGOCYTOSIS AND ACTIN REMODELING ............................ 2 FIGURE 2. CONSERVED DOMAINS OF HAEMATOPOIETIC CELL SPECIFIC LYN SUBSTRATE 1 ... ... ; ... 3 FIGURE 3. CONSERVED DOMAINS FOR ANNEXINS ........................................................................ 4 FIGURE 4. FLOW CHART OF THE CONDUCTED EXPERIMENTS ........................................................ 9 FIGURE 5. CAPTURING THE PC-RECEPTOR COMPLEX ....... ........... .............. ....... ...... ,. .................. 26 FIGURE 6. CAPTURING THE PC-RECEPTOR COMPLEX ........ ...... ,. .................. ,. ........................ ... .. 27 FIGURE 7A. SPECTRA OF ACTIN, HS 1 AND ANNEXINS OBSERVED IN THE CAPTURED PC-RECEPTOR COMPLEX BY LC-MS/MS ................... ,. ............................................ ,. ......... 29 FIGURE 7B. SPECTRA OF ACTIN BINDING PROTEINS OBSERVED IN THE CAPTURED PC-RECEPTOR COMPLEX ......................... ....... ...... ............... . ,. .............................................. 30 FIGURE 8. WESTERN BLOT ANALYSIS OF A PROTEIN 0-HS 1 AFFINITY CHROMATOGRAPHY IN THE PRESENCE OF NA-DEOXYCHOLATE AND N-OCTYL GLUCOSIDE ............................... 32 FIGURE] 0. WESTERN BLOT ANALYSIS OF A NHS-ANTI-ACTIN AFFINITY CHROMATOGRAPHY COLUMN .................................................................... ,. ........................ 34 FIGURE 11. FARP2, G3BP, RAB25, FRAPl, FLT1 AND ST.A.RD13 OBSERVED IN THE NHS AFFINITY CHROMATOGRAPHY PULLDOWNS BY LC-MS/MS ............................ 40 FIGURE 12. FARP2, G3BP, RAB25, FRAP1, FLTl AND STARD13 OBSERVED IN CAPTURED FC-RECEPTOR COMPLEX BY LC-MS/MS ............................... ,. ...................... 41 FIGURE 13. !MMUNO FLUORESCENCE STAINING OF ACTIN, HSl, ANXAl, ANXA2, ANXA4, ANXA5 AND ANXA6 IN RA W264.7 MACROPHAGES ............ .............................. FIGURE 14. IMMUNOFLUORESCENCE STAINING OF RAB25, FERM, RHoGEF AND PLECKSTRIN DOMAIN PROTEIN 2 AND RHOGTPASE ACTIVATING PROTEIN IN RA W264. 7 MACROPHA.GES ............................................................................................ FIGURE 15. EXPRESSION OF GFP FUSION PROTEINS IN RA W264.7 MACROPHAGES .................. FIGURE 16. PROTEIN-PROTEIN INTERACTIONS OBSERVED FROM LITERATURE .. ... ... ... .................

42

43 44 45

List of tables
TABLE 1. PROTEIN-PROTEIN INTERACTIONS OBSERVED FROM LITERATURE. ... ............... .. ... ........ 46 TABLE 2. NOVEL PROTEIN-PROTEIN INTERACTIONS OBSERVED FROMNHS AFFINITY

CHROMATOGRAPHY COLUMNS ............................................................................................ 4 7

viii

Keywords: Fc-receptor con1plex, affinity capture, LC-MS/MS, Live-cell Affinity Receptor Chromatography, LARC, confocal microscopy, Actin, protein-protein interactions

ABBREVIATIONS

· .·-·--·.·--·.·.-,,·,,·,vc,..-,,._,.,,.,w.v.·-,

i.AI1XA.2-· --·~.--·,·,-.'-'·'-''·"·"' W-'-HW,·C ·''

iADP iAnXA1

;AnXA4 AnXA6

1':AnX!\5 ·-;~Ps
:DN

···· ·· ··'.t\llne)<in 5 ·
'Annexin 6

;Ci~~~()sin~ ~ip~()~p~~t~ . Annexin 1 \Annexin 2 Annexin 4

;Arp2/3 complex ;Actin related protein 2/3 complex iAtP···· ···· · · · · · · ···· · ··· : ~~~~:?~i6~~riph~~P6~t~:······ ······ · · · ·

t~L~~~.c::>~i~.rl'l p~-~~ljlfe~t(;!

fEtoR
:F'ss· ······ · · · · · · · · ·
'FARP2 : Fc-receptor

;Ethanol .. ~. ~. f3ryl .. ~h()~~Fand pl~~~~~~i~ cj_(:l~~~~p~()~~i~ ?
.. . ,
_,,,_.,.._,," _,- , "" " '

i

~9.~i~(;l~~ ~f3~~ti~ """" '''

N'

n =cf1
tG3BP

Fragrr1E}nt cry~taUizablf3 ~ec;f3pt()r ·. Fetal bo'vine serum
·' , .· , ,._,_ -'·' ' .>

h.·.·,·,v.·,·.·,·v.·.v

, ._, ·· . · , .. w,,,·,v·"<HH.>','·'-''·''-'-

·· ·

· ···v- ,-_,, ..w , -·,W.wv.w··-··

''''

·····,··.w.->.wro·hH.>·.~.-,·.>

.>'Y".',W'.>oY·"...-<'-'''·''·'' ' ' ' '

· · ~f\11§~1i~~ ty~()~~~~ _ ki~~~~ ~·.··.· ·.· .· ·.· · · · ·.· .· ···········.... "''' ' ' .. '" .~~?9?..·~.i~cji~~ p~()t~i~~.~ =~~p(!j~yc;i~ ~~~_()(;i~~~cjp~()!~i~.. ~. .·..
·ras-GTPase activating protein SH3-domain binding protein
] ~ f~~-~ ~~:~~~~.~c;~n. t: er9!~:~~~- ·

fGFP [8~1.
iHS1 (-.

. .· · ·· ·· · · · · · · · · · · · · ·· ··· · ····· ··

····· ···~··· ~~-

..: .·..

rlA· Rc·
·· -

lGTPases

.. .... ti~l!l~~c:lP()if}tic; li~~c:l.~~. c;~II .. ~P~(;i~.C:: p~()~\Sl~~ . ~. · guanosine triphosphates . ..... J.~. i~~~'· ' · · affi.~Iiy-- f~~~. P~~~··~-~ ~~rr1.c:I~.()Q~r~p~y '·ig~i.9. ..c..~r()rY"l~.~. c:>Q~C!lP~X .~c:~~.9. f31!1 . . 1"11~~~- ~p~c;t~c:>~~!rx Sodium chloride ... ..

·· hycjr()c;~l()ric; .~c;i9

'LC-MS/MS !NaCI ·--· ..
. ,.
,-.~···''

··

iNHS (... ,,_. ......... . !PIP2

... ~.:~¥9E()~X~~c;g.i_~i!1'"li9~:~C..!i_~!.~~·. ..§.~p~~~c:l~.~ . ~"~.;:l-~! ~~-()~............
phosphatidyl inositol biphosphate

i'Rft.825 '' '
iScar

:~~?$.· rl1~r:rl~~·~ ·~~ '?6~~~~0~ f~i,!lily
l~()cjilj!1lcj()9f3C.YI ~~I!C)te
. _' sh~~Prf3~ ~~9~~ . ~~~~~ . .. . . . . . ·.· .·. ·. · .· · · · · . . . .. 'short interference double stranded RNA ~ kt-lo <3ffiase~aciivaiin9 prot.ein .itri~·(6}j~·r())('t~-~fbyt)~~~·~~~.e~b~6~-·,··········· ··, ;\Yi~~()tt~~~9~ic;~.. §y~· . ~~()~~ _ pr()tei ~. . . .. · ..

r·sos

;~.c:'~.P -~~~~-~.\Sl9 P~()~~-i~ .

isRNAi··· rsrAR513'···
'!("""-"''···,
v·...,.-..c,·c ·c,, · ·

'sRBC

lTris
~

.·..... ....... . ..... . .. . .... .. ...·. ·

'!Yf.\.~p

ix

INTRODUCTION

Innate itnmunity is a significant first line of defense against infection. The innate itnmune system kills pathogens in a non-specific manner to protect the host and includes physical or chemical batTiers such as the skin or stomach acid. The cells of the adaptive imn1une system also defend against infection (1, 2).

Phagocytosis involves the internalization of foreign particles by specialized cells and is a crucial cotnponent of the innate imtnune system (3). In Fc-receptor mediated phagocytosis, the receptor becotnes activated upon binding to foreign particles that are opsonized with IgG (4). Clustering of activated Fc-receptors to the contact site stimulates cell signaling, local rearrangen1ent of the actin cytoskeleton and re1nodeling of the n1embrane (5).Actin filan1ents are assembled at the contact site and push the cell membrane around the opsonized particle and engulf the foreign body ( 6). The formation of filamentous actin stimulates the production of superoxide by NADPH oxidase and intracellular vesicles will transport superoxide to the phagosome. The vesicles fuse with the phagosome and superoxide degrades the internalized particle (7).

Upon stin1ulation of the Fc-receptor, the production of active GTPases and PIP2 activates WASp/Scar. WASp/Scar are nucleation promoting factors that transport actin monomers and the Arp2/3 complex to the elongating barbed end of the actin filan1ents. \VASp/Scar activates the Arp2/3 con1plex, which is responsible for the formation of actin filan1ents. The Arp2/3 con1plex connects actin monomers bound to ATP to the barbed ends of

the actin filaments. Upon binding, ATP hydrolyzes to ADP. The filan1ents grow and push the tnembrane forward until the barbed end is capped by capping proteins. At the pointed ends of the elongating actin t!lan1ents, Actin Depolymerizing Proteins (ADP) such as cofilin bind to the filaments and depolymerize the pointed end and cofilin catalyzes the exchange of ADP for ATP (8) (Figure 1).

PAK

UMkinalSe

J

~OF!..
ADF/eofilin

Figure 1. Fc-receptor mediated phagocytosis and actin remodeling. The Fc-receptor located on the surface of the cell binds to an opsonized partic1e, resulting in the phosphorylation of the Fe-receptor and activation of a cascade of intracellular events including remodeling of the actin cytoskeleton, vesicle fusion and oxidative burst.

Actin, expressed in all eukaryotic cells, is found in two states: monotneric actin or globular actin (G-actin), and filatnentous actin (F-actin). Actin is a highly abundant protein of 42 kDa (9). Filan1ents form the actin cytoskeleton, which is responsible for cellular shape, resisting tension and cell motility (10). Reanangetnent of the actin cytoskeleton is tightly

2

regulated by a large variety of proteins and is not completely understood yet (11 ). This paper will concentrate on actin-protein interactions n1ediated by Fc-receptor activation.

Haen1atopoietic cell specific Lyn substrate 1 (HS 1) is a 486 runino acid, 75 kDa intracellular protein only expressed in haematopoietic cells (12). The conserved dotnains of HS 1 consist of three and a halve I-IS 1 repeats and a SH3 domain (Figure 2). HS 1 contains an acidic region (NTA) that binds and activates the Arp2/3 complex, protnoting modest actin polymerization. HS 1 also includes a coiled-coil domain and a helix-tum-helix domain that can both bind F-actin directly (13). HSl connects the Arp2/3 cotnplex with F-actin and therefore stabilizes the actin filaments (14). Inactive HS1 resides in the cytoplasn1 and translocates to the plasma membrane upon activation. HSl is activated by phosphorylated Syk,. which binds to HSl and in tum phosphorylates at tyrosine residues 397 and 378 (15). Syk detaches from HSl, allowing Src to bind to the Src homology 2 (SH2) or 3 (SH3) domain of HS 1 and phosphorylates at tyrosine residue 222, resulting in the activation ofHSl (16).

Figure 2. Conserved domains ofHaematopoietic cell specific Lyn substrate I.

HS 1 consists of three and a halve HS 1 repeats and a SH3 domain.

Members of the Annexin family are comprised of four annexin repeats (except annexin 6, which has eight repeats) (Figure 3), each of 70 an1ino acids in length, which form the annexin core. The core forms a tightly packed, a-helical, slightly curved disk with two distinct sides. The more spherical side contains the COOH-terminus contains Ca2+ binding sites that interact ·with the cell n1e111brane through phospholipid binding, activation and phosphorylation

3

of annexins (17, 18). The more concave side remains open for the interaction of proteins with the NH2-terminus (17). Each annexin has a structurally unique N-terminus, which is variable in length and establishes the different functions of the isoforms. Activation of annexins occurs upon binding of the N-terminus and phosphorylation of the protein. Annexins have been observed to be involved in intracellular events such as signal transduction and during endocytosis for men1brane fusion (18) as well as ion channel activities (17), cell differentiation and growth (19). The presence of AnXAl-AnXA5 has previously been shown in phagosomes isolated fro1n J774 macrophages (20).

a.

S(·(·

b.

;

(

Figure 3. Conserved domains for annexins. A; The annexin core for annexin Al, A2, A4 and A5 consists of 4 annexin repeats each of 70 amino acids in length. B; Annexin A6 is the only\ member of the annexin family that has 8, instead of 4, annexin repeats.

Annexin Al (AnXAl) is a 346 an1ino acid, 35kDa intracellular protein found in most eukaryotic cells. AnXAl, as well as AnXA2, are able to cross-link membranes due to their ability to aggregate membrane vesicles (21 ). AnXA 1 contains 4 Ca2+-binding sites and interacts with the epidermal growth factor receptor protein kinase \Vhen Ca2+ concentrations are elevated. Upon binding, AnXAl becomes tyrosine phosphorylated at residue 21 (22). AnXAl becon1es serine and threonine phosphorylated ·upon binding to protein kinase C at residue 24 (threonine), 27 and 28 (serine) (23) and fonns a con1plex vvith its substrate SlOOAll in a Ca2+-

4

dependent 1nanner, which binds and inactivates cytosolic phospholipase A (cPLA) (24). AnXAl has been demonstrated to interact with actin as well as selectin, integrin A4, epithelial growth factor receptor and formyl peptide receptor (25).

Annexin A2 (AnXA2) is a 338 an1ino acid, 34kDa intracellular protein and exists in monomeric and heteromeric fonns. Monomeric AnXA2 is located in the cytosol and the heterotetran1er is found at the membrane cytoskeleton. The heterotetramer consists of two AnXA2 and tvvo S 1OOA 10 (S 100 calcium binding protein Al 0) molecules, which are bound to the NH2 -terminus of AnXA2, and interacts with other proteins (26). In response to extracellular stilnulation, AnXA2 is tyrosine phosphorylated by pp60src (27) and protein kinase C (28). AnXA2 has been shown to be associated with the regulation of contact between cells through complex fonnation with cadherin and Rae 1/p21-associated kinase (29). AnXA2 has been observed to be involved in the assembly of actin-rich tight junctions (30) as well as to directly bind actin and interact with the actin cytoskeleton (31 ). AnXA2 is also known to bind insulin receptors, caveolin 1, tissue plasminogen activator, tenascin C and angiostatin (25).

Annexin A4 (AnXA4) is a 321 an1ino acid, 35 kDa intracellular, cytosolic protein. AnXA4 has been demonstrated to regulate vesicle aggregation and trafficking in a Ca2+dependent and phospholipid binding dependent manner. AnXA4 beco1nes inactivated when phosphorylated by protein kinase C (32). In the cytoplasm, soluble, monomeric AnXA4

interacts with other AnXA4 mono1ners to form a trhner that binds to the inner leaflet of the cell metnbrane (33). Upon extracellular stin1ulation, AnXA4 is translocated from the cytosol to the plasma 111embrane. AnXA4 is known to inhibit Ca2+-activated regulation of the chloride ion

5

efflux (32) (34 ). In a study by Diakonova et a! (1997), AnXA4 levels were detnonstrated to increase during the maturation of phagoson1es in J774 macrophages, suggesting a role for AnXA4 in phagocytosis (20). AnXA4 is also known to interact with glycoprotein 2 and lectins (25).

Annexin A5 (AnXA5) is a 320 amino acid, 36 kDa intracellular protein. AnXA5 binds and stabilizes the plasma membrane by binding to the tnembrane n1ore tightly as a result of elevations of Ca2+ levels (35) and is involved in tnembrane aggregation. Binding of the Nterminus of AnXAl to the core of An..t'CA5 stimulates the activation of AnXA5 (36) and this results in an interaction between repeat 1/IV and II/III in AnXA5. .Activated AnXA5 is translocated to the cortical membrane cytoskeleton where it interacts with the plasma membrane and y-actin (37). Ca2+ activity of AnXA5 is inhibited by benzothiazepine K201, which suppresses the joining of the two lobes forn1ed by AnXA5 repeat I/IV and II/III (38). Conserved arginine, serine and threonine residues and unique tryptophan are proven to be crucial for AnXA5 activities (39). AnXA5 inhibits protein kinase C activity, whereas most annexins are phosphorylated by protein kinase C (40). AnXA5 has also been shown to interact with vascular endothelial growth factor receptor 2, collagen type 2, integrin B5, helicase, DNA (cytosine-5-)methyltransferase 1 and n1odulator of immune recognition (25).

Almexin A6 (AnXA6) is a 673 amino acid, 67 kDa intracellular protein and is so far the only n1ember of the annexin family .with eight, rather than four, annexin repeats. Like many annexins, AnXA6 protnotes aggregation of membrane vesicles in a Ca2+-dependent manner. Because of the longer and
Inore

flexible double annexin core of AnXA6, it contains a second

6

for Ca2 + -dependent phospholipid binding for metnbrane interactions (41) such as
...... ,...,..,. ., . . . . T

of clathrin coated vesicles. AnXA6 interacts with cysteine proteases during the final

stages of vesicle budding, resulting in separation of the vesicle from the spectrin membrane Con1plex formation of AnXA6 with its substrates S 1OOA 1 and S 1OOB result in the of S 1OOA 1 and S 1OOB. S 1OOA 1 and S l OOB are known to inhibit the assemblage of intennediate filaments composed of glial fibrillary acidic protein and desmin (43). AnX.A6 is also known to fonn a complex with metnbranes and the actin cytoskeleton (44) and is involved in the regulation of low density lipoprotein (LDL) receptor-mediated endocytosis and degradation of LDL (45). Activation of the Ras signaling pathway is initiated by AnXA6 which promotes accumulation of GTPase-activating protein p 120Gi\P and protein kinase C to the cell membrane (46).

Remodeling of the actin cytoskeleton plays an in1portant role in phagocytosis. Rearrangement of the actin cytoskeleton is tightly regulated by a large variety of different proteins and is not completely understood yet (11 ). Before cmnplex protein-protein interactions that are involved during Fc-receptor n1ediated phagocytosis can be exan1ined, the basic and fundamental interactions between actin and actin binding proteins need to be understood first. Therefore, six proteins (HSl and Annexin Al, A2, A4, A5 and A6) that are known to interact with actin were selected for further characterization and localization of these proteins during Fc-receptor mediated phagocytosis.

Figure 4 shows the flow chart of the experiments that were conducted. RAW 264.7 n1acrophages were grown in Aiv1EM cotnplemented with 5% PBS and were exposed to

7

opsonized latex beads to activate the Fc-receptor. Isolated Fc-receptor complexes were used for SDS-PAGE and Western blotting as well as for Mass spectrometry. For another
experiment~

RAW cells were lysed using a French press or by freeze/thaw cycles. Lysates were used for affinity chromatography and collected elution fractions were subjected to Mass spectrometry. Mass spectron1etry results were used to generate protein-actin or protein-protein interaction models using I-Hop. RAW cells were also cultured on glass microscope slide cover slips and incubated with latex beads or sheep red blood cells to activate the Fc-receptor, fixed and stained with specific antibodies and imaged by using a laser confocal n1icroscope. Live cells expressing fluorescent proteins were also incubated with latex beads or sheep red blood cells to activate the Fc-receptor and the accumulation of Actin, HSl and AnXAs at the nascent Fcreceptor complex were imaged using a laser confocal microscope.

8

Figure 4. Flow chart of the conducted experiments.
1, RA \V cells are exposed to opsonized particles to stimulate phagocytosis. Once Fc-receptor complexes were formed, the Fc-receptor complexes were isolated and subjected to SDS-PAGE and \Vestem blot or Mass spectrometry. 2, RAW cells were lysed and used for affinity chromatography experiments. Proteins that were eluted from the columns were analyzed by SDS-PAGE and Western blot or Mass spectrometry. Mass spectrometry results were compared to the literature in order to generate a protein-protein interaction model.

9

HYPOTHESIS
The hypothesis of this thesis is that actin and actin binding proteins patiicipate in the formation of the Fc-receptor con1plex prior to internalization. Actin and actin binding proteins are predicted to accun1ulate at the site of the nascent Fc-receptor complex by LC-MS/MS and confocal microscopy.

OBJECTIVES
Show the presence of actin binding proteins at the Fc-receptor complex by LC-MS/MS Exan1ine the interaction with actin in vitro Confirm the presence and localization of these proteins to the Fc-receptor by immuno staining and GFP

This document repotis the presence of actin binding proteins at the Fc-receptor con1plex by LC-MS/MS and the interactions of actin in vitro. hnmuno stain and GFP fusion proteins was used to confirm the presence and localization of actin binding proteins to the Fcreceptor. A method to analyze protein-protein interactions in buffers directly compatible vvith mass spectrometry was used.

Standard biochetnical techniques were used to approach the objectives. The novel LARC method was used to isolate the captured Fc-receptor complex prior to LC-MS/MS and Western blot analysis. Standard and novel approaches were used for the protein-protein interactions in vitro using standard buffers (containing detergents) and novel buffers (without

10

detergents) as loading and elution buffers for the affinity chron1atography colutnns. The
'""111"1"\0!;:!P

of the novel approach was to develop a method for purifying proteins over an affinity

chrmnatography column with mass spectro1netry compatible buffers.

11

MATERIALS AND METHODS
Cell culture RAW 264.7 cells derived from mice were obtained from ATTC and grown in Alpha Modification of Eagle's Medium lx (AMEM Multicell, Wisent Bioproducts, St-Bruno, Quebec, Canada) supplemented with 5% Fetal Bovine Serum in an incubator at 7% C02 at 37°C.

Antibodies Monoclonal mouse anti-B-actin antibodies were purchased from Ambion (Austin, TX, USA). Monoclonal mouse anti-HS1 antibodies were obtained from Stressgen (Michigan, USA). Polyclonal goat anti-Annexin Al antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal mouse anti-Annexin A2 and n1onoclonal mouse anti Annexin A6 antibodies were purchased from BD Biosciences Pharmingen (Franklin Lakes, NJ, USA). Polyclonal rabbit anti-Annexin A4 and polyclonal rabbit anti-Annexin AS were obtained fron1 Abeam (Cambridge, MA, USA).

DNA constructs A plasmid encoding B-actin-GFP "Yvas a gift from Dr B. Wehrle-Haller (Centre Medical Universitaire, Geneva, Switzerland). A plasmid encoding HS 1-GFP was provided by Xi Zhan (Dept. of Pathology, Baltimore, MD, USA). A plasmid encoding Annexin Al-GFP was a gift fron1 Dr. lJ. Rescher (Center for Molecular Biology of Inflamtnation, Institute for Medical Biochemistry, Munster, Germany). A plasn1id encoding Annexin A2-GFP was provided by Dr. S.M. Nielsen-Preiss (Univesity of Colorado Health Sciences Center, Departn1ent of

12

JrtJ10t,ae~mcs,

Denver, CO, USA). A plasmid encoding Annexin A4-GFP was a gift from Dr.

·············· I1U_

'Nan:n~~r

(Klinikum der Ernst-Moritz-Arndt-Universitat, Institut fur Medizinische Biochemie

und ·fur Molekularbiologie, Greifswald, Germany). A plasmid encoding Atmexin A5-GFP was provided by Dr. C. Broaddus (University of California, San Francisco, CA, USA). Plasmids
<. \lenc:oatng

Atmexin A6-1-GFP and Annexin A6-2 were a gift from Dr. J. Bandorowicz-Pikula of Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of

'""''""oril"'t,.""1"rt

Sciences, \Varsaw, Poland).

Antibody staining with specific primary antibodies and Cy3 labeled secondary antibody was perfonned on fixed RAW 364.7 macrophages in order to detern1ine the localization of HSl and the annexins. Images were obtained using a 510 zeta laser .confocal microscope with a543 nm HeiNe laser (Zeiss). Prior to fixation, cells were incubated with sRBC or tnicro beads to induce phagocytosis. Antibody staining continued the localization of the proteins of
1 ""~-'"',.""''C'T

during Fc-receptor n1ediated phagocytosis. RAW 264.7 cells were grown on glass

slips (Fisher Scientific, Pittsburgh, PA, USA) in a 6 well plate (BD Biosciences Pharmingen, Franklin Lakes, NJ, USA) for 48 hours in AMEM with
5~o

FBS. Cells were then

. . . . ,.............. . _, ..._ ....,.,.. with sheep red blood cells (sRBC) (MP Biomedicals, LLC, Solon, OH,.USA) coated rabbit anti-sRBC antibodies (ICN Biomedicals Inc, Aurora, OH, USA) for cell staining \vith primary antibody derived fron1 mouse or goat, or with latex beads (2f.!m, Bangs Laboratories Inc, Fisher, IN, USA) opsonized with human innnunoglobulin G (higG) were used for cell staining (3) with primary antibodies derived from rabbit 50 f.!l sRBC plus 5 f.!l rabbit anti-sRBC was resuspended inl50 f.!l PBS (Bioshop, Burlington, ON, Canada) and

13

incubated at37°C for 30 minutes. 5 }.!I latex beads with 4

~tl

hlgG were suspended in PBS and

incubated at rootn tetnperature for 10 n1inutes. Cells were incubated with 30 J!l of the sRBC suspension or latex beads at 37°C for 5 and 7.5 minutes to induce phagocytosis. After incubation \Vith sRBC or latex beads, the 6 well plate was placed on ·ice and cells were fixed with 4% paraformaldehyde (Canernco, St. Laurent, Quebec, Canada) for 2 hours at room temperature. Cover slips were washed twice \Vith 5% glycine in PBS (Bioshop, Burlington, ON, Canada) for 10 1ninutes prior to permeabilizing and blocking with 5% skim tnilk and 1% donkey serun1 in PBS-0.1% Triton Xl 00 (Bioshop, Burlington, ON, Canada) at room temperature for 1 hour with constant gentle agitation. Cells were incubated vvith the pri1nary antibody (1 in 25 dilution in PBS-0.1% Triton Xl 00) at roon1 tetnperature for 1 hour. Cover slips
\~Vere

washed 3 times for 10 minutes each with 2 ml PBS-0.1% Triton Xl 00 per well at

room temperature with constant gentle agitation. Cells were incubated with 2 ml secondary Cy3-labeled antibody (1 in 20.000 dilution in PBS-0.1% Triton X1 00) (Jackson

ImtnunoResearch Laboratories Inc, Hornby, ON, Canada) per well in the dark at room temperature for 1 hour with constant gentle agitation. Cover slips were washed 3 times for 10 minutes each with PBS at room temperature in the dark with constant gentle agitation prior to 1nounting the cover slips on n1icroscope slides (Fisher Scientific, Pittsburgh, PA, USA) using Dako Cyton1ation Fluorescent Mounting Medium (Dako North Atnerica Inc, Carpinteria, CA, USA). Slides were dried at room temperature in the dark for 24 hours and stored at -20°C. Images were recorded using a 510 zeta laser confocal microscope with a HeiNe 543 nm laser (Zeiss).

14

Competent bacterial cells were prepared according to the following procedure. A
~.-.,.. ....-,.,.tip

was dipped into an E. coli DH5a stock and resuspended into 5 tnl of sterile Difco

broth (Becton, Dickinson and Cmnpany, Sparks, MD, USA) and incubated over night at 3 7°C at 300 rptn. A streak plate (Difco LB broth with agar (Becton, Dickinson and
' "' · · ····· · ·· · · ·· · · ·· ,·· · ~-o·J_rJ.p.a'~dy Sparks, MD, USA)) was n1ade from the 0/N culture and incubated (0/N) at 37°C. A

single colony was inoculated into 5 tnl LB broth and incubated for 2 hours at 3 7°C at 300 rpm
. ,. '"""".H ....

the cell suspension had reached an Optical Density of 0.3 (OD 550 0.3). 100 ml pre-

···· · ·· ··· i·' '"'1'"'1"nf'·rl LB broth was inoculated and incubated for 2-3 hours at 37°C at 300 rpm until the cell

.suspension had reached an ODsso 0.45. The cell suspension was chilled on ice and centrifuged for 5 minutes at 4°C at 3500 rpn1 or 6000g. The pellet was resuspended in 40 n1l (2/5 of the
.., .... ,.....u ........ A

volume) Tfbl buffer (30 mM potassium acetate, 10 mM CaCh.2H20, 100 mM RbCh,

50 mM MnCh.4H 20, add glycerol to 15% (v/v) in H20 , adjust pH to pH 5.8 with 10% acetic acid) and left on ice for 5 minutes. The cell suspension was centrifuged for 5 minutes at 4°C at
·· ···· ··· -J.J\J\1

rptn or 6000g. The pellet was resuspended in 4 ml (1/25 of the original volume) Tfbii
(1 0 mM MOPS, 75 mM CaCL2.2H20, 10 mM RbCh, 15% glycerol (v/v), adjust pH to

pH 6.5 with KOH) and left 0/N at 4°C. 10% sterile DMSO was added to the cell suspension and 200 J-Ll aliquots were stored at -80°C.

Transformation of competent DH5a with GFP constructs Competent bacterial cells were thawed on ice. 100 Jll cells were incubated with · 1 Jll DNA for 30 minutes on ice. Cells were heat shocked for 90 seconds at 42

oc and placed on ice

for 2 minutes. Cells were then suspended in 1 n1l LB broth and incubated for 1 hour at 3 7°C at

15

300 rpm. 150 J!l of the cell suspension was plated on LB plates containing no antibiotics, kanamycin (50 flg/ml) (Cellgro, Herndon, VA, USA) or an1picillin (50 J!ghnl) (VWR international, Mississauga, ON, Canada) and incubated 0/N at 37°C. A single colony was inoculated in 2 tnl pre-warmed LB broth containing the appropriate antibiotic (50 J!gl!nl) and incubated for 8 hours at 37°C at 300 rpm. 20 fll of the cell suspension was resuspended in 5 ml LB broth containing the appropriate antibiotic (50 Jlg/n1l) and incubated 0/N at 37°C at 300 rpm. 20 fll of the cell suspension was resuspended in 100 ml LB broth containing the appropriate antibiotic (50 flg/ml) and incubated for 10 hours at 37°C at 300 rpm. 850 J.Ll of the cell suspension was resuspended in 150 J.!l sterile ·glycerol and stored at -80°C. The rest of the cell suspension was centrifuged for 15 n1inutes at 4°C at 6000g. MaxiPrep kits (Qiagen, Mississauga, ON, Canada) were used to isolate the DNA. DNA concentrations were determined with a DNA spectrometer (VWR international, Mississauga, ON, Canada).

GFP transfections Expression of GFP fusion proteins in live cells was also imaged using a 510 zeta laser confocal microscope with a 543 n:m HeiNe laser (Zeiss). Transfected cells were incubated with sRBC or opsonized micro beads to induce phagocytosis and localization of the proteins vvas n1onitored.

RAW 264.7 cells were grovvn on glass cover slips in a 6 well plate for 36 hours in AMEM ·with 5% FBS. 3 Jll Fugene6 HD Transfection Reagent (Roche, Mississauga, ON, Canada) was mixed with 100 J.Ll AMEM and added to 1 jlg of DNA and incubated at room temperature for 6-8 hours. 100 Jll of the DNA/Fugene6/AMEM mixture was added to one well and incubated 0/N at 3 7°C. Opsonized sRBC (30
~Ll

sRBC, 150 }ll PBS, 5 Jll rabbit-anti-sRBC)

16

'\rl:1tex

beads (30 J.!l latex beads, 150 J.!l PBS, 5 fll hlgG) were added to the cells to induce and images were recorded using a 510 zeta laser confocal microscope with an Ar laser (Zeiss).

Affinity chron1atography columns were constructed and run under various conditions to
1 1 """ ··""

'7""' binding and elution. Antibodies or pure protein were linked to NHS beads and RAW

.}

h.r~~tl"'c;;!

were run through the column. Fractions were collected and analyzed using Western or by LC-MS/MS. 9% SDS-PAGE gels were prepared and used to separate proteins

hlnTTtn,n

gels were stained with either Blue Silver Stain or Silver nitrate Stain. For other experiments, the separated proteins in the gels were transferred to a Polyvinylidene Fluoride 1nembrane for Western blotting.

Elution fractions from the NHS affinity colun1ns as well as the captured Fc-receptor complexes using the novel LARC method were analyzed by LC-MS/MS. Spectra for the _ proteins of interest were collected from this data.

-Protein G/ Sepharose, Fast Flow colurnn (1) RAW 264.7 cells were grown, harvested and collected. Protease inhibitors such as 4-(2anlinoethyl)-benzene-sulfonyl fluoride hydrochloride (Sigma, St. Louis, MO, USA) and a protease inhibitor cocktail for use with mamn1alian cells and tissues (Sigtna, St. Louis, MO, were added to the cell suspension. Cells were lysed using a French press. A Protein G/ Sepharose, Fast Flow (Sigma, St. Louis, MO, USA) colun1n was made in a pipette tip with glass wool. 40
~Ll

50% slurry was used to prepare one column and left on ice for 1 hour to

17

settle. The column was washed with 1 ml RIPA buffer (10 n1M Tris-HCl pH 7.4, 15 mM potassium chloride, 1% sodiun1 deoxicholate (w/v), 1% Triton X-1 00 (v/v), 0.1% SDS (w/v) in PBS). 80 Jll Monoclonal n1ouse anti-HS 1 was diluted in PBS (1 in 4) and run through the colutnn by gravity on ice 3 times. The column was washed with 2 rnl RIP A buffer on ice. 200
~Ll

cell lysates were diluted (1 in 10) in RIPA. buffer and run through the colutnn by gravity on

ice 3 tilnes. The colunu1 was washed with 0.5 ml RIP A buffer and protein complexes were eluted off the column with 100 Jll 2% SDS. The experiment was repeated with a RIPA buffer without Triton X-100 and 0.1% SDS. All fractions that came offthe column were collected and used for Western blotting.

-N-hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow
RAW 264.7 cells were grown, harvested and collected. Protease inhibitors such as 4-(2mninoethyl)-benzene-sulfonyl fluoride hydrochloride (Sigma, St. Louis, MO, USA) and a protease inhibitor cocktail for use with mammalian cells and tissues (Sigma, St. Louis, MO, USA) were added to the cell suspension. Cells were lysed using a French press or by freeze/thaw cycles. 100 J.Ll NHS-activated Sepharose 4 Fast Flow was used to prepare one column. Preparation of the resin was performed on ice. The resin was vvashed with 5 ml H 20 and incubated with 10-15 medium volun1es (1 ml) ice cold 1 mM HCI for 15 minutes. The resin was mixed with 50 Jlg antibody or protein and incubated 0/N at 4°C. Non-specific binding sites were blocked with 0.5 I\1 ethanolamine, 0.5 M NaCl pH 8.3 at 4°C for 3 hours. The resin was washed with 300 Jll 100 mM Tris pH 8.0 followed by a wash with 300 !!1 100 mM acetate. This vvas repeated 6 times before storing the resin in 20% EtOH in PBS. The column was n1ade in a pipette tip vvith glass wool and washed v..rith 3 ml H20. 100 J.!l cell lysate

18

"'.._ .. ~-· -~-- in loading buffer ( 1 in 10) and run through the column. The column was washed ml loading buffer prior to elution with 1 M NaCl followed by 0.2% fonnic acid.
: / >> T>iU~ere:nt loading buffers such as RIPA; RIP A without Triton XlOO and SDS; 20 mM Tris pH

20 mM Tris with 0.1% sodium deoxycholate and 0.1% N-octylglucoside pH<8.0; 20 tnlVI with 0.5% sodiutn deoxycholate and 0.5% N-octylglucoside pH<8.0; 20 mM Tris with 1% deoxycholate and 1% N-octylglucoside pH<8.0 were used to optin1ize binding
, ,,. , . .--.,....... ril'r 15.... nco

All fractions that can1e off the column were collected and used for Western blotting

·<

? orJ:na:~s

spectrometry.

SDS-PAGE and Western Blotting Colun1n fractions as well as a molecular weight standards, RAW 364.7 lysates and the antibody were 1nixed with 2x Sample Buffer (10 ml 4xTris-HCl/SDS, pH 6.8, 12 ml glycerol, 4.0 g SDS, 1.55 g DTT, 10 tng Cootnassie Brilliant Blue G-250) or lOx Sample
· ··········--.-.: ·Kn"ttt"'r

(10 ml 4xTris-HCl/SDS, pH 6.8, 2.0 g sucrose, 4.0 g SDS, 1.55 g DTT, 10 mg Brilliant Blue G-250) and heated at 96°C for 5 minutes priorto1oading onto a 9% gel. 9% SDS-PAGE gels were prepared following SynX Standard Operating

...... ..JVJ.JU.U"''"'-'-""'

Procedures for Biochen1istry SOP-BM-011-GN (47) (Separating gel: 4.5 ml 30% Acryl/ 0.8% ,,, . ,. -_.,_..., ....... 4.5 ml 3 M Tris-HCl/0.3%SDS, 4.5 n1l H20, 1.5 ml glycerol, 20 J.!l TEMED, 50 J.!l 20% Stacking gel: 1.62 n1l 30% Acryl/ 0.8% bis, 3.10 n1l 3 M Tris-HC1/0.3%SDS, 7.78 ml H20, 20 J!l TEMED, 50 J.!l 20% APS). A cathode buffer was used to fill the inner c.han1her of gel apparatus and an anode buffer was used to fill the outer chan1ber. Gels were run at 30 for 30 n1inutes, then at 125 Volts until the tracking dye had reached the bottom of the gel. Gels were stained \vith Coomassie Brilliant Blue or Silver stained or used unstained for

19

Western Blotting (48). Proteins were transferred to a Polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA, USA) at 100 Volts for 1 hour. Membranes were stained with Coomassie Brilliant Blue G-250 (0.5 g /1 Cootnassie Brilliant Blue G-250, 500 1nl n1ethanol, 400 ml H20) and destained with 50% tnethanol to ensure that proteins were transferred onto the PVDF men1brane. Membranes were then completely destained vvith 100% methanol and rinsed in H20 prior to blocking with 5% skim milk and 1% goat serum in 10 ml PBS-0.1% Tween-20 at room temperature for 30 tninutes. Blots were then rinsed with 10 n1l PBS-0.1% Tween-20 and washed for 5 1ninutes with 10 n1l PBS-0.1% Tween-20 followed by another rinse with 10 ml PBS-0.1% Tween-20. Blots were incubated with the primary antibody diluted into 2 ml (1 in 1000) at room tetnperature for 30 n1inutes with constant gentle agitation. Unbound prhnary antibody was washed away with 3x5 minutes washes with 10 1nl PBS-0.1% Tween-20 prior to incubating the blot with the secondary HRP-labeled antibody (Jackson Immuno Research Laboratories Inc, Hornby, ON, Canada) diluted into 5 ml (1 in 10.000) at room tetnperature for 30 minutes with constant gentle agitation. After washing the blots with 3x5 tninute withlO ml PBS-0.1% Tween-20 at room tetnperature with constant gentle agitation, blots were incubated with 10 ml Enhanced Chetnilun1inescence (ECL) solution HI for 1 minute at room temperature vvith constant gentle agitation. ECL solution l (9 ml H20, 1 n1ll M Tris-HCI pH 8.8, 4.5
~~

p-coutnaric acid (0.015 gin 1 ml DMSO), 100 f.!lluminol (0.04

g in DMSO)) and ECL solution H (9 ml H20, 1 ml 1 M Tris-HCl pH 8.8, 6 J.!l H20 2) were tnixed in a 1: 1 ratio to prepare solution III. Blots were then wrapped in Saran Wrap and an autoradiography film (Denville, Metuchen, NY, USA) was exposed to the blot in a dark rootn for 1 minute. The autoradiography film was developed using GBX developer and replenisher

20

(~~odaK,

Rochester, NY, USA), rinsed with \Vater and fixed using GBX fixer and replenisher Rochester, NY, USA).

·

(f~odlak,

9% SDS-PAGE gels were run and stained with Blue Silver Stain (0.12% Coon1assie
/ < <i) Etrtlllatlt
··< <><< 1notlf

Blue G-250, 10% an1monium sulphate, 10% phosphoric acid, 20% methanol) for 1

at room tetnperature with constant gentle agitation to visualize the seperated protein Gels were destained with 5% methanol, 7% acetic acid 0/N at roon1 ten1perature with

··· ···················

"'"'~""ct·.;:;n-t

gentle agitation (49).

9% SDS-PAGE gels were run and soaked in 100 ml 7% acetic acid at room tetnperature 7 minutes with constant gentle agitation. Prior to incubating the gels at room te1nperature in 100 ml50% methanol, gels were washed in 100 ml50% n1ethanol at room temperature
· · · ><> tc·w 10 minutes with constant gentle agitation. Gels were rinsed twice in 100 n1l H2 0 at room

for 10 tninutes with constant gentle agitation followed by soaking the gels i.n solution (Solution A: 0.8 g siver nitrate (VWR, West Chester, PA, USA) was
ccn.a" 7 ""..,

in 4 ml H20 and added drop wise to Solution B: 21 n1l H20, 250 f.ll 30% NaOH Burlington, ON, Canada), 1.4 ml 14.8 M ammonium hydroxide (Caledon, ON, Canada). 76 ml H20 was added to the solution) at roo1n tetnperature for 15

~U.AAA~

...,....,

with constant gentle agitation. Gels were rinsed twice in 100 n1l H20 at room

temperature for 5 minutes with constant gentle agitation prior to rinsing the gels in the developing solution (200 tnl H20, 1% citric acid, 100 J!l 27% formaldehyde (Sigma, St Louis,

21

MO, USA)) for 2-15 tninutes with constant gentle agitation until bands are visible. The developn1ent reaction was stopped by rinsing the gels 3 times in 5%
methanol~

7% acetic acid

in H20.

Capturing of the Fc-receptor complex (LARC) The Fc-receptor's cognate ligand IgG was bound to the surface of tnicro beads. RAW 264.7tnacrophages were incubated with the opsonized beads to activate the Fc-receptor on the surface of the n1acrophages. Assembled receptor complexes were isolated using the novel Live-cell Affinity Receptor Chron1atography (LARC) approach (61) and analyzed by LC-MS/MS and Western blotting.

RAW 264.7 macrophages vvere grown and incubated with polystyrene coated with IgG beads (3)on ice for 30 n1inutes to activate the Fc-receptor and formation of the Fc-receptor con1plex. Free beads were washed away 3 times with ice cold mediutn. Cells were warmed to 37°C to con1pletely activate the Fc-receptor prior to scraping the cells with ice cold medium. A French press was used to disrupt the cells and Fc-receptor complexes attached to the micro beads were isolated through a sucrose gradient.

Liquid Chromatography Mass Spectrometry (LC-MS/MS) Elution fractions from the NHS affinity columns as well as the captured Fc-receptor complexes using the novel LARC method were analyzed by LC-MS/MS. Spectra for the proteins of interest were collected from this data.

22

~d

of each elution fraction from the affinity chrmnatography columns was digested

0.5 mg/n1l trypsin in 1% acetic acid (Calbiochem, Gibbstown, NY, USA) in 10 J.tl xdtgesncm buffer (50% Acetonitrile (Caledon, Georgetown, ON, Canada), 2M UREA, 1 M
i""fl'-_,1
IJJ.l

8.8), 18

~d

10M UREA 0/N at 37 °C. 1 n1M DTT and 1 J!l trypsin was added the

H<Jtay au.u

the sample was incubated for 3 hours at 37 °C. The sample was acidified with 5%

.......... ~,~~~~- - acid to pH 3-4. A Cts resin (Millipore, Billerica, MA, USA) was wetted with 65% aJcet,omtrH containing 0.2% fonnic acid and then equilibrated with 5% acetonitrile with 0.2%
>torrn1c

acid. Polypeptides were collected and the resin was washed with 0.2% formic acid prior with acetonitrile in 0.2% formic acid. Peptides were analyzed over a 90 minute

i to

eHUliOn

· · ·· · · i
i

< < ~~ra,Jient

from 5% to 65% acetonitrile at a How rate of 2 ,.._1 per minute with a an Agilent 1100

iJ

s~~ries capillary pmnp via a metal needle to forn1 an electrospray into a Deca XP-1 00 ion trap
(JUj.

~· · · · · · · · · ·

The MS/MS data files fron1 the LC-ESI-ion trap runs were searched against a non-

····· . . . . ······.,. ., . . . . . . . . . . . . .,, . . ~ library of proteins, cDNAs, EST and genon1ic DNA using SEQUEST. A cut off of 1o-3 was applied to obtain results with expectation values of 0.0001 (E-4) or less. The
.< ·······················

nf~nn· des

found in the control colun1ns were removed fron1 the list of proteins found in the

, ............. ,.....,".... body or protein columns.

The 1nanufacturer's softVv'are with the manufacturer's recomn1ended settings and conditions were used and resulted in the peptide spectra (50) (51) and described in Jankowski

et al. (61) using SEQUEST and BIOWORKS (Thermo Electron Corporation) to identify the

23

Generation of protein-protein interaction model using iHOP Proteins observed in the LC-MS/MS results of the NHS-control column were omitted fron1 the LC-MS/MSresults of the NHS-proteinlantibody affinity colwnns. The LC-MS/MS results fr01n the NI-lS affinity colutnns vvere compared to the literature and a protein-protein interaction n1odel generated using iHOP. Protein-protein interactions fron1 the literature were combined in iHOP to generate a protein-protein interaction model (60).

24

Figure 1 shows a proposed phagocytosis pathway. A large variety of proteins involved has been studied and added to the model. The Fc-receptor, located on the
"""''"~"""-'""

of n1acrophages, is activated through binding to opsonized particles. Activation of the results in the phosphorylation of the receptor and initiates a cascade of intracellular

'"'"'"'""-' "'>J'-

such as ren1odeling of the actin cytoskeleton, vesicle fusion and oxidative burst Our lab focused on protein-protein interactions but before those can be studied, the basic,
.!.U... .........

~

u._..,..............

interactions need to be understood first. Therefore, in this thesis the baseline of interactions was examined using different tnethods to support the findings. HS 1 cell specific Lyn substrate 1) and members of the annexin family have

been demonstrated to interact with actin and are here proposed to be involved in

The conserved domains of HSl and AnXAs are sho·wn in Figure 2 and 3. HSl contains 37 amino acid tanden1 repeats and a SH3-domain at the C-terminus as well as an acidic (NTA), a coiled-coil domain and a helix-tum-helix don1ain (13). AnXAs are comprised 4 annexin repeats (except AnXA6, which comprises of eight annexin repeats), each of 70
...........

.~ULI.U' acids in length. The COOH-terminus is responsible for Ca2+ and phospholipid binding

7). Annexins have a structurally unique N-terminus, variable in length, which is responsible binding, activation and phosphorylation ofannexins (18).

25

:apturing the Fc-receptor complex CLARC) Figure 5 shows a 9% gel stained with Blue Silver Stain. Lane 1 shows the molecular weight marker and lane 2 displays a specific band pattern of the proteins present in the crude extract of RAW 1nacrophages. Lane 3 represents a specific band pattern of proteins that were captured ·in the isolated Fc-receptor complex and lane 4 shows a specific band pattern of proteins in the growth media.
0..
E
0
0

~

Q.)

....
Q.)

0..
'"0

Cs
Q.)

-t:
kDa
(!j

u
0

~

u

2

¥

1.1.

250 150
100
75

50 37

Figure 5. Capturing the Fc-receptor complex. Lysates ofRA W macrophages, isolated Fc-receptor complexes and growth media were run on a 9% gel and stained with Blue Silver Stain to determine the presence of proteins in the respective soJutions. Lane l: Molecular weight marker, lane 2: crude extract ofRA W macrophages, lane 3: Fc-receptor complex, lane 4: DMEM with 10% FBS.

25 20
15 10

Figure 6 shows the results of a Western blot using specific antibodies against ~ . . Actin, AnXAl, AnXA2 and AnXA5.
~-Actin

was detected in the crude extract of RAW macrophages

as well as in the captured Fc-receptor complex. AnXAl was not observed in the crude extract of RAW macrophages or in the captured Fc-receptor complex. AnXA2 was detected by two independent anti-AnXA2 antibodies in the isolated Fc-receptor complex but not in the crude

extract from RAW macrophages. AnXA5 was observed in the both the crude extract of RAW

macrophages and in the captured Fc-receptor complex.

26

:X:
<1.)

:X:
[/)
~.)

:X:
U'l

:X:
(1)

<1.)

0.. E

o:J
0

0..
ll)

a
u
Q)

u

0

o'-

IJ;.; .. o

0.. E
0
(.)

a:!
O'

,o

~

0.. E

r/l

+ :$
t.L1

£ 0..
Q)

kDa

2 u

""0

"'-

7 u

Cl

~

2 u

""0

u u

(1)

+
UJ

0

~

0.
11) 11)

a
(.) (.)

u

0

.....
,o
o'

a:!

0..

[/)

<1.)

X

E
0
(.)

co .,_.
'0 ::!!?.
C·

0.. E
0

·[;I.,

t/"1 ~

+ ~
;:;
Q

0

0.
<1.)

a
u
<1.)

+
~ ~

0.
11)

a
u

(.)

¥

[;I.,

0

::?:

2 u

""0

¥
{:.1.,

t.L1

""0

u

2

&

¥

[.I.l

Cl

u

-g

<1.)

[;I.,

¥ u

u.l

+ ;:;
::?:
Cl

0

~

250 150 100
75

50
37

25 20 15 10

B-Actin

AtLXAl

AnXA2 BD

AnXA2
Zymed

AnXA5

Figure 6. Capturing the Fc-receptor complex. Lysates of RAW macrophages, isolated Fc-receptor complexes and growth media were run on a 9% gel and transfened to a PVDF membrane for Western blotting. Blots were probed with anti-B-Actin (lane 1-3), anti-Annexin A 1 (lane 4-6), anti-Annexin A2 (lane 7-9 for anti-Annexin A2 from BD Biosciences, lane 10-12 for anti-Annexin A2 from Zymed), and anti-Annexin A5 (lane 13-15). Lane 1, 4, 7, 10 and 13: crude extract ofRA W macrophages, lane 2, 4, 8, 11 and 14: Fc-receptor complex, lane 3, 5, 9, 12 and 15: DMEM with 10% FBS, lane 4: cmde extract ofRAW macrophages.

Mass spectrotnetry of captured Fc-receptor complexes Fc-receptor complexes were isolated under different physiological conditions, digested with trypsin and analyzed using n1ass spectrometry to determine which proteins participate in the Fc-receptor con1plex. Figure 7a shows the detection of B-Actin, HS1, AnXA1, AnXA2, AnXA4, AnXA5 and AnXA6 by LC-MS/MS analysis of purified Fc-receptor complexes. In MS/MS analysis, scores of 103 or higher 'Were considered to be significant. Appendix Table 1 shows all the different peptides and scores for Actin and many related isoforn1s, HS 1 and the annexins detected by LC-MS/MS. Figure 7a shows the spectrutn of peptide -

.KDL YANTVLSGGTTMYPGIADR.- of P-Actin with a score of 37,139.96 and a total score of 3,626,521.98. The spectrum of peptide -.SAVGHEYVADVEK.- of HS 1 with a score of

27

~,792.167

and a total score of 15,588.70 is shown in Figure 7a. AnXAl peptides were also

detected by LC/MS/MS with peptide -.GVDEATIIDIL TK.- having the highest score of 13,791.86 and a charge of +2 (Figure 7a; Appendix Table 1). Peptide -.WISIMTER.- was detected for AnXA2 (Figure 7a; Appendix Table 1) and peptide -.SETSGSFEDALLAIVK was detected for AnXA4 by LC-MS/MS.- (Figure 7a; Appendix Table 1). LC-MS/MS detected AnXA5 with peptide -.GLGTDEDSILNLL TSR.- having a score of 24,558.30 and total score of 2,008,443.14 and peptide -.GSVHDFPEFDANQDAEALYTAMK.- '>-vas detected by LCMS/MS for AnXA6 with a score of 6,334.528 and a total score of 10,383.01 (Figure 7a; Appendix Table 1).

Other known actin binding proteins that are involved in the rearrangetnent of the actin cytoskeleton such as gelsolin, profilin, Arp2/3 complex, WASp, cofilin, WAVE, LIM kinase and PAK (8) and many associated isoforms were also detected by LC-MS/MS (Figure7b) (these spectra are also found in Appendix Figure 16 and Appendix Table 1). Peptide .TFVSITPAEVGVLVGK.- with a score of 14,304.61 and a total score of charge of
232~299.98

and a -

+2

was

detected

for

profilin

(Figure

7b).

Gelsolin

peptide

.EGNPEEDITADQTNAQAAALYK.-with a score of 12,680.59 and a total score of 80,477.06 and a charge of+2 was detected for gelsolin (Figure 7b). Peptide -.ALAAGGVGSIVR.- with a score of 10,421.79 and a total score of 28,902.90 and charge of +2 was detected for Arp2/3 complex (Figure 7b). WASp peptide -.PPFPGNRGAAFGAGSARQNPSGSSSPFPR.- with

28

B-actin (aa 27-375)
-.KDLYANTVLSGGTTMYPGIADR.-

HSI

-.SAVGHEY VAD VEK.-

AnXAl

-.GV DEA TllD ILTK .-

~ ,,
~:

:~
~j

roJ

~

,-.;,:;

1 3

L f·: ':'~Tii~ ~l~~j-:!Jn~J~~u.~il .,tli .J': .+;.)." .~~.:L"""'··'"''I-L.:~~~~,
.
-.DLVDDLKSEL TG KFE K-

~

AnXA2

WISIMTER

AnXA4

SETSGS FEDALLAIVK

AnXA5

AnXA6

GSVHDFPEFDANQDAEAL YTAMK

Figure 7a. Spectra of actin, HS 1 and annexins observed in the captured Fc-receptor complex by LC-MS/MS.

a score of 1,396.371 and a total score of 3,755.01 and charge of +2 was detected (Figure 7b). Peptide -.HELQANCYEEVK.- with a score of 19,696.62 and a total score of 34,282.87 and a charge of +2 was detected for cofilin (Figure 7b). Peptide -.YAEDIFGELFNEAHSFSFR.with a score of 1,396.371 and a total score of 3,755.01 and a charge of +3 vvas detected for WAVE (Figure 7). Peptide -.KRYTVVGNPYWMAPEMINGR.- with a score of691.0541 and a total score of 1,433.95 and a charge of +3 was detected for LIM kinase (Figure 7b). PAK peptide -.IGQGASGTVYTAMDVATGQEVAIKQMNLQQQPK.- with a score of 396.4179 and a charge of +2 vvas detected (Figure 7b).

29

Actin

Gel sol in
· SQH VQV EEGSEPDA F\\'F.AJ..G GK-

Pr ofilin

Arp2!3 com Ji ex

LIM kinase

Cofilin

PAK

WAVE

Figure 7b. Spectra of actin binding proteins observed in the captured Fc-receptor complex. Proteins that are involved in the rearrangement of the actin cytoskeleton such as gelsolin, profilin, Arp2/3 complex, WASp, cofil in, WAVE, LIM kinase and PAK were detected in the captured F c-receptor complex by
LS~MS/MS.

30

Affinity Chrmnatography
-Protein Gl Sepharose, Fast Flow column

Protein G columns were run to optimize binding and elution conditions. Anti-HSl antibodies were linked to Protein G beads and RAW lysates were run over the affinity colwnns. The colmnn was \Vashed with PBS and eluted with 0.1% Na-Deoxycholate and 0.1% N-Octyl Glucoside prior to elution with 2% SDS. Figure 8 shows a Western blot of the elution fractions of the Protein G-HS 1 column versus a control column (NHS beads alone). Other controls included the HS 1 antibody alone, represented in lane 3. The blot shows the presence of HS 1 in the crude sample (lane 1) and in the Flow Through of the control colun1n (lane 3). HSl was observed in the Flow Through of the NHS-anti-HSl column (lane 6) as well as the control column (lane 7). HS 1 \Vas eluted from the NHS-anti-HS 1 column with 0.1% NaDeoxycholate and 0.1% N-Octyl Glucoside (lane 10) but not in the control column (lane 11 ). More HS1 eluted from the NHS-anti-HSl column with 2% SDS (lane 12) but no HS1 was detected for the control column (lane 13). The same experin1ent was performed with a RIP A buffer without Triton X-100 and 0.1%
SDS~

results are shown in Figure 9. Buffers without detergents were used to create mass

spectrometry friendly conditions so that the elutions from the affinity chromatography could be directly prepared for the n1ass spectrometer.

-N-hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow

NHS columns were prepared with 7 different columns: NHS-Actin, NHS-anti-Actin, NHS-anti-HSl, NHS-anti-AnXAl, NHS-anti-AnXA2, NHS-anti-AnXA4, NHS-anti-AnXA5

31

and a control colutnn ·with no antibodies linked to NHS beads. A NHS-Actin column was used to optimize the binding conditions \Vith different loading buffers such

0 .]::l r:: 0 0
11)

~ 0
C\:l
!

:;;...
0
I

u

~

"'0

Q)

./::J

"'d

u
.£: 0
OJ)

0

~

z ....._
q
:e ......
r::
ttl

;::I

0

0
..c: 00
~
C\:l

~

./::J

'""' .s

Ei:
kDa

0

~

en ::I:

...c: U'l
~
e\3

u

0

~

0

u

....._

z
u
!Zl

0 .1::l c::
u
0

>. ......
r:: .9 ......
0

Cl

lZJ

Cf)

Cl

·.g
f.i3

r:: 0

lZJ

..a ~

.9

..a ~

- ri3 09
:::l

c:::

r::

250 ---150

100

1s
50-.-37
25

!JU{.

20
15 10

Figure 8. Western blot analysis of a protein G-HSl Affinity chromatography in the presence ofNa-Deoxycholate and N-Octyl Glucoside. Protein G-HSI Affinity chromatography fractions were run on a 9% gel and transferred to a PVDF membrane or Western blotting. The blot was probed with anti-HS 1. Lane 1: crude extract of RAW macrophages, Jane 2: Flow through control column, lane 3: anti-HSl antibody, lane 4: Protein G-HSl column wash, lane 5: Control column wash, lane 6: Protein G-HSl column flow through, lane 7: Control column (beads alone) flow through, lane 8: Protein G-HSl column wash, lane 9: Control column (beads alone) wash, lane 10: Protein G-HS 1 column elution with Na-Deoxycholate and N-Octyl Glucoside, lane 11: control column elution with Na-Deoxycholate and N-Octyl Glucoside, lane 12: Protein G-HSl column elution with SDS, lane 13: control column elution with SDS.

as 20 n1M Tris pH 8.0 (Appendix Figure 1); 20 mM Tris with 0.1% sodium deoxycholate and 0.1% N-octylglucoside pH<8.0 (Appendix Figure 2); 20 mM Tris with 0.5% sodium deoxycholate and 0.5% N-octylglucoside pH<8.0 (Appendix Figure 3); 20 mM Tris 'With 1%

32

sodium deoxycholate and 1% N-octylglucoside pH<8.0 (Appendix Figure 4). Proteins were eluted with lM NaCl and any ren1aining proteins were eluted with 0.2% Formic Acid.

0
0

.b
:::::.:

u

0

.!:::1
!:::::

0 t:
~
(.)

0 0 "'0

~
I

0
0

>-. ><
B

"'0

u
~

0

0

bl)

;:I

0
"'0
0

.£i
r.I:
0

·;:
CI'J

;>.. "'0 0 ..0

0 :.....
0
0

u

2

~

kDa

:t

us

=

:::
Cl:l

...c:
:;...

O[J

..c.:
~

(Jl

..s.:: (Jl

.s
iS: ..9
IJ;.,.,

0

;::s

~ ;::s
0

0
~
(Jl

t:
0
0
~

.;:;
iS: ..9
[:.I..

:;...

>. ~
u """

~
0
~

0
U')

..!::
0
~

'">,

u

0

c(j

..s.:: (Jl

C\l

:s

f$
·.

f$
.

tl:l

.9 ..... ;:I
~
....

= ·.g
0

0

0

V1

U')

Q

::: 0 ·.;:; ~
:::::1

V1

c

iil

]

0

j;JJ
.

'

250
150
..

100
75

50
.

I
··

37 25

..

20
15
10
..,
.....
. .

..
. .

Figure 9. Western blot analysis of a protein G-HSl affinity column using RIPA without SDS or Triton X -100. Protein G-HS 1. Affinity chromatography fractions were run on a 9% gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-HS 1. Lane 1: crude extract of RAW macrophages, lane 2: Flow through control column, lane 3: anti-HSl antibody, lane 4: Protein G-HSI column wash, lane 5: Control column wash, lane 6: Protein G-HS1 column flow through, lane 7: Control column (beads alone) flow through, lane 8: Protein G-HSl column wash, lane 9: Control column (beads alone) wash, Jane 10: Protein G-HS 1 column elution with Na-Deoxycholate and N-Octyl Glucoside, Jane 11: control column elution with Na-Deoxycholate and N-Octyl Glucoside, lane 12: Protein G-HS l column elution with SDS, lane 13: control column elution with SDS.

33

Figure 10 shows the results of a Western blot of all the collected fractions from a NHSActin column using 20 mM Tris pH 8.0 as loading buffer as well as a control column (NHS beads alone). Western blot was performed using a monoclonal anti-Actin antibody. Actin was observed in the crude sample (lane 1). Lane 2 displays another control, the anti-Actin antibody alone. Furthern1ore, actin was present in the Flow Throughs of the NHS-Actin colunm (lane 3) as well as in the Flow Through of the control colun1n (lane 4). Actin was also detected in the

e CE
.£:;

'"0 0

:>.

(.)

0

~
::::1

..c;
bf)

~ z
0 .!= s::

·~
(.)

2 u

'"0

·.;:::
u

s::

;S
~
0

e
~

.s
~
0

::::1 0

~

<C

-;; ro

..s::

0 u

cs:

cs:

~

rlJ

·.8
s::

~

u u 2! z ~
(.)

~
0

]
~

u u zu
(.)
(.)

s::
0

~ 0
~

2

c:
(.)

0

~
s::

N

z ;;E

;;E
c
0

.9

.9

s::

...,
-~

~

z

<
~
N 0
~

<
,o
~

m

"'ei

]

~

§ " § 5.3

.9

s::

"'' <"'l
6 s::
0

Ell

1ii

!5

c .9

1ii

!5

]

u:J

kDa
250_
150 100 75

37 25

20

10
Figure 10. Western blot analysis of a NHS-anti-Actin affinity chromatography column. 50 11g anti-Actin was bound to 100 J.Il NHS resin, 20 mM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-Actin. Lane 1: crude extract ofRAW macrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 100 ~1 RAW cell lysate in 1 ml binding buffer of anti-Actin column, lane 4: Flow trough of 100 ~tl RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 5: anti-Actin column wash~ lane 6: control column wash, lane 7: elution 1 of anti-Actin column with I 00 J.!l 1 M NaCl, Jane 8: elution 1 of control column with 100 J.tll M NaCJ, lane 9: elution 2 of anti-Actin column with 100 J.!ll M NaCl, lane 10: elution 2 of control column with 100 ~tl 1 M NaCl, lane 11: elution 3 of anti-Actin column with 100 J.!l 1 M NaCI, \lane 12: elution 3 of control column with 100 ~11 M NaCJ, lane 13: elution of anti-HS 1 column with 500 ~ll 0.2% FA, lane 14: elution of control column with 500 J!l 0.2% FA.

washes of the NHS-Actin colutnn (lane 5) and the control column (lane 6) with 20 mM Tris pH 8.0. Actin eluted fron1 the NHS-Actin column with l M NaCl (lane 7) and the control colun111 (lane

34

8) as well as with 0.2% FA from the NHS-Actin colun1n with 1 M NaCl (lane 9) and the control column (lane 10). In another experiment, NHS beads were activated and non-specific binding sites were blocked according to n1anufacturer's instructions. To optimize the binding conditions, RAW lysates were diluted 1 in 10 in different loading buffers and run through columns with no antibodies linked to the NHS beads. Flow Throughs were collected and run on a 9% SDSPAGE gel and the gel was stained with Blue Silver Stain. Results are shown in Appendix Figure 5. Proteins that did not bind to the beads when using 20 m_M Tris pH 8.0 as binding buffer are shown in lane 3. The proteins in the Flow Tluough of a column where 20 mM Tris, 0.1% N-octyl glucoside pH 8.0 \Vas used as binding buffer are seen in lane 4. Proteins that did not bind to the beads when using 20 tnM Tris, 0.5% N-octyl glucoside pH 8.0 as binding buffer are represented in lane 5. Lane 6 reveals the presence of proteins that flowed through the column where 20 mM Tris, 1% N-octyl glucoside pH 8.0 was used as binding buffer. Proteins that did not bind to the beads vvhen using 20 mM Tris, 0.1% Na-deoxycholate pH 8.0 as binding buffer is shown in lane 7. The proteins in the Flow Through of a column where 20 mM Tris, 0.5% Na-deoxycholate pH 8.0 \Vas used as binding buffer are represented in lane 8. Lane 9 reveals the presence of proteins that flowed through the column where 20 mM Tris, 1% Nadeoxycholate p~I 8.0 was used as binding buffer. Proteins that did not bind to the beads when using 20 mM Tris, 0.1% N-octyl glucoside, 0.1% Na-deoxycholate pH 8.0 as binding buffer are shown in lane 10. The proteins in the Flow Through of a column where 20 mM Tris, 0.5% N-octyl glucoside, 0.5% Na. .deoxycholate pH 8.0 was used as binding buffer are observed in lane 11 and lane 12 reveals the presence of proteins that flovved through the column where 20 mM Tris, 1% N-octyl glucoside, 1% Na-deoxycholate pH 8.0 was used as binding buffer. 20

35

mM Tris, 40rnM NaCl p. H 8.0 vvas also used as binding buffer and the proteins that flowed through the column are observed in lane 13.

Appendix Figure 6 shows a Blue silver stained gel of the elutions of a NHS-anti-actin colmnn. Anti-actin vvas bound to 25
~~

NHS resin and washed 5 times with 100 J.!l 20 tnM Tris

pH 8.0 and incubated with 50 f.!l RAW cell lysate in 1 ml binding buffer for 1 hom·. Actin was eluted off the colunm in different fractions with anti-Actin, 1M NaCl and FA. Proteins present in the crude extract ofRA W macrophages are represented in lane 2. The anti-Actin antibody was run on the gel to serve as an additional control. RAW lysates were run through the colun1n and the column vvas washed with 20 mM Tris pH 8.0. Proteins were eluted from the NI-lS-antiactin column with the anti-actin antibody (lane 4). Proteins re1naining on the column were eluted with 5 fractions of 100 J.!l 1M NaCl (lane 5-9) and lane 10 shows the elution of proteins from the control colmnn (beads alone) with 500 J.tl 1M NaCL Remaining proteins were eluted from the column using 500 Ill 0.2% FA for the NI-lS-anti-Actin colunm (lane ll) and the control colunm (lane 12).

Appendix Figure 7 shows a SDS-PAGE gel of the optimization of the binding and elution conditions of a NHS-anti-Actin affinity column versus a control column stained with Silver nitrate. Anti-Actin was bound to 25 J.Ll NHS resin washed 5 times with l 00 11120 mM Tris pH 8.0 and incubated with 50 J.!l RAW cell lysate in 1 ml binding buffer for 1 hour. Lane 2 shows the presence of different proteins present in the crude extract of RAW macrophages. The anti-Actin antibody was n1n on a gel to serve as an additional control (lane 3). Proteins that did not bind to the NHS-anti-Actin affinity colunu1 (lane 4) or the control column (lane 5)

36

ran through the column. The NHS-anti-Actin affinity column (lane 6) and the control column (lane 7) were washed \Vith the 20 tnM Tris pH 8.0 prior to eluting the proteins from the NHSanti-Actin affinity column (lane 8) and the control colmnn (lane 9) 500 Jtl1M NaCl. Remaining proteins were eluted fron1 the NHS-anti-Actin affinity colun1n (lane 10) and the control column (lane 11) with 500
~~

0.2% FA.

Appendix Figure 8 shows a Western blot of a NHS-anti-HS 1 affinity chron1atography column, blotted with anti-Actin. 50
~g

anti-HS 1 was bound to 100 J.tl NHS resin and 20 n1M

Iris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9~b SDS-PAGE gel and transferred to a PVDF n1embrane for Westen1 blotting. Lane 1 shows the presence of actin in the crude extract of RAW macrophages and the anti-HS 1 antibody {lane 2) and anti .. Actin antibody (lane 3) were run on the gel as additional controls. 100
~~

RAW cell lysate in 1

ml binding buffer was n1n through the NHS-anti-HS1 column (lane 4) and the control column (lane 5) prior to washing the NHS-anti-HS 1 column (lane 6) and the control column (lane 7) with 20 n1M Tris pH 8.0. Proteins \vere eluted from the NHS-anti-HSl column (lane 8) and the control column (lane 9) with an anti-Actin antibody. Remaining proteins were eluted of the NHS-anti-HS 1 column (lane 10) and the control column (lane 11) with500 f.!l 1 M NaCl. A similar experiment was perfonned using the elutions of a NHS-anti-HSl affinity chromatography column for Western blotting \Vith anti-liS 1 antibodies (Appendix Figure 9).

In a con1parable study, NHS-Actin (Appendix Figure 10), NHS-anti-Actin (Appendix Figure 11), NHS-anti-HS1 (Appendix Figure 12), NHS-anti-AnXAl (Appendix Figure 13),

37

~HS-AnXA2 ~olumns

{Appendix Figure 14) and NHS-anti-AnXA5 (Appendix Figure 15) affinity

were run and collected elution fractions were run on 9% gels and transferred to PVDF

for Western blotting. Blots were probed with anti-Actin to detect the presence of Actin in the elution fractions. 50 J..Lg anti-AnXA5 was bound to 100 J.Ll NHS resin and 20 mM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF membrane for Westen1 blotting. The blot was probed vvith anti-actin. In Appendix Figure 10-14, lane 1 represents the presence of actin in the crude extract of RAW macrophages and lane 2 shovvs the antibody alone for the corresponding antibody column. Proteins that did not bind to the NHS-antibody columns (lane 3) or control columns (lane 4) flovved through the colutnns. NHS-antibody columns (lane 5) and control columns (lane 6) vvere \vashed with 20 mM Tris pH 8.0 prior to eluting the proteins fron1 the NHS-antibody columns (lane 7) and

control columns (lane 8) with 500 J.Ll 1 M NaCl. Remaining proteins were eluted fro1n the NHS-antibody columns (lane 9) and control columns (lane 10) with 500
~-tl

0.2% FA.

LC-MS/MS of proteins observed in affinity chromatography pull downs After running the NHS affinity chrotnatography columns, the collected elution fractions

with NaCl and FA were prepared for LC--MS/lviS. Elution fractions were digested with trypsin

and ziptipped using C18 tips. Proteins that were detected in the control columns were otnitted

from the protein/antibody affinity column results. NHS afflnity chromatography using Actin,

anti-Actin, anti-Atmexin I, II, IV and V and anti-I-ISl revealed the presence of more than 50

proteins not found in control beads alone that showed expectation values of 0.0001 (E-4) or

less (Appendix Table 1). Six proteins vvere selected from the result list: Ras-GTPase-activating

SH3-dotnain binding protein (G3BP), FMS-like tyrosine kinase 1 (FLTl ), FERM RhoGEF

38

pleckstrin dotnain protein 2 (F ARP2), RhoGTPase-activating protein (STARD 13), RAB25, n1ember RAS oncogene family (RAB25) and FKBP-rapamycin (FRAPl) and their spectra are shown in Figure 11. Peptide LPNFGFVVFDDSEPVQK was detected for Ras-GTPaseactivating SHJ-don1ain binding protein (Appendix Table 1) and peptide

SFILDPSSNLGNRIESISQR \vas detected for FMS-like tyrosine kinase 1, also known as the vascular endothelial growth factor receptor (Appendix Table 1). Peptides associated with PERM RhoGEF pleckstrin domain protein 2 and peptides associated with RhoGTPaseactivating protein were observed (Appendix Table 1). Peptide STNVELAFQTVLKEIFAK for RAB25 was detected as shown in Appendix Table 1 as well as the peptides that were found to be associated with FKBP-rapan1ycin.

G3BP, FLTl, FARP2, STARD13, RAB25 and FRAPl were also detected in the captured Fc-receptor cmnplex. Figure 12 (these spectra are also found in Figure 16 of the appendix) shows the LC-MS/MS results of these proteins. Peptide LPNFGFVVFDDSEPVQK was detected for Ras-GTPase-activating SH3-domain binding protein with a score of 18,803.69 and a total score of 26,117.53 (Appendix Table 2) and peptide SFILDPSSNLGNRIESISQR with a score of 1,785.737 and a total score of 3,622.36 was detected for FMS-1ike tyrosine kinase 1, also known as the vascular endothelial growth factor receptor (Appendix Table 2). Peptide -.LTELQRDLVGVENLIAPGREFIR.- with a score of 2,822.381 and a total score of 13,282.41 was detected for FERM RhoGEF pleckstrin domain protein 2 (Appendix Table 2) and peptide -.SVPISRTEVPPDDEPAYCPRPVYQYK.- with a score of 1,050.46 was detected for RhoGTPase-activating protein (Appendix Table 1). Peptide -.STNVELAFQTVLKEIFAK.was detected for RAB25 with a score of 781.4144 and peptide -.YI-IPQALIYPLTVASK.-was

39

found to be associated with FKBP-rapmnycin with a score of 1,114.9 and a total score of
6,210.96.

FARP2

FRAP1

FLT1 SFILDPSSNLGNRIESISQ

RHDEVLTELEK

TVGRLSSMNI' AFVMPFLR

~i-~~
~
~ ~

~

~

~ --~~~ ~ 1

l

II

~ ~·

j~\,
, . . ;t:·_:·:·

f~<c~.; : l'
:

.l& J :_

rr,j.':,tf.
g(Jl

,I; t(~.l
l>im
1mu 1

t

0

RAB25

G3BP

STARD13

STNVELAFQTVLKEIFAK

LPNFGFVVFDDSEPVQK

SFLDSLGYTR

Figure 11. FARP2, G3BP, RAB25, FRAPI, FLT1 and STARDI3 observed in the NHS affinity chromatography pulldowns by LC~MS/MS. RAW lysates were run through NHS~affinity chromatography columns and eluted with NaCl and fonnic acid. FARP2, G3BP and RAB25 were shown to interact with the NHS-anti-HS 1 column, FRAPl eluted from the NHSanti-AnXA4 column, FLTI, G3BP was shown to interact with the NHS-actin column and STARD13 was observed to interact with the NHS-anti-AnXA5 column by LS-MS/MS.

40

FARP2
-LTELQRDLVGVENLIAPGREFIR. -

FRAP 1
-. YHPQALIYPL TV ASK.-

FLTI
MPAEGEDLKLSCVVNKFL YR.-

RAB25
-. VVLIGESGVGKTNLLSRFTR.-

G3BP
-.LPNFGFVVFDDSEPVQK.-

STARD13
-. SVPISRTEVPPDDEP AYCPRPVYQYK.-

Figure 12. FARP2, G3BP, RAB25, FRAPl , FLTl and STARD13 observed in captured Fc-receptor complex by LC-MS/MS. Fc-receptor complexes were isolated and analyzed by LC-MS/MS.

Confocal microscopy
-lmmuno fluorescent staining

Laser confocal microscopy conflrn1ed the recruit1nent of proteins to the F c~receptor complex in RAW 264.7 macrophages. Cells were grown on cover slips, incubated with opsonized sRBC or latex beads, fixed and stained with specific antibodies. Proteins accwnulated to the site of the plasma n1e1nbrane where the activated Fe-receptor complex was formed by contact to opsonized particles. Actin and HS 1 were observed to strongly accumulate to the site of the activated Fc-receptor con1plex, as shown in Figure 13. Specific anti-AnXAl

41

and anti-AnXA2 antibodies revealed the presence of AnXAl and AnXA2 in the cells although no strong accumulation was observed. AnXA4 and

Figure 13. Immuno fluorescence staining of actin, HS 1~ AnXA 1, AnXA2, AnXA4, AnXA5 and AnXA6 in RAW264.7 macrophages. Arrows indicate the protein accumulation at the site of the nascent Fc-receptor complex.

AnXA5 strongly accumulate at the site of the activated Fc-receptor complex as well as AnXA6. Figure 14 shows accun1tllation of RAB25, FRAPl and STARD13 in RAW tnacrophages.

-GFP transfection
In another experiment~ cells vvere grown on cover slips and transfected with GFP fusion proteins. Cells were incubated with opsonized sRBC or latex beads to activate the Fc-receptor.

42

Figure 15 shows the localisation of ~-Actin at the active receptor site. Expression of the HS 1GFP fusion proteins accumulated to the nascent Fc-receptor

RAB25

FERM, RhoGEF and pleckstrin domain protein 2

RhoGTPase activating protein

Figure 14. Immunofluorescence stainingofRAB25, FERM, RhoGEF and pleckstrin domain protein 2 and RhoGTPase activating protein in RA W264. 7 macrophages. Arrows indicate the protein accumulation at the site of the nascent Fc-receptor complex.

complex. The presence of AnXA2 to the site of receptor activation was confirmed by the expression of the AnXA2 coding sequence fused to GFP. AnXA5-GFP was observed to strongly accumulate at the active receptor site and AnXA6-GFP was found to be recruited to the plastna membrane at the site of the activated fc .. receptor.

Protein-protein interaction models (iHOP) Proteins observed in the LC-MS/MS results of the NBS-control column were omitted fro1n the LC-MS/MS results of the NHS-protein/antibody affinity columns. The proteins that eluted from the NHS affinity chron1atography columns and that were detected by LC-MS/MS

43

were compared to the literature in order to compose a protein-protein interaction modeL Figure 16 and Table 1 show the protein..,protein interactions

Actin GFP

AnXA6GFP

AnXA2 GFP

AnXA5GFP

Figure 15. Expression ofGFP fusion proteins in RAW 264.7 macrophages. Arrows indicate the protein accumulation at the site of the nascent Fc-receptor complex.

betvveen Actin and the Annexins and the interacting proteins fron1 the literature with Appendix Table 2 showing the abbreviations of the proteins represented in the model. Although HS 1 is known to interact with actin directly, the software used did not show this interaction. MAP4Kl, RAB25 and RAB11FIP5 also showed no direct interaction with Actin or the Annexins. Furthermore, over 50 other proteins that were observed in the NHS affinity chron1atography colmnns were found to have no direct interaction with Actin, HS 1 or the Annexins (Table 2).
44

Figure 16. Protein-protein interactions observed from literature. Proteins that eluted from the NHS affinity chromatography columns were subjected to a literature review using the iHOP computer software program (60) and combined to a protein-protein interaction diagram.

45

Table 1. Protein-protein interactions observed from literature. Proteins that eluted from the NBS affinity chromatography columns were subjected to a literature review using the iHOP computer software program (60) and combined to a protein-protein interaction table.

46

Table 2. Novel protein-protein interactions observed from NHS affinity chromatography columns. Proteins that eluted from the NHS affinity chromatography columns were subjected to a literature review using the iHOP computer sofuvare program (60). Over 50 proteins that were observed in the NHS affinity chromatography columns were found to have no direct interaction with Actin, HS 1 or the Annexins.

47

DISCUSSION
Capturing the Fc-receptor complex RAW 264.7 macrophages were incubated with opsonized microbeads to activate the Fc-receptor and fo1n1ed cotnplexes were isolated using the LARC approach and analyzed by LC-MS/MS and Western blotting. LC-MS/MS confirmed the presence of Actin, HSl and AnXAl, AnXA2, AnXA4, AnXA5 and AnXA6 in the captured Fc-receptor complex (Figure 6). Actin and HS 1 were observed in the crude as \vell as in the isolated Fe-receptor complex by Western blot but not in the culture media. However, Westen1 blot did not show the presence of AnXAl in the crude, Fc-receptor cotnplex or the culture media. AnXA2 was observed in the Fc-receptor complex and in the crude extract from RAW 264.7 n1acrophages butnot in the culture media. AnXA5 was also present in the crude extract and the isolated Fc-receptor complex but not in the culture media (Figure 5). Because HSl (13), AnXAl (25), AnXA2 (30), AnXA4 (20), AnXA5 (37) and AnXA6 (44) are known to interact with actin and the actin cytoskeleton, these proteins were expected to be observed in the captured Fc-receptor complex. Other proteins that are known to interact with actin such as Arp2/3 complex, cofilin, gelsolin, profilin, WASp, LIK kinase, PAK and WAVE were also observed in the captured Fc-receptor complex.

Mass spectrometry of captured Fc-receptor complexes Isolated Fc-receptor con1plexes were analyzed by LC-MS/MS and a large variety of proteins associated with the rearrangen1ent of the actin cytoskeleton were observed. These proteins include gelsolin, profilin, Arp2/3 complex, WASp, cofilin, WAVE, LIM kinase and PAK (8) as well as HSl (13), AnXAl (25), AnXA2 (30), AnXA4 (20), AnXA5 (37) and

48

AnXA6 (44). GJBP, FLTl, FARP2, STARD13, RAB25 and FRAPl were observed in the elution of the NI-lS affinity chromatography columns detected by LC-MS/MS and were also present in the captured Fc-receptor complexes. GJBP (Ras-GTPase-activating SHJ-dotnain binding protein) regulates the assembly of cytoplasmic stress granules (52) and was shown to bind to the tumor suppresser p53. G3BP redistributes p53 fron1 the nucleus to the cytoplasm and inhibits its activity (53). The oncogene FLTl (FMS-like tyrosine kinase 1 or vascular endothelial growth factor/vascular permeability factor receptor) is a men1ber of the scr family and has a key role in cell proliferation and differentiation (54) whereas the tumor suppresser FRAPl (FKBP-rapamycin) is associated with the phosphatidyl-inosito1 3-kinase signal transduction pathway (55). It was therefore no surprise that these knovvn actin interacting proteins were observed in the captured Fc-receptor cotnplex.

However, to date there is no genetic or biochemical evidence that FARP2, STARD13 or RAB25 are involved in the rearrangetnent of the actin cytoskeleton or the function of the Fereceptor. FARP2 (FERM RhoGEF pleckstrin domain protein 2) has a key role. in. neuronal growth cone responses and in Sen1a3A-stimulated axonal repulsion. FARP2 is also known to activate Rae and down regulate R-Ras as well as to suppress focal adhesion (56). STARD13 is a member of the Ras superfamily and are involved in the Rho mediated signaling pathway (57). RAB25 is a n1ember of the stnall RAB GTPases and are associated with hydrolysis, nucleotide binding (58) and membrane trafficking (59).

Affinity. Chron1atography RAW lysates were run through NHS-protein/antibody columns using different binding and elution buffers. Buffers containing stnall atnounts of detergents such as Triton X-1 00, sodium deoxycholate and N-octylglucoside were observed to be the optimal conditions to bind proteins to the colutnn, wash away unbound proteins and elute proteins from the aftinity columns. High concentrations of detergents inhibited NBS-protein/antibody-protein binding. However, detergents are not tnass spectrometer compatible therefore binding and elution buffers without detergents were used in order to analyze the elution fractions from the columns by LC-MS/MS and Western blotting. In addition to the NHS-protein/antibody columns, a control column without any antibodies linked to the NHS beads was also run and analyzed. The 1nass spectrometer compatibility binding buffer
used~

20 n1M Tris pH8.0, was not always

able to wash away all unbound proteins resulting in non-specific binding in the control column. However, LC-J\t1S/MS did shovv differences between NHS-protein/antibody columns and the control colmnn and revealed at least 51 ·protein-protein interactions with Actin, HS 1 and the Annexins which to date have not been addressed in the literature (Table 2).

LC-MS/MS of proteins observed in affinity chron1atography pull downs Proteins observed in the LC-MS/MS results of the NHS-control column were on1itted from the LC-MS/MS results of the NBS-protein/antibody affinity columns. G3BP, FL Tl, FARP2, STARD13, RAB25 and FRAPl were detected by LC-MS/MS in the NHS affinity columns as well as in the captured Fc-receptor complex. However, to date there is no genetic or biochemical evidence that FARP2, STARD13 or RAB25 are involved in the reanangement of the actin cytoskeleton or the function of the Fc-receptor. Confocal microscopy showed weak

50

staining of these proteins and needs to be further examined. LC-MS/MS revealed at least 51 protein-protein interactions with Actin, HS 1 and the Annexins which to date have not been addressed in the literature (Table 2).

Confocal microscopy

-Immuno fluore.~'cent staining
Laser confocal microscopy confirmed the recruittnent of proteins to the Fc-receptor con1plex in RAW 264.7 macrophages. Staining with specific antibodies was used to image the localization of Actin, HS 1, AnXA 1, AnXA2, AnXA4, AnXA5 and AnXA6 to the site of activated Fc-receptor. Laser confocal images of antibody staining were found to be in agreement with the LC-MS/MS results. Actin, HS 1, AnXA4, AnXA5 and AnXA6 were found to strongly accumulate at the site of phagocytosis. However, AnXA 1 and AnXA2 were not found to be particularly associated 'With the Fc-receptor con1plex. Because HSl (13), AnXAl (25), AnXA2 (30), AnXA4 (20), AnXAS (3 7) and AnXA6 (44} are k11o\vn to interact with actin and the actin cytoskeleton, these proteins vvere expected to accumulate at the site of the activated Fc-receptor.

-GFP transfection
In an additional experiment using GFP fusion proteins, laser confocal n1icroscopy confirmed the recruitment of proteins to the Fc-receptor complex in RAW 264.7 tnacrophages. Transfecting RAW 264.7 1nacrophages vvith GFP fusion proteins allowed imaging of the localization of Actin, HSl, AnXA2, AnXA5 and i\nXA6 to the site of the activated Fcreceptor in live cells. Laser confocal images of GFP fusion proteins were found to be in

51

agreement with the LC-MS/MS results. Actin, HS 1, AnXA2, AnXA5 and AnXA6 were found to strongly accumulate at the site of phagocytosis.

Protein-protein interaction models (iHOP) LC-MS/MS results from the NHS aft1nity chromatography columns were compared to the literature to generate a protein-protein interaction n1odel (Figure 16, Table 1). To date, there is no genetic or biochemical evidence showing that CCT, SNF1LK2, RBPSUH, RRBPl, CCNK, FN3K, HSPAlL, DNAJC8, ITGBP3BP, PPFIA2, CASZl, INPPl, DDX3Y, TOPBPl, HD, PTPRE or DDX46 interact with Actin. However, these proteins eluted fron1 the NBSActin and NHS-anti-.Actin affinity columns (Appendix Table 1). HSl was observed to interact with WDR70, HSPAlL, FARP2, DNAJC8, RAB25 and MFI2 although there is no biochemical or genetic evidence of interaction between HS 1 and these proteins (Table 2). AnXAl was observed to interact with DNAJC8, PPFIA2, INPPSF, PRFl, ARHGAP5 as well as WDR40A but no evidence was found for interactions between AnXAl and these proteins (Table 2). DNAJC8, CCT, PA2G4, SYT15, PRFl, TTLL12, HIPK4 and FAT eluted offthe NHSanti-AnXA2 suggesting interactions of these proteins with AnXA2 (Table 2). AnXA4 was observed to interact with HSPA1L, PRFl, PIK3R5, CDH15, ZPBP2 and PSTPIP2 but no biochemical or genetic evidence was found for interactions between AnXA4 and these proteins (Table 2). HSPAlL, DNAJC8, CASZl, PRFl, TAGAP, PDRGl, DDX3Y and STARD13 eluted off the NHS-anti-AnXA5 suggesting interactions of these proteins with AnXA5 (Table 2).

52

CONCLUSION
Standard biochemical techniques were used to approach the objectives. The novel LARC method was used to isolate the captured Fc-receptor cmnplex prior to LC-MS/MS and Westen1 blot analysis. Standard and novel approaches were used for the protein-protein interactions in vitro using standard buffers (containing detergents) and novel buffers (without detergents) as loading and elution buffers for the affinity chron1atography columns. The purpose of the novel approach was to develop a method for purifying proteins over an affinity chromatography column with mass spectrometry compatible buffers. The classic technique for affinity chromatography uses buffers that contain detergents. Proteins eluted from the colwnns are separated on SDS-PAGE gels and stained with either Coomassie Brilliant Blue or Silver nitrate. A band of interest is cut from the gel and prepared for tnass spectrometry. With the novel approach, purified proteins from the affinity chromatography columns can be directly analyzed by mass the smnple.
spectron1etry~

eliminating SDS-PAGE and resulting in a faster analysis of

Actin, HS 1 and AnXA 1, AnXA2, AnXA4, AnXA5 and AnXA6 \Vere found to participate in the formation of the Fc-receptor complex prior to internalization. Actin and actin binding proteins accumulated at the site of the nascent Fc-receptor complex confirmed by LC-MS/MS and confocal n1icroscopy. NHS affinity colun1ns revealed at least 51 protein-protein interactions with Actin, HS 1, AnXAl, AnXA2, AnXA4 and AnXA5 with 36 different proteins, which have not been reported in the literature yet. Furthennore, G3BP, FLTl, FARP2, STARD13, RAB25 and FRAPl were detected by LC-MS/MS and affinity chromatography, ho\vever, to date there is no biochemical or genetic evidence ofSTARD13,

53

RAB25 and FRAPl being associated \Vith the rearrangetnent of the actin cytoskeleton or the function ofthe Fc-receptor.

Affinity chromatography columns \vork best with binding/elution buffers that contain a

sn1all amount of detergent to reduce non-specific binding. Ho·wever, such conditions are not
1nass spectrometer compatible.

54

REFERENCES
(1) Nakatani Y, Ogryzko V. Imn1unoaffinity purification ofman1malian protein complexes. Methods Enzyn1ol. 2003;370:430-444. (2) Janeway CA,Jr, Medzhitov R. Innate immune recognition. Annu.Rev.Inununol. 2002;20: 197-216. (3) Marshall JG, Booth JW, Stambolic V, Mak T, Balla T, Schreiber AD, et al. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasn1alen1mal subdon1ain during Fe gamtna receptor-mediated phagocytosis. J.Cell Biol. 2001 Jun 25;153(7):1369-1380. (4) Swanson JA, Hoppe AD. The coordination of signaling during Fe receptor-n1ediated phagocytosis. J.Leukoc.Biol. 2004 Dec;76(6):1093-1103 . (5) Corbett-Nelson EF, Mason D, Marshall JG, Collette Y, Grinstein S. Signaling-dependent im1nobilization of acylated proteins in the inner monolayer of the plasn1a 1netnbrane. J.Cell Biol. 2006 Jul 17; 174(2):255-265. (6) Niedergang F, Chavrier P. Regulation of phagocytosis by Rho GTPases. Cun.Top.Microbiol.Immunol. 2005;291 :43-60. (7) Adachi R, Takeuchi K, Suzuki K. Antisense oligonucleotide to cofilin enhances respiratory burst and phagocytosis in opsonized zyn1osan-stimulated mouse macrophage 1774.1 cel1s. J.Biol.Chem. 2002 Nov 22;277(47):45566-45571. (8) Pollard TD. Regulation of actin filament assembly by Arp2/3 complex and formins. Annu.Rev.Biophys.Bion1ol.Struct. 2007;36:451-477. (9) Reisler E, Egelman EH. Actin structure and function: what we still do not understand. J.Biol.Chen1. 2007 Dec 14;282(50):36133-36137. (10) Pollard TD, Borisy GG. Cellular motility driven by assembly and disassetnbly of actin filan1ents. Cell 2003 Feb 21;112(4):453-465. (11) Kodan1a A, Lechler T, Fuchs E. Coordinating cytoskeletal tracks to polarize cellular n1ovements. J.Cell Bioi. 2004 Oct 25;167(2):203-207. (12) Kitmnura D, KanekoH, Miyagoe Y, Ariyasu T, Watanabe T. Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. Nucleic Acids Res. 1989 Nov 25;17(22):9367-9379. (13) Hao JJ, Zhu J, Zhou K, Smith N, Zhan X. The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex. J.Biol.Chem. 2005 Nov 11;280(45):37988-37994.

55

(14) Uruno T, Zhang P, Liu J, Hao JJ, Zhan X. Haematopoietic lineage cell-specific protein 1 (HS 1) pron1otes actin-related protein (Arp) 2/3 complex-n1ediated actin polyn1erization. Biochetn.J. 2003 Apr 15;371(Pt 2):485-493. (15) Yamanashi Y, Fukuda T, Nishizutni H, Inazu T, Higashi K, Kitamura D, et al. Role of tyrosine phosphorylation ofHSl in B cell antigen receptor-n1ediated apoptosis. J.Exp.Med. 1997 Apr 7;185(7):1387-1392. (16) Yamanashi Y, Okada M, Setnba T, Yamori T, Umemori H, Tsunasavva S, et al. Identification ofHSl protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc.Natl.Acad.Sci.U.S.A. 1993 Apr 15;90(8):3631-3635. (17) Gerke V, Moss SE. Annexins: from structure to function. Physiol.Rev. 2002 Apr;82(2):331-371. (18) Gerke V, Creutz CE, Moss SE. Am1exins: linldng Ca2+ signalling to n1embrane dynamics. Nat.Rev.MoLCeU Biol. 2005 Jun;6(6):449-461. (19) Mailliard WS, Haigler HT, Schlaepfer DD. Calcium-dependent binding of S 1OOC to the N-terminal domain ofannexin I. J.Biol.Chem. 1996 Jan 12;271(2):719-725. (20) Diakonova M, Gerke V, En1st J, Liautard JP, van der Vusse G, Griffiths G. Localization of five annexins in J774 macrophages and on isolated phagoson1es. J.Cell.Sci.1997 May;110 ( Pt 10)(Pt 10):1199-1213. (21) Fan X, Krahling S, Sn1ith D, Williamson P, Schlegel RA. Macrophage surface expression of annexins I and H in the phagocytosis of apoptotic lymphocytes. Mol.Biol.Cell 2004 Jun; 15(6):2863-2872. (22) Schlaepfer DD, Haigler HT. Characterization of Ca2+-dependent phospholipid binding and phosphorylation oflipocortin I. J.Biol.Chen1. 1987 May 15;262(14):6931-6937. (23) Schlaepfer DD, Haigler HT. In vitro protein kinase C phosphorylation sites of placental lipocortin. Biochemistry 1988 Jun 14;27(12):4253-4258. (24) Sakaguchi M, Murata H, Sonegawa H, Sakaguchi Y, Futami J, Kitazoe M, et aL Truncation of annexin A 1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J.Biol.Chem. 2007 Dec 7;282(49):35679-35686. (25) Moss SE, Morgan RO. The annexins. Genome BioL 2004;5(4):219. (26) van de GraafSF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, et al. Functional expression of the epithelial Ca(2+) channels (TRPV 5 and TRPV 6) requires association of the SlOOAlO-annexin 2 complex. EMBO J. 2003 Apr 1;22(7):1478-1487.

56

(27) Glenney JR,Jr, Tack BF. Amino-terminal sequence ofp36 and associated plO: identification of the site of tyrosine phosphorylation and homology with S-1 00. Proc.Natl.Acad.Sci.U.S.A. 1985 Dec;82(23):7884-7888. (28) Gould KL, Woodgett JR, Isacke CM~ Hunter T. The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol.CelLBiol. 1986 Jul;6(7):27382744. (29) Hansen MD, Ehrlich JS, Nelson WJ. Molecular mechanisn1 for orienting membrane and actin dynan1ics to nascent cell-cell contacts in epithelial cells. J.Biol.Chen1. 2002 Nov 22;277(47):45371-45376. (30) Lee DB, Jamgotchian N, Allen SG, Kan FW, Hale IL. Atmexin A2 heterotetramer: role in tight junction assembly. Am.J.Physiol.Renal Physiol. 2004 Sep;287(3):F481-91. (31) Hayes MJ, Shao D, Bailly M, Moss SE. Regulation of actin dynamics by annexin 2. EMBO J. 2006 May 3;25(9):1816-1826. (32) Piljic A, Schultz C. Annexin A4 self-association modulates general membrane protein mobility in living cells. Mol.Biol.Cell 2006 Jul; 17(7):3318-3328. (33) Ponnampalan1 AP, Rogers PA. Cyclic changes and honnonal regulation of annexin IV mRNA and protein in hun1an endometrium. Mol.Hum.Reprod. 2006 Nov;12(11):66l-669. (34) Chan HC, Kaetzel MA, Gotter AL, Ded1nan JR, Nelson DJ. Annexin IV inhibits cahnodulin-dependent protein kinase II -activated chloride conductance. ·A novel n1echanism for ion channel regulation. J.Biol.Chem. 1994 Dec 23;269(51):32464-32468. (35) Goossens EL, Reutelingsperger CP, Jongs1na FH, KraayenhofR, Hennens WT. Annexin V perturbs or stabilises phospholipid n1en1branes in a calcium-dependent manner. FEBS Lett. 1995 Feb 13;359(2-3): 155-158. (36) Bitto E, Cho W. Structural determinant of the vesicle aggregation activity of annexin I. Biochen1istry 1999 Oct 19;38(42): 14094-14100. (3 7) Tzima E, Trotter P J, Orchard MA, Walker JH. Annexin V relocates to the platelet cytoskeleton upon activation and binds to a specific isoform of actin. Eur.J.Biochem. 2000 Aug;267( 15):4 720-4 730. (38) Kaneko N, Ago H, Matsuda R,Inagaki E, Miyano M. Crystal structure of annexin V with its ligand K-201 as a calciun1 channel activity inhibitor. J.Mol.Biol. 1997 Nov 21;274(1):1620. (39) Can1pos B, Wang S, Retzinger GS, Kaetzel MA, Seaton BA, Karin NJ, et al. Mutation of highly conserved arginine residues disrupts the structure and function of annexin V. Arch.Med.Res. 1999 Sep-Oct;30(5):360-367.

57

(40) Russo-Marie F. Annexin V and phospholipid metabolism. Clin.Chem.Lab.Med. 1999 Mar;3 7(3):287 -291. (41) Avila-Sakar AJ, Kretsinger RH, Creutz CE. Membrane-bound 3D structures reveal the intrinsic flexibility of annexin VI. J.Struct.Biol. 2000 May; 130(1 ):54-62. (42) Kmnal A, Ying Y, Anderson RG. Annexin VI-mediated loss ofspectrin during coated pit budding is coupled to delivery ofLDL to lysosomes. J.Cell Bioi. 1998 Aug 24;142(4):937-947. (43) Garbuglia M, Verzini M, DonatoR. Annexin VI binds S100A1 and SIOOB and blocks the ability ofS100Al and SIOOB to inhibit desmin and GFAP assemblies into inte1n1ediate filaments. Cell Calcium 1998 Sep;24(3):177-191. (44) Babiychuk EB, Palstra RJ, Schaller J, Kan1pfer U, Draeger A. Annexin VI participates in the formation of a reversible, membrane-cytoskeleton complex in smooth muscle cells. J.Biol.Chem. 1999 Dec 3;274(49):35191-35195. (45) Grewal T, Heeren J, Mewawala D, Schnitgerhans T, Wendt D, Salotnon G, et aL Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J.Biol.Chem.2000 Oct 27;275(43):33806-33813. (46) Rentero C, Evans R, Wood P, Tebar F, Vila de Muga S, Cubells L, et al. Inhibition ofHRas and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells. Cell. Signal. 2006 Jul; 18{7): 1006-1016. (47) Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal.Biochem. 1987 Nov 1;166(2):368-379. (48) Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylmnide gels to unn1odified nitrocellulose and radiographic detection with antibody and radio iodinated protein A. Anal.Biochetn. 1981 Apr; 112(2): 195-203. (49) Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Camemolla B, et al. Blue silver: a very sensitive colloidal Coon1assie G-250 staining for proteome analysis. Electrophoresis 2004 May;25(9): 1327-1333. (50) Marshall J, Jankowski A, Furesz S, Kireeva I, Barker L, Dombrovsky M, et al. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J.Proteotne Res. 2004 May-Jun;3(3):364-382.

(51) Guzzetta A W, Thakur RA, Mylchreest IC. A robust Inicro-electrospray ionization technique for high-throughput liquid chromatography/mass spectron1etry proteomics using a sanded metal needle as an emitter. Rapid Co1nmun.Mass Spectrom. 2002;16(21):2067-2072.

58

(52) SolomonS, Xu Y, Wang B, David MD, Schubert P, Kennedy D, et al. Distinct structural features of caprin~ 1 mediate its interaction with G3BP~ 1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs. Mol.Cell.Biol. 2007 Mar;27(6):2324-2342. (53) Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 2007 Jun 21;26(29):4209-4215. (54) Kappas NC, Zeng G, Chappell JC, Kean1ey JB, Hazarika S, Kallianos KG, et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J.Cell Biol. 2008 Jun 2;181(5):847-858. (55) Bliskovsky V, Ramsay ES, Scott J, DuBois W, Shi W, Zhang S, et al. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tum.or suppressor gene. Proc.Natl.Acad.Sci.U.S.A. 2003 Dec9;100(25):1498214987. (56) Toyofuku T, Yoshida J, Sugimoto T, Zhang H, Kumanogoh A, Hori M, et al. FARP2 triggers signals for Setna3A-mediated axonal repulsion. Nat.Neurosci. 2005 Dec;8(12):17121719. (57) Kandpal RP. Rho GTPase activating proteins in cancer phenotypes. Curr.Protein Pept.Sci. 2006 Aug;7(4):355-365. (58) Scapin SM, Carneiro FR, Alves AC, Medrano FJ, Guin1araes BG, Zanchin NL The crystal structure of the small GTPase Rab 11 b reveals critical differences relative to the Rab 1 I a isoform. J.Struct.Biol. 2006 Jun; 154(3):260-268. (59) Kuroda TS, Fukuda M, Ariga H, Mikoshiba K. The Slp hon1ology don1ain of synaptotagmin-like proteins 1-4 and Slac2 functions as a novel Rab27 A binding domain. J.Biol.Chetn. 2002 Mar 15;277(11):9212-9218. (60) IHOP reference: A Gene Network for Navigating the Literature. Hotimann, R., Valencia, A. Nature Genetics 36, 664 (2004) and - iHOP~~~~~~~=~~-~~~~=~

(61) Jankowski A, Zhu P, Marshall JG. Capture of an activated receptor cotnplex from the surface of live cells by affinity receptor chromatography. Anal Bioche1n. 2008 Sep 15;380(2):235-48

59

APPENDIX

kDa

1
~y.~

2

3

4

5

7

8

9

10

200
116

97
66

45

21

14

Figure 1. Optimizing binding conditions for NHS Actin affinity chromatography columns. 50 ~tg Actin was bound to 100 J.tl NHS resin, 20 mM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transfened to a PVDF membrane for Western blotting. The blot was probed with anti-Actin. Lane 1: cn1de extract of RAW macrophages, lane 2: antiActin antibody, lane 3: Flow trough of 100 J.tl RAW cell lysate in 1 ml binding buffer of Actin colun1n, lane 4: Flow trough of 100 J.!l RAW cell lysate in 1 ml binding buffer of control colunu1 (beads alone), lane 5: Actin column wash, lane 6: control column wash, lane 7: elution of Actin column with 500 ~Ll 1M NaCl, lane 8: elution of control colun1n \vith 500 J.!l 1M NaCl, lane 9: elution of Actin colunu1 \vith 500 J-Ll 0 .2% FA~ lane 10: elution of control colunn1 with 500 J.tl 0.2% FA.

60

1
kDa

2

3

4

5

6

7

8

9

10

250
150

100 75 50 37 25 20 15
10

Figure 2. Optimizing binding conditions for NHS Actin affinity chromatography colu1nns. 50 Jlg Actin was bound to 100 fll NHS resin~ 20 mM Tris pH 8.0, 0.1% N-octyl glucoside, 0.1% Na deoxycholate was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-Actin. Lane 1: crude extract of RAW 1nacrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 1 00 J.Ll RAW cell lysate in 1 ml binding buffer ofActin column, lane 4: Flow trough of 100 fll RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 5: Actin column wash, lane 6: control column wash, lane 7: elution of Actin column with 500 ~tl 1M NaCI, lane 8: elution of control column with 500 fll 1M NaCl, lane 9: elution of Actin column vvith 500 J.tl 0.2% FA, lane 10: elution of control colun1n vvith 500 J.Ll 0.2% FA.

61

1

2

3

4

5

6

7

8

9

10

kDa 250 150

100
75 50

37
25 20 15 10

Figure 3. Optin1izing binding conditions for NHS Actin affinity chron1atography columns. 50 Jlg Actin was bound to 100 Jll NI-IS resin, 20 1nM Tris pH 8.0, 0.5% N-octyl glucoside~ 0.5% Na deoxycholate was used as binding buffer. Fractions were collected and run on a 9o/o gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-Actin. Lane 1: crude extract ofRA W n1acrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 100 !ll RAW cell lysate in 1 ml binding buffer of Actin column, lane 4: Flow trough of 100 J!l RAW cell lysate in 1 n1l binding buffer of control colun1n (beads alone), lane 5: Actin column wash, lane 6: control column \Vash, lane 7: elution of Actin column with 500 f..ll 1M NaCl, lane 8: elution of control column with 500 Jll 1M NaCl, lane 9: elution of Actin column with 500 jll 0.2% FA, lane 10: elution of control colun1n with 500 J.tl 0.2% FA.

62

1

2

3

4

5

6

7

10

kDa 250
150 100

75
50 37

25 20 15
10

Figure 4. Optimizing binding conditions for NHS Actin affinity chromatography columns. 50 J.tg Actin was bound to 100 J.tl NHS resin, 20 mM Tris pH 8.0, 1% N-octyl glucoside, 1% Na deoxycholate was used as binding buffer. Fractions were collected and ntn on ·a 9% gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-Actin. Lane 1: crude extract of RAW macrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 100 Jil RAW cell lysate in 1 1nl binding buffer of Actin column, lane 4: Flow trough of 100 gl RAW cell lysate in 1 m1 binding buffer of control column (beads alone), lane 5: Actin column wash, lane 6: control column wash, lane 7: elution of Actin colun1n with 500 ~-tl 1M NaCl, lane 8: elution of control colun1n with 500 J.Ll 1M NaCI, lane 9: elution of Actin column with 500 111 0.2% FA, lane 10: elution of control column vvith 500 J.d 0.2% FA.

63

kDa

1

2

3

4

5

6

7

8

9

10

11

12

13

250 150

50
37

25

20 15
10

Figure 5. Opthnizing background binding NHS affinity chromatography. 25 Ill NHS resin was washed 5 times with 100 ~tl of the appropriate binding buffer and incubated with 50 J.d RAW cell lysate in 1 ml binding buffer for 1 hour. Elutions were run on a 9% gel and stained with Blue Silver Stain to determine the non-specific binding of NI--IS beads. Lane 1: Molecular weight marker, lane 2: crude extract of RAW 1nacrophages, lane 3: 20 mM Tris pH 8.0 was used as binding buffer, lane 4: 20 mM Tris, 0.1% N-octyl glucoside pH 8.0 was used as binding buffer, lane 5: 20 n1M Tris, 0.5% N-octyl glucoside pH 8.0 w·as used as binding buffer, lane 6: 20 mM Tris, 1% N-octyl glucoside pH 8.0 was used as binding buffer, lane 7: 20 mM Tris, 0.1% Nadeoxycholate pH 8.0 was used as binding buffer, lane 8: 20 mM Tris, 0.5% Na-deoxycholate pH 8.0 was used as binding buffer, lane ·9: 20 n1M Tris, 1% Na-deoxycholate pH 8.0 was used as binding buffer, lane 10: 20 mM Tris, OJ% N-octyl glucoside, 0.1% Na-deoxycholate pH 8.0 was used as binding buffer, lane 11: 20 n1M Tris, 0.5% N-octyl glucoside, 0.5% Na-deoxycholate pH 8.0 was used as binding buffer, lane 12: 20 mM Tris, 1% N-octyl glucoside, 1% Na-deoxycholate pH 8.0 was used as binding buffer, lane 13: 20 mM Tris, 40mM NaCl pH 8.0 vvas used as binding buffer.

64

1

2

3

4

5

6

7

8

9

10

11

12

kDa

250 --'-····· ·.. . 150
l

100 --····
75

50
37

25 20 15 10

Figure 6. Optimizing elution conditions of a NHS-anti-Actin affinity colmnn. 25 J.Ll NHS resin was washed 5 thnes with 100 J.tl 20 mM Tris pH 8.0 and incubated with. 50 J.tl RAW cell lysate in 1 ml binding buffer for 1 hour. Actin was eluted off the column in different fractions with anti-Actin, 1M NaCl and FA. Fractions were run on a 9% gel and the gel was stained \Vith Blue Silver Stain. Lane 1: Molecular weight n1arker, lane 2: crude extract of RAW macrophages, lane 3: anti-Actin antibody, lane 4: elution with anti-Actin,lane 5: elution 1 with 100 ~-tl 1M NaCl,lane 6: elution 2 with 100 J.tl 1M NaCl, lane 7: elution 3 with 100 pJ 1M NaCl, lane 8: elution 4 with 100 Jd 1M NaCl, lane 9: elution 5 with 100 J.tl 1M NaCI, lane 10: elution control column (beads alone) \vith 500 ~tl 1M NaCl, lane 11: elution \Vith 500 J.tl 0.2% FA, lane 12: elution control column (beads alone) with 500 ~-tl 0.2% FA.

65

1
kDa 250

2

3

4

5

6

7

9

10

11

150 100
75

50
37

25 20
15
lO

Figure 7. Optimizing binding and elution conditions of a NHS-anti-Actin affinity colunm versus a control column. 25 ~1 NHS resin was washed 5 times with 100 Jll of the appropriate binding buffer and incubated with 50 Jll RAW cell lysate in 1 ml binding buffer for 1 hour. All fractions were collected and run on a 9% gel. The gel was stained with Silver nitrate. Lane 1: Molecular weight marker, lane 2: crude extract of RAW macrophages, lane 3: anti-Actin antibody, lane 4: Flow trough of 50 ~Ll RAW cell lysate in 1 ml binding buffer of anti-Actin column, lane 5: Flow trough of 50 !J.l RA \V cell lysate in 1 n1l binding buffer of control colmnn (beads alone), lane 6: anti-Actin column wash, lane 7: control colun1n wash, lane 8: elution of anti-Actin colutnn with 500 Jll 1M NaCl, lane 9: elution of control column with 500 ~~ 1M NaCl, lane 10: elution of anti-Actin column with 500 Jll 0.2% FA, elution of control column with 500 ~tl 0.2% FA.

66

kDa
1
2

3

4

5

6

7

8

9

10

11

250 150
100

75

50
37

25
20

15 10

Figure 8. NHS-anti-HSI affinity chromatography column. 50 ~tg anti-fiSt was bound to 100 ~~ NHS resin, 20 mM Tris pH 8.0 ·was used as binding buffer. Fractions were collected and run on a 9% gel and transfen·ed to a PVDF membrane for Western blotting. The blot was probed with antiActin. Lane 1: crude extract of RAW n1acrophages, lane 2: anti-HS 1 antibody, lane 3: anti-Actin antibody, lane 4: Flow trough of 100 !Jl RAW cell lysate in 1 ml binding buffer ofanti-HSl colunm, lane 5: Flow trough of 100 ~tl RAW cell lysate in 1 ml binding buffer of control colunm (beads alone), lane 6: anti-HS 1 colun1n wash, lane 7: control column \vash, lane 8: elution of antiHSl column with anti-HSI antibody, lane 9: elution of anti-HSl colunm with anti-Actin antibody, lane 10: elution of anti-HS 1 column vvith 500 J.!l 1 M NaCl, lane 11: elution of control colun1n with 500 JJ-l 1 M NaCl.

67

kDa

1

2

3

4

5

6

7

8

9

10

11

250 150 100 75
50

37
25 20 15 10

Figure 9. NHS-anti-HSl affinity chromatography column. 50 1-!g anti-HSl was bound to 100 J.Ll NHS resin, 20 tnM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF n1e1nbrane for Western blotting. The blot was probed with antiHS1. Lane 1: crude extract of RAW macrophages, lane 2: anti-HSl antibody, lane 3: anti-Actin antibody, lane 4: Flow trough of 100 fll RAW cell lysate in 1 ml binding buffer of anti-HSl column, lane 5: Flow trough of 100 ~1 RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 6: anti-HSl column \Vash, lane 7: control colunm wash, lane 8: elution of antiHS 1 colun1n with anti-HS 1 antibody, lane 9: elution of anti-HS 1 column with anti-Actin antibody, lane 10: elution of anti-HS 1 colutnn with 500 Jtl 1 M NaCl, lane 11: elution of control column with 500 ~tl 1 M NaCl.

68

1

2

3

4

5

6

7

8

9

10

kDa

200
11 6

97
66

45

21
14

Figure 10. NHS-Actin affinity chromatography colun1n. 50 ~g Actin was bound to 100 111 NHS resin, 20 mM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF men1brane for Western blotting. The blot was probed with anti-actin. Lane 1: crude extract of RAW macrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 100 J.Ll RAW cell lysate in 1 1nl binding buffer of Actin column, lane 4: Flow trough of 100 J.Ll RAW cell lysate in 1 n1l binding buffer of control colmnn (beads alone), lane 5: Actin colwnn wash, lane 6: control colun1n wash, lane 7: elution of Actin colmnn with 500 f.!ll M NaCl, lane 8: elution of control column with 500 Jill M NaCl, lane 9: elution of Actin column with 500 f.!l 0.2% FA, lane 10: elution of control colun1n with 500 J!l 0,2% FA.

69

kDa

1

2

3

4

5

6

7

8

9

10

200
116

97

66

45

21 14

Figure 11. NHS-anti-Actin affinity chrotnatography column. 50 J.tg anti-Actin \Vas bound to 100 Jll NHS resin, 20 mM Tris pH 8.0 was usedas binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF n1e1nbrane for Western blotting. The blot was probed with antiactin. Lane 1: crude extract ofRA W n1acrophages, lane 2: anti-Actin antibody, lane 3: Flow trough of 100 J.!l RAW cell lysate in 1 tnl binding buffer of Actin column, lane 4: Flow trough of 100 ~tl RAW cell lysate in 1 tnl binding buffer of control column (beads alone), lane 5: Actin colwnn wash, lane 6: control column wash, lane 7: elution of Actin column with 500 f.!l 1 M NaCl, lane 8: elution of control column with 500 J.Ll 1 M NaCl, lane 9: elution of Actin column with 500 fll 0.2% FA, lane 10: elution of control column with 500 J.Ll 0.2% FA.

70

kDa

1

3

4

5

6

1

9

10

200
116

97 66 - - - -

45

21

14

Figure 12. NHS-anti-HSl affinity chromatography column. 50 flg anti-HSl was bound to 100 J.tl NHS resin, 20 mM Tris pH 8.0 \Vas used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF metnbrane for Western blotting. The blot was probed with antiactin. Lane 1: crude extract ofRA W macrophages, lane 2: anti-HS1 antibody, lane 3: Flow trough of 100 ~tl RAW cell lysate in 1 ml binding buffer of anti-HSl colunm, lane 4: Flo\V trough of 100 J.tl RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 5: anti-HSl column wash, lane 6: control colutnn wash, lane 7: elution of anti-HS 1 column with 500 fll 1 M NaCl, lane 8: elution of control colu1nn with 500 ~tl 1 M NaCl, lane 9: elution of anti-HS 1 column with 500 J.tl 0.2% FA, lane 10: elution of control column with 500 J.tl 0.2% FA.

71

1
kDa

2

3

4

5

6

7

9

10

200
116

97
66

45

! ... Jlti .]ffi-ilil

21

14

Figure 13. NHS-anti-AnXAl affinity chromatography column. 50 J..tg anti-AnXAl was bound to 100 Jll NHS resin, 20 mM Tris pH 8.0 'vas used as binding buffer. Fractions were collected and runon a 9% gel and transferred to a PVDF membrane for Westen1 blotting. The blot was probed with anti-actin. Lane 1: cn1de extract ofRAW macrophages, lane 2: anti-AnXAl antibody, lane 3: Flow trough of 100 J.!l RAW cell lysate in 1 n1l binding buffer of anti-AnXAl colunm, lane 4: Flow trough of 100 J!l RAW cell lysate in 1 ml binding buffer of control colun1n (beads alone), lane 5: anti-AnXAl column wash, lane 6: control colunm wash, lane 7: elution of anti-AnXAl column vvith 500 Jll 1 M NaCI, lane 8: elution of control colunu1with 500 J..tl 1 M NaCI, lane 9: elution of anti-AnXAl column with 500 1-11 0.2% FA, lane 10: elution of control colutnn with 500 Jll 0.2% FA.

72

kDa
200
116

2

3

4

5

6

7

8

9

10

97

66

45

21
14

Figure 14. NHS-anti-AnXA2 affinity chromatography colu1nn. 50 J.tg anti-AnXA2 was bound to 100 J.tl NHS resin, 20 mM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF membrane for Western blotting. The blot was probed with anti-actin. Lane 1: crude extract of RAW tnacrophages, lane 2: anti-AnXA5 antibody, lane 3: Flow trough of 100 J!l RAW cell lysate in 1 ml binding buffer of anti-AnXA5 colun1n, lane 4: Flow trough of 100 J.tl RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 5: anti-AnXA5 column wash, lane 6: control colu1nn wash, lane 7: elution of anti . .AnXA5 column ·with 500 ~Ll 1 M NaCl, lane 8: elution of control column with 500 J.tl 1 M NaCl, lane 9: elution of anti-AnXA5 colmnn with 500 ~d 0.2% FA, lane 10: elution of control column with 500 J.!l 0.2% FA.

73

1
kDa

2

3

4

5

6

7

8

9

10

200
116

97
66

45

21 14

Figure 15. NHS-anti-AnXA5 affinity chromatography column. 50 J.tg anti-AnXA5 was bound to 100 j..tl NHS resin, 20 tnM Tris pH 8.0 was used as binding buffer. Fractions were collected and run on a 9% gel and transferred to a PVDF men1brane for Western blotting. The blot was probed with anti-actin. Lane 1: crude extract of RAW macrophages, lane 2: anti-AnXA5 antibody,lane 3: Flo"Vv trough of 100 f.!l RAW cell lysate in 1 1nl binding buffer of anti-AnXA5 colunm, lane 4: Flow trough of 100 J.tl RAW cell lysate in 1 ml binding buffer of control column (beads alone), lane 5: anti-AnXA5 column wash, lane 6: control colmnn wash, lane 7: elution of anti-AnXA5 colun1n with 500 J.tl 1 Ivl NaCl, lane 8: elution of control colmnn with 500 j..tl 1 M NaCI, lane 9: elution of anti-AnXA5 column \vith 500 ~Ll 0.2% FA, lane 10: elution of control colmnn with 500 J.tl 0.2% FA.

74

Figure .16

KDL Y ANTVLSGGTTMYPGIADR

IWHHTFYNELR

"'"'"'"''"" QLLEEKQEEALSGDGHSWETLK
~srz

similar to beta-actin Accession 38 086 870.0 .,,.,,,,.., ..,.EGNPEEDITADQTNAQAAAL YK EAIIRINVGGKLLTNHLK

~~--~

capping protein (actin filament), gelsolin-like Accession 6 680 842

actin related protein 6 Accession 21 3 13 172

T30847 actin binding protein ACF7, neural isofonn 2 Accession 7 513 5 86 EYEEDGAR

"'

..

LLKYIEGVSDFNLR

LLLRKEGADFHTSAEFEVVR

FHLLPEQRGVLGTSRTR
~23

ADVL_MOUSE Advillin (p92) (Actin binfing protein DOC6) Accession 14 547 906

actinfilin Accession 2 I 728 394

75

Figure 16 continued

WNLLLDTLLHSGGLIPRILLKSSK

IWHHTFYNELR

KDLYANTVLSGGTTMYPGLADR

similar to beta actin Accession 38 086 870 YPIEHGIITNWDDMEK

actin-like Accession 8 850 209

.~;.u

::

actin Accession 4 50 I 881

B25819 actin: fetal ;kelei~Vadul;"" cardiac muscle-mouse Accession 90 263

.iJHhJJb~?~'"~"" ""' actin-related protein T I Accession 13 386 318

' li:~,i~\, :;ii.,

SPWSNKYDPPLEDGAMPSAR WSPLPPMGTR AVFPSIVGRPR
l~.(l

j:i
es-~· 90-~

~~

::~

E t
·~

~ '\1 ,~.:~. ,!.: ~.l~t·fl;J;,~7~. ~. _ MOUSE
IPP Acti~ binditrg p~otein"' IPP (MIPP protein) Accession 13 432 168 "' AGFAGNDAPR

~

,~.illl.t.,~..,u.~ct.IJ,,bJ.L.Jl '··IU,J~,...,...,....Jt"--~~~"""L·-~,., Accession I 363 149 Accession 38 089 775 MQEITIIAPPERK RGILTLK Accession I 345 668

similar to actin, gamma, cytopla smic Accession 38 090 438

similar to mutant beta-a~~tin Accession 38 086 842

76

Figure I6 continued
EMAKVVSPDFCVK PEYDEAGPSIVHR GKVLGFR

similar to actin-12 Accession 38 087 599

actin, gamma 2 propeptide; actin, alpha 3 Accession 4 501 889

kaptin; actin binding protein Accession 19 526 916

AGY AGEDCPKVDFPT AIGVVLER
~i~2 ~b~2

PLL VLRGLDGFVCPR """""~-"0E' EDEEEEEGSIVNGSTTEDEEQTR

BRGl/bnn-associated factor 53A; actin-like 6 Accession 9 789 893

Fascin homolog 2; actin binding protein retinal Accession 27 370 192

Nexilin; nF actin binding protein Accession 41 054 994

ETADFKVDTKAAGSGELGVTVK ACSAIHA VNLR

EARQALS WS YSIL TGHIWVNPL VK

WSPLPPMGTR

FLNB __MOUSE Filamin B (FLN-B) (Beta-filamin) Accession 38 257 404 AELINIHHLMVELKKHK

Accession 27 370 318 LTELQRDL VGVENLIAPGREFIR

MOUSE (MIPPprotein) Accession 13 432 168

FERM, RhoGEF and pleckstrin domain protein 2 Accession 21 704 022

77

Figure 16 continued
HPDSPALLYQFRLGDEK DDEETTALVCDNGSGLVK YGSARRSMTSSTPPTSTANASR

related protein 8 homolog Accession 13 937 369 QFMNKSLSGPGQ LLLNNDNLLR

~:,
t

ALERHQGGASR

microtubule-actin crosslinking factor I Accession 25 021 548 QVQLDPLPK EVEGKSPEEVMEYSA VFWER
~6.0

INALMH ALI ELR

dependant regulator Accession 34 785 644

TLQTISLLGYMK
tOO :;

DLAAGAFATK

LDPRLARLLGVHTQTR

:t :l
7c-J

l :i ~J.

~

..J
"l
lS~
1

"'' ~ ~7J~' ~~ 15: ~ ~9$ ~:
'fl~

I ,,

~;'

.
I
:

I
~~8·
1

1 oJ ~~~

:k\;,~~.TJ~J ;JJJ1 ~ ·., LJ_.,
]

3~3

!i

I I1"' )1.~.· I l. ""I r,,·: ! ] !
I ·· : ·

:
I
I

m··
~o::A
t

~

,.

.

t?~ j f'
i

'f
'

I

II

1

I

!

!
1

I II

SWVSNF related, matrix'associated, actin dependant regulator Accession 7 I 06 417

78

Figure 16 continued
NELRRQAPPPPPPSR '"'""'"' ""' GGGGGGGGGGGGGGGGGGQPLR AAPTTPPPPVK

Accession 38 083 702

Accession6 678 581

NIDPRHLCHT ALPR

KTPGPVRGLAPPPPTSATPSLLSNR

Wiskott-Aldtich syndrome homolog (human) binding protein Accession 13 507 686 GSPAGLGAPRPPFPGNRGAAFGAGSAR

Wiskott-Aidrich syndrome protein interacting protein Accession 23 346 579 KA VLFCLSDDK

TFVSITPAEVGVLVGK GAPPPPPSR
100:i

:l

~~l . "j

I ;

§ "l ~ 40~~

J:l

k~:~:.ll~1: ·~ I ~tJ,,,~:ltL~~"
,;, Profiiin I; aCi1n binding 'Protein Accession 6 755 040
""' "" ,,.,.,.._,.,., NWSGNMASGV ADSDDVIK · HELQANCYEEVK
1~ -.

LSEVKKLVPK

~.4

:j

:I
6$ ~

ni

v. ~
$~ ~

~

h~1~~-~~Ll'i~~ilJ~~f
cofllin'"'I, ti~n-ii'ms~'iei~ofo~m ·&~
'"' '"' '"'

I

roo

&oo

Accession 6 680 924

similar to cofilin, non-muscle isofonn Accession 38 080 273

similar to ARPI actin-related protein 1 homologA Accession 38 080 491

79

Figure 16 continued
EMAKVVSPDFCVK

actin-related protein 2; ARP2; homo sapiens Accession 5 031 571

similar to actin related protein 2/3 complex, subunit 5 Accession 38 049 444 YFEITSEAPFLHYLSMFSSK

similar to actin-12 Accession 38 087 599

~ ~~~ .,~. E
!

~~·
.. I

NLNAIVQK

PVHAVFVSEGKIL1t:GFSR

~ll

I
!

·m
1S~

·' .., , ., J ,: . il I I, ~ I·, ~ , ~;, j ',':· .· .·~··."".·'·,.·,. j· ·' , ,·. l r;~''i ',4 i i:'~'~~' ·-' · '~",·,·l", ,i : 'J " ~~,.,, · o.'I·.:,!J,l.I..:J:J..Wl;~i;.l);!J!.lhtil ' ,,L.J.;,..\~-'···-~--~·~--- ,l~L; ·~L'*~IJ-t:,,lJJ ];., 11 I ' :.!i~ I· '--~~~ Cor';nin~ acti~1 bi~;ding p..6tein"'] A Coronin, actin binding protein
t

1·~

!

·I

~~4.0 t

.... ~.-~~ Lj .1
4(lt: (

I

~~ ~. ~.., .~. ·"·~·~L
1

j; · ~
1& ~

"'·'"·~r.,i
:

'/<1

55~)'~

C~<l ~~l.i

jj!
I

T ----.-

VA

'""

""

"''

Accession31 418 362

lA;coronin-Iike actin binding protein Accession 6 753 492 KCEPIVMTVPRK

TVPIEA VTSKTSNIRANFENLAK

YAVGIEYQSK

TISVRVTTMDAELEFAIQPNTTGK

IIi.

extensi~n spike protein
Accession 462 608

MOES MOUSE MoeS'in (Membrane organizing

80

Figure 16 continued
KQLFDQVE AKDLEGVD!ILGVCSSGLLVYKDK

Accession 38 570 129

Accession 7 305 031

ATPLPAEGKKNTLR

GAAGLGDERDGGPR

GIHPSAPHRNGGGGGGSGLHCAGNGGG "'"'""'"''""oGGGPRVVR

SCCANDPASILPGLTDECCAPHIK

GMGLGDERDGGPR

VTPLPFQPQASSHETLNVVEEKK
~~~.3

KTTPIEAASSGARGLK

"""'""'"""' SAVGHEYVADVEK

Accession 29 789 052

Hematopoietic cell specific lyn substrate 1 Accession 13 938 627

81

Figure 16 continued
W1SIMTER

AnXAl protein Accession 4 502 I01

AnXA2 protein Accession 13 435 564

An.'XA4 protein Accession 33 416 530

CIEDSFKSETHGSLEEAMLTVVKCTR GLGTDEDSILNLLTSR QLKKAMEGAGTDEK

f'vfPAEGEDLKLSCVVN'hl'L YR.-

-.LPNFGFVVFDDSEPVQK· -. YHPQALIYPLTVASK.-

FRAPl Accession 9 910 228

Accession 34 328 180
-.VVLIGESGVGKTNLLSRFTR-SVPISRTEVPPDDEPA YCPRPVYQYK.-

LVDFVIHFMEEIDKEISEMK

RAB25 Accession 31 980 838

STARD13 Accession 28 893 539

Arp2/3 complex Accession 5 031 595

82

-.IGQGASGTVYTAMDVATGQEVAIKQMNLQQQPK.-.KRYTVVGNPYWMAPEMINGR.-. YAEDIFGELFNEAHSFSFR.-

::,
~'

:..
{~

'~
t'

~"
;;:\;"

rL

i!

i

I

·w

LIM kinase Accession 6 754 548

WAVE Accession 13 994 209

PAK Accession 6 754 978

Figure 16. Peptides detected in captured Fc-receptor co1nplexes by LC-MS/MS. Fc-receptor con1plexes were captured using the LARC n1ethod and analysed by LC-MS/MS. Alpha, beta, and gamma actin and n1any related actin isofonns were observed in the phagosome as well as HS 1 and AnXAl, AnXA2, AnXA4, AnXA5, AnXA6 and ras-GTPase-activating protein SH3-domain binding protein, FMS-like tyrosine kinase 1, FERM, RhoGEF and pleckstrin domain protein 2, RhoGTPase-activating protein, RAB25 and FKBP-rapmnycin.

83

Table 1. Peptides detected in the elutions with NaCl and FA ofNHS affinity columns by LC~ MS/MS. NHS affinity columns with the protein actin or antibodies against actin, HSl, AnXAl, AnXA2, AnXA4 or AnxA5 affixed to the beads \Vere incubated with RAW lysates. Proteins that bound to the affinity columns were eluted from the column with NaCl followed by elution with FA. Mass spectron1etry analysis of the elutions resulted in a large variety of ditierent peptides detected by LC-MS/MS.

Reference CokJmn elutioo
Scan(s)

P(pro) Sf Score

MW

Accession PepMe (Hits)

Actin ENaCI

2gii66BOn41reijNP_fl31713.11 cofilin 1, non·muscle [Mus musculus]
5gil31712036lreijNP_853613.11 eukaryotic translation initiatoo factor 5A [Mus musruusj 8gil73050271re~NP_ 038537.11 enolase 2, gamma neuronal [Mus musculus]

P(pep) Sf XC Sp RSp Ions 5.02E-12 3.14 34.26 18559.4 6680924 4(3 001 0)
1 .01E-11 0 .97 1 .81E·10 2.38 4.50E-10 4 .12 5 .19E.09 1.34 1.99E.08 2.03 4.48E·08 3.08 7.16E-08 1.36 1.64E·07 0.95 1.93Eo07 0 .98 2.05E-07 0.94 2 .55E-07 1.46 2.81E.07 1.89 4.53E·07 1.66 5.58E.07 1.15 6.62E·071.53 8.17E-07 4.79 1.04E·06 0 .93 1.23E-061.80 1 .38E·06 0 .92 1.40E·06 0.81 1.54E·06 0.90 1.58E.06 0.94 2.68E~6 0.76 2.75E·06 0.90 3.04E·OO 0.78 3.43E·06 1 .69 4.37E·06 0.52 10.25 16832.2 31712036 1(10000)

9gil70778976~ef]NP_032854.21 phos~oglycerate kinase 1[MJs musculus] 15 gil67534921re~NP_ 034028,11 coronin, actin binding protein 1A [MJs musculus] 18 gil41350312~eijNP_Q38636.2I nascent polypeptide-assodated COOlplex alpha subunit isoform b[Mus musculus] 23 gil114326446lrefiNP_ 071855.21 myosin, heavy pol)~epMe 9, non-muscle isofonn 1[MJs musculus] 25 gil31982186~eijNP_Q32643.21 mala!e dehydrogenase~ NAD (mitochondrial) [Mus musculus] 28 gil7305075~e~NP_D38744.11 ras-GTPase·activating prolein SH3-domain binding protein [Mus musc~usj 29 gil13385408~eijNP_Q80195.1I ribosomal pro!ein l11 [Mus musculus] 30 gil124517663;eijNP_Q34860.~ anne~n A1 [MJ smuscuk13] 31 gil94378264~efjXP_983381.11 PREDICTED:similar to ribosomal protein l38 [Mus musculus] 32 gil52353955teijNP_Q58662.21 J.phosphoglycerate dehydrogenase [Mus musculus] 34 gir0794816yeijNP_ 001020559.11 hypothetical protein LOC433182 [Mus. musculus! 36 g ir106439lreijNP_Q35785.11 !uboon, beta 5[Mus musruusj 37 gil8393544lreijNP_Q58580.11 heterogeneo us nuclear nbonucleoprot~n C [Mus musculus] 39 gil112293264yeijNP_ 031978.~ f1o!ein disulfide isomerase assodated 3[Mus musculus] 41 gil14927 4531jreijXP_ 001473875.11 PREDICTED: similar to heterogeneous nuclear ribonucleoprotem A21B 1[Mus 43 gil37674277reijNP_932758.11 heterogeneous nuclear ribonucleoprot~n A3 isoform a[Mus muscu1us] 45 gij94388148lreijXP_912877.21 PREDICTED: similar to Npm 1protsn [Mus musruus] 46 gil114326546lre~NP_ 075907.21 phosphoglycerate mutase 1[Mus mus~us] 47 gil116256512lre~NP_001 070733.11 heterogeneous nuclear ribonucleoprotein Disofonn a[Mus musculus] 48 gij13385598~e~NP_Q80371.11 small nuclear ribonucleoprotein D3 [Mus muscu~sl 49 gil31 980669'e~NP_058655.21 ribosomal protein S3a ~Ius musculus] 50 gil149233662lreijXP_001473770.11 PREDICTED: similar to Ribosomal pro!einl17 [Mus musculus] 52 gil149267407~e~XP_Q01480522.11 PREDICTED:hypotheticat prot~n [MJs musculus] 53 gil83004436lrei1XP_894928.11 PREDICTED: similarloribosomal prol~n 57 isoform 1[Mus musculus] 54 gil149256684lre~XP_Q01481125.11 PREDICTED: simi~r to macrophage migrar.on inlibitory factor isoform 1[Mus 55 gij13384620ire~NP_Q79555.1I heterogeneous nuclear ribonucleoprotein K[Mus musculus] 56 gil30061401lreijNP_835734.11 histone duster 2 ,H3c1 isoform 2[Mus musc~us] 58 gi]82898939lreijXP_921877.11 PREDICTED: F-box only pro!e\n 24 [Mus musc~us] 59 gir106331jreijNP_Q34566.11 H2Ahistone fam~y, member X[Mus muscukls] 60 gil133778949~ei1NP_Q01 003911.21 adisintegrin·like and metalloprotease jreprolysin lype)with thrombospondin ty 62 gil58037267~eijNP_082235.11 proteindisuffide isomerase-associated 6[Mus rnusc~us] 63 gil149255974lrefiXP_Q01475303.1I PREDICTED: hypothetical prot~n [Mus musruusj 64 gil33468857yefiNP_Q32274.11 histidine triad nucleotide b~ding p rotein 1[MJs musculus] 65 gil149261626,ef1XPJ85520.21 PREDICTED: similar to ribosomal prol~n S17 [tills musculus] 66 gil6678471ye~NP~033475.1 1 tub~in, alpha 7[Mus musculus] 67 gil19111158~eijNP_579~27.1 1 zinc f~ger, AN1·type domain 2A[Musmusruusj 68 gil7657357ye~NP_ 056596.11 nucleosome assembly prolein 1~ike 1[Mus musculus] 69 gi~7~97~re~NP_035164.11 peroxiredo~n 1[Mls musculus] 70 gill4n70876yefjXP_001473955.11 PREDICTED: hypothetical protein [Mus musculus] 71 gil94385999,eijXP_ 486188.41 PREDICTED: sim~ar to Nucleophosmin 1isoform 1[Mus musc~usj 72 gil126723461lrei1NP_Q33970.3I chaperonin subuntt 8(lheta) !Mus musculus] 73 gil149261616~eijXP_ 001476809.11 PREDICTED: ~m~ar to nbosom~ IJOiein l22 [Mus musruusj 75 gij6680067lreijNP_032181.11 glucose phosphate isomerase 1jMus musruus]

24.19 47296.3 7305027 3(2001 0) 54.23 44550.2 70778976 6(50 01 0)
24.21 50988.9 6753492 30.24 23383.7 41350312 4424 226369.7 114326446 34.24 35611.2 31982186 10.21 51828.4 7305075 10.24 20252.3 13385408 10.16 38734.0 124517663 20.22 8203.8 94378264 30.19 56585.3 52353955 26.16 47140.5 70794816 28.22 49670.5 7106439 20.16 34384.5 8393~4 70.18 56678.0 112293264 10.16 87620.5 149274531 26.1i 39651.7 37674277 10.18 17276.4 94388148
3(2 001 0)

3(3 0000)

6(3 012 0) 5(311 00) 1(1 0000) 1(1 0000)
1(1 0000)

2(2 0000) 3(3 0000) 3(2 0100)
3(21 000) 2(20000) 7(7 0000) 1(1 0000) 3(201 00) 1(1 0000) 1(1 0000)

20.11 28831.8114326546 2(20000) 1(1 0000) 2(2 0000) 1(1 0000) 1(1 0000)
3(3 0000)

10.14 38353.9116256512 10.15 13916.2 13385598 20.13 29885.6 31930669 10.18 17579.2 149233662 10.15 9820.6 149267407 30.17 22084.6 83004436 10.10 12517.2 149256684 4 .63E·06 1.07 20.16 50975.9 13384620 5.48E-06 1.42 20.14 20246.6 30061401

1(1 0000) 2(2 0000) 2(20000) 8.24E·06 0 .14 20.09 654292 82898939 2(2 0000) 9.11E·06 0.84 10.18 15142.5 7106331 1(1 0000) 210 o2oOl 1(1 0000)

9.70E·06 o.os 12.09 1m10.3 133778949 1.33E.05 0.97 10.25 48688.8 58037267 1.36E-051.23 20.14 13757.1149255974 1.39E·05 0.60 16.12 13776.8 33468857 2.04E-05 0.61 10.13 17639.4149261626 2.06E·05 2 .01 40.16 49959.2 6678471 2.33E-05 0.31 10.10 19281.1 19111158 2.91E·05 0 :64 10.13 45344.8 7657357 2 .93E-05 0.64 18.13 22176.3 6754976 2 .93E·05 0 .96 12.16 32837.8 149270876

2(20000)
2(1 0100) 1(10000) 4(4 0000)

1(1 0000) 1(1 0000) 2(11 000) 2(1 0001) 3.28E·05 0.~ 10.10 31404.0 94385999 1(1 0000) 3 .6 1 E-05 0.89 10.14 59555.1126723461 1(1 0000)

4.01E·05 0.92 10.16 18495.2 149261616 1(1 0000) 5.98E-05 0.82 18.17 62767.5 6680067 2(11 000)

84

Table 1 continued

Aclin EFA

a-Aclin ENaCI

Tl gi[6677813[renNP_033'124.11 nbosomal protein S8 [Mus musculus] 78 gi[6753320[re~NP_033966.11 chaperonin subumt 3 (gamma) [Mus musculus] 79 gi[110625979[ref[NP_080283.3[ eukaryotic translation elongation factor 1 gamma [Mus musculus] 81 gi[6678439[re~NP_033456.11 protease. serine. 2 [Mus musculus] 82 gi[6679078[re~NP_032731.11 nucleoside-diphosphate kinase 2 [Mus musculus] 83 gi[6753324[re~NP_033968.1[ chaperomn subunit 6a (zeta) [Mus musculus] 84 g1[51772073[reqXP_486686.1[ PREDICTED· hypothetical protein [Mus musculus] 85 Q1[94400775[reqNP_033061.3[ recombining binding protein suppressor of hairless isoform ·1 [Mus musculus] 86 gi[6753060[re~NP_033803.1[ annex1n A5 [Mus musculus] 87 gi[77404392[reQNP_062750.2[ staphylococcal nuclease domain containing 1 [Mus musculus] 88 gi[149251893[tef[XP_001481376.1[ PREDICTED: RIKEN eDNA 4922501 L14 gene [Mus musculus) 89 gi[31542131[re1[NP_075699.2[ acidic (leucine-rich) nuclear phosphopro1ein 32 family. member E [Mu~ musculus] 90 gi[94410198[reqXP_999357.11 PREDICTED: hypothetical protein [Mus musculus] 92 gi[124485712[re~NP_077243.2[ ribosome binding protein1 isoform a [Mus musculus[ 93 gi[124486680[re~NP_032426.2[ integrin alpha L [Mus musculus[ 94 gi[22122497[re~NP_666132.11 glycolipid transfer protein domain containing 2 [Mus musculus] 95 gi[27370366[re~NP_765481.11 poly (ADP-ribose) polymerase family, member 12[Mus musculus] 96 gi[139949022lre~NP_001077279.1[ hypothetical pro1ein LOC72446 [Mus musculus] 97 gi[30425250[re~NP_780706.11 hypothetical protein LOC238680[Mus musculus] 98 gi[94375BOO[reQXP_980967.1[ PREDICTED: similar to nucleoside diphosphate kinase B [Mus musculus] 99 gi[149259714[rei[XP_001480396.11 PREDICTED: hypothetical protein ~OC73673 Jsoform 2[Mus musculus] 100 gi[21450625[re~NP_659207.11 eukaryotic lransla1ion initia1ion factor 4A1 [Mus musculus] 101 gi[15S17203[reijNP_254279.11 chlonde in1racellular channel 1 [Mus musculus] 102 gi[13399310[reijNP_080239.1I ribosomal protein S10 [Mus musculus] 103 gi[82930015[reijXP_486217.21 PREDICTED: s1m1Jar to nuclear pro1ein-NHP2-Iike protein [Mus musculus] 104 gi[149249349[ref[XP..;001471896.11 PREDICTED hypothetical proteln[Mus musculus! 106 gi[6753066[reqNP_033817.11 apuriniclapyrimidinic endonuclease 1 [Mus musculus] 107 gi[28077005[reijNP_082631.1ftransmembrane protein 48 [Mus musculus} 108 gi[41 054990[re~NP_955761.11 hypothetical protein LOC212377 [Mus musculus} 109 gi[2394391B[reqNP_705693.11 Nice-4 protein homolog isofonn ~[Mus musculus] 110 gi[34328180[reijNP_034358.2f FMS~ike tyrosine kinase 1[Mus musculus] 111 gi[1492635221reqXP_282560.61 PREDICTED: serine (or cysteine) proteinase inhibitor. clade A, memb~r 3A isoforr 112 gij146231960jre~NP_620570.2[ chondroitin sulfate proteoglycan 4 [Mus musculus] 113 gi[31981925[re~NP_033552.2[ tyrosine 3-monooxygenase/tryptophan 5-monoox)i!Jenase activation protein, epsilor 114 gi[149252715jre~XP_920617.3[ PREDICTED: similar to hCG33036. 1sofom1 5 [Mus musculus] 115 gi[62526048[re~NP_001004066.11 zinc finger protein 366 (Kruppel-fike) 1sotorm a [Mus musculus] 119 gi[6753020[reqNP_033776.1[ autoimmune regulator (autoimmune polyendocnnopathy candidiasis ectodermal dysl 120 gi[27734060[re~NP_775545.11 ubiquKin carboxyl-terminal hydrolase CYLD [Mus musculus] 121 gi[3198064B[reijNP_058054.21 ATP synthase. H+ transporting mitochondrial F1 complex, beta subunit [Mus muse· 122 gi[149289767lref1XP_001476231.1[ PREDICTED: hypothetical protein [Mus musculus] 123 gl[111162657[ref[NP_001 036115.1[ OCN1. defective in cullin nedd:/lation 1, domain containing 2 isoform d [Mus m 124 gi[83004553[re~XP_358238.31 PREDICTED: similar to Hmgb1 protein [Mus musculus] 126 gi[26986Eo69[re~NP_758475.11 solute carrier family 6 (neurotransmi1ter 1ransporter). member 17 [Mus musculus] 127 gi[94381279[re~XP_997159. 1lPREDICTED: ubiqu!tin specific peptidase 31.[Mus musculus] 128 gi[31560030[ref!NP_om45.2[ tropomyosin 1, alpha [Mus musculus] 129 gi[157S41168]ref]NP.;033962.2f cyclin K [Mus musculus] 130 gi[162461907jretjNP_034611.21 heat shock protein 9[Mus musculus] 131 gi[149234328]ref[XP_001480230.1[ PREDICTED: similar to Zinc finger. BED domain containing 4 [Mus musculus! 132 gi[124487331[ref]NP_080954.4[ biliverdin reductase A [Mus musculus! 133 gi[40549397lreijNP_112148,2[ ankyrin repeat domain pro1ein17 isoform a [Mus musculus] 1 gi[6671509[re~NP_031419.1[ actin, beta, cytoplasmic [Mus musculus] 2 gi[6680924[re~NP_03t713.1l cofilin 1. non-muscle [Mus musculus] 3 gi[7077&976[re~NP_032854.2[ phosphoglycerate kinase 1 [Mus musculus] 4 gi[67S5863[renNP_035761.11 tumor rejection antigen gp96 [Mus musculus] 5 gi[33563240jref[NP_033736.1[ actin. alpha 1. skeletal muscle [Mus musculus) 6 gi[7242197[re~NP_035315.11 proteasome (prosome, macropain) subunit. beta type 1 [Mus musculus] 8 gi[149249466[ref[XP_001477320.1[ PREDICTED· hypothetical protein [Mus musculus] 9 gil6671539[re~NP_031464.1[ aldolase 1, A isoform [Mus musculus] 10 gij319B0645[re~NP_081628.2( golgi reassembly stacking protein 2[Mus musculus] 12 gi[126032329[ref[NP~034236.2[ eukaryotic translation elongation factor 1 alpha 1 [Mus musculus] 13 gil124487183[ref1NP_001074638.1[ hypothetical protein LOC104816 [Mus musculus) 15 gi[124301208)rei[NP_7$6004.2[ dedicator of cytokinesis 6 {Mus musculus] 18 gi[52421788)reqNP_001 003955.1[ RAB11 family interacting prolein 5 (class I) isoform 1 [Mus musculus] 19 gil149269907[ref[XP_001472447.1[ PREDICTED similatto ribosomal protein L35 [Mus musculus) 20 gil22122485[reijNP_666129.1[ gamma-aminobutyric acid (GABA-A) receptor. pi [Mus musculus) 21 gil94393045lreijXP_138107.7[ PREDICTED: hypothetical protein [Mus musculus) 22 gi[8290S666jreijXP_912823. 11 PREDICTED: similar 1o longevity assurance 3-like prole1n[Mus musculus] 23 gil30425068lreijNP_780576.1[ stonin 2 [Mus musculus] 24 gil51 092277jreijNP_932785.1[ pro1ocadhenn alpha 2[Mus musculus] 25 gif13439B90[reijNP_056602.1I histone cluster 1. H1 e {Mus musculus] 26 gil11 02273771ref[NP_001035999.11 gelsolin-like capping protein [Mus musculus] 27 gi[6680229[reqNP_032278.11 high mobiiRy group box 2[Mus musculus] 28 gi[149249099freqXP_916226.31 PREDICTED: similar 1o Ankrd26 protein [Mus musculus] 29 gi[149241501lrefjXP_001480767.1[ PREDICTED: similar to interferon-Inducible protein 203isoform 1[Mus museu 30 gij82956899[ref[XP_926227.11 PREDICTED: hypothetical protein isoform 4 [Mus musculus] 31 gi[118026904!renNP_631982.2[ nucleolar protein family 6 [Mus musculus] 32 giJ158749576lrefjNP_0011 03632.1[ cell division cycle associated 2[Mus musculus] 33 gi[22122743jre~NP_66&309.1[ acyl-GoA synthetase medium-chain family member 2[Mus musculus] 35 gif82993022]reijXP_619443.2I PREDICTED similar to mKlAA0734 protein [Mus musculus] 36 gi[84794617[reqNP_D01 028399.1[ solule carrier family 5 (sodium/glucose co1ranspol1er), member 10 [Mus museu 37 gi[124486863~ef[NP_001074753.1[ hypothetical LOC620779[Mus musculus] 38 gil84662727)reijNP_001033788.1[ fruclosamine 3 kmase isoform b [Mus musculus) 39 gi[6680245[re~NP_032290. 11 homeobox A13 [Mus musculus] 40 gi[68319958jreqNP_001034844.1[ cytochrome P450. family 2, subfamily c, polypeptide 68(Mus musculus] 1 gi[6680924[re~NP_031713.11 coftlin 1, non-muscle [Mus musculus] 2 gi[33659580lreQNP_034835.1[ galectin 3[Mus musculus] 4 gi[72384374lreqNP_062426.2[ DEAD (A$p..Giu-Aia-Asp) box polypeptide 21(Mus musculus] 5 gi[112293254[ref]NP_031978.2[ protein disulfide isomerase associated 3 [Mus musculus] 9 gij6681095[re~NP_031834.1[ cytochrome c. somatic (Mus musculus] 11 gi[124339838lrefjNP_036566.2[ heat shock 70kDa protein 1-like [Mus musculus] 13 gij8393739jreijNP~05B066.1(1ysozyme {Mus musculus] 17 gi[31982186(reqNP_032643.2( malate dehydrogenase 2, NAD (mrtochondrial) [Mus musculus] 18 gif157951608(ref[NP_765988.2[ OnaJ (Hsp40) homolog. subfamily C, member 8 [Mus musculus] 19 gif94380203[re~XP_001 003154.1[ PREDICTED: similar to Gluco.se phosphate isomerase 1 isoform 2[Mus museu 21 gi[45544613jre~NP_035168.1[ paired box 4 [Mus musculus] 23 gi(33563240frenNP_033736.11 actin. alpha 1, skeletal muscle [Mos musculus] 25 gi[31982724fte~NP_058056.2( MYB binding. protein (P160) 1a [Mus musculus] 26 gi[117938312lreqNP_031798.2[ human immunodeficiency virus type I enhancer binding protein 1{Mus musculus] 27 gi(161760867(refjNP_001104572.1flamin A isoform C [Mus musculus] 28 gi(82930015jreijXP_486217.21 PREDICTED: similar to nueleor pro!ein·NHP2-Iike protein [Mus musculus]

6.20E-05 6.71E-05 6.97E..05 9.19E-05 9.77E-05 1.01E-04 1.04E·04 1.06E..04 1.12E-04 1.17E..04 1.28E..04 1.34E..04 1.44E-04 1.59E·04 1.62E-04 1.64E-04 1.73E-04 1.87E-04 1.90E-04 1.95E..04 2.1QE..04 2.31E-04 2.34E·04 2.42E-04

0.93

0.65 2.71 0.52 0.76 0.79 0.76 0.43 1.57 2.82

0.83
0.92 1.27
1.03

0.21 0.26 0;01 0.09 1.48 0.86 0.83

1.75

0.90 0.93 2.43E-04 0.89 2.48E-04 0.24 2.64E-04 1.06 2.69E-04 0.32 3.02E-04 0.67 4.40E·04 0.72 4.53E-04 0.03 4.63E-04 0.04 4.80E-04 0.20 5.01E-04 0.60 5.01E-04 1.17 5.40E-04 0.24 5.81E-IJ.4 0.07 5.90E·IJ.4 0.03 6.12E-04 0,54 6.52E-04 0.05 6.83E-IJ.4 0.89 6.83E-IJ.4 0.43 7.19E.Q4 0.18 7.24E.Q4 0.57 8.04E-04 0.52 9.49E-04 0.23 9.57E-04 1.29 9.65E..04 0.12 9.82E-04 0.21 9.97E..04 0.78 7.07E-12 3.18 3.63E-11 2.77 2.42E-10 0.95 2.00E-08 0.81 2.22E-07 3.54 7.85E·07 0.80 1.79E-06 0.94 2.25E-06 0.39 4.57E-06 0.05 9.51E.06 2.78 1.46E-05 0.07 3.37E-05 0.26 6.12E-05 0.08 7.31 E-05 0.71

7.95E·05 0.12
9.13E-05 1.36E-04 2.05E-04 2.19E'04 3.33E-04 3.37E-04 3.99E-04 4.46E.Q4 4.55E-D4 5.36E-Il4 5.37E-04 5.59E-04 5.95E-04 7.83E.04 7.90E-04 8.62E-04 8.64E-04 9.59E.04 9. 76E.04 1.43E-13 t.OBE-10 1.22E-OO 0.03 0.04 0.06 o.16 O.S2 0.24 0.27 0.12

0.23 0.95

252304.7 146231980 29188.7 31981925 22.18 303993.4 149252715 12.10 72494.8 62526046 8.06 59042.0 6753020 8.05 106584.8 27734060 10.13 56300.1 31960648 16.06 74158.6 149269767 10.19 22868.8 111162657 8.12 21307.8 83004553 80756.6 26966569 8.11 10.11 148553,5 94381279 18.11 32708.5 31560030 18.10 54349.5 157841168 18.17 73460.8. 162461907 12.09 130639.4 149234328 10.11 33524.3 124487331 32.12 274209.9 40549397 48.23 41736.5 6671509 30.25 18559.4 6680924 10.19 44550.2 70778976 10.14 92475.1 6755863 50.20 42050.8 33563240 10.13 283no 7242197 10.23 31315.9 149249466 16.10 39355.7 6671539 10.07 47054.1 31980645 30.16 50113.5 1260323:29 8.08 60584.3 124487"183 22.11 236562.3 124301208 8.12 139554.9 52421788 10.12 14585.5 149289907 10.10 50435.7 22122485 8.09 52333.3 94393945 8.09 50031.8 82906666 99610.4 30425068 8.08 6.08 102285.6 51092277 21977.1 13430890 18.11 18.10 38768.6 110227377 10.09 24161.8 6680229 8.10 64351.3 149249099 26.08 95137.2 149241501 12.15 29990.2 82956899

10.16 10.16 44.19 10.12 10.15 10,13 10.14 10.10 26.14 46.16 20.13 10.18 20.13 14.14 22.10 8.10 8.06 10.09 26.18 18.14 10.15 22,14 20.15 10.14 10.15 10.11 26.19 8.11 12.11 24.12 10.09 14.06 20.10 20.12

24205.0 6677813 60629.7 6753320 50080.4 110625979 26203.4 6678439
17363.0 6679078

1 (1 0000)

1 (1 0000)
5 (4 0 0 1 0)

1 (1 0000)
1 (1 0000)

5801J.4.0
40984.6 58537.1 35752.2 102087.5 185392.8 29636.3 16224.6 158394.0 128085.7 34452.7 79900.3 40981.7

4201J.4.0
20502.7 28428.9 46153.7

27012.6
18915.6

14173.5
63949.9 35490.2 75409.0 109241.6 112450.6 149844.9

6753324 51772073 94400775 6753080 77404392 149251893 31542131 94410198 124486712 124486680 22122497 27370386 139949022 30425250 94375800 149259714 21450625 15617203 13399310 82930015 149249349 6753086 28077005 41054990 23943918 34328180

1 (1 0000) 1 (1 0000) 1 (1 0000) 3(201 00) 5(401 00) 4(02002) 1 (1 0000) 2 (2 00 0 G) 2(1 001 0) 4(11 002) 2(00 1 0 1) 1 (01 000) '1(1 0000) 3(201 00) 2(11 000) 1 (1 0000) 3(20001) 3(11 001) 1 (1 0000) 1 (1 0000)

1 (1 00 00)
3(201 00)
2.(000 2 0)

47902.3 149263522

2(1 0001) 4(20002) 1(10000) 2(011 00)
2(20000) 2(20000) 3 (1 0 2 0 0) 3(01 002) 1 (01 000) 2(001 01)

1 (1 0000) 2(02000) 1(1 0000) 1(01 000) 1 (01 000) 1 (1 0000) 2(11 000) 3(00300)
2(11000) 3(00111)

1 (1 0000) 5(20111) 6(3111 0) 3(30000) 1 (1 0000) 1 (1 0000) 5(50000) 1 (1 0000) 1 (1 0000) 2(1 01 00)
1 (1 0000)

3(30000)
1 (0 1 000)

3(021 00) 1 (0 1 00 0)
1 (1 000 0) 1 (1 0000) 1 (01 000)

1 (01 000) 1 (01 000) 2(00011)
2(11 000) 3{1 0020) 1 (1 0000)
1 (01 000) 3(2 01 00) 2(1 000 1)

3.27-09
5.36E-08

9. 72E,08 3.09E·07 2.00E-06 3.80E..06 5.70E-06 9.25E-06 1.97E-05 2.50E-05 3.19E-05 4.10E-05 4.55E-05

0.06 8.07 129227.1 118026904 0.20 4.09 106355.6 158749576 0.06 12.07 64268.8 22122743 0.04 10.10 129084,7 82993022 0.07 8.07 64705.9 84794617 14;09 62440.1 124486863 0.31 10.10 22687.0 84662727 0.04 16.07 39566.2 6680245 0.02 8.08 55968.6 88319958 1.90 20.26 18559.4 6680924 4.88 76.19 27414.5 33859580 93550.6 72364374 0.99 10.31 3.99 74.24 56678.0 112293264 0.88 10.17 11605.4 6681095 0.87 16.13 70636.8 124339838 0.96 10.25 16688.9 8393739 1.49 20.27 35611.2 31982186 0.69 10.17 29812.4 157951606 1.10 20.13 37843.3 94360203 0.18 20:08 38008.1 45544613 42050.8 33563240 3.48 58.21 1.09 44.16 152035.8 31982724 0.76 12.14 288324.7 117938312 0.65 10.12 65445.6 161760667 0.80 10.14 14173.5 82930015

1 (01 ()00)

2(00002)
2(01 01 0) 2(0 1 0 0 1)

o.oa

1 (01 000)
2(011 00) 1 (1 0000) 2(1 01 00)

1 (01 000) 2(20000)
9(6111 0)

1 (1 0000) 8(611 00) 1 (1 0000) 2(1 01 00) 1 (1 0000)
2(20000)

1 (1 0000) 2(20000) 2(20000)
8(31301)

5(311 00) 2(1 0001)
1 (1 0000) 1 (1 0000)

85

Table 1 continued

··Actin EFA

HS1 ElhCI

gi[163310765[ref[NP_033764.21albumin (Mus musculus] gi[1 10625979lref1NP_080233.31 eukaryotlc translation elongation factor 1 gamma (Mus musculus] gij31559817lre~NP_795953.2jtopoisomerase (DNA) II beta binding protein (Mus musculus] gi(82892443lre~XP _925627.11 PREDICTED: hypothetical protein LOC66625 isoform 32 [Mus musculus] gil31560224lre~NP~077141 .2\ hypothetical protein LOC66839(Mus musculus! 37 gil1 23858774lref1NP_001074175.11 BTAF1 RNA polymerase IL 8-TFIID transcription factor-associated [Mus muse 38 gip579516041re~NP_031624.21 CAP. adenyiate cyclase-associated protein 1jMus musculus] 39 gij1 0946676lre~NP_067328.11 solute carrier family 26, member 3 [Mus musculus] 40 gij56506023lrenNP_001008419.11 aldehyde owidase 3-like 1 [Mus musculus] 41 gij5755212lrefiNP_035319.11 proteasome (prosomc. macropaL'l) 28 subunn. alpha jMus musculus! 43 gil18087751jrenNP_291061.11 protocadherin gamma subfamily C. 5 [Mus musculus] 44 gij124487113lrefjNP_001 074866.11 myosin XVI [Mus musculus] 45gij77812699jrenNP_082280.21titin isoform N2·B [Mus musculus] 46 gij454393D4IrenNP_034544.11 huntingtin [Mus musculus] 47 gil33859474jrenNP_031784.1 1complement recep!or 2 jMus musculus] 48. gi[t 14326469jrenNP_035059.21Notch gene homolog 4 [Mus musculus] 49 gij153945814lref1 NP_035342.31 protein tyrosine phosphatase, receptor type, E jMus musculus) 50 g!I124269710irenNP_033584.31 zinc finger protein 51 [Mus musculus] 51 gij34850068jre~NP_080988.11 zinc finger protein 414 [Mus musculus] 52 giJ 82905709IrenxP_919376.11 PREDICTED: kaHikrein 12JMus musculus] 54 gil132626693jref1NP_001010833.2[ mediator of DNfldamage checkpoint 1 [Mus musculus) 55 gil157057150jref1NP_001026792.21 ATP-binding cassette, su~family A (ABC1), member 17 [Mus musculus] 56 gij160420299lre~NP_666087.3J DEAD box polypeptide 46 jMus musculus] 57 gi[124486835jre~NP_001074759.1[ BAT2 domain containing 1 [Mus musculus] 58 gij83716011~enNP_058358.21vesicular acetylcholine transporter [Mus musculus} 59 giJ67763B261renNP_075023.21 solute earner fomily 30 (zinc transporter), member 5jMus musculus) 60 gij7242183jrefjNP_035264.1 1parao~onase t jMus musculus] 61 gij21312790~eqNP_080646.1 1MYST histone acetyllransterase 1jMus musculus] 62 giJ46488923IreqNP_062387.21 astrolactin 2 isoform a jMus musculusj 63 Q!)124487133jrenNP_001 074861.11 midasin [Mus musculus] M gil33859640jreqNP.:.,035658.1) transalrlolase 1 [Mus musculus] 65 gij 12963637lre~NP_075809.1[ TNF intracellular domain-interacting protein [Mus musculus} 67 gij9790087jrefjNP_062662.11 cAMP-regulated guanine nucleotide exchange factor II [Mus musculus] 68 giJ131956281reqNP_077161.11 cleavage stimulation factor, 3' pre-RNA, subunit 1 [Mus musculus) 69 gij616756961reqNP _080579.1[ alkB. alkylation repair homolog 8JMus musculus] 1 gij730"..S99jrefjNP_038725.11 transthyret111jMus muscutusj 2 gi)110347469lrefjNP_031402.31pregnancy zone protein [Mus musculus] 3 gij6671509jref1NP_031419.11 actin, beta, cytoplasmic [Mus musculus] 4 gi)6680924lreqNP_031713.1 1cofilin I , non-muscie [Mus musculus] 5 gi)31 982300jrefjNP_032246.21 hemoglobin, beta adult major chain [Mus musculus] 6 gij76881807jref)NP_033270.3j serine (or cysteine) proteinase mhibitor, clade A, member 1b (Mus musculus] 7 gil149264482lrenxP_001471658.11 PREDICTED: hypothetical protein [Mus musculus] 8 gijt63310765lreqNP_033784.21 albumin [Mus musculus] 9 gij145301549jreqNP_OOI077424.11 hemoglobin alpha, adut. cham 2{Mus musculus] 10 gil6671539jrenNP_031464.1[ aldolase 1, A isoform [Mus musculus] 14 gij6753912[reqNP_034369.1] ferritin heavy chain 1 [Mus musculus] 16 gil11 0227377frefjNP_oct 035999.11gelsoUn-llke capping protein [Mus musculus] 17 gil1487475461ref1NP_035583.21serine (or cysteine) proteinase inhibitor, clade A, member 3K [Mus musculus] 18 gil178474991reqNP_058652.1[ hemoglobin, beta adutt minor chain [Mus musculus] 19 gil54287684jreqNP_075729.2) eukaryotic translation ~longation factor 1 dena isoform b [Mus musculus] 20 gi)1537920011ref)NP_035369.21RAN binding protein 1 [Mus musculusj 21 Qil1 49265i60jreijXP_OO·I478558.1I PREDICTED: similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPD~ 22 gij19527130jreqNP_598679.11 elastin microfibril interfacer 1 [Mus musculus] 23 gil1265t8317lrefjNP_033908.21 complement component 3 [Mus musculus] 25 Qii13385850irenNP_080524.1 1integrin beta 3 binding protein [Mus musculus] 26 gil94374469jreqXP_001 001 363.11 PREDICTED: similar to Centaurin-detta 1 (Cnt-dt ) lsoform 5 [Mus musculusj 27 Qii33563240jrefiNP _033736. 11 actin, alpha 1, skeletal muscle [Mus musculus] 28 gil31981562lrenNP_035229.21pyruvate kinase, muscle [Mus flliJsculusj 29 gi)85662377{reqNP_80B342.2I hypothetical protein LOC544678 [Mus musculus] 30 Qii33859580ireqNP_034835.1 1galectin 3 jMus musculusI 31. gil30425250jre~NP_780706.1 1hypothetical protein LOC238680 [Mus musculus] 33 g1[28077005jre~NP_082631.1 1transmembrane pro!ein48jMus musculus] 34 glj1.o\9257960jre~XP_001481361.11 PREDICTED: similar to very large inducible GTPase 1jMus musculus! 35 gll1 24286823jref1 NP_001074399.11 ataxin !~ike [Mus musculus] 36 gi)S5677482Ire~NP_766397.21 saCSJn [Mus musculiJsj 37 giJ31542095IreqNP_59S608.2j transmembrane 9 superfamily protein member 4 [Mus musculus! 38 gil70778749lre~ NP_444442.1(taste receptor. type 2, member 116 [Mus musculus] 39 gij9506541jre~NP_062378.11 diacylglycerol kinase, epsilon [Mus musculus] 40 gijS30042471re~XP_9151 24.11 PREDICTED: sim~ar to NADH dehydrogenase (ubiquinone) 1, subcomplex unkno\1\ 41 gij149270673jre~XP_999161.21 PREDICTED: similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [IV 42 gil40769298~e~NP_796347.21PTPRF interacting protein alpha 2(Mus musculusj 43 giJ 1492491 90JrenxP_001478B38.1 JPREDICTED: hypothetical protein [Mus musculusj 44 gij86990460jreijNP_997565.2j ku>esin family member tB isoform b [Mus musculus] 45 giJ23956334jreqNP_705787.1 1quiescin 06 sulfhydryl oxidase 2 [Mus musculus[ 46 gi\149250061 lrefjXP_619828.41PREDICTED: similar to Transcriptional repressor scratch 2 (Scratch homolog 2 zi1 47 gil31982472jrefjNP_031664.21 chaperonin subunit 7 (eta) jMils nlusculusj 48 gij157041258jref1NP_081471.21 castor homolog 1, zinc fi11f1er [Mus musculus] 49 gij6880457~efjNP_03241 0.1[ inositol polyphosphale-1 -phosphatase [Mus musculus] 2 gij6680924lre~NP_031713.1[ eofitin 1, non-muscle jMus musculus] 7 gi)112293264(ref1NP_031978.21protein disulfide isomerase associated 3 [Mus musculus) 8 gij31982186~eqNP_032643.2[ malate dehydrogenase 2, NAD (mitochondrial) [Mus musculus] 13 gij41350312jrenNP_038636.2) nascent polypeptide-associated complex alpha subunit isoform b [Mus musculus] 14 gil6753060[ref)NP_033803.11 annexin AS [Mus musculus] 17 gij66B1095~ef)NP_031834.11 cytochrome c, somatic [Mus ITlliSCUiusj 19 gijB 393739jrenNP_059068.1 j lysozyme [Mus musculus] 21 gil31560030~e~NP_077745.2j tropomyosin 1, alpha [Mus musculus] 23 gi)31982724~e~NP_058058,2j MYB binding protein (P16011a [Mus musculus] 26.gij6678359lreqNP_033414.11 transketolase [Mus musculus] 27 gij730507Sjre~NP_038744.1) ras-GTPase-activating protein SH3-rlomain binding protein [Mus musculus] 31 gij153792337jrefjNP_035394.2j RE\/3-Iike. catalytic subunit of DNA polymerase zeta RAD54 1 ike jMus musculus] 34 gil304252501re~NP_780706J I hypothetical protein LOC238S80 [Mus musculus] 36 gil82956899jre~XP_926227.11 PREDICTED: hypothetical protein isoform 4jMus musculusj 37 gij12433983BirefjNP_038586.2) heat shock 70kDa protein 1-fike [Mus musculus] 38 gij94385999jre~XP_486188.41 PREDICTED: similar to Nucleophosmin 1 isoform ! (Mus musculus] 39 gil146134409lrefjNP_080704.21 diacetyl/L-xyllJose reductase [Mus musculus) 40 gi[66801771 reqNP_032247.11 hemoglobin Y, bela~ike embryonic chain [Mus musculus] 44 gij31982302~eijNP_032240.2j hlstidyf-tRNA synthetase jMus musculus] 46 gilt34288917lreqNP_084514.21dynein, cy1oplasmic, heavy chain !(Mus musculus] 48 gij121949760jref[NP_035735.21thymopoietin isoform alpha )Mus musculus] 51 gil1455870921reqNP_034936.11 mye!QidJ1ymphoid or mixed tineage~eukemia tran~!ocation to 4 homolog jMus mm

31 32 34 35 36

5.23E·05 0.82 6.41E-os o.as 1.14E-04 0.50 1.15E-04 0.20 1.40E-04 0.42 t.48E-04 0.06 1.61E..Q4 0.88 1.75E-04 0.12 2.07E-04 0.35 2.33E·04 0.25 2.65E-04 0.20 3.82E·04 0.37 4.25E..Q4 2.16 4.49E-04 0.38 4.55E·04 0.08 4.93E..Q4 0.33 S.OOE-04 0.50 5.16E..Q4 0.05 5.30E..Q4 0.73 5.30E-04 0.62 5. 78E-04 0.34 5.80E-04 0.25 5.84E-04 0.02 6.28E·04 0.17 6.42E·04 0.1 0 6.62E..Q4 0.21 7.31E-04 0.14 7.61E·04 0.08 7.85E-04 0.10 8.30E'04 0.82 8.47E..Q4 0.07 s,ssE-o4 o.o8 9.38E-04 0.22 9.50E..Q4 0.09 9.64E-04 0.05 3.33E-15 1.94 9.62E·12 1.50 1.10E,1 1 3.77 2.02E·t 0 2.62 7.05E·09 2.92 9.44E-09 1.05 1.73E..Q8 0.97 3.76E·08 1.89 4.86E·08 2,64 1.26E-07 1.03 5.32E·07 1.90 9.89E..Q7 1.56 3.47E-06 2.72 4.81E-06 t .45 2.46E-05 1.00 7.59E-05 0.89 8.01 E-05 0.79 9.15E·05 0.09 1.34E-04 3.81 2.45E·04 0.11 2.57E-04 0.22 3.02E..Q4 0.51 3;08E..Q4 1.07 3.15E·04 0.22 3.49E-04 0.77 3.81 E..Q4 1.30 4.59E-04 0.20 4.62E-04 0.12 4.91 E-04 0.06 4.91E-04 0.24 5.57E-04 0.10 5.58E-04 0.06 6.17E·04 0.04 6.80E-04 0.05 6.90E·04 0.53 6.93E-04 0.01 s.96E·04 a.92 7.49E·04 1.46 7.71E-04 0.50 7.85E-04 0.59 8.29E-04 0.09 B.96E-04 0.06 9.91 E-04 0.20 1.28E-10 0.95 1.42E-OS 3.52 1.82E..Q8 1.07 6.38E-OB 1.02 7.97E·OB 1.62 2.70E..Q7 0.89 4.47E·07 1.18 5.41E·07 1.01 t.39E..Q6 0.94 2.75E-06 0.70 4.64E·06 1.18 9.28E-08 0,94 1.84E-05 0.81 2.35E..Q5 0.93 2.86E·05 R66 2.89E-05 0.91 2.9SE-05 0.16 3.4BE-05 0.83 5.37E·05 0.91 6.18E-05 0.55 6.50E-05 0.09 1.41E..Q4 0.04

10.13 10.18 30.10 14.10 8.11 10.06 18.18 8.11 22.10 8.11 18.11 32.1 o 170.12 20.09 8.07 16.11 10.14 14.09 18.12 10.15 24.11 10.10

8.06
20.08 10.09 30.09 18.09 10.10 16.08 36.1 3 8.07 10.07 12.08 18.09 8.09 20.28 40.28 50.23 30.32 36.26 16.28 10.21 24.20 30.19 18.19 30.16 30.18 34.21 20.15 12.18 10.15 10.18 12.09 62.18 10.05 26.11 22.13 40.16 20.09 10.15 18.20 12.10 14.10 8.07 12.09 8. 11 12.06 10.08 8.08 8.1 5 8.07 26.14 28.13 8.14 30.11 8.09 14.06 8.12 10.27 6020 20.24 12.27 20.24 10.15 12.23 20.15 10.19 10.15 20.18 24.12 16.15 10.18 26.11 10.1 6 10.12 20.14 10.16 46.10 12.09 8.08

1 (1 0 0 0 0) 68692.2 163310765 1 (1 00 00) 50060.4 110625979 4 (20 11 0) 168858.7 31559817 93095.7 82892443 2 (0 1 1 0 0) 1 (0 10 00) 55429.2 31560224 2 (00 1 t 0) 207049.6 123858774 2 (11 00 0) 51584.5 157951604 1 (01 000) 83589.1 10948676 4 (0 120 t) 147912.0 56606023 2 (00 1 0 1) 28672.7 6755212 2 (t 100 0) 101890.0 18087751 207653.9 t 24487113 5(0 1400) 2986264.0 77812699 27 (8 42 tO 3) 344784.7 45439304 3 (1 t 0 0 t) 1 (0 100 0) 113335.6 33859474 4 (0 101 2) 206700.0 t 14326469 80667.1 15394581 4 1 (1 0000) 2 (0 11 00) 91963.0 124269710 2 (11 0 00) 31987.8 34850058 27305.3 82905709 2 (2 000 0) 4 (1 0 1 20) 184797.6 132626693 1 (1 0 00 0) 196017.8 157057150 1 (0 1 000) 117348.4 160420299 2(20000) 310888.6 124486835 56612.9 8371601 1 1 (1 0 00 0) 4 (20 11 0) 83772.7 67763826 3(00300) 39530.9 7242183 1 (t 0 0 0 0) 52573.6 21312790 2 (1 01 00) 143641.9 46488928 629582.9 124487133 5(2021 0) 1 (0 1 00 0) 37386.7 33858640 2 (00 1 1 0) 45996.4 12963637 2 (1 00 0 1) 11 3488.3 9790087 2 (11 000) 48381.5 13195623 2 (0 0 1 0 1) 74767.1 61675696 15775.8 7305599 2(200 0 0) 5(50000) 165851.0 110347469 5(50000) 41736.5 6671509 3(3 00 0 0) 18559.4 8680924 4(3 01 0 0) 15748.0 31982300 3 (1 001 t) 45974.4 76881 807 1 (1 0 000) 20772.2 149264482 3(2001 0) 68692.2 163310765 15112.1 145301549 4 (3 0 1 0 0) 2 (11 000) 39355.7 6671539 3(3 00 0 0) 21066.5 6753912 3{30000) 38768.6 110227377 4 (3 001 0) 46672.5 148747546 15878.1 17647499 2(2 0000) 2 (1 000 1) 31291 .8 54287684 1 (1 0 000) 23596.3 153792001 1 (1 00 00) 35811 .7 149265160 2 (0 101 0) 107584.2 19527130 7 (6 0001) 186482.t 126518317 1 (1 00 0 0) 20026.0 13365850 3 (12000) 193420.4 94374469 3(2 0 0 01 ) 42050.8 33563240 6(220 0 2) 57844.6 31981562 3(02010) 90381.3 85662377 1 (1 00 00) 27414.5 33859580 2 (11 00 0) 42004.0 30425250 2 (0 101 0) 75409;0 28077005 3(00201) 276425,3 149257960 1 (0 1 000) 73373.9 124286823 2(0 0200) 85487.8 85677482 3(0 0201) 74692.8 315420..QS 2 (0 101 0) 35095.0 70778749 63634.2 9508541 1 (1 0 0 DO) 1 (0 t 000) 14211 .6 83004247 39712.0 149270873 1 (0 1 000) t (0 1 000) 143245.5 40789298 3(201 00) 111160.2 149249190 198918.2 86990460 4(1 200 t ) 71476.5 . 23958334 1 (0 1 000) 4 (120 t 0) 66126.2 ·149250061 1 (0 100 0) 59635.9 31982472 2(1 001 0) 125595.3 157041258 1 (0 100 0) 43371.0 6680457 1 (1 0000) 18559.4 6680924 6(60000) 56678.0 112293264 3 (1 011 0) 3561 1.2 31 982186 2 (1 000 1) 233&3.7 41350312 2 (2 0 000) 35752.2 6753060 11605.4 6681095 1 (1 00 0 0) 16688.9. 8393739 2 (1 OGO t) 3270&5 31560030 2 (20000) 152035.8 31982724 1 (1 0000) 6578359 1 (1 0000) 67630.1 2 (2 0 0 0.0) 51828.4 7305075 3 (11 1 00) 350708.7 153792337 2(02000) 42004.0 30425250 1 (1 0000) 29990.2 82956899 4(1 1 1 01) 70636,8 124339838 31404.0 94385999 1 (1 0000) 1 (1 0000) 25745.7 146134409 2 (20000) 16145.5 6680177 1 (1 000 0) 57543.1 31982302 532044.3 134288917 7 (123 0 1) 75167;8 121949760 2 (0 101 0) 1 (0 1 000) 206496.4 145587092

86

Table 1 continued
1.59E-04 1.89E-04 2.08E-04 2.16E-04 2.21E-04 2.42E-04 2;61E-04 2.92E-04 3.43E-04 3.89E-04 3.90E-04 4.15E-04 4.83E-04 4.93E-04 5.14E-04 5.16E-04 5.93E-04 6.30E-04 6.82E-04 6.85E-04 7.80E-04 7.93E-04 8.09E-04 8.90E-04 9.48E-04 9.49E-04 2.31E-09 1.04E·06 1.95E-06 2.17E-06 1.19E-05 1.77E-05 3.84E-05 7.34&05 7.73E-05 0.33 0.33 0.14 0.07 0.05 0.56 0.42 0.16 0.34 0.74 0.09 0.17 0.08 0.00 0.16 0.88 0.04 0.47 0.14 10.11 16.09 4.11 14.10 10.09 30.11 18.12 16.06 8.10 22.11 22.10 10.11 8.09 10.05 16.10 10.15 16.08 12.10 10.11 10.11 18.13 24.12 8.07 12.10 28.09 16.10 10.34 18.11 42.21 10.17 8.16 10.09 14.11 14.10 10.08 14.09 62734.5 91534.3 169043.1 81292.8 125608.2 122518.6 123515.7 115257.9 19281.1 175770.7 88918.2 121295.8 65224.8 164902.7 37996.3 47296.3 66838.9 37574080 101944153 61557468 13994140 149251516 6753234 53037517 82894802 19111158 114205395 28893223 21704022 9055386 82942342 6755568 7305027 27532956 149260134 30425202 157951606 38348566 145207986 31560366 110556631 156303335 124486743 6680924 31981562 6671509 54287684 29244176 21313506 13386014 149233925 7304963 41350312 27734096
2 (00 11 0) 3 (1 00 11) 2(00002) 2 (0 11 0 0) 2 (00 11 0) 4(1 201 0) 2 (11 00 0) 2 (1 01 0 0) 1 (0 1 00 0) 5 (1 01 0 3) 3 (11 01 0) 1 (1 000 0) 1 (0 1 00 0) 1 (1 000 0) 3 (0 11 0 1) 1 (1 000 0) 2(02000) 2 (1 000 1) 1 (1 000 0) 1 (1 0000) 3 (0 111 0) 4(0 1 21 0) 1 (0 1 000) 2(1 000 1) 4(0301 0) 2 (1 01 00)

HS1 EFA

AnXA1 ENaCI

AnXA1 EFA

gi]37574080irenNP_S32116.1J hyppthetical protein LOC72361 JMus musculus! giJ1 01944153JrefJNP_032305.21 m~ogen activated protein kinase kinase kinase kinase I !Mus musculus] giJ61557468jre~NP_080330.11 hypothetical protein LOC67246 [Mus musculus] gij13994140jre~NP_038928.11 antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 56 giJ149251516]refJXP_912140.31 PREDICTED: similarto mKIAA1450 protein [Mus musculus] 58 gii6753234JrefJNP_033914.11 calcium channel, voltage-dependent, alpha21de~a subunit 1 isoform e [Mus musculu 60 gil580375171re~NP_084301.11 hypothetical protein LOC78016 [Mus musculus] 62 giJ82894802Ire~XP_916068.11 PREDICTED: similar to mKIAA0754 protein [Mus musculus] 63 gij1911l158lreijNP_579927.11 zinc finger, ANi-type domain 2A [Mus musculus] 65 gii114205395JrefiNP_766269.31 hypothetical protein LOC229473 [Mus musculus] 66 gii28893223Jre~NP_796175.11 PHD finger protein S[Mus musculus] 68 gii21704022JrefjNP_663494.11 FERM, RhoGEF and pleckstrin domain protein 2[Mus musculus} 69 gii9055386Jre~NP_061229.11 zinc finger protein 326 [Mus musculus] 70 gii82942342JreijXP_921807.11 PREDICTED: similar to mKIAA0586 protein {Mus musculus} 71 gii6755568Jref1NP_035537.11 schlafen 1 [Mus musculus] 72 gil7305027}refiNP_038537.1] enolase 2, gamma neuronai[Mus musculus} 73 gii27532956JrefjNP_080783.2I Z11'ilch [Mus musculus] 74 gii149260134Jref]XP_001473289.1] PREDICTED: hypothetical protein [Mus musculus] 75 gii30425202Jre~NP_780669.1] nicotinamide nucleotide adenylyltransferase 2 [Mus musculus] 76 gi[157951606Jre~NP_765988.21 DnaJ (Hsp40) homolog, subfamily C, member 8 [Mus musculus} 78 gij3S348566Jre~NP_941 024.1] H1 histone family. member X[Mus musculus] 79 giJ145207986JrefiNP_84891 0.3j histidine acid phosphatase domain containing 2A [Mus musculus] 80 giJ31560366JrenNP_064362.21 illpha-1,3-mannosyltransferase ALG2 [Mus musculus} 82 gil11 0556631JrefJNP_796361.21 uronyl-2-sulfotransferase [Mus musculus] 83 giJ158303335IrefiNP_796314.2] synaptopodin isoform A (Mus musculus] 84 giJ124486743jrenNP_001074800.11 hypothetical protein LOC71 007 [Mus musculus} 4 giJ6680924jrefjNP_031713.11 cofilin 1. non-muscle [Mus musculus] 6 giJ31981 562JrenNP_035229.2] pyruvate kinase, muscle[Mus musculus] 8 giJ6671509jrefJNP_031419.11 actin, beta, cytoplasmic [Mus musculus) 9 gij54287684JrenNP_075729.21 eukaryotic translation elongation factor 1 delta isoform b [Mus musculus] 11 giJ29244176jreijNP~808385.11 hypothetical protein 4732456N10 [Mus musculus] 12 glj21313506]re~NP_084475.11 zinc finger protein 623 [Mus musculus] 14 giJ13386014]re~NP_080795.11 hypothetical protein LOC68032 [Mus musculus] 15 giJ.149233925IreQXP_001002308.21 PREDICTED: ATP·blnding cassette, sub-family P. (A8C 1), member 12 isofon~ 16 giJ7304963Ire~NP_038913.11 chloride intracellular channel4 (mitochondrial) [Mus musculus] 17 giJ41350312jreqNP_038636.21 nascent polypeptide-associated complex alpha subunit iso!orm b [Mus musculus] 20 giJ277340951reqNP_775622.11 transmembrane protein 28 [Mus musculus] 21 gi]31980838]reqNP_056595.21 RAB25, member RAS oncogene family[Mus musculus] 22 gi]S46970311reijNP_001 033799.11 tropomodulin 2 [Mus musculus} 23 gi]157426871JrefjNP~001 098722.1 Itransmembrane channel-like 5 isoform a [Mus musculus] 24 gi]40254525jreqNP_071709.21 tropomyosin 3, gamma [Mus musculus] 25 gil77404229lrenNP_080963, 11 epsin [Mus musculus] 26 gij1492671 09JrefjXP_001476961.1l PREDICTED: similar to Bridging integrator 2 [Mus musculus] 27 gii21704042JrefiNP_663504.11 cleavage stimulation factor subunit 3 isoform 1 [Mus musculus} 28 gii32401429Jref1NP_660253.21 UDP-GaiNAc:polypeptide N-acetylgalactosaminykransferase-like 3 [Mus musculus] 29 gij126032329Jref]NP_034236.21 eukaryotictranslation elongation factor 1 alpha 1 [Mus musculus] 30 gij124487376Jref]NP_001074570.11 hypothetical protein LOC7i101 [Mus musculus! 31 giJ124487149JrefjNP_001074871.11 WD repeat domain 70 jMus musculus] 32 giJ6754048jreqNP_034466.11 endothelial differentiation, lysophosphatidic acid G..protein-coupled receptor, 2 [Mus 33 giJ15676603BjrenNP_035816.11 vomeronasal2, receptor 88 [Mus musculus} 1 giJ31712036JreqNP_853613.11 eukaryotic translation initiation factor SA [Mus musculus] 2 giJ157951596]ref[NP_033931.4j carbonic anhydrase 2jMus musculus] 3 giJ157951604trefJNP_031624.2] CAP, adenylate cyclase-associated protein 1 (Mus musculus! 5 giJ1176063351refJNP_035470.31 serine (or cysteine) proteinase inhibitor, clade F. member 1 [Mus musculus! 6 giJ6680067jrenNP_032181.1[ glucose phosphate isomerase 1 jMus musculus] 7 giJ157951606IrefJNP_765988.2I DnaJ (Hsp40) homolog, subfamilyC, memberSjMus musculus] 9 giJ21426823]renNP_085112.1] histone cluster 1, H1 a [Mus musculus] 12 giJ319B2724]reqNP_058056.2I MY!l binding protein (P160) 1a .[Mus musculus] 13 giJ6753086]renNP_033817.1] apurinlclapyrtmidinic endonuclease 1 [Mus musculus] 15 giJ31982186Iref]NP_032643.21 malate dehydrogenase 2, NAD (mitochondrial) [Mus musculus] 16 gii112293264JrefJNP_031978.21 protein disulfide isomerase associated 3 [Mus musculus] 18 gi]33239214lreqNP_666717. 1] offactory receptor 945[Mus musculus] 22 gi]34808712lreqNP_035203.21 perforin1 [Mus musculus] 24 gi]6680924Jre~NP_031713.1J cotilin 1. non-muscle [Mus musculus] 26 gij94385999jrenXP_486188.4J PREDICTED: similar to Nucleophosmin 1 isoform 1 [Mus musculus] 28 gil149233958lref]XP_001473161.1J PREDICTED: Similar to ciliary dynein heavy chain 7 [Mus musculus] 29 gii149256880Jre~XP_001477749.1I PREDICTED: similar to ribosomal protein L22 [Mus musculus] 35 gi]82930015JreqXP_486217.21 PREDICTED: similar to nuclear protein-NHP2-Iike protein [Mus musculus) 36 gi[31542017JrefiNP_848756.21 inositol polyphosphate-5-phosphataseF [Mus musculus] 37 gi]6680868Jre1JNP.031657.1[cyclin D1 [Mus musculus] 38 gi]6678439JrefiNP_033456.11 protease. serine. 2[Mus musculus] 41 gi]82917230ireijXP_926154.1[ PREDICTED: hypothetical protein [Mus musculus] 45 gi]766778951reqNP_598452.21 poly-U bihding splicing factor 60 isoform b [Mus musculus] 46 gi]153791474JrenNP~4733S4.3] G protein-coupled receptor 98 [Mus musculus] 47 gi[149256684JrefJXP_001481125.1]PREDICTED: similar to macrophage migration inhibnory factor isofonn 1 [Mus 48 gil31324532[reqNP_083821. 11 hypothetical protein LOC328092 [Mus musculus] 49 gii50726896JreijNP_001002842.11 PML-RARA regulated adaptor molecule 1 [Mus musculus] 50 gi]86262151Jre~NP_033836.21 Rho GTPase activating protein 5[Mus musculus] 51 gil1 25660464[ref1NP_001009947.21 dedicator of cytokinesis 11 [Mus musculus] 52 gi]31541822JreijNP_081 169.2!WD repeat domain 40A [Mus musculus} 53 gi]85662408JrenNP_031786.21 carnitine acetyltransferase [Mus musculus] 54 gii29789329Jre~NP_596578.11 zinc finger protein 451 [Mus musculus! 55 gii27370290Jre~NP_766441.11 cadherin 7, type 2 [Mus musculus] 56 gii21312790JrenNP_080646.11 MYST histone acetyltransferase 1[Mus musculus] 57 gil146149270jref1NP_001 078890.11 testis-specific protein, Y-encoded-like 5 [Mus musculus] 58 gi]140307771re~NP_114391,11 neuregulin 4[Mus musculus] 59 giJ37595742Jre~NP_OB3n4.2l zinc finger protein 198 [Mus musculus] 61 gi]31982828JrenNP_033346.21 solute carrier family 6 (neurotransmitter transporter, taurine). member 6 [Mus muse 62 gij31652266Jre~NP_663$15.21 integrator complex subunit 3 [Mus musculus] 63 gi]33859580]re~NP_034835.1J galectin 3[Mus musculus] 65 gi]145580623jref[NP_796166.21 hypothetical protein LOC320560 {Mus musculus] 66 gi]31542~84jreqNP_659120.21 suppressor of variegation 4-20 homolog 1 [Mus musculus] 67 gi]124244106[ref]NP_033262.21.SRY-box containing gene 18 [Mus musculus] 1 gij157951604lref]NP_031624.21 CAP, adenylate cyclase-assoCiated protein 1jMus musculus] 2 giJ6671509JrefJNP_031419. t[ actin, beta, cytoplasmic [Mus musculus] 5 giJ523539551re~NP_058662.213-phosphoglycerate dehydrogenase [Mus musculus) 6 giJ31981562jre~NP_035229.21 pyruvate kinase, muscle [Mus musculus] 7 gij31 712036[reijNP_853613.11 eukaryotic translation initiation factor SA jMus musculus] 9 gij113199769[renNP_035031.21 cytoplasmic nuclear factor of activated T<ells 3 [Mus musculus] 10 gi]6680924JrefjNP_031713.11 cofilin 1, non-muscle [Mus musculus]

52 53 54 55

28222.0
34504.5 29812.4 20151.0 159921.0 47370.7 47729.7 96249.6 71520.6 18559.4 57844.6 4173$.5 31291.8

0.42

0.72
0.70 0.05 0.18 0.14 0.36 0.98 0.43 2.00 0.92 0.92 0.12 0.23

1 (1 000 0)
2 (11 000)

5(4000 1)

58266.0
57142.1 20116.5

0.03 292272.1 0.06 28728.9 8.65E-05 0.91 10.17 23353.7
1.84E-04 1.68E-04 2.31E-04 2.64e-o4 2.89E-04 2.99E·04 3.50E-04 3.72E-04 4.20E-Q4 5.30E-04 5.46E-04 5.74E-04 B.21E·04 9.77E-04 l.OOE-30 2.36E-11 1.57E-1 0 8.48E-09 I.OBE-08 0.25 0.20 0.03 o.33 0.81 52738.8

10.1 0

23472.4 31980838

10:07 39510.5 84697031 1s.B 111oas.3 157428671 10.13 33149.2 40254525 0.08 4.06 46380.6 77404229 0.22 10.12 58985.2 149267109 0.11 12.07 82876.1 21704042 0.19 18.10 67690.6 32401429 0.86 22.09 50113.5 126032329 0.02 8.09 81758.9 124487376 0.12 14.08 73060.4 124487149 0.19 10.10 41178.1 6754048 0.36 10.10 98178.7 156766038 1.95 20.30 16832.2 31712036 0.97 10.23 29032.3 157951596 1.86 26.25 51564.5 157951604 0.92 10.22 46233.7 117606335 0.98 10.24 ~2767 .5 6680067 1.99E..08 0.96 10.27 29812.4 1579$1606 4.69E-08 0.97 14.28 21785.0 21426823 9.67E-07 1.00 15.18 152035.8 · 31982724 2.35E-06 1.1$ 20.18 35490.2 · 6753086 3.52E-06 1.30 20.25 35611.2 31982186 6.96E-06 1.90 38.18 55678.0 112293264 1.20E-05 0.04 8.09 35861.1 33239214 3.05E-05 0.51 10.14 62094.7 34808712 3, 15E-05 1.37 20.21 18559.4 6580924 3.45E-05 0.96 10.21 31404.0 94385999 4.01E-05 0.49 24.10 462284.0 149233958 4.14E·05 0,60 10.10 14758.8 149256880 8.S6E·05 0.90 14.16 14173.5 82930015 9.25E-05 0.17 14.11 127607.6 31542017 1.05E-04 0.08 8.09 33428.6 6680868 1.07E·04 0.58 12.10 26203.4 8678439 1.34E·04 o.as 1o.ts 1i14tS.3 82917230 1.9SE-04 0.98 4J5 58544;6 76677895 1.97E-04 0.69 54.11 687610.3 153791474 2.01 E-04 0.21 10;09 t2517.2 149256684 2.40E-04 0.78 18.15 18235.7 ·31324532 2.62E-04 0.01 8.07 75491.6 · 50728896 2.99E-04 0.39 20.11 172470.2 86262151 MOE-04 0,13 8.09 237768.6 125660464 3.75E..04 0.08 10.07 50458.9 31541822 3.77E-04 0.12 8.09 70839.3 85862408 4.11E-04 0.58 10.16 120069.2 29789329 4.20E-04 0.12 18.06 87200.9 · 27370290 4.34E·04 0.07 10.09 52573.6 21312790 4.74E-04 0.19 10.11 44302.8 146149270 s.zsE·04 o.o2 a.os 12743.6 14o3om 5.61E-04 0.21 18.09 154640.4 37595742 6.02E-04 0.02 10.06 69855.7 31982626 6.15E-04 0.10 8.10 117936.9 31652266 6.57E-04 0.40 16.12 27414.5 33859580 7.01E-04 0.19 14.12 144628.0 145580623 7.0&E-04 0.09 8.09 96037.0 31542284 7.62E·04 0.58 18.14 40897.9 124244106 5.28E-13 2.84 48.21 51564.5 157951604 9.82E-09 1.61 40.23 41736.5 6671509 2.38E-07 1.27 20.20 56585.3 52353955 5.67E-07 1.54 20.20 57844.6 31981562 2.12E-06 0.63 18.13 16832.2 31712036 8.90E-06 0.20 10.09 115536;0 113199769 1.55E·05 0.93 10.19 18559.4 8660924

1\1 0000) 1(01000) 1 (1 0000) 3(2001 0) 2 (1 001 0) 1 (1 0 0 00) 1 (1 00 0 0) 2{0 11 00) 1 (1 0 000) 1 (1 0 D00) 3(0111 0) 1 (1 0 00 0) 2(00002) 1 (1 000 0) 2 (0 1 01 0) 2 (11 00 0) 3(2000 1) 1 (0 1 000) 2(1 001 0) 1 (1 0000) 1 (1 0000) 2(2 0 0 00) 1 (1 0000) 3 (2 0 1 0 0) 1 (1 00 00) 1 (1 0 0 00) 1(1 0 0 0 0) 2(1 001 0) 3(1 0 0 11) 2 (2()0 0 0)
2(20000)

4(31 0 00) 1 (0 1 000) 1 (1 0000) 2(20000) 1(1 0000) 4(02020) 1(1 0000) 2 (1 001 0) 2(1 001 0) 1 (01 00 0) 2 (1 000 1) 1 (1 000 0) 2(00002) 9(221 22) 1 (1 000 0) 2 (11 00 0) 1(01 000) 3(1. 011 0) 1 (0 1 000) 1 (1 0000) 1 (0 100 0) 1 (1 000 0) 2(11 000) 1{1 0000) 1 (1 0000) 1(0 1 000) 2(11 000) 1 (1 0000)
1 (0 1 0 00)

2(1 01 00) 2(0 110 0) 2(00 1 0 1) 2(11 0 0 0) 6(23010) 5(2201 0) 2 (200 0 0) 2(20000) 2(11 000) 1 (1 000 0) 1 (1 0000)

87

Table 1 continued
gil34147232lre~NP_899002.11 potassium channel, subfamily V, member 21Mus musculus] 16 gll29244176lreijNP_808385.11 hypothetical protein 4732456N1 0 [Mus musculus] 18 gil51772073lref1XP_486686.11 PREDICTED: hypothetical protein [Mus musculus] 19 gil·l0789298jreijNP_796347.21 PTPRF interacting protein alpha 2 [Mus musculus] 20 gil11 0625972fref)I'IIP_766294.21 hypothetical protein LOC231 014 [Mus musculus] 21 gil13430890[re~NP_056602.11 histone cluster 1, H1e [Mus musculus] 22 gil6678319[reijNP~033394.11 transforming grO'Iilh factor, beta 3 [Mus musculus] 23 Qll23346495lre~NP_694721.11 solute carrier famRy 16, member 11 {Mus musculus] 24 gii40254190ire~NP_666194.21 hypothetical protein LOC225004{Mus musculus] 25 gii149233560irefiXP_001473646.11 PREDICTED: similar to Potassium voltage-gated channel subfamily B membe 26 g~119964712lrefjNP_084450.21 muhiple C2 domains, transmembrane 1 {Mus musculus] 28 gij86198318[re~NP_031656.21 cycijn B2{Mus musculus] 29 gij8487S537Jre~NP_035010.31 nudeolin [Mus musculus! 30 gij162138926jref1NP_031794.31C.reactive protein, pentraxin-related [Mus musc(.jusj 31 gij134031976lref1NP_OB2509.211 eucine-rich PPR motif-containing protein [Mus muscL~us] 32 gil160358787jrefjNP_031430.21a disintegnn and metalloprotease domain 9 precursor [Mus musculus] 33 giiJ~9267887[re~XP_922530.21 PREDICTED: similar to MSP23 isoform 1 {Mus musculus! 34 gi[7948999lre~NP_058044.1[ peroxlredoxin 4 [Mus musculus] 35 gi[133507240~ef1NP_082595.11 zinc finger protein 518 {Mus musculus] 35 gij20982847jfe~NP"'831889.1 1caiCJum response factor [Mus musculus] 37 g~21312790Jre~Nf'_080646.1 1MYST histone acetyltransferase 1 [Mus musculus) 38 g~6678946fre~NP_032660.11 microiubule-assooiated protein 1 8 (Mus musculus] 39 gi[375375221re~NP_559097.21 epiplakin 1{Mus musculus] 1 gi[157951604~ef[NP_03·1624.21 CAP, adenylate cyclase-associated protein 1{Mus musc,Jius) 2 gif21426823[te~NP_OB5112.11 histone cluster 1, H1a {Mus musculus] 3 gil31712036[re~NP_853613.11 eukaryotic translation Initiation factor SA {Mus musculus] 5 gil157951606~eqNP_765988.21 DnaJ (Hsp40) homolog, subfamily C, member 8 [Mus musculus] 6 gil94380203lreqXP_001003154.11 PREDICTED: similarto Glucose phosphate isomerase 1 isofom1 2[Mus museu 7 g~158Q80.,88[reqNP_291 039.11 eukaryotic transla~·on initiation factor 4H (Mus musculus] 10 g~117606335(reqNP_035470.31 serine (or cysteine) proteinase inhibitor, clade F, member 1 [Mus musculus] 11 gii6680309JreqNP_032329.11 heat shock protein 1 (chaperonin 10) [Mus musculus] 13 gll6680067lreqNP_032181.11 glucose phosphate isomerase i {Mus musculus] 14 gil112293264~efiNP_031978.21 protein disulfide Isomerase assotiated 3IMus musculus! 15 gij66B0924IreqNP_031713.11 cofllin ·1, non-muscle {Mus musculus] 19 gif11464971 ~eqNP_062422.11 pleckstrin [Mus musculus] 20 gi[7305061 ~eqNP_038930.11 FK506 birnling protein 3 [Mus musculus! 21 gi(6753086[reqNP_0338H.1I apuriniclapyrimidinic endonuclease 1{Mus musculus] 22 gij31982724~eijNP_058056.21 MYB binding proteih (P160) 1a {Mus musculus] 23 gi(67560411reqNP_035870.11 tyrosine 3-monooxygenaseftryptophan 5-monooxygenase activation protein, zeta pol 2J gil6678439lreqNP_033456.11 protease, serine, 2[Mus musculus] 30 gil116517303lref1NP_032982.21 polypyrimidine tract binding protein 1 isoform 2{Mus musculus] 31 Q ll217037841reqNP_663367.11 Bcl2-associated athanogene 2 [Mus musculus] 33 gii82917230Jre~XP_926154.1[ PREDICTED: hypothetical protein [Mus musculus) 35 gii4055S386Jre~NP_955006.1lleucine rich repeat and sterile alpha motff containing 1 [Mus rnusctlus] 35 gil94385999(rel1XP_486188.41 PREDICTED: simNar to Nucleophosmin 1 isoform 1 [Mus musculus] 37 gi[6679803(fe~NP_032045.1 1FK506 bir.ding protein 1a {Mus musculus] 38 gil857016741ref1NP_001028328.11 F-box protein 33{Mus musculus] 39 gil149262849lre~XP_001 480231 .11 PREDICTED: hypothetical protein [Mus musculus] 43 gil211058551re~NP_631939.1[ pleck:;trin homology, Sec7 and coiled"coil domains, binding protein [Mus musculusj 48 gil85662397lre~NP_001 028536.1 1protocadherin LKC [Mus musculus! 47 g~3Q425112Ire~NP_780612.11hypothetical protein I.OC109154 [Mus musculus] 50 gi[6755100[re~NP_035249.11 ErbB3-binding protein 1 [Mus musculus] 51 gii14925798Ciref[XP_001478336.1I PREDICTED: hypothetical protein LOC785521Mus musculusj 52 g~BS702355jre~NP_001034268.11 bicaudal D homolog 2 isoform 1 {Mus musculus] 53 gi[2080810.9[re~NP_031441.21 poly (ADP-ribose) polymerase famijy, member 1 [Mus musculus] 54 gil149253671[ref1XP_893843.31 PREDICTED: similar toC~RN2 protein [Mus musculus] 56 gil31542~7~[re~NP_852682.1 1synaptotagm1n XV isoform a {Mus musculus] 57 gq315434871re~NP_032887.21 polycystic kidney disease 2{Mus musculus] 58 g~38708163[re~NP_035841 .11 formin-like 3 protein [Mus musculus] 59 g~40254337JreqNP_848724.2[ E2f transcription factor 7 [Mus musculus] 60 gil149266314~ef1XP_909743.21 PREDICTED: hypothetical protein LOC223825 [Mus musCLdus] 61 gij149267887~ef1XP_922530.21 PREDICTED: similar to M$P23 isoform 1 [Mus musculus] 62 gil7948999lre~NP_058044.1 1peroxiredoldn 4{Mus musculus] 63 gii 11741417Q~ef1NP_033257.21 son of sevenless 1{Mus muscL~us] 64 gilf4925134 1 ~ef1XP_001479436.11 PREDICTED: hypothetical protein [Mus musculus] 65 gil67542581reqNP_034612.1 15-hydrox)lryptamine (serotonin) receptor 18 [Mus musculus) 66 g~149263536Jre~P_001475822.11 PREDICTED: tudor domain contalnnlQ 9 [Mus musculus) 67 g~20888581 (re~XP_134800.11PREDICTED: hypothetical protein LOC69809 isoform 1 {Mus musct.dus] 6!1 gi[159110787~ef1NP_032661.2I microtubule-associated protein 7 [ML!s musculus) 70 gil157277988~ef1NP_001098107. 11 vomeronasal receptor Vmn2r22{Mus musculus] 71 gij34808712lreqNP_035203.21 perforin 1 (Mus musculus! 72 gi[149250077~e~XP_001480604.11 PREDICTED: zinc linger protein 690 {Mus musculus] 73 gii6755040ire~NP_035202.11profilin 1 [Mus musculus) 74 gii21703B12[ref1 NP_863381.1 1protein P3 [Mus musculus) 75 gil9910602[reqNP_064333.11 ubiquiUn-oonjugatn1g enz'pne E2L 6 [Mus musculus] 76 gii98985S141re~NP_570947.2lpaternally expressed 10 isoform RF1/RF2 [Mus musculus] 1 gil '1 57951604~ef1NP_031624.21 Ci'J', adenylate cyclase-associated protein 1 [Mus musculus] 3 gil29244176lre~NP_808385.11 hypothetical protein 4732456N1 0 [Mus musculus] 6 gi(31981552lreqNP_035229.21 pyruvate kinase, muscle {Mus mu~culusj a gil 13430890(re~NP_056602.11 histone cluster 1, H1e [Mus musculus] 9 gil82917230(ref[XP_926154.1[ PREDICTED: hypothetical protein {Mus musculus] 11 g~76677895(reijNP_593452.2j poly-U binding spliCing factor 60 isofom1 b [Mus musculusj 12 gil31981690(reijNP_112442.21 heal shock protein 8 [Mus musculus] 13 gi(6671509[re~NP_031419.11 actin, beta, cytoplasmic [Mus musculus! 14 gil331869211reijNP_806332.21 plasticity related gene 1 [Mus nlUGculusl 15 gil117647243lreqNP_038934.21 a disintegnn-ike and metaUoprotease (reprolysin type) with thromboiipondin type· 16 gii58B01478Jr~~NP_001011860.11 onactoryreceptor 1222 {Mus musculus] H gii667S649[re~NP_031958.11 endog~n [Mus musculus] 18 gi(42476097~enNP_766536.21 mannoside acetylglucosaminyltransferase 5, isoenzyme 8 [Mus musculus) 19 g~94408011 ~e~XP_990665.11 PREDICTED: similar to valosin isoform 1 {Mus musculus! 20 g~33942091 ~eqNP_898835.1J !ubulin !)7osine ligase~ ike family, member 12{Mus musculus! 22 g~3f560462[reqNP_058077.2[ s~axin 7 (Mus musculus] 24 gii10S62J652ireffi\IP_034018.21 complement component factor H {Mus musculus] 25 gil1244866601ref1NP_032426.21 integrin alpha L [Mus musculus! 26 gil214269931reqNP_064418.11 histone cl~1ster 1, H1 b {MUs musculus] 27 gil9438~759lreqXP_001 004138.11 PREDICTED: similarto serine bela lactamase~ike protein LACT-1 isoform 2{M 28 gil1 49266532~efiXP_001475762.11 PREDICTED: Similar to ribosomal protein L23a [Mus musculus] 29 g~8679377Jre~NP_032899.1[ plasminogen activator, urokinase [Mus musculus) 3D gif41393059jreqNP_Oo'72SS.21 phospholipase C, gamma 1 [Mus musculus] 31 gij30017395Jre~NP_835182.11 macrophage MHC receptor 2 isoform 2 [Mus musculus]

"13

AnXA2 ENaCI

AnXA2 EFA

0.11 1.10 0.23 0.08 0.07 0.86 0.34 0.23 0.54 0.33 0.10 0.11 0.92 0. 70 0.11 0.19 0.85 0.83 0.79 0.90 0.16 0.05 0.71 3.46 0.98 1.95 1.31 2.80 0.93 0.56 0.97 9.~8E-08 1.04 U 1E·D7 0.81 1.85E-07 1.84 1.77E-OS 0.13 2.36E-08 1.01 2.44E·08 1.95 2.97E-08 1.09 3.72E-06 0.88 1.59E-05 0.84 2.06E-05 1.04 2AOE-05 0.49 3.74E-05 0.68 4.99E..()5 0.12 6.39E.OS 0.95 6.BOE·05 0.91 6.98E·05 0.00 7.7~E-05 0.19 1.35E·04 0.09 1.95E·04 0.09 1.98E·04 0.37 2.18E·04 0.79 2.92E-04 0.31 3.05E·04 0.16 3.20E-04 0.64 3.27E·04 0.24 3.54E·04 0.11 3.59E·04 0.06 3.71 E-04 0.07 4.39E·04 0.22 4.42E-04 0.51 4.54E-04 1.59 4.54E-04 0.87 4.70E-04 0.22 5.28E·04 0.32 5.51E-04 0.35 5.74E·04 0.12 5.78E..Q.I 0.17 6.74E-04 0.13 7.27E-04 0.39 7.45E-04 0.39 7.49E-04 0.06 7.67E·04 0.93 7.95E·04 0.34 8.34E-04 0.23 8.58E..Q.I 0.12 1.70E·1'1 2.09 3.67E·08 1.90 2.37E·08 .1.60 1.91E..()5 0.. 91 2.02E·05 0.73 2.84E..()5 1.08 3.14E·05 0.13 4.28E·05 0.45 5.47E-05 0.03 9.94E-05 0.03 1.03E·04 0.05 1.11E·04 0.23 1.22E·04 0.54 1.29E..()4 0.64 2.18E..()4 0.40 2.29E-04 0.04 2.98E-04 0.22 3.48E-04 0.22 3.62E-04 1.24 3.84E·04 0.06 3.86E-04 0.69 3.91E..()4 0.09 4.20E·04 0.49 4.32E..Q.I 0.42

1.98E·05 2.77E-05 4.64E-05 5.43E·05 5.55E..Q5 5.69E·05 9.28E-05 1.03E·04 2.1 5E·04 2.25E·04 2.88E·04 3.88E-04 3.90E..()4 3.98E..()4 4.18E·04 4.31E·04 6.22E·04 6.22E-04 6.83E-04 7.75E-04 8.14E-04 9.32E-04 9.63E-04 4.61E-13 2.00E-12 2.05E·12 1.7BE·10 2.00E·1 0 6.71E..()9 3.43E-08 4.25E-08

12.08 22.15 10.10 20.10 10.08 10.15 28.11 20.09 10.12 18.09 10.08 26.08 10.15 10.12 10.10 18.08 18.15 12.15 16.12 10.18 10.11 18.06 10.12 60.25 10.30 20.31 28.27 32.24 10.22 10.11 10.22 16.23 10.15 20.19 10.09 18.22 30.21 26.21 10.17 10.14 20.15 10.13 10.15 26.10 10.20 10.17 8.06 18.11 10.08 10.08 10.12 20.14 24.14 14.08 12.12 12.11 8.09 16.10 8.09 16.13 34.11 18.15 10.15 16.11 10.11 10.10 10.08 10.09 18.06 20.13 8.12
8.09

10.21 8.11 10.08 8.09 36.25 26.17 28.16 10.16 8.15 22.16 10.11 10.12 4.07 18.10 10.08 16.10 18.11 10.12 10.09 4.08 18.10 8.09 20.13 12.09 10.13

aoa
1().14 12.13

64461 .1 34147232 58266.0 29244176 40984.6 51772073 143245.5 40789298 113558.9 110625972 21977.1 13430800 46884.4 6678319 29030.3 23346495 139296.7 40254190 102349.3 149233660 80593.3 119964712 45382.5 86198318 76722.7 34875537 2f.359.8 162138926 156613.3 134031976 92079.0 160358787 3. 3775.4 149267887 31052.3 7946999 165602.5 133507240 76396.2 20982847 52573.6 21312790 270407.9 6678946 724671.4 37537522 51564.5 157951604 21785.0 21426823 16832.2 31712036 2981 2.4 157951606 37843.3 94380203 27340.8 15608988 46233.7 117606335 10962.6 6680309 62767.5 6680067 56678.0 112293264 18559.4 6680924 39900.4 11464971 25147.6 7305051 35490.2 6753086 152035.8 31982724 2m1.o 6756041 26203.4 6678439 56691.5.. 116517303 23473.5 21703784 12418.3 82917230 83976.0 40555366 31404.0 94385999 11922.6 6879803 33530.1 85701674 39304.9 149262349 40142.7 21105855 142633.2 85652397 32283.6 30425112 43698.6 6755100 23369.5 149257960 96646.7 85702355 112720.6 20806109 32561.7 149253871 47270.0 31542579 108995.4 31543487 117167.8 38708163 99534.4 40254337 186920.6 149266314 33775.4 149267887 31052.3 7948999 150881.8 117414170 27772.0 149251341 43078.4 6754258 138782.0 14926.3535 25444.9 20888581 81973.0 159110787 98139.4 157277998 62094.7 34808712 95460.9. 149250077 6755040 14957.1 50254.6 21703812 17757.6 9910502 115499.4 98985814 51564.5 15795Hi04 58266.0 29244176 57844.6 31981562 21sn1 13430890 12418.3 . 82917230 58544.6 76677895 70870.6 31981690 41736.5 6671509 83361.8 33186921 96922.5 117647243 35222.8 58801478 70034.4 6679349 89472.5 42476097 88850.7 94408011 74039.8 33942091 29736.3 31560462 141270.4 109827552 128085.7 124486680 22576.0 21426893 60705.1 . 94355759 17724.9 149266532 48267.7 8679377 149667.1 41393059 86075.1 30017395

2(01 01 0) 3(1 1 01 0) 1 (1 0000) 3 (11 001) 1 (1 0000) 1 (1 0000) 3(21 000) 2(20000) 1 (1 0000) 3(1 0 1 0 1) 1 (1 000 0) 3(12000) 1 (1 0000) 1 (1 0000) 1 (1 0 0 0 0) 3 (0 111 0) 2 (11 000) 2(1 0001) 2(1 01 00) 1 (1 0000) 1 (1 0000) 3(00300) 3(00H2) 6(60000) 1 (1 0000) 2(20000) 3(21000) 4(30001) 1 (1 0000) 1 (1 0000) 1 (1 0000) 2(1 01 00) 1 (1 000 0) 2(20000) 1 (1 0000) 2(11 000) 3(300 00) 3(201 00) 1 (1 0000) 1 (1 0000) 2(20000) 1 (1 0000) 1 (1 00 00) 4(30 1 00) 1 (1 0000) 1 (1 0000) 1 (01 000) 2 (11 000) 2(0011 0) 2(0011 0) 1 (1 0000) 2(20000) 3(2001 0) 3(1 0002) 2(1 0001) 2 (0 1 01 0) 1 (01 000) 3(011 01 ) 2(001 01) 3(01 02 0) 4 (211 00) 2(11 000) 1 (1 0000) 2(02000) 1 (1 0000) 1 (1 0000) 2 (001 1 0) 1 (1 0000) 3(0111 0) 2(20000) 1 (01 000) 1 (0 100 0) 1 (1 00 00) 2(00020) 2(0011 0) 1 (01 000) 5 (30 0 11) 3(12000) 4 (20 1 0 1) 1 (1 00 0 0) 1 (01 0 0 0) 3 (11 01 0) 1 (1 0000) 1 (1 0000) 2(00002) 2(11 000) 1 (1 0000) 2(02000) 2(11 0 0 0) t (1 0000) 1 (1 0000) 2(00002) 2 (11 000) 1 (01 000) 2(20000) 2(1 0 001) 1 (1 00 0 0) 1 (01 000) 1 (1 0000) 2 (1 0001)

88

Table 1 continued
32 gij6678902jrefjNP_032636.11 matrix metalloproteinase 2 (Mus musculus] 33 gij23956314jrenNP_705774.1j membrane bound 0-acyllransferase domain containing 1 (Mus musculus] 34 gif19705424jre~NP_033465.1j proteasome 268 non-ATPase subunit 3 [Mus musculus] 35 gij37497112jreijNP_058089.21 RNAbinding motif protein 3 [Mus musculus] 36 gij34808712jref!NP_035203.21 perforin 1 [Mus musculus] 37 gij161333817jreijNP_001028487.21 homeodomain interacting protein kinase 4 (Mus musculus) 36 gij85701740jreijNP_001028413.11 hypothetical protein LOC211208 [Mus musculus] 39 gij157951655jrenNP_033765.21adviUin [Mus musculus! 40 gij40353214jreijNP_9'"J4665.1[ . suppressor of zeste 12 homolog (Mus musculus] 41 gij7857417jrefjNP_035987.2j odd Ozilen-m homolog 3 [Mus musculus] 42 gij149256458jrenxP_194337.71 PREDICTED: mukiple EGF~ike-domains 8 (Mus musculus[ 43 gij157951641jrenNP_001074755.21 FATiumtirsuppressorhomolog 1[Mus musculus] 44 gij84993750jreijNP_001034204.1Iz.inc fJnQer protein ~ke {Mus musculliS) 45 gij1636442iOjreijNP_00'1074747.21 TBC1 domain family, member 4 [Mus musculus] 46 gij126032329jreijNP_034236.21 eukaryotic translation elongation factor 1 alpha 1JMus musculus) 47 gij84875498jre~NP_067519.21 voltage,gated sodium channel type Valpha (Mus musculus] 48 gij21704042jre~NP_663504.1 1cleavage stimulation factor subunit3 isoform 1[Mus musculus] 49 gij75677440JreijNP_0~1427.21 adisintagrin and metallopeptidase domainS [Mus musculus) 1 gij31712036Jre~NP_853513.11 eukaryotic translation initiation factor SA [Mus musculus] 2 gij42415475jreijNP_:035162.11 prolyl4-hydroxylase, beta polypeptide (Mus musculus] 7 giJ47894398ireijNP_001001491.1jtropomyosin 4 [Mus musculus] 8 gij6680067!reijNP_032181.11 glucose phosphate iscmerase 1 [Mus musculus] 10 gij94380203jreqXP_001003154.11 PREDICTED: simi!;lrto Glucose phosphate isomerase 1 isoform 2 [Mus museu 11 gij157951604jrefjNP_031624.21 CftP, ad~ate c}'Ciase-associated protein 1(Mus muscuus] 17 gij157951S96~eqNP_033931 .41 carbonic art,ydrase 2 [Mus musculus] 18 g~41350312~eijNP_038636.21 nascent polypeptide-associated complex ~subunit isoform b [Mus musculus] 19 gij319S2724~eijNP_058056.2[ MYB binding proten1 (P160) 1a [Mus musculus] 24 gij829172301reijXP_926154.11 PREDICTED: hypothetical protein (Mus musculus) 26 gij12435e946jreijNP_606448.21 dedicator of cytokinesis 5 [Mus musculus] 28 giJ124339338JreijNP_036586.2I heal shock 70kDa protein 1~ike [Mus musculus) 31 gij34808712jreijNP_035203,2j perforin 1 [Mus musculus) 33 gij67530S6JrefjNP_03.3817.11 apurinicJapyrimidinic endonuclease 1 [Mus musculus! 36 gij62933260jre~XP_9104!)1 .1jPREOICTED: simMarto RFamide-related peptide receptor [Mus musculus] 39 gij124487249jreijNP'"00·1 074886.11 chromodomain helicase DNA binding protein 7(Mus musculus] 40 giJ76677895jreijNP_598452.21 poly-U binding splicing factor 60 isoform b (Mus musculus[ 42 giJ82930015jreijXP_486217.21 PREDICTED: similarto nuclear prolein-NHP2-Iike protein (MLIS musculus] 43 gij153945822~eqNP_033036.21 RADSO homolog !Mus musculus] 44 gij66262161jre~NP_796294.21 phosphoinosilide-3-ldnase, regulatory subunitS. p1()1 [Mus musculus] 45 gij6679533jre~NP_032049.11 forkhead box 82 [Mus musculus] 46 gij94385999JreijXP_466185.41PREDICTED: simiar to Nucleophosmin 1 isoform 1(Mus musculus[ 47 giJ1537914381feijNP_660256.21 Alstrom syndrome 1 [Mus musculus[ 48 gij9790197jrenNP_062773.11 Rhesus blood group-associated C glycoprotein !Mus musculus] 49 gij119954694jrenNP_031668.21 cadherin 15 [Mus musculus] 50 gij33239431jre~NP_776292.11 RCC1-Iike [Mus musculus] 51 gij31542192jre~NP_659190.2I microtubule-associated protsln 7 domain containing 1jMus musculus] 52 gi!6755040jreijNP_035202.11 profilin 1 [Mus musculus] 53 gij149256064jreqXP_001475846.1 j PREDICTED: sim~arlo LAIR hlog [Mus musculus) 54 giJ121247243jreONP_001073400.11 hypothetical protein LOC384814 [Mus musculus[ 55 gij46048256jreijNP_08444-4.21 RIKEN eDNA 4921505C17 (Mus musculus] 56 gij20S06109jrenNP_031441.21 poly (ADP-ribose) polymerase family, member 1[Mus musculus[ 58 gij149256116trenXP_001477495.11 PREDICTED: simHar to putative pheromone receptor [Mus musculus] 59 gij22128965jreijNP_667194.11 olfactory receptor 1256 !Mus musculus[ 60 gij101811801reijNP_065650.11zirlc f111ger protein 297(Mus musculus] 61 gijS6804231renNP_032391.11 interleukin 18 receptor 1[Mus musculus] 62 gij34328045jreijNP_031761.11 procollagen, type IV, alpha 4[Mus musculus) 65 gij40766536jreijNP_955451.11zona peDucirla binding pro!ein 2 iscform 2(Mus musculus[ S7 gij145048239~eijNP_082679.21 RanBP-iy]le anrl C3HC4-ty!Je zinc finger containing 1 [Mus musculus! 66 gi!6679203jrefjNP_032603.11 phenylalanine hydroxylase {Mus musculus) 69 giJ82801083jreqXP_920730.11 PREDICTED: simHarto REX1, RNA exonuclease 1 homolog (S. cerevisiae)[Mus n 70 gij6679156jrefjNP_032774.11 dual specificity phosphatase 8[Mus musculus) 71 gij29135339freijNP_619515.21 polycystic kidney and hepatic disease 1~ike 1 [Mus.musculus] 1 gij112181167jrenNP:..031559.2j complement component t q subcomponentbinding prptein [Mus musculus) 2 gij66B0924jrefJNP_031713c 11 co(~ln 1, non-muscle [Mus musculus] 3 gij31981562jreqNP_035229.2jpyrwate kinase, muscle [Mus musculus] 5 gij149258641jreijXP_001478027.11 PREDICTED: similar to Phosphoserine aminotransferase 1isoform 1 [Mus ml 9 gij29244176jte~NP_6063SS.1 j hypothetical protein 4732456N10 (Mus musculus] 10 gij149274047JrenXP_993966.21 PREDICTED: similar to pol protsin[Mus musculus[ 12 gij82917230~eqXP_926154.11 PREDICTED: hypothetical protein [Mus musculus] 13 gif6671509JrefjNP_031419.11 actin, be!a, cytoplasmic [Mus musculus] 14 gij13195628jreijNP_077151.1 j cleavage stimulatioo. factllf, 3'Jlle-RNA, subun~ 1[Mus muscllt1s] 15 gij21704162jreijNP_883583.11 kinesin lamily member 22 [Mus muscoosf 16 gq15743554jreijNP_277059.11 sprouty-related protem 1with EVH-1 domain jMus musculus) 17 gij51921287JreijNP_001004141.11 cytochrome P450, farnily 2, subfamily j, polypeptide 11 [Mus musculus] 21 gij6754900JreijNP_03598t1j5' nucleotidase, eclo (Mus musculus] 22 gij94365999jrefjXP_486166.41 PREDICTED: similar to Nucleophosmin 1 isoform 1[Mus musculus] 23 giJ47078289JreijNP_035408.31 ring finger protein 12 [Mus musculus] 24 giJ149266556jreijXP_001476902.11PREDICTED: simnar to PES1 protein (Mus musculus! 26 gij42475992jreijNP_780358.21hypoihetical protein LOC89551 .[Mus musculus] 27 gij149260366jreqXP_;001474560.'1 1PREDICTED: simHarto Zfp167 protein (Mus musculus) 28 giJ126032329jreqNP_034236.21 eukaiyillic translation elongation factor 1 alpha 1 [Mus musculus] 29 gij18485510Jre~NP_569721.1j RecQ protein-like S(Mus musculus] 30 gij29244494jre~NP_808548.11 hypothetical protein LOC330228 [Mus musculus) 31 gq31541815jre~NP_076226.21 L-specific multifunctional be!a-oxdiatkm protein [Mus musculusI 32 giJ84000005jreijNP_796320.2! G protein-coupled receptor 149 [Mus musculus) 33 gij149271040jreijXP_001481302.11 PREDICTED: hypothetic.alpmtein (Mus mu5Cldus] 34 gij90553i4jreW~P_051285.11 nucleoporin 210 !Mus musct.ius) 35 gij1244B6765JrenNP_001074790.11 PDSS, regulator of cohesion maintenance, homolog A [Mus muscllus] 36 gif30425250jreijNP_760706.11 hy]lothetical protein L(JC238880 [Mus musculus) 37 gij157951804jreijNP_0~1624.21 CAP, adenylaie cyclase-associated protein 1 [Mus musculus) 38 gij29789329jreqNP,.598578.11 zinc finger protein 451 [Mus musculus) 39 gij49227563jreqNP_667135.11 olfact01y receptor 476 [Mus musculus] 40 giJ9910228jrefJNP_064393.1. 1FK506 binding protein 12·rapamycin associated protein 1 [Mus musculus] 41 gij149259276jreijXP_921766,2I PREDICTED: similar to Phlppl protein isoform 3 [Mus musculus[ 42 gil94408062jreijXP~91 4446.21 PREDICTED: hypothetical protein LOC71030 [Mus musculus] 43 gij21703970jreijNP_663468.11 complexin 4(Mus musculus) 44 giJ124430766jreijNP_659122.21 ubiqUiiMJ-§ke, containing PHD and RING finger domains 2 [Mus musculus[ 45 gij160333799~eijNP_067314.21 eel adhesion mofeculwelatedldowiHegulaled by oncogenes (Mus musculus! 46 gij149266953~enXP_001475495.1! PREDICTED: hypothetical protein [Mus musc.UUS] 47 gij22507327JreijNP_683731.11 Na-H exchanger isoform NHE8 isoform a [Mus musculus] 48 gij21426893jreijNP_064418.11 histone cluster 1, H1 b jl\!us musculus) 4.39E-04 0.75 5.40E-04 0.19 5.54E-04 0.55 5.56E-04 0.07 5.64E-04 0.68 5.83E-04 0.03 6.08E-04 0.18 6.93E-04 0.24 7.03E-04 0.03 7.05E-04 0.19 a.OSE-04 0.34 8.07E-04 0.38 8.15E-04 0.56 8.37E-04 0.63 8.53E-04 2.60 8.57E-04 0.11 8.92E-04 0.14 9.83E-04 0.15 3.33E-16 1.94 7.33E-13 0.96 S.OSE-09 2.67 3.93E-OB 0.95 1.55E-071.66 3.04E-07 2.00 1.32E-06 0.92 1.62E-06 0.85 U3E-08 0.92 4.39E-08 0.78 7.66E-06 0.38 1.96E-05 0.63 4:16E·05 0.62 5.5SE-05 0.89 6.09E-05 0.02 1.00E-04 1.00 1.31E-04 0.99 2.08E-04 0.86 2.25E-04 0.10 2.53E-04 0.03 2.71E-04 0.41 3.22E-04 1.01 3.9SE-04 0.57 4.31 E-04 0.03 4.33E-04 0.06 4.46E-04 0.60 5.11E-04 0.10 5.23E-tl4 1.03 5. 77E-04 0.08 6.10E-04 0.11 6.1 1E-04 0.08 6.41E-04 0.55 7.13E-04 0.01 7.20E-04 0.18 7.28E-04 0.09 7.30E-04 0.27 7.43E-04 il.23 8.83E'04 0.14 9.18E-04 0.35 9.85E'04 0.05 9.85E-04 0.'1 0 9.85E-04 0.06 9.89E-04 0.54 7.33E-14 0.88 1.12E-09 1.66 2.01E-09 3.31 9. 76E·08 0.91 5.44E-06 2.73 1.02E-05 0.04 1.67E-05 0.46 2.23E·05 1.48 4.11E-05 0.03 5.79E-05 OJO t49E-04 0.37 1.75E-04 0.26 1.88E-04 0.05 1.97E-04 0.78 2.08E'04 0.61 2.08E-04 0.1 7 2.30E-04 0.25 2.45E-04 0.19 2.64E-04 2.83 3.00E-04 0.40 3.26E-04 0.28 3.94E-04 0.01 4.17E-04 0,07 4.58E-04 0.08 4.60E-04 0.28 4.83E-04 0.29 4. 70E-04 0.59 4.93E-04 0.48 5.29E-04 0.88 5.37E-04 0.02 5.47E-04 0.13 S.SOE-04 0.31 5.65E-04 0.23 6.32E-04 0.47 6.50E-04 0.03 6.58E-04 0.08 6.69E-04 0.05 6.82E-04 0.03 7.19E-04 0.34 10.14 12.12

8.11
8.10 10.13 10.07 12.14 6.11 8.08 14.11 24.10 20.11 10.10 28.10 48.20 24.10 14.09 10.11 20.28 10.24 28.17 18.19 20.21 38.21 10.19 10.16 16.16 10.16 26.09 12.12 10:14 10.18 10.05 20.13 8.15 10.15 10.10 10.08

AnXA4EN~CI

18;13
12.19 24.10 18.06 10.07 12.13 10.11 18.19

10.09
14.07 10.09 10.12 10.{)3 12.10 20.09 20.08 20.10

8.10
22.11 8.07 14.09 8.09 48.10 10.21 20.21 42.19 10.16 30.17 10.07 8.11 30.19 10.07 10.06 14.12 10.12 14.08 10.t3 10,14 18.07 10.09 8.09 46.20 12,09 18.07 8.05 14.06 10.07 22.10 10.13 8.18 12.12 18.18 10.09 24.10 14.09 14.12 10.11 18.08 8.07 10.08 10.09 10.11

AnXA4EFA

74101.9 6678902 56159.7 23956314 60717.9 19705424 16760.8 37497112 62094.7 34808712 69278.4 161333817 142106.2 85701740 92031 .2 157951655 83025.3 40353214 303063.9 7657417 303496.9 149256458 506263.6 157951641 54068.3 84993750 140330.2 163644270 50113.5 126032329 227704.3 84875496 82876.1 21704042 84534.0 756.77440 161l:l2.2 31712036 57058.0 42415475 26467.6 47694398 66. 80067 ~767.5 37643.3 94360203 51564.5 157951604 29032.3 157951598 23383.7 41350312 152035.8 31982724 12418.3 82917230 214426.5 124358946 70636.6 124339838 62094.7 34808712 35490.2 6753086 51198.7. 8?933260 334058,5 124487249 58544.6 76677695 14173.5 829~0015 153.."45.6 1$3945822 96953.1 86262161 45170.0 6679833 31404.0 e-4.185999 3"o0212.1 153791438 54947.5 9790197 85643.1 119964694 55983;0 ·. 33239431 93341.4 . 31542192 14957.1 .·. 6755040 19857,5 149256084 80679.0 121247243 191567.6 ·. 46048256 112720.6 . 20806109 84630.6 149256116 34695.5 22128965 "66028.2 10181180 61600.4 6680423 164095.5 34328045 28450.6 407$6536 57534.3 145046239 51928.6 6679203 69035.3 82801ll63 $8B4U · 6679156 464728.1 . 29135339 31024.7 .1)21.81167 18559.4 · . 6680924 57844.5 . 31981562 4053t4 149258641 58266.0 29244176 24400.9 149274047 12418.3 82917230 41736.5 6671509 48381.5 13195628 73189.4 2'1704182 50663.9 15743554 57490.3 51921287 63$64.0 6754900 31404.0 94365999 6$376.5 47078289. 64761;3 .149266556 3~2 .. 42475992 8135'L2 149260366 50113.5 126032329 108244.9 18485510 27894.9 29244494 78301.0 31541815 60519.1 84000005 20232.8 149271040 204137.2 9055314 150221.1 124485765 42004.0 30425250 51564.5 157951604 120059.2 29789329 34192.4 49227563 288733.5 9910228 147771.2 149259276 81779.1 94408082 18350.4 21703970 90105.2 124430766 135420.8 160333799 44722.6 149265953 4736.5 22507327 22576.0 21426893

2(20000) 2(0 101 0) 2 (001 0 1) 1 (0 1000) 1 (1 0000) 1 (1 0000) 3(01 002) 2(000 11) 1(01000) 3(10002) 5(01121) 3(1 011 0) 1 (1 0000) 3(21 000)' 5(41 000) 3(03000) 2(1 001 0) 2(1 001 0) 2(20000) 1 (1 000 0) 3(21 000) 2 (11 000) 2(20000) 4(31000) 1 (10000) 1 (1 0000) 2(1 01 00) 1 (10000) 4(11 020) 3(01002) 1 (1 0000) 1 (1 0000) 1 (1 0000) 3(0201 0) 2(00020) 1 (1 0000) 2(01 00 1) 2 (0011 0) 2(11 000) 2(1 0001) 5(101 '12) 2 (11 000) 2(01001) 2(1 0001) 1 (1 0000) 2(11 000) 1 (1 0000) 3(01 0 11) 2(0011 0) 1(10000) 1 (1 0000) 2(01010) 6(20310) 2(20000) 2(20000) 1 (01 000) 3(11 01 0) 1 (01 000) 2(011 00) 2(001 01) 7(31102) 1(10000) 2(20000) 5(40001) 1 (1 0000) 4(21 00 1) 1 (1 0000) 1 (0 1 000) 3(300 00) 1 {1 0000) 1 (1 00 0 0) 2(1 00111) 1 (1 0000) 2(1 001 0) 1 (1 0000) 1 (1 00 00) 3(1 010 1) 1 (1 0000) 2(00020) 5(40100) 3(0 1002) 2(1 1 000) 1 (01 000) 2(011 00) 1(1 0000) 3(1 10 I()) 1(1 0000) 1 (01 000) 2(1 000 1) 2(11 000) 1 (1 0000) 3(03000) 2{011 00) 3(00201) 2(01 0 0 1) 2 (11 000) 1 (01 000) 1 (1 0000) 1 (1 00 00) 1 (1 0000)

89

Table 1 continued
7.72E·04 0.36 7.98E-04 0.7i 8.25-04 0.23 B.Bl!E-04 0.1& 9.02E-04 0.44 9.21E-04 0.06 9.71E·04 0.10 9.92E·04 0.09 SASE-12 2.89 4.11E-10 1.71 1.44E-08 3.60 1.53E-08 0.98 6.21E-08 0.93 6.49E-08 0.97 2.19E-07 1.34 5.51E-07 0.65 6.92E-07 1.11 1.22E-06 1.57 1.66E..OO 0.87 2A3E-C6 0.20 2.58E-C6 0.82 8.64E-06 0.87 tB1E-05 2.49 3.62E·05 0.38 3.91E-05 0.87 5.63E-05 o.ea 8.78E-05 0.93 1.18E-04 D.30 1.21E-04 0.36 1.28£-04 0.43 1.34E-04 0.10 1.391:.()4 0.68 1.97E-04 0.32 2.18E.04 0.26 2.22E-04 0.18 2.27E-04 0.43 2.9GE-04 0.58 3.55E-04 0.19 3.73E-04 0.02 4.63E·04 0.18 5.47E-04 0.61 5.53E-04 0.38 5.76E-04 0.03 6.31E-04 0.07 7.11E-04 0.24 7.30E-04 0;65 7.54E-04 0.03 7.69E.()4 0.05 7.38E-04 0.39 9.09E-04 0.82 9.16E-04 0.43 9.41E-04 0.23 9.6BE-C4 0.28 7.14E-09 2.10 4.39E-08 2.55 JAGE-07 0.19 7.08E·08 0.20 8.'15E-06 1.18 1.06E-05 0.27 1.61E-05 0.62 4.96E-05 0.42 s:93E-05 o.14 7.S2E-C5 0.04 t.OSE-04 0.01 1.17E-04 0.41 1.42E-04 0.53 1.52E-04 0.12 1.60E-04 0.06 1.60E-04 0.08 2.71E-04 0.27 3.30E.fl4 0.10 3.84E-04 0.59 4.91E-04 0.20 4.96E-04 0.03 5;t4E-04 0.01 5.30E-04 1.28 5.72E-04 0.02 6.77E-04 0.16 6.81 E-04 0.50 8.01E-04 0.27 8.53E-04 0.23 8.90£-04 0.20 9.23E-04 2.45 9.47E-04 1.60 9.52E-04 0.03 9.82E-04 0.81 8.23E·13 1.35 1.01E-12 5.19 4.81E-10 5.70 5.00E'1G 1.84 1.19E-09 3.38 1.32E-09 5.14 1.32E-O!l 2.44 1.32E-09 2.44 3.36E-09 0.90 3.59E-09 0.87 6.24E-09 3.70 6.41JE-09 6.48 8.06E-09 0.92 1.71E-OS 1.11 4.10 40981.7 139949022 2 (00002) 20.15 28951.9 41235747 2 (20000) 26.10 156513.3 134031976 3(2 01 00) 10.11 148633.5 58037343 2(0011 0) 14.10 35416.2 22128741 2(1 001 0) 8.08 38947.9 86355499 1(01 000) 12.09 37817.3 31559990 2(1 000 1) 1 (01 000) 8.09 108495.9 113865911 30.28 16832.2 31712036 3(30000) 20.23 37843.3 94380203 2(20000) 40.25 18559.4 6680924 4(40000) 10.27 35611.2 31982186 1 (1 0000) 10.15 11605.4 6681095 1 (1 0000) 1 (1 0000) 10.24 27n1 .0 6755041 20.23 56078.0 112293284 2(20000) 1 (1 0000) 70636.8 124339838 10.14 22.18 152035.8 31962724 4(1 0111) 24.19 14957.1 6755040 3(2001 0) 1 (1 0000) 10.15 25147.6 7305061 12.11 297586.7 113722131 2(0 101 0) 10.19 29912.4 157951606 1 (1 0000) 10.16 29032.3 157951596 1 (1 0000) 38.20 31404.0 94385999 4(31000) 10.10 36271.3 149257635 1 (1 0000) 1 (1 0000) 10.14 14427.4 6755384 56.12 466573.3 124487380 8(31130) 10.19 35490.2 6753085 1 (1 0000) 10.12 33775.-i 149267887 1 (1 0000) 18.10 105076.3 7305383 2 (11 000) 14.12 71084.1 117606316 2(011 00) 20.08 40095.4 34878726 2(20000) 22.12 71726.7 110347527 4(1201 0) 12.13 39228.7 27229050 2 (00200) 2 (00200) 12.09 71588.9 21311877 3(1 00 11) 16.10 119748.2 124487341 8.11 55746.6 148228285 1 (01 000) 16.09 136369.0 126000572 2(1 01 00) 8.11 75409.0 28077005 1 (01 000) 8.05 65662.2 31982823 1 (01 000) 8.08 50140.2 133893022 2(001 01) 12.12 62094.1 348fl8712 2(1 0001) 18.11 178895.3 ·. 66787t 6 3(1 01 01) 8.08 34794.1 30142685 2(001 01) 2 (1 001 0) 14.08 63381.5 31982322 12.09 57534.3 145046239 2(1 0001) 22.10 144512.3 17978290 4(11 002) 8.11 134425.2 52350563 1 (01 000) 2(11 000) 18.08 56939.6 50345972 12.10 63480.3 29244242 2(1 0001) 10.12 17207.7 149262292 1 (1 0000) 10.12 67789.7 91598598 1 (1 0000) 10.09 64989.2 9507023 1 (1 0000) 8.10 21307.8 33004553 1 (01 000) 30.20 41736.5 6671509 3(30000) 4(31 QOO) 38.24 57644.6 31981562 1 (1 0000) 10.08 40531.4 149258641 18.10 71153.6 42734467 3(1 010 1) 26.16 56266.0 29244176 3(12000) 24.08 101066.5 28269697 3(111 00) 10.11 25359.8 162138926 1 (1 0000) 20.10 425828.7 6681203 3(1 011 0) 2 (20000) 20.09 36040.2 22128781 12.00 70836.8 124339838 2(01 01 0) 8.05 112773.2 82958179 1 (0 1 000) 10.11 15381.8 32490570 1 (1 0000) 10.15 67630.1 6678359 1 (1 0000) 10.08 15401.1 13385876 1(10000) 10.07 73427.5 25141235 1 (1 0000) 3(1 0002) 14.08 150793.6 114158711 8.10 35227.8 16716543 2 (001 01) 14.09 38595.9 149274726 2(1 001 0) 12.11 96561.8 15-l240724 2(1 0001) 8.09 58102.2 149258234 1 (01 000) 1 (1 0000) 10.o7 10686.2 149253921 10.06 34934.5 13385196 1 (1 0000) 24.15 35811.7 149285160 3(2001 0) 8.05 125595.3157041258 2(00020) 10.09 94232.9 116089290 1 (1 0000) 20.10 122777.0 6753236 4(1 0021) 12.13 34643.4 22129345 2 (1 0001) 32.08 190329.7 28893539 5(03020) 1 (1 0000) 10.11 35216.7 6678824 36.17 50113.5 128032329 4(301 00) 32.15 26203.4 6678439 5(20300) 1 (01 000) 8.07 38524.8 124487441 28.12 404059.9 94402846 5(200 12) 20.26 35911.7 149265160 2(20000) 78.22 41738.5 6671509 3(71 000) 74.22 76722.7 84875537 8(7001 0) 36.26 13906.0 66131547 4(301 00) 58.17 57844.6 31981562 6(51 000) 59.19 65605.5 126116585 7(31 300) 36.21 112284.6 145580629 4(22000) 3(12000) 26.21 54565;0 114145561 10.17 17i24.9 149266532 1 (1 0000) 10.13 87917.2 160333923 1 (1 0000) 50.21 84787.3 6754254 7(24100) 100,20 11367.3 21361209 10 (t00000) 10.19 28302.4 31543976 1 (1 0000) 16.22 39712.0 149270573 4(01 012)

AnXA5 ENaCI

AnXA5EFA

ControlEN~CI

4B gij139949022lref1NP_001077279.1 1hypothetical protein LOCi2446[Mus musculus] 50 gi[412357471ref~'lP_958747.11hypothetical protein LOC380967[Mus musculus) 51 grl134031976jref]NP_082509.2lleucine-rlch PPR motif-containing protein [Mus musculuS) 52 gi[58037343~efjNP_083011.1 [ tetratricopeptlde repeat domain 21A (Mus musculus] 53 gi[22128741[refjNP_667323.1[ olfactory receptor 559 [Mus musculus] 54 gi[863554B9[refjNP_038859.3[ proline-serine-threonine phosphatase~nteractrng protein 2 [Mus musoulus) 55 gi[31 5599SO[ref[NP_598434.2[ torsin family 1, member B [Mus musculus) 56 gi[113865911[reqNP_001038994.11 microrchldia 3[Mus musculuS] 1 gij31712036[ref{NP_853513.11 eukaryotic banslation AJitialion factor 5A (Mus musruus] 3 gi[94380203Jre11XP_001003154.11 PREDICTED: similar to Glucose ph<lsphate rsomerase 1 isoform 2[Mus museu 9 gi[6680924~ef[NP_031713.11 cofifin 1, non-muscle {Mus musculus) 10 gi[31982186[ref[NP_032843.2[ malate dehydrogenase 2, NAD (m~ochondrial) (Mus musculus) 12 gij6681095~ef)NP_031£34.1[ cytochrome c, scmatic [Mus musculus] 14 gi[675604ttefiNP_035970.1[1yrosine 3-monooxygern~seltryptophan 5-monooxmenase aclivation protel1, zeta pol 15 gi[112293264[re~NP_031978.2[ ~~ote;n dis\Mide isomerase aSiociated 3[Mus musculus] 17 gi[124339838lreijNP_038586.2[ heat shock 70kDa protem 1~ike {Mus musculus) 19 gi[31982724[ref[NP_058056.2[ MYB binding protein (P160) 1a (Mus musculus] 20 gil6755040jref[NP_035202.1 [ profilin 1[Mus musculus) 21 gi[7305061~effNP_038930.11FKSOO binding protein3{Mus muswlus] 24 gi[113722131~e~NP_932150.2f senatalrin (Mus musculus] 25 gi[157951601ljre~NP_765988.21 DnaJ (Hsp40) homolog, subfamily C. mehlber S(Mus musculus) 27 gi(157951596jreqNP_033931.4[ carbonic anhydrase 2 {Mus musculus) 32 gil94385999jref[XP_4861 88.4[ PREDICTED: similar to Nucleophosmin 1 isof~rm 1 (Mus musculus] 35 gr[149257635jreqxr_001476931.1( PREDICTED: olfactory receptor 654 (Mus musculus] 37 gil6755384~eqNP~035424.11 RNA polymerase ntranscriptional coactivator [Mus musculus) 38 gij1244873BO[reijNP_038658.2[ pc!ycystin 1(Mus musculus] 39 gij6753086)ref[NP_033817 .1[ apuriniclapyrimidinic endonuclease 1 [Mus musculus) 43 gil149267887[reijXP_922530.21 PREDICTED: eirniar to MSP23 isoform 1 [Mus musculus] 44 gi[7305383~ei[NP_038812.1( phosphatidytin!'Sitol glycan anchor biosynthesis, class N [Mus musculus] 45 gi[117606316jreqNP_076362.2[ centrosomal protein 70 (Mus mUSCl~us] 47 gi[34878i26[refjNP_919239.1[ T-box 20 isofonn a [Mus musculus] 48 gi[110347527[re~NP_084223.2[ PR domain containing 8[Mus musculus] 50 gi[272290501ref[NP_080532.1[ gonad specifiC ankyrin repeat protein isolorm 1 [Mus musculus] 51 gi[213118771ref[NP_083037.1 1poly(A~specifrc ribonuclease (deadenylation nuclease) [Mus musculus) 52!!il124487341lreijNP_808276.21 hypothetical protein LOC7035-i (Mus musculus) 53 gi[t48228285lre~NP_671511.2[ T-ceU activation GTPase activating protein ![Mus musculus] 54 gij1260905721reqNP_001028547.2[ hypothetical protein LOC319277[Mus musculus) 58 gil28077005jref[NP_082631.11 transmembrane protein 48[Mus musculus) 59 gi[31982823jrefjNP_033355.2[ zinc finger protein 354A (Mus musculus] 60 gi)133893022lre~NP_780005.3[ Sp110 nuclear body protein (Musmusculus] 62 gi[34808712[re~NP_035203.21 perforin 1(Mus musculus) 63 gi[6678716lreijNP_032539.1[1ow density kpoprotein receptor-related protein 5(Mus musculus) 64 gi[30142635jref1NP_839975.1llransmembrahe epididymal protein 1[Mus musculus) 65 gi[31982322(refjNP_032174.2[ glycoprotein 5 (platelet) (Mus musculus) 66 gi)145046239jre~NP_062679.2[ RanBP-type and C3HC-i-type zinc finger containing 1[Mus musculus) 69 gil17978290[refjNP_53S718.11 SMC(structural maintenace of chromosomes 1)-like 2(Mus musculus] 70 gil52350563[refjNP_cot 004751.1[ Gprotein-coupled receptor 158 [Nus musculus) 71 gi[50345972[refjNP_032618.21 forkhead box C1 [Mus musculus) 72 gi[29244242FeflNP_808420.1[ essential meiotic endonuclease 1 homolog 1 [Mus musculus) 73 gi[149262292[re1jXP_001476969.1[ PREDICTED: similar to Nucleoside dij)llosphate kinase A (NDK A) (NDP kina· 74 gij9159S59elref[NP_5705i4.2(sorting nexin asaociated gotgi protein 1(Mus musculus) 75 gi[9507023~e~NP_082392.1[ Rab geranylgeran)1 transferase, a subUf\~ [Mus musculus) 77 gi[S30045531ref[XP_35823S.3j PREDICTED: simnar to Hmgb1 prctein [Mus musculus) 1 gi[6671509[ref[NP_031419,1[ actin, beta, cytoplasmic [Mus musculus) 2 gij3t981662[refjNP_035229.21 pyruvate kinase, muscje [Mus musculus] 5 g~149258641 ~e~XP_001478627.11 PREDICTED: similof to Phosphoserme amilotransferase 1 isoform 1[Mus mt 7 gil427344671rei[NP_663574.2) transmembrane protein 34[Mils musculus) 8 gi[29244176jrefiNP_80838.5.1[ hypothetical prc~ein 4732456N10 [Mus musculus) 11 gi[28269697[ref!NP_444319.2[ NMDA receptor-regulated gene 1 [Mus musculus] 12 gi[16213892BirefjNP_03179-4.31 C-reaclive protein, pentraxin-related (Mus musculus) 15 gij668120:J;reflNP.;.031894.11dystrophin, muscular O)"'.Jrophy{Mus musculus] 16 gi[22128781lref!NP..c67305.1[ olfactory receptor 605(Mus musculus) 17 gi[12433983B[re~NP_038586.2[ heat shock 70kDa protein 1-like !Mus musculus) 19 gi[82959179[reQXP_914504.1[ PREDICTED: hypothebcal protein LOC69439(Mus musculus] 20 gi[32490570[refjNP_849270.1 [ p53 and DNA damage regulated 1 (Mus musculus) 21 gij6678359jre~NP_033414.11 transketolase (Mus musculus) 22 gi(13385876[rei]NP_086659.1[ proline-rich nuclear receptor coactivator 2[Mus musculus) 23 gi[25141235lrei]NP_036138.1[ DEAD (Asp-Glu-Aia-Asp) box pcl)lleplide 3, Y~in!<ed [Mus.rnusculus) 24 gi[114158711[re~NP_001041059.1[ tetratricopeptide repeat domai1121B {Mus mll$culus) 26 gr(16716543~efjNP_444460.1[ vomemnasal1 receptor, B9{Mus musculus) 27 gij149274726~eQXP_486431.4( PREDICTED: similar tQ but)1o¢lilin-tike 4 (Mus musculus) 28 gi[154240124~ei]NP_598766.2lect01ltlcleotide pyrophosphatase/phosphodiesterase 3{Mus musculus) 30 gi[149256234[re~Xi'_001472600.1[ PREDICTED: similar to zinc finger protein 758 [Mus musculuS) 31 gi[149253921[reijXP~001477202.1[ PREDICTED: IJypothetical protein [Mus musculus] 33 gi[133S5196jref[NP_080012.1[ tetratricopeptide repeat domain 35[Mus musculus] 34 gi(149265160jreijXP_001476568.1) PREDICTED: similar to Glyceraldehyde-3-phosphete dehydroganase (GAPDI35 gij157041258jref[NP~081471.2[ castor homolog 1. zinc finger [Mus musculus) 37 gif115089290fre~NP-808558.2[ hypothetical protein LOC330513 {Mus musculus] 38 gi[6753236[refjNP_033915.1[ calcium channel, voltage-dependent, alpha21delta subunr. 3[Mus musculus) 40 gi[22129345~efiNP_666963.1[ olfactory receptor 1108 (Mus musculus) 41 gi[28893539jref(NP_798353.11Rho GTPase-ildivating proteifl(Mus musculus] 42 g~6878824~e~NP_032588.11myeloid ceU leukemia sequence 1 [Mus musculus) 43 gij126032329[reqNP_034235.2[ eukaryotic translation elongation factor 1 alpha !(Mus musculuS) 44 gi[6678439)ref[NP_033456.1[ protease, serine, 2[Mus musculus] 45 gr[124487441 [re~NP_001074588.11 abhydrolase domain containing13{Mus musculus) 48 gi[9440264~ef[XP_522820.3j PREDICTED: similar to axonemal dynein heavy chain 8lcng form (Mus musculus] 1 Qil149265160jreqXP_001478568.11PREDICTED: similar to G~'Ce<aldehyde.J..phosphale dehydrogenase (GAPDI2 gij6571509JreijNP_031419.1[ actin, beta , cytoplasmic (Mus musculus) 3 gi[84875537[ref[NP_035010.31 nucleolin [Mus musculus) 4 gi[681315-l7[refjNP_075911.2[ histone cluster 1, H2bc [Mus musoulus) 5 gi[31981562~efjNP_035229.2[ pyruvate kinase, muscle [Mus musculus) 6 gij12611G585[refjNP_032499.21keratin con1pleX 2, basic, gene 1 (Mos musoulus) 7 gij14558082Sjrei]NP_997652.'11 keratin Kb40 (MU$ musculus] 8 gif114145561[re~NP_112447.2[ keratin complex 2, basic, gene 8[Mus musculus] 9 gi[14B266532[reqXP_001475762.11 PREDICTED: Similar to ribosomal protein L23a {Mus musculus] 10 gij160333923[reijNP_058085.2[ heterogeneous nuclear ribonucleoprotein U [Mus musculus) 11 !Jil6754254jref[NP...;034610.1[ heat shocl< protein 1, alpha fMus mll$culus) 12 gij21381209frefjNP_291074.11 histone cluster 2, H4{Mus musculus] 13 gi[31543976)refjNP_061359.2[3-mQnooxgenase.~ryptophan 5-monooxygenase activation protein, gamma p.Jtypep 14 gi[149270873fre~XP_999161.2[ PREDICTED: similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [r1

90

Table 1 continued
15 gil30061399lre~NP_835584.11 histone cluster 2, H2aa2 [Mus musculus] 16 gil338594821re~NP_031933.11 eukaryotic translatlon elongation factor 2 [Mus musculus] 17 gil20808532lrefiNP_035863.11 cold shock domain protein A short isoform [Mus musculus] 18 gil319317221re~NP_071705.21 heat shock protein 5 [Mus musculus] 19 gil6755863lrefiNP_035761.11 tumor rejection antigen gp96 [Mus musculus] 20 gil51092293lre~NP_001003667.11 keratin 77 [Mus musculus] 21 gil13385998lre~NP_080784.11 TNF receptor-associated protein 1[Mus musculus} 22 gil29243942lre~NP_808254.11 eukaryotic translation iOKiation factor 5A2 [Mus musculus] 23 gti149259999Jref1XP_0014737·15.11 PREDICTED: Similar to Hmgb1 protein [Mus musculus] 24 91151 092301lre~NP_001003670.11 type II keratin Kb141Mus musculus] 25 Q118S198323Ire~NP_057869.21 high mobility group AT-hook 1(Mus musculus] 26 911829501471re~XP_621314.21 PREDICTED: desmoplakin isoform 1[Mus musculus] 27 gil21313438lreijNP_079864.11 exocyst complex component 2 [Mus musculus) 28 gii70778915IreijNP_034963.21 moesin [Mus musculus] 29 gil1129836361ref1NP_034790.21 keratin complex 1, acidrc, gene 10 [Mus musculus] 30 gil20911031lre~NP_081287.11 keratin 5 [Mus musculus] 31 gil292441761re~NP_308385.11 hypothetical protein 4732455N1 0 [Mus musculus] 32 gil31931690jre~NP_112442.21 heat shock protein 8 [Mus musculus) 33 gi(56606037Jre~NP_001 008551.11 hypothetical protein LOC434632[Mus musculus] 34 gil1537927721re11NP_001 093249.11 pvuvate kinase liver and red blond ceU isoform 2 [I\~ us musculus] 35 gil113205059lre~NP_035862.2) nuclease sensttive element binding protein 1 {Mus musculus] 36 gif71774133jref1NP_035279.21 peptidylprolyl isomerase B [Mus musculus] 37 Q1{1200323291re11NP_034235.21 eukaryotic translation elongation factor 1 alpha 1 [Mus musculus] 38 g1[11 0227377lrefiNP_001 035999.11 gelsolin-like capping protein [Mus musculus] 39 Q1{94395014jreijXP_001001311.11 PREDICTED: heterogeneous nuclear ribonucleoprotein AO [Mus musculus) 40 gil17978262lre~NP_536694.11 helicase (DNA) B [Mus musculus] 41 gil6671539lref]NP_031464.11 aldolase 1, A 1soform [Mus musculus] 42 gi)i t 3931158lref1NP_081457.1) protein (peptidyl-prol)i cis/trans Isomerase) NIMA-interacting, 4 (parvulin) [Mus mt 43 gil112807207lref1NP_034507.21 histone cluster 1, H1t }Mus musculus] 44 gil94372553lreijXP_978405.11 PREDICTED: s»mlarto fusion protein: ubiquKin (bases 43_513); ribosomal protein: 45 gil83921618lrefJNP_033536.21 vffiin 2 [Mus musculus] 46 gil6680229lref1NP_032278.11 high mobil~y group box 2[Mus musculus! 47 gil315435951ref1NP_542129.2[ U box domain containing 5 [Mus musculus] 48 gii4055650Biref1NP_032328.21heat shock protein 1, beta [Mus musculus] 49 gii162138926Jref1NP_031794.31 C-reactive protein, pentraxin-related [Mus musculus! 50 gilt3430890ire~NP_056602.11 histone cluster 1, H1e [Mus musculus] 51 gil83022023lreijXP_914836.11 PREDICTED: hypothetical protein [Mus musculus] 52 gil62241 030ire~NP_083061.21 dedicator of cytokinesis B[Mus musculus] 53 gi)73049351ref1NP_038511.t.l bucytophilin, subfamily 1, member At [Mus musculus) 54 gil154091026jref1NP_033487.21 ubiqurtin protein ligase E3 component n.recognin 1 [Mus musculus] 55 gii1338542SireijNP_080210.1j RIO kinase 2 [Mus musculus) 56 gii50399B60)reijNP_113580.21 debranching enzyme homolog 1[Mus musculus] 57 gii9845257Jref!NP_056501.11 histone cluster 1, H1 c [Mus musculus] 58 gil21389311[reijNP_034623.1) intercellular adhesion molecule [Mus musculus] 59 gil40254525lre~NP_071709.21 tropomyosin 3, gamma [Mus musculus] 60 gi[31982178[re~NP_032644.2) malate dehydrogenase 1, NAD (soluble) [Mus musculus] 61 gil153791358ltefiNP_112456.21 splicing factor 3b, subunit 1 [Mus musculus] 62 gil84662721[re~NP_001033784.1)1umonji domain containing 1A 1soform 21Mus musculus] 63 gil31980723lre~NP_038918.21 F-box and WD-40 domain protein 2 [Mus musculus] 64 gil148238335lref)NP_062357.31 RNA and export factor bindrng protein 2 [Mus musculus] 65 gil1111859051re~NP_031990.21 ecotropk: viral integration sr.e 5 [Mus musculus] 66 gi}162287042lref)NP_cot 094923.11 angiotensin I converting enzyme (peptidyl-dip<lptidase A) 3 [Mus musculus] 67 gil47059476)reijNP_705766.2) zinc finger, CCHC domain containing 6 [Mus musculus] 68 gi)86198333)reijNP_001034442.1) nucleolar and coiled·body phosphoprotein 1 isoform D }Mus musculus] 69 gi(149251400lre~XP_t 43529.61 PREDICTED: similar to FLJ44691 protein }Mus musculus] 70 gi[1492494661refJXP_OOW7320.1) PREDICTED: hypoti1etical protein }Mus musculus} 71 gil22129197[reijNP_667042.11 olfactory receptor 133 [Mus musculus] 72 gil162951865jref1NP_033724.21 v-abl Abelson murine leukemia oncogene 1isoloml b [Mus musculus] 73 gij47271413lreijNP_932777.21 slingshot homolog 1 [Mus musculus] 74 gil1640909411re~NP_997646.21 keratin 42 [Mus musculus] 75 gil149253262jref1XP_20643S.51 PREDICTED. hypothetical protein [Mus musculus] 76 giJ125628634jrefiNP_064329.21 microtubule associated serine/threonine kinase 1 [Mus musculus] 77 gi]84370320ire~NP_001028561.11 far upstream element (FUSE) binding protein 3 [Mus musculus] 78 gi)6678113)re11NP_033239.1) secreted phosphoprotein 1 [Mus musculus] 79 gii149260081Jref1XP_001478733.11 PREDICTED: hypothetical protein LOC69642 [Mus musculus] 80 gil1492604991refiXP_001477537.11 PREDICTED: similar to experimental autotmmune prostatKIS an~gen 1 [Mus m 81 gi}71 063351re11NP~034793.1) keratin 17 [Mus musculus] 82 gi)149267892lrefiXP_921350.2j PREDICTED: similar to ubiquitin A-52 residue ribosomal protein fusion product 1[ 83 gil167165691re~NP_444473.1 1protease, ser~1e, 1[Mus musculus] 84 gil21312532lre~P_082329.1( transmembrane protein 388 }Mus musculus] 85 gil22164776lre~NP_668175.1[ keratin 6l[Mus musculus] 86 gii149258S941refjXP_911841.31 PREDICTED: simdar to BAF57}Mus musculus} 87 gi[149261346ltefjXP~001472756.1I PREDICTED: similar to mKIAA0184protein [Mus musculus] sa gii1215S3906Iref1NP_598788.21 Ppar bind1ng protein isoform 2 [Mus musculus] 89 gii4053B8381reijNP_835166.21 hypothetical protein LOC68497 [Mus musculus] 90 gil6681099lref[NP_031836.11 cytochrome P450, family 19, subfamily a. polypeptide 1 [Mus musculus] 91 gil33563305lreijNP_766317.11 nucleotide-binding oilgomelization domain contaimng 1 [Mus musculus] 92 gil82997081jreijXP_915830.1J PREDICTED: sim!ar to YTH domain containing 2 [Mus musculus] 93 gi)113930737jref1NP_033021.21 p<lroxin 5 isoform 1[Mus musculus] 94 gij7305143lre~P-038848.1) he~okinase 2 [Mus musculus] 95 gil20270043lre~NP_061299.21 adaptor-related protein complex 3, mu 1 subuntt [Mus musculus] 96 gil13122606lre~NP_076013.11 TCF3 (E2A) fusion partner [Mus musculus) 97 gil23958056lreijNP_034772.11 kamkrein 1-related peptidase b21 [Mus musculus] 98 gil149254113lref1XP_992145.2IPREDICTED: HFM1 protein [Mus musculus] 99 gi)6755372lrei1NP_036182.111ibosomal protein 83 [Mus musculus] 100 gil87042277lte~NP_035080.21 numb-like [Mus musculus] 101 gil21426693lre~NP_064418.11 histone cluster 1, Ht b[Mus musculus] 102 gil315599681refjNP_653105.21 TBC1 domain family. member 10b [Mus musculus] 103 gil85701585lre~NP~001 032723.11 placenta-spec~ic 1·flke [Mus musculus] 104 gil38796741lre~NP~082305.11 dynamin binding protein [Mus musculus] 105 gil213123351re~NP_081403.11 hypothetical protein LOC69590 [Mus musculus] 106 gil124487265lref1NP_001 074891.1 1h)!lothebcal protein lOC665775 [Mus musculus] 1 gil300613991re~NP_835584.11 histone cluster 2, H2aa2 [Mus musculus] 2 gi[9845257[re~P_056601.11 histone cluster 1, H1c [Mus musculus] 3 gil21361209lre~NP_291074.11 histone cluster 2, H4 [Mus musculus] 4 gil273699241re~NP_766229.11 hypotl1etical protein LOC226245 [Mus musculus) 5 gtl34328303lre~NP_081676.21 hypothetical protein LOC70809[Mus musculus] 6 gtl222965891reqNP_083179.11 scavenger receptor class A, member 5[Mus musculus! 7 gll28316756lre~NP_733589.11 histone duster 1, H2aa [Mus musculus] 8 gi)Sil080239lrefiNP_001007573.1) transient receptor potential cation channel, subfamily V, member 5 [Mus museu 2.41E-08 9.88£-08 1.80E-07 1.96E-07 2.36E-07 3.59E-07 6.57E-07 1.19E-06 1.43E-06 1.99E-06 3.08E.IJ6 3.74E-06 3.94E.IJ6 4.03E-05 5.20E-OS 5.48E.IJS 5.48E.IJS 7.92E.IJS 1.10E-05 1.24E-05 1.31E-05 1.60E-05 i.74E-05 2.42E-05 2.52E·05 2.63E-05 2.73E-05 2.76E-05 3.27E-05 5.26E.IJ5 6.12E-D5 6.40E.IJ5 7.27E.IJ5 8.06E.IJ5 8.72E-05 9.63E-05 9.89E-05 1.05E.IJ4 1.14E-!l4 1.1BE-04 1.21E-O>! 1.30E-04 1.37E-04
1.44E.IJ~

ControiEFA

1.47E.IJ4 1.50E-04 1.65E.IJ4 1.65E-04 1.66E-04 1.6BE·04 1.87E-04 2.12E-04 2.15E-04 2.35E-04 2.44E-04 2.73E-04 2.83E-04 2.85E·04 3.50E-04 3.87E·04 4.07E.04 4AOE-04 4.42E-04 4.44E-04 4.69E-04 5.04E-04 5.05E-04 5.14E-04 5.32E-04 6.09E-04 6.14E-04 6.15E-04 6.50E-04 6.62E-04 6.66E-04 6.69E-04 6.82E·04 6.91 E-04 7.07E-04 7.21E-04 7.50E-04 8.12E-04 S.35E-04 8. 74E-04 9.05E-04 9.18E-04 9.22E-04 9.24E-04 9.24E.IJ4 9.43E-04 9.57E-04 9.67E-04 1.48E-10 5.88£-07 2.35E-05 8.97E.IJ5 9.82E.IJ5 1.19E·04 1.93E-04 2.93E·04

5.51 0.96 0.96 1.29 0.96 4.77 0.98 0.97 1.22 2.18 0.38 1.15 0.19 1.58 4.95 2.54 1.87 3.31 2.07 1.15 0.74 2.08 2.82 0.89 0.36 0.48 0.55 0.78 0.93 0.80 1.72 1.94 0.51 1.36 U.48 2c63 0.74 0.05 0.20 0.13 0.18 0.47 0.80 0.35 1.08 0.68 0,03 0.08 0.08 0.63 0.18 0.29 0.59 0.86 0.18 0.85 0.28 0.10 0.42 2.97 0;05 0.65 0.39 0.05 0.01 0.03 2.03 0.35 0.31 0.90 1.08 0.18 0.22 0.89 0.24 0.09 0.57 0.13 0.17 0.08 0.16 0.38 0.67 0.25 1.41 0.01 0,58 0.26 0.47 0.08 0.01 0.13 1.02 1.39 1.08 0.09 0.05 0.09 0.74 0.13

60.24 10.26 12.21 26.20 10.20 60.27 12.21 10.19 20.19 34.17 20.13 42.18 18.09 26.14 74.21 30.20 28.15 56.21 34.18 22.15 10.14 28.19 50.16 10.17 10.11 10.10 28.12 10.13 18.15 10c17 24.14 20.16 10.13 22.17 10.11 40.16 16.13 16.07 10.11 14.11 10.09 16.11 10.13 22.12 20.13 10.12 14.07 8.09 8.10 10.12 18.07 34.1 0 16.10

10.1 1
12.11 10.15 16.10 14.09 18.12 44.16 10.10 34.12 16.11 10,09 8.05 10.09 34.15 14.11

8.10
20.15 26.20 8.10 18.09 28.11 20.11 10.09 16.13 20.08 16.10 14.11 10.07 10.13 10.12 12.11 30.14 10.07 10.11 12.10

18.14
8.08 10.09 16.09 26.21 20.15 16.17 10.09 10.08

10.07
10.10 10.08

30061399 6(60000) 33859482 1(1 0000) 20809532 2(1 0001) 31981722 4(30 100) 6755863 1(1 0000) 51092293 6{60000) 13385998 3(20001) 29243942 1(1 0000) 149259999 2(20000) 51092301 4(211 00) 86198323 2(20000) 82950147 6(22011) 21313438 2(11000) 70778915 3(201 00) 112983636 11(60212) 3(30000) 20911031 29244176 4(02200) 31981690 6(501 00) 56606037 4(3001 0) 153792772 3(2000 1) 113205059 1 (1 000 0) 71774133 3(21 000) 126032329 5(50000) 110227377 1 (1 0000) 94395014 1(1 0000) 17978262 3(00102) 6671539 4(1111 0) 113931 156 1 (1 0000) 112807207 2 (11 000) 94372553 1(1 0000) 83921618 3(2001 0) 6880229 2(20000) 31543595 1(1 0000) 40556608 3(20001) 162138926 1 (1 QOOO) 13430890 4(40000) 83022023 2(02000) 62241030 2(1 01 00) 7304935 1(1 0000) 154091026 3(0 1011) 13395428 1 (1 0000) 50399860 2(1 01 00) 212Ei6.5 9845257 i (1 0000) 3(1 101 0) 58843.9 21389311 33149.2 40254525 2(20000) 36467.9 31982178 1 (1 0000) 145829.1 153791358 2(1 001 0) 2(001 01) 134780.5 84662721 51483.8 31980723 1 (0 1000) 23785.3 148238335 1(1 0000) 92900.3 111185905 2(11 000) 87185.5 162287042 4(211 00) t67168.9 47059476 2(02000) 73555.1 86198333 3(001 02) 74826.8 149251400 2(1 0001) 31315.9 149249466 1 (1 0000) 34968.8 22129197 2(1 01 00) 122671.9 162951865 3(1 0002) 115298.1 47271413 2(11 000) 50132.8 154000941 5(31100) 54378.3 149253262 1 (1 0000) 170995.6 125628634 5(21 011) 61900.5 84370320 2(1 01 00) 32443.2 8678113 2(0011 0) 87870.1 1492801}81 1 (01 000) 64800.2 149260499 1(1 0000) 48161.6 7108335 5(121 0 1) 16444.6 149267892 2(01 100) 26134.5 167"16569 1 (01 000) 32639.3 21312532 2(20000) 57551.9 22164776 3(12000) 28672.6 149258694 1 (Of 000) 147909.2 149261346 3 (00 300) 61585.9 121583908 4(20020) 94210.2 40538838 3(1 011 0) 58014.9 6681099 1(10000) 107739.2 33$3305 2(02000) 3(11 001) 161090.5 82997081 70755.1 113930737 2(1 01 00) 102534.6 7305143 3(0 1011) 46922.8 20270043 1 (1 0000) 20012.8 13122608 1 (1 0000) 28689.8 23956056 1 (1 0000) 151377.1 149264113 2(1 000 1) 26674.1 6755372 3(30000) 84t30.1 87042277 1 (1 0000) 22576.0 21426893 1 (1 0000) 61988.4 31559968 2 (01 01 0) 19222.9 85701586 2(11 000) 177217.1 38796741 2(0002 0) 24148.1 21312336 1 (1 0000) 327450.5 124487265 5(001 i 3) 14095.4 30061399 3(12000) 21266.5 9845257 2(20000) 11367.3 21361209 2(1 01 00) 53004.2 27369924 2(01 00 1) 65215.0 34328303 1 (1 0000) 53636.4 22296589 1 (1 0000) 14056.2 28316756 1 {1 0000) 82217.9 56090239 1 {1 0000)

14095.4 95313.5 30764.6 72422.5 92475.1 61358.3 80208.5 16793.1 20199.2 00227.7 11613.9 332909.9 103956.6 67766.5 57040.7 61766.3 58266.0 70870.6 33339.5 58820.3 35729,6 23713.3 50113.5 38768.6 30530.1 121484.4 39355.7 138t4.9 21669.3 13537.7 69406.3 24161.8 58731.8 83280.7 25359.3 21977.1 15956.9 238975.3 58406.4 200237.7 62490.1 62289.0

91

Table 1 continued
9 gil630039231ref1NP_081216.11 hypothetical protein LOC69101 (Mus musculus] 10 gij1102273771reijNP_001035999.11 gelsolin~1ke capping protein {Mus musculus] 11 gij126116587jreQNP_084542.21 inositol po.lyphosphate-4-phosphatase, type I isoform 1 [Mus musculus] 12 gij39930549jre~NP_919324.11 tripart~e motif-containing 45[Mus musculus] 13 gil 149256982~ef1XP_001475535.11 PREDICTED: hypothetical protein !Mus musculus] 14 gil6677973lrenNP_033211.11 Sci1Tal1 interrupting locus [Mus musculus] 15 gil21312236lref1NP_082582.11 HSPA128 [Mus musculus] 16 gil87162474lref1NP_001034577.11 receptor-interacting factor 1 isoform 1 [Mus musculus] 17 gii6678277JrefJNP_033373.1 1teetorin alpha !Mus musculus] 18 gil21687186lref1NP_573453.11 voltage-dependent calcium ch;;nnel gamma-8 subunrt {Mus musculus] 19 gii149256340irenXP_001479253.11 PREDICTED: similar to pheromone receptor V3R8 [Mus musculus] 20 giJ12748428IrenNP_075540.11 twisted gastrulation homolog 1 [Mus musculus] 3.06E-04 3.70E-04 4.67E-04 5.27E-04 6.48E·04 6.81 E-04 6.91 E-04 7.13E·04 9.18E-04 9.41E·04 9.SOE-04 9.83E-04 0.30 1.00 0.58 0.01 0. t 5 0.06 0.27 0.20 0.01 0.01 0.04 0.07 10.09 33093.4 63003923 20.14 38768.6 110227377 10.16 105573.0 126116587 4.07 641 85.0 39930549 10.11 27800.7 149258982 12.10 138756.5 6677973 14.11 76118.9 21312236 10.10 82997.0 87162474 8.06 239533.6 6678277 16.07 43452.7 21687186 8.08 14656.5 149256340 18.08 24800.6 12746428 1 (1 0 0 00) 2 (2 0 0 0 0) 1 (1 000 0) 2(00002) 1 (1 0000) 2 (1 0 00 1) 2 (1 0 01 0) 1 (1 Q 000) 1 (0 1 00 0) 2(02000) 1 (0 1 000) 2(11 000)

92

Table 2. Peptides detected in captured Fc-receptor cmnplexes by LC-MS/MS. Fc-receptor complexes were captured using the LARC n1ethod and analysed by LC-MS/MS, Alpha, beta, and gamma actin and n1any related actin isoforn1s were observed in the phagosome as well as HSl and AnXAl, AnXA2, AnXA4, AnXA5, AnXA6 and ras-GTPase-activating protein SH3domain binding protein, FMS-like tyrosine kinase 1, FERM, RhoGEF and pleckstrin dotnain protein 2, RhoGTPase-activating protein, RAB25 and FKBP-rapamycin.
Reference put. bela·&e!in (aa 27· 375) [Mus musculus]
rawextr_150beadlgg2_Mar04, 18 ra"""xtr_150beadigg2_Mar04, 26 rawextr_150beadlgg2~Mar04, 192-194 rawextr_150bsadigg2 _Mar04, 198-200 rawextr_actinbeadigg_Mar04, 256 rawextr_actinbeadigg __Mar04, 279 rawextr _450beadigg,_Mar04, 606 rawextr_450beadigg_Mar04, 612 rawextr_150beadlgg_Mar04, 622 rawextr_300beadigg_Mar4. 652 rawextr_150bead_Mar04,653-655 rawextr_chlfbead_Mar04, 658 rawextr_150beadigg2_Mar04, 704 rawextr_150beadlgg2._Mar04,710-712 rawextr ·.150beadigg2_Mar04, 764 rawextr 450bead Mar04, 768 rawextr-700bsad-Mai04,777-779 ra....,xtr=200beadigg_Mar04, 787-789 rawextr_actinbeadigg_Mar04, 805 rawextr_450beadigg__Mar04,808-810 rawextr_aotinbeadigg_Mar04, 813 FPbeads150 Dec19. 815 rawaxtr_300bead_Mar04, 818 rawextr_500beadigg_Mar04, 842 rawextr _800bead_Mar04,884-886 rawextr_350bead_Mar04, 896 rawextr_400beadigg_Mar04,896-898 rawextr_350beadigg2 _Mar04,90S-91 0 rawextr_450beadlgg_Mar04,926-928 rawextr _250beadigg_Mar04,930-932 rawextr_200beadigg __Mar04, 943-945 rawextr 900bead Mar04, 962 rawextr)00bead=Mai04, 962 rawextr_1000_beadigg_Mai04,967 -969 rawextr_250bead_Mar04, 976 rawextr_500beadlgg_Mai04, 984 rawextr_800beadigg_Mar04, 1014 rawextr_800beadigg_Mar04. 1028 rawextr_60Me0Hbead_Mar04, 1028 rawextr _actinbead ..Mar04, 1032 rawextr_ 400beadigg_Mar04, 1034-1036 rawextr_700bsadigg_Mar04, 1042-1044 rawextr_450be8d_Mar04, 1048 rawextr_350be8digg2_Mar04, 1050 rawextr_350beadigg2_Mar04, 1054 rawextr_300beadigg_Mar4, 1058 rawextr_350bsad_Mar04, 1058 ra....,xtr_300beadigg_Mar4, 1062 rawextr_700bsadigg_Mar04, 1072 rawextr_450beadigg_Mar04, 1092 rawextr_ 450be8dlgg_Mar04. 1096 rawextr_250beadigg_Mar04, 1098 rawextr_450beadigg_Mar04, 1100 rawextr_250baadigg_Mar04, 1102 rawextr _700bsad_Mar04, 1105 rawextr_ 450beadigg_Mar04. 1124 rawextr_400b®adigg_Mar04, 1182 rawextr_.actinbead_Mar04, 1186-1188 rawextr_400baadlgg_Mar04, 1198 rawextr ·.350beadigg2 _Mar04, 1222- 1224 rawextr_800bead_Mar04, 1232 rawextr_300beadigg_Mar4. 1240 rawextr ·.300beadigg_Mar4, 1246 rawextr_300beadigg_Mar4, 1252 FPbeads200_Dec19, 1299 rawextr_500beadigg_Mar04. 1306 FPbead$200_Dec19. 1309 rawextr_.500beadigg_Mar04. 1316 rawextr_300bead _Mar04, 1318-1320 rawextr_400bead_Mar04, 1325 rawextr_900be8digg_Mar04, 1332 FPbeads150 Dec19.1335-1337 rawextr_200beadigg_Mar04, 1339 rawextr_200beadigg_Mar04, 1343 rawextr_ 450beadigg_Mar04, 1348 ra.....,xtr_800beadigg_Mar04, 1358 rawextr_800beadigg_Mar04, 1366 rawextr_actinbeadigg_Mar04, 1367-1369 rawextr 700beadigg Mar04,1376-1378 rawextr=150bead_Mar04, 1385-1387 ra.....,xtr_200be8digg_Mar04. 1389 rawextr_200beadigg_Mar04, 1397 rawextr_450t>ead_Mar04, 1416 rawextr_actinbeadigg_Mai04, 1419 FPbeads150_Dec19, 1419 rav.extr_actinbeadigg,_Mar04, 1423 rawextr_150bead_Mar04, 1437-1439 rawextr_350bead_Mar04, 1456-1458 rawextr_ 450beadigg_Mar04. 1480 rawextr_450beadlgg_Mar04, 1486 rawextr_250beadigg,_Mar04, 1502-1504 rawextr_250bead_Mar04, 1514 r2waxtr_250bead_Mar04, 1518 rawextr_500bead_Mar04, 1532 rawextr_500bead _Mar04, 1536 rawextr _chlfbead __Mar04, 1540 rawextr_600bead _Mar04, 1542

Sequence
·.EITALAPSTMK.· -.EITALAPSTMK.-.VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLLTEAPLNPK.-.HQGVMVGMGQK.- .HQGVMVGMGQK.- .HQGVMVGMGQK.-.HQGVMVGMGQK.-.HQGVMVGMGQK.-.HQGVMVGMGQK.-.QEYDESGPSIVHR.-.IIAPPERK.-.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.SYELPDGQVITIGNER.-.Dl TDYLMK· -.GYSFTTTAER-. VAPEEHPVLL TEAPLNPK.-.EITALAPSTMK.-.EITALAPSTMI<.-.GYSFTTTAER.-.EITALAPSTMK.· -.EITALAPSTMK.· -.E!T ALAPSTMK.· -.EITALAPSTMK.· -.VAPEEHPVLLTEAPLNPK.-.EITALAPSTMK.-.GYSFTTTAER.-.GYSFTITAER.· -.EITALAPSTMK.-.EITALAPSTMK.-.VAPEEHPVLLTEAPLNPI<.· -.VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.·.EITALAPSTMK.-.VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLLTEAPLNPK-.VAPEEHPVLLTEAPLNPK.-.EITALAPSTMK.-.EITALI'.PSTMK.- EITALAPSTMK.-.VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLL TEAPLNPK.-.EITALAPSTMK-.EITALAPSTMK.-.EITALAPSTMf\.-.VAPEEHPVLLTEAPLNPK.-.EITALAPSTMK.· ·.VAPEEHPVLL TEAPLNPK.· -.VAPEEHPVLL TEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLLTEAPLNPK.-.SYELPDGQVIT IGNER.-.VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLLTEAPLNPK.-. VAPEEHPYLLTEAPLNPI\.-. VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLL TEAPLNPK.-.SYELPDGQVITIGNER.-.VAPEEHPVI.LTEAPLNPK.-.VAPEEHPVLLTEAPL~JPK.-

MH.. 1162.38 1162.38 1955.24 1955.24 1172.41 1172.41 1172.41 1172.41 117241 1172.41 1517.58 924.12 3185.60 1791.94 999.16 1133.HI 1955.24 1162.38 1162.38 1133.19 1162.38 1162.38 1162.38 1162.38 1955.24 1162.38 1133.19 1133.19

Charge Score 2 3419.61

Score XC

DeiiaCN

Sp
0,3 0.4 0.4 0.5 765 552 473 792

Peptidesllons

3626521.98 2 3925.98
3 2 2 3 2 2 2 3 2 3 5701.13 13577.45 7902.74 5929.77 9645.53 4155.99 5844.01 1918.71 2493.98 4130.77 18797.72 1098.57 3871.18 9059.12 2371.31 4745.46 4057.55 2329.20 1201.43 1539.63 3033.27 4232.19 3977.42 5970.13 7846.29 2978.87 4307.30 12096.82 1167.35 2705.56 3604.76 3975.86 1273.93 2265.20 5019,44 2047.44 4686.24 2966.24 1.76 2.13 2.70 3.58 2.82

49868.0

11
7/10 7110 21/68

0.4 878
0.3 1003 0.4 1379 0.4 622 0.5 952 0.4 750 0.2 338 0.3 487 0.3 938 0.5 1651 0.1 611 0.4 523

21134 4/5
11120 9/10

2 8608.51

1.92 2.73 2.30 2.17 1.77

7110
4/5 314

5116
517 15158 11115 517

2.42
4.$8 1.40 1.89 3.25 2.07 2.41 2.35 2.33 1.62 1.52 1,89 2.26 1.83 2.41

2
1 2 3

2/3
27/68 3/5

2
2 2 2 2 2 2 3 2 2 2 2 2 3 3 3 3 2 3 3 3 2 2 2

0.4 1064 0.3 434 0.4 569 0.3 751 0.2 606
0.2 0.2 299

3/5
13118

7110
1/2 13120 11/20 19168 13120

725
378 358 735

0.4
0.4

0.4

2.59
1.96 2.43 3.89 1.70 2.05 3.07 1.81 2.04

-. VAPEEHPVLLTEAPLNPK.·.SYELPDGQVITIGNER.· -.SYELPDGQVlTIGNER.· -.SYELPDGQVITIGNER.· -.SYELPDGQI/ITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.·.SYELPDGQVITIGNER.·.SYELPDGQVITIGNER.-.KDLYANTVLSGGTTMYPGII'.DR.-.SYELPDGQVITIGNER.· -.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-. TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· -. TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.SYELPDGQVITIGNER.-. TTGIVMDSGDGVTHTVPIYEGYALPHAILR-.DL TDYLMK.-.TTG IVMDSGDGVTHTVPIYEGYALPHAILR.-. TTGIVMDSGDGVTHTVPIYEGYALPHAfLR.·.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.· -.SYELPDGQVITIGNER.-.SYELPDGQVIT!GNER.-.SYELPDGQVITIGNER.-.SYELPDGQV!TIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.-

116.2.38 1162.38 1955.24 1955.24 1955.24 1955.24 1162.38 1955.24 1955.24 1955.24 1162.38 1162.38 1162.38 1955.24 1955.24 1162.38 1162.38 1162.38 1955.24 1162.38 1955.24 1955.24 1955.24 1955.24 1955.24 1955.24 1791.94 1955.24 1955.24 1955.24 1955.24 1955.24 1791.94 1955.24 1955.24 1955.24 1791.94 1791.94 1791.94 1791.94 179'1.94 1791.94 1791.94 1791.94 1791.94 1791.94 2344.63 1791.94 1791.94 1791.94 1791.94 1791.94 3185.60 3185.60 1791.94 3185.60 999.16 3185.60 3185.60 1791.94 1791.94 1791.94 1791.94 1791.94 1791.94 1791.94 1791.94 1791.94 1791.94

2.24
2.42 2,03

2.21
1.94 3.93

0.4 860 0.4 1078 522 0.4 459 0.5 810 0.2 420 0.3 523 0.3 418 0.4 799 0.2 394 0.2 519 0.4 773 0.2 535 0.4 576 0.3 505

7/9 516
13/20 3/5 6/17

0.3

5/17
21/68

5/17 3i4
19/os 21/68

6117
13/20

315
3/5
13/34 11134 11/20 3/5 '1/2 13/34 11/20

3 8552.32
3 4234,25 2 3718.97 2 2121.47 2 2694.86 3 5954.79 2 2718.21 2 4291.92 3 13966.84 3 8120.44 3 5705.82 2 10137.31 3 6126.29 2 9558.47 2 1142.13 3 3099.18 3 6872.54 2 16809.52 3 10031.07 2 9931.77 3 2033.78 3 3507.68 2 15400.27 2 8475.07 2 11757.92 2 12155.13 2 13923.97 2 14420.65 2 121 66.94 2 4837.06 2 18334.32 2 11910.14 2 14803.93 3 3525.12 2 10114.32 2 9871.63 2 15855.05 2 12927.54 2 19790.11 3 5390.55 3 11624.70 2 12775.88 3 11153.20 2 733.18 3 12109.60

0.4
0.3 0.4

73$
484

2.54 2.05
1.95 1.66 2.59 1.97 2.01 3.78

0.3 0.4 0.4
0.3 0.4

434 459
331

775

3.12 2.74
3.25 3.07 3.85 1.43 1.93 2.46 3.86 3.70 3.51 2.56 2.57 4.14

4112 240 0.5 984 0.4 1018

6/17
25168 15/34
~117

0.4 0.5
0.3

6118
826
772 928 339

10/17
25168

0.4
0.2

19i30
13/34

0.3 654
0.5 579 0.6 785 0.4 849 0.4 1032 0.2 568

21/68
11134 10117

13/34
2/3 23168 23168 10117

0.3

556

2.83
3.37 3.25 3.93 4.45 3.63

2.83
4.04 3.61 3.99 2.19

3.58
3.22 4.02 3.91

4.65
2.23 3.39 3.26 3.93 1.33 3.29 5.03 4.35 3.93

0.5 785 0.4 1161 0.5 1046 0.5 1340 0.5 1309 0.4 1378 0.5 1194 0.3 702 0.6 1441 0.4 1297 0.5 1540 0.3 486 0.4 1059 0.5 537 0.5 1252 0.5 1129 0.5 1380

2i3 19/30 213 23/30 23/30
7110

17130
7110

23/30
23/30 114 2/3

1i2
7/10 19/30 11/15 27/116 331116 213 311116 417 31/116 9/29 2/3 2/3 7/10 11/15 8/15 2/3 3/5 17130

0.4

772

0.5 1060 0.5 1103 0.4 919

0.2

193

3 26566.00
2 2 2 2 2 2 2 2 2 2 15454.13 11778.07 17622.73 15382.22 4147.85 9219.39 7786.66 11102.18 2413.25 13756.69

4.60
4.12

2.55 2.98
2.78 3.20 1.95

4.00

0.5 1043 0.6 1421 0.5 978 0.4 1230 0.5 1123 0.5 1393 0.3 601 0.5 1035 0.4 824 0.5 733 0.3 450 0.5 1268

13/30

213

93

Tab1e 2 continued

rawextr_ 400boadigg_Mar 04,1552-1554 rawextr_600bead_Mar 04, 1558 FPbeads250_Dec19, 1572-1574 rawoxtr_250beadigg_Mar 04,1586-1588 mwextr _ctctinbead_Mar 04,1592·1594
rawextr_400beadigg_Mar 04.1598-1600

rawoxtr _3501mldigg2_Mar 04, 1622·1624

rawextr_300beadigg_Mar 4, 1636 rawextr_300besdigg_Mar 4, 1640 rawextr _260bead_Mar 04,166<3- 1668
FPbeads300~D oc19,2264·2266

rawsucrfp_60MeOHphaglgg_MAr04. 632 rawsuc:rfp_60MoOHph·gigg_MAr04, 6 78

rawsucrfp_actinphagigg_Mer 04, 712 rewsucrfp_chlfphagigg_M Elr04, 756 rawsucrfp_elJM eOHphoglgg_MA r04, 790· 792 rawsucrfp_"60Me0Hphag~gg_MA r04, 630 mws ucrfp_.60Me0Hphegigg_MAr04,918·920 rawsucrfp_60MeOHphagigg_MAr04 , 930 rawsucrfp_ohffphagigg_M ar04, 950 phagrawFsuc60MeOH_dec23 . 966 rawsucrfp_300phElgi gg_Mar04,959~971 rawsucrfp_OOOphagi gg_Mar04. 1022 rawsucrfp_900phagi gg_Mer04, 1026 rawsucrfp_800phagi Qg_Mar04, 1034 rawsucrfp_800phagi gg_Mar04; 1040 rawoucrfp_chlfphagigg_M ar04, 1072·1074 rawsucrfp.,...150phagi gg_Mar04, 1126
rawsucrfp_450phagi gg_Mar04, 1152

rw.vsucrfp_450phagi oo..Mer04, 1160
rswsucrfp_700phagi gg_.Mar04,1161-1163

rawsucrfp_400phagigg_Mar04, 1162
rawt ucrfp_400phagi gg_Mar04, 1168

rawsucrfp_300phsgi gg_Mar04, 1175 rawoucrfp_ehlfphagigg_M ar04, 1238·1240
raw~ucrfp_chlfphagigg_M

ar04, 1242

rawsucrfp_60MeOHph·gigg_MAr04.1242·1244 rawsucrfp_ 1000phagi gg_Mar04. 1269 rawsucrfp_60MeOHphaglgg_MAr04. 1282
rawsucrfp_300phagi gg_Mar 04,1301-1303

rawsucr-fp_actinphagigg_Mar 04, 1340 rawsuc:rfp_SOOphagi gg...:Mar04, 1360 rawsucrfp_900ph!:\gi gg_Mar04, 1369 rawsucrfp_150phagi gg_Mar04, 1450~ 1452 rawsucrfp_eooph~gi gg_M~r04 , 1472 rawoucrfpJOOphagi gg_Mar04, 1492 mw&ucrfp _400phegi gg_Mer04, 1499~ 1501 r·woucrfp_250phagi gg_Mar04, 1500 rawsucrfp_250phagi gg_Mar04, 1500 raw3ucrfp_chlfphagigg_M sr04, 1"594·1596 raw$ucrfp_chtfphagigg__M ar04. 1644 jmfag5m inigg1000m mnac:1,124-126 jmfag5m iniggb·ad. 1:?8 jmfag5minigg150m mnacl, 130 jmfag5minigg600m mnOcl, 132-134 jmfag5mlnigg350m mnacl, 134 jmfao1mnacl2,5mlnigg, 136 jmfsg1mnacl2.5minigg,· 162 jmfag1mnacrOminigg, 406 jmf8g1mnactomlnigg, 410 jmfag5m iniggl:>ead, 41 (>.412 jmfsg5m inigg350m mnad. 449 JMMAGNEGBI6D3. 450 JMMAGNEG816D3, 452 jmfag5minigg150mmnSC:l,460·A62 jmfag5m inigg350m mnacl, 461 jmfag5mlnigg600m mnacl,462·484 jmf3g5mii1igg350m mnacl , 463 JMMAGTube1B 16E3,464·4e6 jmfag5minigg600m mnacl, 470 JMMAGTube1816E3, 472 jmfag5mini{JgCOOmmnacl, 480 JMMAGTube1B16E3, 482 JMMAGTube1816E3, 488 jmf291mnac17,5m inigg, 492
jmfsg1mnaci.2 , Sminigg.496~49S

· .SYELPDGQVITJGNER.· · .SYELPDGQVITIGNER.· · .VP.PEEHPVLL TEAPLNPK.· · .DLTDYLMK.· · .SYELPDGOVITIGNER.· · .TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· · .SYELPDGQVITIGNER.· ·.SYELPDGQVITIGNER.· ·.SYELPDGQVJTIGNER.· · SYELPDGQVITIGNER.· ·.SYELPDGQVJTIGNER.· ·.HQGVMVGMGQKDSYVGDEAQSKR.· · .GYSFTTTAER.· · .OEYDESGPSIVHR.· · .IIAPPER.· ·.E ITALAPSTMK.· - .EITALAPSTMJ<IK. · · .VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.· · .GYSFTTTAER.· · .DSYVGDEAQSK.· ·.VAPEEHPVLLTEAPLNPK.· · .VAPEEHPVLLTEAPLNPK.· ·. VAPEEHPVLLTEAPLNPK.· · .VAPEEHPVLL TEAPLNPK.· -. V APEEHPVLLTEAPLN PK. · -.EITALAPSTMK.· · .VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.· · .VAPEEHPVLL TE,\PLNPK.· ·.VAPEEHPVLLTEAPLNPK.· ·.KDLYANTVLSGGTTMYPGIADR.· ·.VAPEEHPVLLTEAPLNPK· ·.VAPEEHPVLLTEAPLNPK.· ·.SYELPDGQVITIGNER.· · .VAPEEHPVLLTEAPLNPK.· ·.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· · .SYELPDGQVJTIGNER.· · .SYELPDGQVJTIGNER.· · .SYELPDGQVITIGNER.· ·.SYELPDGOVITIGNER.· ·.SYELPDGQVITIGNER.· ·.SYELPDGQVITJGNER.· GNER.· · .SYELPDGQVITJ ·.SYELPDGQVITIGNER.· ·.SYELPDGQVITIGNER.·.SYELPDGOVJTIGNER.· · .SYELPDGQVITIGNER.· · .TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· · .HQGVMVGMGQK.· · .HOGVMVGMGOK· - .HQGVMVGMGQK.· ·.HQGVMVGMGQK.· · HQGVMVGMGOK.· ·.HQGVMVGMGQK.· -.IIAPPER.· ·.OEYDESGPSIVHR.· ·.OEYDESGPSIVliR.· · .OEYDESGPSIVHR.· · .OEYDE.SGPSIVHR.· · .GYSFTTTAER.· · .OEYDESGPSIVHR · ·.QEYDESGPSIVHR.· · .OE:YOESGPSIVHR.· ·.OEYDESGPSIVHR.· - .GYSFTTTAF.R.· ·.GYSFTTTAER.· -.GYSFTTTAER.·
-. QEYDESGPSIV~IR.·

1791.94 1791 .94 1955.24 999.16 1791.94 3185.60 1791 .94 1791.94 1791.94 1791.1)4 1791.94

2 2 3 1

2
3 2

2
2 2 2 3 2 3 2 2 2 3 2 2 2 3 3 3 3 3 2 3 3 3 3 3 3 3 3 2 2 3 3 2 2 2 2 2 2 2 2 2 2 3 2 3 3 2 2

25013.78
1133.19 151 7.58 795.95 1162.38 1403.71 1955.24 1955.24 1133.19 1199.21 195524 1955.24 1955.24 1955.24 1955.24 1162.38 1955.24 1955.24 1955.24 1955.24 1955.24 1955.24 2344.63 1955.24 1955.24 1791.94 1955.24 3185.60 1791.94 1791.94 179L94 1791.94 1791.94 1791 .94 1791 .94 1791.94 1791.94 1791 .94 1791.94 3185.60

11989.55 12845.91 3064.02 1502.22 14201.01 17821.41 15216.37 9275.25 6734.69 16823.59 7067.21 17608.46 7036.16 1189.58
758.7~

2651.52 2418.22 5577.68 19018.02 8407.18 521.80
6978.~9

6559.72 0024.20 767052 2188.81 2526.71 1466.56 8632.12 172765 6276.01 483028 5755.60 336.12 2703.38 6956.42 15411.63 3274.72 4950.73 10050.99 11398.93 13790.81 15840.58 7763 89

3.37 3.65 2.43 1.90 4.02 3. 76 3.60 3.28 2.86 4.43 2.67 4.41 2.07 1.86 1.53 2.34 2.76 3.24 4.55 2.28 1.02 3.35 3.11 3.16 2.86 1.96 2.30 2.40 3.02 2.01 2.94 2.09
2.74

0.5 1313
0.5

11115

995

1.60 2.08 3. 05 4.17

2.6!)
3.25 3.67 3.73

3.42
3.73 3.12 3.66 3.57 4.56

11 72.41
1172.41 1172.41 1172.41 1172.41 1172.41 795.95 1517.58 1517.58 1517. 68 1517.58 1133.19 1517.58 1517.58 1517.58

jmfag1mnacl2,5minigg , 500

jmfaQ1mnecl7,5minigg. 502 jmfsg5miniog400mmnacl, 510 jmf~g5minigg1000m mn.acl , 510 jmfag5minigg400m mnacl, 516 jmfag5m inigg460m mnacl, 520 jmfag5minigg400m mn3cl, 526 jmfag1m nacl5minigg,526--52S jmfag5mintgg·tooom mnacl, 528 jmfag1m n&cl5minigg,-530 jmfag1mnacl5mlnigg, 534 jmfag1mnacl5mincon, 538 jmfag1mnacl5mlncon, 544 jnlf~g 5m inigg200m m~cl , 544 jmfsg1mnacl5mlncon, 546 jmfag5m inJQQ1000m mnt;cl,54_6..5.48 jmfsg5m inigg200m mnQCI, 54S.550 jmfag5minigg200mmnacl, 564 jmf3g5minigg200m mnacl, 572 jmfag5miniggbead, 623·625 jmfaQ5m inigg350m mnacl,695-697 jmfag1mnacl0minigg, 710 jmfag1mn...~IOminigg, 714 jmfsg5minigg000m mnacl, 714-716

· .GYSFTTT AER · · .OEYDESGPSIVHR.· · .OEYDESGPSIVHR.· ·.QEYDESGPSIVHR.· ·. QEYDESGPSIVHR.· · .GYSFTTTAER.· · QEYDESGPSIVHR.· · .GYSFTTT AER.· · .GYSFTTTAER.· ·.GYSFTTTAER.· · .OEYDESGPSIVHR.· · .OEYDESGPSIVHR· ·.GYSFTTTAER.· · .GYSFTTTAER.·.QEYDESGPSIVHR.· ·.OEYDESGPSIVHR.· ·.GYSFTTTAER.· -.GYSFTTTAER.- .QEYDESGPSIVHR.· ·.OEYDESGPSIVHR.· · .OEYDESGPSIVHR.· ·.OEYDESGPSIVHR.· - .GYSFTTTAER.· · .GYSFTTTAER.· · .EITALAPSTMK.· · .EITALAPSTMI<.·
·.EITA~APSTMK.·

1517.53 113319 1133.19 1133.19 1517.58 1133.19 1517.88 1517.58
1517.58

2 9251.99 9130.78 18195.39 11832.00 8019.45 15130.52 2659.61 7344.98 4646.39 9121 . 27 7873.38 7463 .30 2 7814.16 2 309.67 3 5905.12 3 5427.81 3 3239. 98 3 3120.04 2 6308.99 3 3537.31 3 1593.95 3 4819.01 3 6520.87 2 8172.44
2 12327.80

3.:?:1
3.89 4.32 1.93
2.1j3

2.60 2.95 3.01 2 .71 2.89 1.24

2.62
2.46 2.70 2.00 1.94

2.09
2.06 2.16 2.79

2.08
2.56 1.92

2 5867,14 2 5241.18 2 10922.84

2.07
2.78 2.05 2.35 2.61
2.65

·.EITALAPSTMK.· · .EITALAPSTMK.·

1517.58 1133.19 1517.58 11 33.19 1133.19 1133.19 1517.58 1517.68 1133.19 1133.19 1517.58 1517.53 1133.19 1133.19 1517.65 1517.58 1517.65 1517. 58 1133.19 1133.19 1162.38 1162.38 1162.38 1162.38 1162. 38

3 2 3 3 2 3 2 2 2 3 3 2 2 3 3 2 2 2 3 3 3 2 2
2 2 2 2 2

2755.26 5184.19 7083.98 6531.03 11370.98 6406.74 10666.18 7567.19 11040.95 7554.47 4677.58 13680.23 11511.73 5285.63 4183.99 10465.70 1065590 1498.44 8875.02 6740.84 3711.83 8037.01 9968.72
4006.95 4307.93 4625.42 5427.38 4610. 04

2.84 2.37 2.37 2.27
2.66

2.54 2.19 2.90 2.74 2.49 2 .57
2.66

2.72 1.32 2.94 2.91 2.41 2.15 2. 02 2.21 2.13 2c03 2.41 2.78

0 .3 526 0.1 6:2;; 0.5 1204 0.6 1189 0.5 - 1313 0.4 1016 0.4 543 0.5 1524 0.4 1209 0.6 894 0.5 1199 0.1 524 0.2 254 0.2 595 0.2 479 0.3 691 0.6 765 0.5 1319 0.2 178 0.4 652 0.4 800 0.4 738 0.5 518 0.2 771 0.2 508 0.1 568 0.5 795 0.2 461 0 4 685 0.4 755 04 689 0.1 184 0.3 681 0.5 421 0.5 1498 0.5 670 0.3 650 0.4 1371 0.4 1474 0.5 1199 0.() 1040 0.4 807 0.4 767 0.4 1223 0.5 1489 0.5 1333 0.3 961 0.5 1356 0.3 464 0.4 847 0.3 674 0.3 1930 0.4 906 0.4 844 0.4 1075 0.1 193 0.3 1074 0.4 683 0.2 615 0.3 914 0.5 709 0.3 797 0.1 642 0.4 921 0.4 745 0.5 978 0.6 1279 0.5 868 0.5 477 0.5 1255 0.3 716 0.4 364 0.4 929 0.4 865 0.5 1046 0.4 968 0.6 1020 0.5 1285 0.6 901 0.4 1351 0.4 884 0 G 1560 0.6 1029 0.4 614 0.3 772 0.5 1388 0.5 1135
0.3

2/3 5/17

517
11115 17158 11/15 19i30 7115 1111 5 19130 31188 5/6 17/48

2/3
13/20 5/8 23/68 10117 819 7/20 6/17 13/34 27168 21168

23i68 13120 11i34 13134 5117

.23/GS
13134 6117 4121 11/34 112 4/5 25168 25/116 7110 11115

2/3
19130 315 17130 2/3

4/5 7110

213
11115 251116 4/5 112 315

4/5
415 9110 112

7118
5/12 17148

7i16
2/3 19/46 17148 7116 19148

719 8/9
13/18 13124 ll/9 318 13124 11/24 5/12 516 7116 7/9 5/6 616 112 7116 8/9 516 19148 19148

8/9 5/6
11124

324

0.3 1238 0.4 747 0.3 915 0.5 1609 0.6 1019 0.4 439

23/48
5112 19/48 7/9 516 11120 13/20 7/10 13120 315

0 .4
0.4 0.4 0.4

558
618 540 364

94

Table 2 continued

jmfag5minlgg150mmnacl, 746 jmfag5minigg150mmnacl, 750 jmfag5mtnl gg500mmnacl, 762 jmfag5minigg500mmnacl, 766 jmfag1mnacl2.5mlnigg. 782 -784 JMMAGT ube 1616E3, 790-792 jmfag1mnacl 7,5minlgg, 798 jmfag5mln~gg250mm nacl, 798-800

jmfag1mnac!7,5minigg. 802 jmfag5minlggbead. 803 jmfag5miniggbead,805-807 jmfag5miniggbaad_0 30528200105,809-811 j n1fag5mlnigg400mmnacl,828·830 jmfag5mintgg1000mmnaci ,864-866 jmfag5mlnigg200mmnacl,872-874
jmag5m lnc:on50 0mmnacl.876~878

jmfag5minigg450mm nacl_030527025134.878-880 jmtag5minigg350mmnacl,881 -883 jmlag5minigg350mmnacl, 893 jmfag5mintgg300mmnacl,894-896 jmtag5minigg500mmnac1,900-902 jmf ag5minigg600mmnacl,904-906 jmfag5minigg600mmnacl,908-9 10 JMFAGNACL 10_2B21E3. 914 jmfag1moacl5minigg,918-920 jmlag1mnacl0minigg.926-928 jmfag1mnael5mincon,940-942 jmfag5mlnigg150mm nacl, 958

jmfag5rninlgg500mmnacl, 962 jmfag5min igg450mmnaci_030527025134, 982 JMMAGNEG61603, 982 jmfag1mnacl2.5minigg,988-990 jmfag5miniggbead_030528200105, 997 jmfag1 mnacl7.5tninigg.998-IOOO JMMAGTube 1616E3,1000-1002 jmfag 1mnacl7,5minigg, 1004 JMMAGTube 1B16E3.1008-1 o·10 jmfag5miniggbead. 1009 jmfag5minlggboad_030528200105, 1017 jmlag5minigg250mmnacl, 1020 jmfag5minigg400mmnacl.1044-1046 jmiag5minigg150mmnact, 1066 jmfag5minig.J1000mrnnacl.1086-1 088 jmfag5minigg200mmnacl.1092-1094 jmfag5minigg1000mmnaci, 1100 jmfag5minigg200mmnacl,1100-1102 jmfag5minigg350mmnacl. 1103 jmiag5minlgg500mmnacl,1104-11 06 JMFAGNACL 10 1621E3, 1110-1112 jmfag5minigg450mmnaci_030527025134, 1116-1118 jmfag5minigg300mmnaci, 1130-1132 j mfag5miniggbead, 1137 jmfag5mini ggbead, 1141 jmag5mlncon500mmnaci, 1144 jmfaglmnac15minigg,1148-1150 Jmag5rnincon500mmnacl, 1152 jmfag5minigg450mmnaci_030527025134, 1154 jmfag1 mnacl5minigg. 1156 Jmf ag5minigg450mmnaei_030527025134, 1158 jmfag1mnacl5minigg, 1160 jmfag5minigg250mm nl'ICI, 1160-1162 Jmfag5minigg300mmnacl, 1176 jmf2g 1mnacl5mincon, 1178-1180 jmfag5minigg300mm nocl, 1182 Jmfag 1mnaci5mtncon, 1184 jmag5mincon800mmnacl, 1184-1186 jmfag1mnecl5mincon, 1188 Jmfag1 mnaci2,5minigg, 1204-1206 jmfag5minlggbead __ 030528200 105,1209-1211 JMMAGTube1616E3, 1228-1230 jmfag5miniggbe ad, 1229 .imfag5miniggbead, 1233 jmfag5minlgg350mmnaci, 1233-1235 JMMAGTube1616E3, 1238-1240 jmfag5minlgg350mmnacl, 1241 jmfag5minigg600mmnacl, 1258-1260 jmfag1mnacl0minigg,1298-1300 j mfag5minigg500mmnacl, 1300-1302 )mfag5minigg350mmnacl, 1309 jmfag5minigg500mm nacl, 1312 jmfag5mintgg350mmnacl. 1315 jmfag5minigg500mmnacl, 1318 jmfag5mtn1Qg150mmnacl, 1328-1330 jmfag5mioigg600mmnocl, 1332 jmfag5minigg350mmnacl, 1335-1337 jmfag5minigg600mmnacl, 1336 jmfag5miniggbead_030528200105, 1337 jmfag5miniggbead_030528200105, 1341 jmfag1 mnacl2,5minigg,1342-1344 j mfag5minigg450mmnaci_030527025134, 1342-1344 jmfag5mlnigg300m.m nacl.1344-1346 JMMAGNEGB16D3, 1348 JMMAGNEG616D3, 1352 jmfag5minigg600mmnact, 1358 jmfag1mnacl7,5minigg, 1366 jmlag1mnacl7,5minigg, 1372 jmfag1mnacl0minigg, 1374 jmfag 5mtnigg250mmnacl, 137 4-1376 JMMAGTube1616E3, 1374·1376 jmag5mlhcon500mmnaci, 1380-1382

-.EITALAPSTMK.-. EITALA PSTMK.-.HQGVMVGMGQK. ·.HQGVMVGMGQK.·.EITALAPSTMK.· -.EI TALAPSTMK.-.EITALAPSTMK.-.HQGVMVGMGQK.-.EITALAPSTMK-.VAPEEHPVLLTEAPLNPK · -.VAPEEHPVLLTEAPLNPK.· ·.EITALA PSTMK-.EITALAPSTM K., -.EITALAPSTM K.· -.EITALAPSTMK.-.HQGV MVGMGQK.-.HQGVMVGMGQK.·.VAPEEHPVLLTEAPLNPK.- .VAPEEHPVLL TEAPLNPK.-.HQGVMVGMGQK.-.QEYDESGPSIVHR.-. VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLL TEAPLNPK.- .VAPEEHPVLLTEAPLNPK.· - .EITALAPSTM K.-.VAPEEH PVLL TEAPLNPK.-.EITAL!\PSTMK. -.VAPEEHPVLLTEAPLNPK.-.GYSFTIT AER.-.IIAPPER. ·. VAPEEHPVLL TEAPLNPK.-.VAPEEHPVLL TEAPLNPK-.VAPE~H PVLLTEAPLNPK. -

1162.38 1162.38 1172 .41 1172.41 1162.38 1162.38 11 62.38 1172.41 1162.38 1955.24

2 4999.93

2 3608.30
2 4275.03

2 4855.74
2 2 2 2 2 3 2 2 2 2 2 5160.34 3010.50 3100.35 6421 .20 6626.41 5386 .28 1S121.68 5006.87 2878.94 6069.05 5448.36 5708.44 10169.85 6879.65 14903.45 6251.60 1892.'10 584.69 18926.07 4839.fo1 6840.34 9659.67 5451.83 14625.46 8867.17 818.31 14453.15 16791.42 5330.31 8075.38 20048.28 9769.82 13967. 18 6610.63 0718.16 14585.62 15441.35 728.27 2130.00 9124 .01 16130.06 19285.36 539.76 667H7 2869.79 7275.44 7566. 14 8188.61 16086.67 1245.46 11140.69 2171.07 10809.15 15838.2 1 14403.66 7627.04 6354.44 8583.33 2498.82 4806.66 1'1051.30 9243.76 16298.52 6303.52

1955.24
1162.38 '1162.38 1162.38 1162.38 1172.41 1172.41 1955.24 1955.24 1172.41 1517.58 1955.24 1955.24 1955.24 1162.38 1955.24 1162.38 1955.24 1133.19 795.95 1955.24 1955.24 1955.24 1955.24 1955.24 1955.24 1955.24 2344.63

2
2 3 2 2 3 3 2 3

2
3 2 2 2 2 2 2 3 3 2 2 3 3 2 2

-.VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK.-.VA PEEHPVLLTEAPLNPK.-.VAPEEHPVLL TEAPLNPK.-.KDL YANTVLSGGTTMYPGIADR.-.VAPEEHPVLLTEAPLNPK.-.GYSFTTT AER -.VAPEEHPVLLTEAPLNPK.- .VAPEEHPVLLTEAPLNPK.-.VAPEEHPVLL TEAPLN PK- .VAPEEHPVLLTEAPLNPK.· -.VAPEEHPVLLTEAPLNPK. -.VAPEEHPVLL TEAPLNPK·.KDLYANTVLSGGTTMY PGIADR- .EITALAPSTMK,' -.VAPEEHPVLL TEAPLNPI\.-.QEYOESGi"SIVHR.· -.OEYDESGf'S IVHRc-.SYELPDGOVITIGNER.·.SYELPOGQVITIGNER.-.OEYDESGPS IVHR.· -.VAPEEHPVLLTEAPLNPI\.-.QEYDESGPSIVHR.-.GYSFTTTAER.-.VAPEEHPVLLTEAPLNPI\.- .GYSFTTIAER.- VAPEEHPVL LTEAPI.NPK.-. EI TALAPSTMK.-.GYSFTTI AER. - .VAPEEHPVL LTEAPLNPK.-.GYSFTTT AER' -.VAPEEHPVLLTEA PLNPK.-.GYSFTTT AER.· -.VAPEE. H PVLLTEAPLNPK.- .KDLYANTVLSGGTIMY PGIADR · - .KDL YANTVLSGGTTMY PGIADR.-.KDLYANTVLSGGTTMY PGIADR.· -.TTGIVMDSGDGVTHTVPIYEGYALPHAI LR.-.TIGIVMDSGDGVTHTVPIYEGY ALPH.A.ILR.-.SYELPOOQVITIGNER. -.KDl Y ANTVLSGGTIMY PGIAOR.-.SYELPOGQVlTIGNER-.SYELpDGQVI TIGNER.-.SYELPDGQVITIGNER.-.VAPEEHPVLL TEAPLNPK.-. DLTDYLMK.-.VAPEEHPVLLTEAPLNPK.-.DLTDYLMK-.VAPEEHPVLLTEAPLNPK.-.SYELPDGQVITIGNER.· .DLTDYLMI\.· ·.Ti'GIVMDSGDGVTHTV PIYEGYALPHAILR. -.DLTDYLMK.- .SYELPDGQVITIGNER.-.SYELPDGQVITIGNER.·.8'iELPDGQVITIG NER.-.EITALAPSTMK.-.EITALAPSTMK.-.SYELPDGQVITIGNER.-.SYELPDGQVITIGNER-.TIGIVMDSG DGVTHTVPIYEGY ALPHAI LR.-.SYELPOOQVITIGNER.·.SYELPDGQVITIGNER.- .DL TDYLMK.· -.VAPEEHPVLL TEAPLNPK.-.SYELPDGQVITIGNER.-.EITALAPSTMK.-

1955.24
1133. 19 1955.24 1955.24 1955.24 1955.24 1955.24 195. 5.24 2344 .63 1162.38 1955.24 1517.58 15'17.58 1791.94 1791 .94 15'17.58 1955.24 1517.58 1133.19 1955.24 11 33.19 1955.24 1162.38 1133.19 1955.24 1133.19 1955.24 11.33.19 1955.24 2344.63 2344.63 2344.63 3185.60 31$5.60 1791.94 2344.63 17\l 1.94 1791 .94 1791 .94 1955.24 999.16 1955.24 999.16 1955.2 4 1791 .94 999 .16 3185.60 999.16 1791.94 1791.94 1791 .94 1162.38 1162.38 1791.94 179 1.94 3185.60 1791.94 1791 .94 999. 16 1955.24 1791.94 1162.38

2
3 3 3

2
2 3 2 3 3 3 2 2 3 3 3 2 2

2.40 2.32 2.04 2.09 2. 13 2.06 1.75 2.68 2.47 2.40 4.80 253 2.09 2.24 2.43 2.54 2.96 2.9 1 3.27 2.46 2.26 1.66 4.4 1 2.55 2.38 3.42 2.30 3.33 2.24 1.;36 3.64 4.10 2.63 3.17 4.46 3.83 3. 99 2.77 2.96 2.98 4.50 1.38 1.77 3.24 4.35 4.72 1.87 2,35

0.4 0.3 0.4 0.4

0.4
0.3 0.4 0.4 0.4 0.4

0.5
0.4 0.3 0.4

514 396 508 920 785 444 349 1043 699 420 927 442

315
1/2 7/10 4/5 4/5 3/5 1/2 4/5 711 0 11/34 21/34

315
13/20

545
733

3/4
11i20 4/5 17/20 6/17 10/17 3/4 3/8 9/34 11/ 17 21168 7/10 27/68 7110 19134

2.88 2.64

2.82
322 4.40 1.65 3.46 2.06 2 51 3.55 2.59 3.97

2
2 2 2 3 2 2 2 2 3

2.49
2.26 2.38 1.74

3 5984.02
3 14322.25 3 2592 1.37 3 16388.67

2 16522.50
2 2 2 2 3 2 2 2 37139.96 14014.35 14741.63 9514.51 6227 .85 1103.24 17925.21 1641.77 11223.00 13753.61 3595.89 8234.49 3838.09 13908.87 9849.26 16697,46 5890.90 3912.g1

2
2 2 3 2 2 2 2 2 2

2 2 3 2 2 2 2 2 2

8809.57 9959.49 805839 10025,61 7637.53 1291.48 13311.89 15881.82 7683.43

3.21 2.60 4.44 3.19 2.69 3.86 5.88 4.27 4.05 5.37 4.52 4.18 3.42 3.09 1.46 3.82 1.52 3.79 3.97 2.54 3. 32 2.09 3.56 3.62 4.29 2.33 2.20 3.36 3.34 3.08 4.09 2.89 1.80 4.21 4.32 2.70

0.4 352 0.4 865 0.5 978 0.4 748 0.6 752 0.4 691 0.2 586 0.0 329 0.6 1105 0.4 437 0.5 618 0.4 920 0.4 605 0.6 815 0.5 1309 0.2 221 0 .5 1009 0.6 951 0.4 772 OA 636 0.6 998 0.4 752 0 .5 945 0.4 445 0.5 602 0.6 1530 0.5 730 0.0 527 0.3 426 0.4 874 0.5 817 0.5 11 30 0 .0 287 0. 5 449 Oc 2 634 0.4 1157 OA 985 0.4 893 0.5 1423 0.1 538 0.5 .. 630 0.2 471 0.6 1170 0~ 6 828 0.1 1t03 0.3 713 0.5 488 0.5 972 0.3 422 0.5 703 0.5 768 0.5 1450 0.5 882 0.4 470 0.4 478 0.5 910 0.5 1454 0 .5 1279 0.5 1627 0.7 234-7 0.4 1306 0.5 1242 0.4 t205 0.4 740 0.2 239 0.6 1.134 0.3 425 0.5 699 0.5 1205 0.3. 388 0.4 831

819
7/12 11/17 11117 6117 25/68 11/17

10/17
7117 23184 9/17

Ml
19134 19/66 5.'17 13134 10/17 11117 3114 3/5 23168 7/16 7/16 19/30 11115 17/48 23168 17/48

5/6
10/17

5!6
10111 3/5 1311 8 19/68

213 21/34
8/9 21/34

217
5121 9/28

9/29
351116 11 /15 9/14 11115 213 11ii5 25168 9/14 11 /17

6i7
19/34 11/15

111'14
15/58 11/14 7i10 19/30 23/30

0.4
0.5 0.4 0.5 0.5 0.4 0.4 0.5

391

1216 1029 1802 468 491 1084 751 0.4 1172 0.4 1399 0 .4 812 0.2 429 0.5 586 0.5 1402 0.5 471

13/20
13120 7/10 315 8/29 23130 3/5 11/14 9117 4/5 315

95

Table 2 continued
jmag5mmcon500mmnocl, 1388 JMMAGTube1B16E3, 1388 jmfag5minigg400mmnacl, 1392 Jmfag5mlnigg400mmnecl, 1396 jmfag5mini99150mmnacl. 1410 jmfag1mnacl0mini99, 1412 Jmfag 1mnac!Omini99, 1418 jmfag1mnacl5mincon,1418-1420 jmfag1mnacl2,5minigg , 1420 JMMAGNEGB16D3, 1420-1422 JMMAGNEGB1603. 1428 jmfag1mnacl2,5mini99, 1428 jmf"'.J5minigg150mmnacl, 1428 jmfag5minlggbead_030528200105, 1441-1443 jmfag5minigg1000mmnacl, 1450 ;mfag1mnacl7.5minigg, 1452 jmfag1mnacl2,5mini99, 1454 jmfag5minigg1000mmnacl, 1454 JMMAGTuba1616E3, 1454-1456 jmfag1mnacl2,5minigg, 1458 )mfag5minigg400mmnacl, 1458 jmfag5minigg1000mmnacl, 1460 jmfag5mimgg400mmnacl. 1482 jmfag5minigg400mmn ;a.ol, 1464-1466 jmfagominlgg200mmnacl, 1478-1480 JMMAGTube1816E3.1480-1482 jmfag1mnacl7,5niinigg,1484-1486 JMMAGTube1616E3. 1486 JMMAGTubS1B16E3, 1492 jmfag5minigg400mmnael, 1498-1500 jmlag5minigg1000mmnacl, 1526 jmfag1mnacl5minigg.1526-1528 jmfag5minigg1000mmnacl, 1530 jmfag5minigg200mmnacl, 1548-1550 jmfag 1mnacl5mincon. 1558-1560 jmlag1mnacl5mincon, 1574 jmfag5minigg200mmnacl,1574-1576 jmfag5minigg300mmnacl, 1580 -.EITALAPSTM K.- .SYELPDGQVITIGNER.-.SYELPDGQVITIGNER. -.SYELPDGQVITIGNER.-.DL TDYLM K. -.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-. TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.1\DL YANTVLSGGTTMYPGIADR.-.DLTDYLMK.-.DL TDYLMK.-.DLTOYLMK.-.Dl TOYLMK.-.TTGIVMDSGDGVT11TVPIYEGYALPHAILR.· -.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· -.SYELPOGQVITIGNER.-.OL TOYLMK.- .TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.SYELPDGQVITIGNER.-.OL TDYLMK. · -.TTGIVMOSGOGVTHTVPIYEGYALPHAILR.-.DL TOYLMK.-.SYELPDGQVITIGNER.-.DL TOYLMK.-.DL TDYLMK.-. SYELPOGQVITIGNER. -.TTGIVMOSGDGVTHTVPIYEGYALPHAILR.· -.TTGIVMOSGDGVTHTVPIYEGYALPHAILR.-.TTGIVM OSGOGVTHTVPIYEGYALPHAILR.-.TTGIVMDSGOGVTHTVPIYEGYALPHAILR.-.lTG IVMDSGOGVTI'fTVPIYEGYALPHAILR.-.OL TOYLMK.-.SYELPOGQVITIGNER." -.DL TDYLMK.-.Dl TDYLMK-.SYELPDGQVlTIGNER.-. SYELPDGOVITIGNER.-.TTGIVMDSGOGVTHTVPIYEGYALPHAILR.-.VAPEEHPVLLTEAPLNPK.-.SYELPDGQVITIGNER.-VAPEEHPVLLTEAPLNPK. -.Dl TOYLM K .-.SYELPDGOVITIGNER.-.SYELPDGQVITIGNER.-.DLTOYLMK.-.TTGIVMDSGOGVT11TVPIYEGYALPHAILR.-.Dl TDYLMK.-.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.Dl TDYLMK-.OL TOYLMK.·.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.DL TOYLMK-.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.TTGIVMDSGOGVTHTVPIYEGYALPHAILR.-.TTGIVMOSGDGVTHTVPIYEGYALPHAILR.-.COVOIRKDLYANTVLSGGTTMYPGIAOR.-.QEYOESGPSIVHR.-. VAPEEHPVLLTEAPLNPK.-VAPEEHPVLLTEAPLNPK.- .VAPEEHPVLL TEAPLNPK.-.DL TDYLMK.-.OLTOYLMK.-. VAPEEHPVLLTEAPLNPK.-.OL TOYLMK.- .VAPEEHPVLLTEAPLNPK.- .VAPEEHPVLLTEAPLNPK. - . TTGIVMDSGOGVT~ITVPIYEGYALPHAILR. -

jmfag 1mnact5mincon, 1580 jrnfag5rnini99300mmnacl. 1588 jmfag1mnacl5minigg: 1596 Jmfag5monigg300mmnaci,2W0-2062 jmfag5min,gg300mmnacl. 2076 jmfag5minigg450mmnacl_030527025134,2136-2138 jmfag5minl99450mmnaci_030527025134, 2144 jmfag5mi111gg450mmnacl_030527025134, 2146 Jmfag5mini99450mmnac1_030527025134, 2148 jmag5mincon500mmnael,2160-2162 jmfag5mlnigg300mmnacl,2162-2164 jmag5mincon500mmnacl, 2166 jma_ g5mincon500mmnacl, 2172 Jmfag5minigg300mmnacl, 2174 jmfag5mini99300mmnacl, 2178 jmag5mincon500mmnacl, 2178 jmfag1mnacl7,5minigg, 2514 jmfag5mlnigg250mmnacl,964-966 JMMAGNEGB 1603,974-976 JMMAGNEGB16D3, 978 jmfag1mnacl2,5minigg.978-980 jmfag1mnacl7.5minigg, 1456 jmfag1mnacl5minigg, 1600 jmag5mincon500mmnacl, 1600-1602 jmfag1mnacl5minigg. 1604 jmag5mincon500mmnacl, 1604 jmag5mincon500mmnacl, 1608 jmfag 1mnacl5minigg. 1640 jmfag1mnacl5mlncon, 1642-1644 jmfag1mnacl5mincon, 1646 jmfag1mnacl5mincol1, 1674 jmfag 1mnacl5m!ncon, -1684 jmfag5minigg500mmnacl.1754-1756 jmfag1mnacl7,5mlnigg, 1822-1824 Jmfag5minlgg500mmnacl, 1850 jmfag51nimgg500mmnacl. 1854 jmfag5minigg500mmnacl, 1862 jmfag5minigg250mmnacl,1862-1864 jmfag5minigg450nimnaci_030527025134. 1372 jmfag5minigg500mmnaci, 1874 jmfag.5mimgg500mmnacl, 1878 jmfag5minigg450mmnaci_030527025134, 1878 Jmag5mincon500mmnac1,.1886 jmfag5minigg1000mmnacl, 1910 jmfag5minigg200mmnacl, 1918-1920 jmfag5minlgg250mmnacl, 1956-1958 jmfag5minigg250mmnacl, 1966-1 968 jmfag5mini99250mmnacl, 1970 jmfag5minigg250mmnacl, 1976 Jmfag5minigg450mmnaci_030527025134, 2034 jmfag1mnacl5h1incon,2042-2044 jmag5mincon500mmnacl, 2048 jmag5mincon500mmnacl, 2052 jmrawigg5min150mmnacl, 474 jmlgG150rawp/lag3007. 756 jmrawrminigg200mmnacls)Tingdnas. 700 jmlgG150rawphag3007, 762 jmlgG250rawphag3007,772-774 jmlgG300rawphag3007, 796 jmlgG300rawphag3007,8oo-802 jmrffi.ViggSmin·lSOmmnacl. 818 jmt'awigg5min300mmnacls)Tingednase,825-827

-.DL TDYI.MK.-.OL TDYLMK.-.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.-.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.- .SYELPOGQVITIGNER.-.CPEALFQPSFLGMESCGIHETTFNSIMK.-.OL TDYLMK.-.OL TDYLMK.-.DL TOYLMK.-.SYELPDGOVITIGNER.-.KOLYANTVLSGGTTMYPGIAOR.-.TTGIVMDSGOGVTHTVPIYEGYALPHAILR.-. TTGIVMOSGOGVTHTVPIYEGYALPHAILR.-.KDLYANTVLSGGTTMYPGIAOR.-.KDL YANTVLSGGTTMYPGIAOR.-.CPEALFQPSF(GMESCGIHETTFNSIMK.-.CPEALFQPSFLGMESCGIHETTFNSIMK.- .TTGIVMDSGOGVTHTVPIYEGYALPHAILR.-.DL TOYLMK.-.OL TOYLMK.-.DL TDYLMK.-.SYELPDGQVITIGNER.-.CPEALFQPSFLGMESCGIHETTFNSIMK.-.SYELPDGQVITIGNER-.SYELPDGQVITIGNER.-.QEYDESGPSIVHR.-.HQGVMVGMGQK .-.HQGVMVGMGOK.- .HQGVMVGMGQI<.-.HOGVMVGMGQK.-.HQGVMVGMGQK.-.HQGVMVGMGQK,- .EITALAPSTMK.-.VAPEEHPVLLTEAPLNPI<.-

1162.38 1791.94 1791.94 1791.94 999.16 3185.60 3185.60 2344.63 999.16 999.15 999.16 999. 16 3185.60 3185.60 1791 .94 999.16 3185.60 1791 .94 999.16 3185.60 999,16 1791.94 999.16 999.16 1791 .94 3185.60 3185.60 3185.60 3185.60 3185.60 999.16 1791.94 999.16 999.16 1791 .94 1791.94 3185.60 1955.24 1791.94 1955.24 992.16 1791.94 1791 .94 999.16 3185.60 999.16 3185.00 999.16 999.16 3185.60 999.16 3185.60 3185.50 3185.60 3046.43 1517.58 1955.24 1955.24 1955.24 999.16 999 .16 1955.24 999:16 1955.24 1955.24 3'185.80 999 .1fo 999.16 3185.60 3185.60 1791.94 3119.61 999.16 999.16 999 .16 1791 .94 2344.63 3185.60 3185.60 2344.53 234463 3119.61 3119.61 3185.60 999.16 999.1 6 999.16 1791 .94 3119.61 1791.94 1791.94 1517.58 1172.41 1172.41 1172.41 1172.41 1172.41 1172.41 1162.38 1955.24

1555.60 189.74 11 339.6 9 15706.86 2047.29 11590.12 19317. 74 4855.45 2899.40 1351.67 3809.43 2008.86 24360.79 9446.21 '13004.29 1815.08 15771.92 11992.78 2 3610.92 3 6226.96 2 2512.52 1 1565.08 2 3376.52 1 4715.62 2 16111 .10 3 15897.46 3 6164.07 2 657.83 2 14028.15 3 3152.29 2 1239.25 2 13465.08 2 667.83 2 3866.65 2 13124.34 1 3186.18 3 8125.64 2 10930.59 2 8322.33 2 7927.36 2 1214.55 2 20205.50 3 1555.40 2 3401.64 3 8613.59 1 856.42 3 10263.38 2 881.04 2 3024.23 3 21172.58 1 838 .55 3 15454.15 3 4764.54 3 9497.38 2 225.49 3 6742.33 3 2594.74 2 15316.70 3 5639.91 2 1555.48 2 34ti4.59 3 4396.72 1 1630.59 2 12434.89 2 16755.86 3 10162.43 2 3099.0'1 1 1414.10 3 17537.05 2 7416.88 2 13151.62 3 602.57 2 1973.16 2 472.48 1 717.58 2 15015.73 3 4642.09 3 15532.24 3 2226.92 3 6470.44 3 15301.57 2 1598.06 2 203.49 3 15275.64 2 1054.12 1 2844.74 1 2423.73 2 5137.61 2 H63.68 2 7927.73

2 1 2 2 2 3 3 3 2 1 2 2 3 3 2 2 3 2

2.05

0.2
0.1 0.4 0.5 0.3 0.5 0.5 0.4 0.3 0.1 0.3 0.2 0.5 0.4 0.4 0.2 0.5 0.4 0.3 0.4 0.3 0.2 0.3 0 .3 0.5 0.6 0.4 0.2 0.6 0. 3 0.2 0.5 0. 1 0.4 0.4

348
84 1213 202 3 314 831 2056

1..26
3.79 3.81 1.79 3.67 4.55 2.76 2.20 1.50 2.39 1.84 5.54 3.19 4.10 1.81 4.14 3.86 2. 22 2.70 1.90 1.96 2.25 2.68 4.17 4.20 2.55 1.36 3.48 1.94 1.74 3.70 1.74 2.16 4.11 1.70 3.08 2.83 3.07 2.72 2 .12 4.50 1.84 2.21 3. 39 1.40 3.09 1.58 2.31 4.32 1.33 3.53 2.82 2.94 1.03 2.99 2.48 3.63 2.53 1.68 2.27 2.49 1.63 3.67 4.1 9 2.97 2.40 1.63 4.78 2.97

50 · 1
398 766 393 501 1661 1075 1388 461 1015 1161 467 944 400 176 406 776 1533

11/20 3/10 11/15 5/6 11 / 14 15158 39/116 23/84 W14 5/7 11114 6/7 37/116 8/29 23/30 617 1/4

2/3
617 31/116 11114 2/5 11/14

517
11/15 1/4 1/4 7129 21 /58 31 / 116 6/7 11/ 15

598

3.63 1.72 1.66 1.56 1.23 4.59 2.56 3.49 1.69 2.92 4.26 1.74 1.54

3.69
1.56 1.85 1.75

2.56
1.57 2 .46 3.61 2.50 2.49 2.54 2.13 2.87 2.25 3.03

2 3 2 2 2 2 3 2 2 3

11415.55
6868.79 6368.18 5806.60 6134.16 6901.41 1926.95 9624.49 1719.78 4555.21

1.69
3.16

907 15a 387 978 464 1540 209 475 1421 0.4 161 0.4 694 0.6 503 0.4 698 0.5 844 0.0 560 0.5 1478 0.0 833 0.4 289 0.4 589 0.1 535 0.4 1686 0.2 272 0.3 371 0,6 1705 0.1 551 0.5 1820 0.3 858 0.5 936 96 0.1 0.3 1106 0.3 291 0.6 974 0.4 746 0.2 458 0.3 511 0.3 700 0.2 595 0.5 869 0.6 748 0.5 1374 0.3 434 0.0 852 0.5 1025 0.5 326 0.5 1018 0.1 304 0.3 400 0.1 240 0.0 557 0.5 1469 0.3 755 0.6 1261 0.2 955 0.4 774 0.5 590 0.3 146 0.0 118 0.5 1397 0,2 236 0.3 523 0.3 749 0.4 643 0.3 187 0.5 778 0.4 1243 0.4 1154 0.4 927 0.4 739 0.4 1204 0.4 1065 0.2 418 0.5 1086 0 .3 245 0.3 584

417
6/7 2/3 2/5

71 29
1/2 17/30 10/17 6/7 23130 23!60 5/7 7129 517 19/58 9/14 11/14 37/116 9/14 35/116 31/116 31/116 5/27 11124 19/68 10117 25168 6/7 11/14

23/68
517 10/ 17 19/34 35!116 6/7 11/14 17/58 17/58 19/30 19/1 08 11/14 9/14 5/7 23/30 13/42 33/116 15/58 9/28 25184 5/27 1/6 17/56 9/14 9/14

517
8/15 11/54

3/5
213
11/24 4/5 3/4 9/10 17/20 2/5 17/20 9/20 21/68

96

Table 2 continued

jmlgG350naclrawphag3007,849-851 AJRA WActinlgG _june 13,888-890 jmrawigg5minbeadsfreezethaw,954·956 jmrawigg5minbeadsfreezethaw, 962 Jmrav,igg5minbead:J'reezethaw, 966 jmlgG300rawphag3007, 1004 jmlgG350naclrawphag3007, 1015 JmlgG350naclrawphag3007, 1019 j mrawigg5min 150mmnacl, 1026-1028 j mlgG350naclrawphag300 7, 1057 jmrawtgg5min30 Ommnacl syringednase, 1155 ajrawphag 1MNaCI20, 1182 aJra\vphag 1MNaCI20, 1186 jmrawigg5minbeadsfreezethaw, 1196 jmlgG350naclrawphag3007, 1203 jmlgG350naclrawphag3007, 1207 jmrawlgg5min150mmnacl. 1244 AJRA WActinlgG _june 13,1288- 1290 jmrawigg5minbeadsfreezethaw, 1324 jmr&wiggSminbsadsfreszethaw. 1328 jmrawigg5minbudslreezethaw, 1330·1332 jmrawrminigg200mmnacl syringdna s_ , 1350-1352 jmrawrminigg200mmnsclsyringdnas, 1360 jmraw5minigg500mrnnael sd, 1350·1362 jmrawrmtnigg200mmnaclsyringdnas, 1364 jmrawigg5min150mmnacl , 1370..1372 jm5miniggrawlowionic, 1422 jmrawigg5mlnbe adsfreezethaw y 1426 jm5miniggrawlowionic, 1426 jmrawigg5mlnbeodsfreezethaw, 1430-1432 AJRAWActinlgG_juna13, 1470 AJRAWActlnlgG_june13, 1474 AJRAWActinlgG_june13, 1478 jmraW5mintggtiOOmmnacl sd, 1534 jmraw5minigg250mmnaclsyringdnase, 1536· 1538 jmraw5minigglowionic, _ 1609 jmraw5mintgg500mmnaclsd, 1624 jm5m inlggrawlowionic , 1626- 1628 jmraw5minigg500mrmaclsd, 1628 jmrawrmtnigg200mmnaclsyringdnas, 1634 jmSminiggrawlow'ionic, 1638 jmrawrminigg200mmnacl S}'ringdnas, 1638 jmSminiggr·wlowionic, 1642 jmigg4 50raw;>hag3007, 1740 jmlgG300rawphag3007, 1750 jmlgG400rawphag3007, 1752 AJ.R AWActinlgG_june13, 1756·1758 jmlgG350naclrawphag3007, 1763·1765 jmraw5minigg500mmnaclsd, 1782·1784 jmlgG250rawphag3007, 1786-1788 jmrawrmlnlgg200mmnacl syringdnas, 1804-1806 jmraw5tninigg250mmnaclsyringdnase, 1820-1822 jmrawrminigg 200mm naclsyringdnas, 1894-1896 jm5miniggr~wlowionic, 1918~ 1920 AJRAWACtinlgG_june13,1924·1926 jmraw5minigg250mmnaclsyringdnasa, 1984-1 986 AJRAWActinlgG_june13,1992·1994 jm5miruggrawlowionic,2086·2088 jm5miniggrawlowionic, 2100 jm5mlnigQrawlowionic,2174· 2176 IPP_MOUSE Actin-binding protei n IPP {MIPP protein) (Murine lAP-promoted place jmfag5mincont200mmnacl ,478'480 AJRAWpellet2_contr_jun13, 1279 jmfagcon5 mtn1000mmnaci_030601180404, 1320 jmfag1 mnacl5minigg, 1326 jmlag5minirofo00mmnacl, 1984 ~imilat to oclln (Muo muscu lu s ] soulus)] orv"9l JMFAGNACL 10._1B21E3, 494 jmfag5miniggbead_0305282 00105, 1977 jmfag5niinigg150mmnac I, 2008 jmfag5mini gg500mmnac I, 2044 actin monomer ..blnding protein [Mus musculus] jmfag1mnacl7,5minigg, 1064 jmfag1mnacl5mincon, 1254 jmfag5mini gg250mrr·1ac I. 1492 slmiiiJr to Actin monomero.b ~nd ing protein (Mus muBCulus] jmbeads150rowphag3007, 1410 jmfsgtimooont10min_030601202502. 2486 actlnfllln (R·Itus norveglcus) jmfag5minigg150mmnacl, 2258 jmfag1 mnacl2,5minigg, 2276 JMFAGNACL5B21E3, 2358 jmfag ·l mnacl5mlncon, 2548 jmfag5mlni gg450mmnaci_030527025134, 3852 S:WIISNF related, matrix associated, actin dependent rsguiSitor of chrom JMFAGNACL 10_1B21E3,450·452 jmfag5minigg300mmnac I, 786 jmfag5miniggbead, 1987 phograwF250_dec22, 2177 phagrawFSOO __ Dec23, 2536 SWI/SNF related, matrix assoclo!ed, actin dependent rogulotor of chromo phagrawF400_dec20. 1066 phagrawFchlf_.dec23, 1522 rawextr_200bead_Mar04, 864 slmllor to SWIISNF related, mtrtrix assoc iated, acti n depondonl regur..t phagrawFsucchlibead_dec23, 2026 phagmwF300_dsc20, 1435 rawextr_aclinbeadigg_Mar04, 313 rawextr ·.350beadigg2_Mar04, 1698 raw.;xtr_ 400beadigg_Mar04, 2068

· .HQGVMVGMGQK.·.HQGVMVGMGQK.· :.VAPEEHPVLL TEAPLNPK.· · .VAPEEHPVLL TEAPLNPK.· ·.VAPEEHPVLL TEAPLNPK.· -.HQGVMVGMGQKDSYVGDEAQSK.· ·.QEYDESGPSIVHR.· -.QEYDESGPSIVHR· · .VAPEEHPVLL TEAPLNPK.· · ,HQGVMVGMGOKDSYVGDEAQSK.· · .SYELPDGQVITIGNER· ·.IIAPPER.· - .IIAPPER.· ·.KDLYANTVLS.GGTTMY PGIADR.· ·.EITALAPSTMK.· ·.EITALAPSTMK.· · XDL YANTVLSGGTTMY PGIADR.· · .EITALAPSTMK.· ·.SYELPDGQVITIGNER· · .SYELPDGQVITIGNER.· ·.SYELPDGQVITIGNER.· ·.VAPEEHPVLL TEAPLNPK.· · .VAPEEHPVLL TEAPLNPK.· · .VAPEEHPVLL TEAPLNPK.· -.VAPEEHPVLL TEAPLNPK.· · .SYELPOGQVITIGNER.· ·. EITALAPSTMK.· ·.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· ·.EITALAPSTMK.· ·.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· ·.VAPEEHPVLL TEAPLNPK.· · .VAPEEHPVLL TEAPLNPK.· ·.VAPEEHPVLL TEAPLNPK.· ·.VAPE.EHPVLL TEAPLNPK.· ·.VAPEEHPVLLTEAPLNPK.· · .EIVRDIK.· ·.KDLY ANTVLSGGTTMYPGIADR· · .VAPEEHPVLL TEAPLNPK.· ·.KDLYANTVLSGGTTMY PGIADR.· ·.KDL Y ANTVLSGGTT MYPGIADR.· ·.VAPEEHPVLL TEAPLNPK.· ·.KDLY ANTVLSGGTTMYPGIADR.· ·.VAPEEHPVLL TEAPLNPK.· ·.SYELPDGQVITIGNER.· -.SYELPDGQVITIGNER.· ·.SYELPDGQVITIGNER.· ·.KDLY ANTVLSGGTTMYPGIADR.· -.SYELPDGQVITIGNER.· ·.SYELPOGQVITIGNER·.SYELPOGQVITIGNER.· -.SYELPDGQVITIGNER.· ·.KDLY ANTVLSGGTTMYPGIADR. · ·.TTGIVMD$GDGVTHTVPIYEGYALPHAILR.· ·.KDLYANTVLSGGTTMYPGIADR.· ·.SYELPDGQVIT IGNER.· · .SYELPDGQVITIGNER.· ·.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.· ·.SYELPDGQVITIGNER.· -.SYELPDGQVITIGNER.· · .T TGIVMOSGDGVTHTVPIYEGYALPHAILR.· ·.WSPLPPMGTR.· · .RWSPLPPMGTRR.· ·.RKHWEVLDPVR.· ·.RWSPLPPMGTR.· ·.LLKYIEGVSDFNLR.· ·.QEMTTAAR.· ·.MDGLHEGRWNEDDSNGR· ·.ALLQSSFLGIESCGIHETTFHSIMK· ·.PCYVALDFKQEMTTAARSSSSLEK· · .LPSSSEQVILDLK.· ·.REPDSNGGGPTTTGGPPAGAEEAQRPR.· ·.LPSSSEQVILDLK.· ·.OLLEEKQEEALSGDGHSWETLK.· ·.QLLEEKQEEALSGDGHSWETLK.· ·.FHLLPEQRGVLGTS RTR.· .FHLLPEQRGVLGTSRTR.· · .FHLLPEQRGVLGTSRTR.· ·.FHLLPEQRGVLGTSRTR.· ·.PAGRTQSPEHSSPGPGPEAPPPPQPPAPEAERAR.· .OLKIITDVI GNPEEER.· - .KPLTQI< .· · .LDPRLARLLGVHTQTR.· ·.MPMAGLQVGPPAGSPFGTAAPLR.· ·.LLVPQAQPPMPAQRR.· -.FQNTEAGSPTISTVLK.· ·.AGGVGLNLCARSRVFLM DPAWNPAAEDQCFDR.· ·.DLAAGAFATK.· · .MWLVFPDSCVASTEFACWYMEAFK.· ·.LIVKDSVEENMLK.· ·.CHRLLQKQEMIITK.· ·.ASGFVFTPLDGSMAQKKR.· ·.DSVEENMLKIQNTKXDLAAGAFGTK.·

1172.41 1172.41 1955.24 1955.24 1955.24 2352.59 1517.58 1517.58 1955.24 2352.59 1791.94 795.95 795.95 2344.63 1162.38 1162.38 2344.63

1162.:)8
1791.94 1791.94 1791.94 1955.24 1955.24 1955.24 1955.24 179Ul4 1162.38 31 85.60 1162.36 3185.60 1955.24 195 5.24 1955.24 1955. 24 1955.24

873.03 2344.63 1955.24 2344.63 2344.63 1955.24 2344.63 1955.24 1791.94 1791.94 1791.94 2344.63 1791.94 1791.94 1791.94 1791.94 2344.63 3185.60 2344.63 1791.94 1791.94 3185.60 1791 .94 1791 .94 3185.60
1142.36 1454.73 1447.71 1298.54 1667.93 908.02 1939.03 2751.18 2664.01 1429.64 2663.76 1429.64 2528.71 2523.71 1968.25 1963.25 1968.25 1008.25 3451.71 1842.04 714.83 184.7.16 2224.64 1703.05 1693.88 3481.93 965.09 2863.35 1518.60 1742.15 1941.24 2695.04

2 9 192.44 2 10826.72 3 6057.5£ 2 12094.23 2 10896.33 3 11422.19 3 4672.49 3 1967.03 3 8617.18 3 22994.35 2 7328.04 2 1196.35 2 813.35 2 23579.68 2 3247.76 2 338 1.48 3 16734.41 2 3457.09 2 9923.37 2 11 482.80 1 4079.88 3 38 17.98 2 10825.02 3 1087.92 10959.90 2 16401.43 2 6507.93 2 9676.99 2 1652.45 3 20093.27 3 1205.00 3 937.68 2 46 79.36 3 1238.04 3 3729.24 1 388.94 3 6563.10 3 3819.26 3 9176.67 3 7585.69 2 14140.30 3 4616.92 2 10639,73 2 8171.38 2 11078.70 2 8316.90 3 10926.63 2 14649.15 2 17104.53 2 14314.01 2 14868.15 3 402.93 3 30885.94 34070. 13 2 15899.61 2 11003.90 3 24002.15 2 12499.20 3 371.57 3 1810.80

z

2.69 3.30 3.14 3.01 3.39 3.47 2.70 1.97 3.33 4.33 3.25 1.35 1.35 4.49 1.66 1.99 4.63 2.13 3.75 3.69 2.13 2.49 3.30 1.56 3.64 4.22 2.48 3.2 '1 1.68

0.5 0.5 0.4 0.6 0.5 0.5 0 .3 0.2 0.4 0.6 0.3 0.3 0.2 0.6 0.4 0.3

943
970 458 667 717 1047 785 760 735 1458 1086 244 199 1662 582 487 893 454 1255 1234 276 972 690 502 571 '1591 674 299 590 951 410 430 560 244 760 288 447 525 712 420

4/5
4/5 5/17 21134 10/17 1/3 5/12 19/46

25168
17142 2/3

7/12
1/2 4/7

3/5
3/5 29/84

0.5
0.3 0.4 0.4 0.4

0.2
0.5 0.1 0:5 0.5 0.4 0.5 0.2 0.5

5.22
1,58

1.85
2.82 1,57 2:61 1.03

0.2 0,1 0.3 0.2

11/20 7/10 7/10 1/2 13/34 9117 5117 9/17 23130 13/20 9/29 13120 8/29 5/17 5117 9117

0.3
0.1 0.4 0.4 0.5 0.4

1/4 23i68
7112 11/42

2.89
2.16 2.92 3.20 4.05 2.48 2.96 2.57 3.50 2.50 3.87 3.68 440 M7 4.45

11/34
25/84 1/4

0.5
0.4 0 .5

572
510 689

9/17
23/84 19/34

0.5

724

8115
7110 3/5 13/42 11/15 7/10 23130 23/30

0 ..4 1286 0.5 683 OA . 803 0.5 1353 0.5 14'.35

0.4 1654
0.4 .Q:'I 0.6 0.3 Oo 5 0.5 0.6 0.4 0.1 0.2 13432163.0 0.0 0.2 0.0 0.0 0.2 1330 143 .1822 458 1492 1013 1806 1475 221 499 469 128 231 305 234 258 235

1.51
5.89

5!28
41/116 1/4 11/15 19/30

3 2 2 2 2

745.21 467.77 311.65 357.19 1221.21

2 346.17
3 327.35

3. 490.31
3 1514.58 2 396.32 3 693.05 2 1492.47 3 429:69 3 520.27 2 2 2 2 2 3 2 2 3 2 415.85 289.67 132.28 1684.76 55.19 484.26 444.24 1496.46 1054.61 439.78

2.48 4.36 3.34 4.61 3.98 1.27 2.11 3103.02 1.59 1.00 1.27 1.17 1.52 2878.4'1 1.01 1.35 1.31 1.96

19;58
11/15

1i4 13/58
17136 3/11 9/22

91:10 9/26
417
13164

38068ll31.0
0,1 0.0 0.0

360
307 244 237

5/24
11/46 11/24 211104 1/2

0.2
21450159.0 0.0 0.1 0.1

2581.85
1.61 1.93 2.07

628
262 24$ 230 129 73 247 36

949.96
1.56 1.50 2557.75 1.81 1.49 1.22 1.83 0.73 391 9.34 1.42 1.14 1,64 1.50 1.15 1622.10 1.44 1.11

38077530.0
0.0 0.1

23184
11/42 11i32 5/16

21728394.0 0.0
0.1 0.1 0.3 0.1 13994211.0 0.1 0:0

7132
13132 1/11 4/15 7110 13130 23188 11/28 3110 171124 11/18 4/23 1/3 15/52 15/68 17/96

259
381 407 378 260

0.2
0.2 0. 1 7106417.0. 0.0 0.0 0.1 38086734.0 0.2 0.1 0.1 0.0 0.1

3 552.52 3 150.23 2 919.36 3 2 3 3 3 '1565.49 292.08 408.19 423.95 535.33

382
123 532 260 180 250 280 223

1.4
3293.14 1.G6 1.19 1.27 1.45 1.58

97

Table 2 continued

rawextr_60Mc·0Hbeadlgg_Mar04, 2134 SWI/SNF retat&d, mstrix associated, actin dependent regulator of chrom rawextr_chtfbe. adtgG.c,Mar04, 157 FPbeads500_dec19, 2703 FPbeads300 __Dec19, 3652 Swi/SNF r&lated matrix associated, actin dependant regulator of chromat rawextr_SOObeadigg_Mar04, 676 r.wextr_150beadigg2 _Mar04, 726 rawextr_500beadigg_Mar04 . 902 rawextr_700beadigg_Mar04, 1210 rawextr _ 300beadigg_Mar4, 1230-1232 rawextr _450beadlgg_Mar04. 1626 FPbeads150_Dec19, 1713 rawphag2007chfbaad2,1022-1024 RawPhag200760MeBeadsdigest, 2198 JMFAGNACL 10_1S21E3, 500 jmfag5minigg1 ooommnaol, 678 jmfag5mini gg400mmnac 1, 1016 JMFAGNACL5621E3, 2274 jmfag5mlni gg300mmnac I, 2940 jmfag5mlniggbead_030528200105, 3035 SWI/SNF related, matrix associated, act.in dep~ndent regulator of chromat rawextr_actinbead_Mar04, 1898 rawsuclfp _500phagigg_Mar04. 1018 rswsucrfp_700phaglgg_Mar04, 1359 phagrawF350 _dec20, 2528 phagrawFsuc450 _dec20, 3818 rawextr~300beadigg_Mar4, 844 rawextr_150boadigg2_M3r04, 1308 rawextr _900beadigg_Mar04, 1600 rawextr_200beadigg_Mar04, 1971 T30S47 octin binding protein ACF7, neural i3ofom· 2- mous& (fragment) jmfag5minigg200mmnac I, 1166 jmfag5minlggbead, 1541 aclln-rclsted protoln G [Mus musculus) JMMAGTuba1816E3.616-618 jmfag5minigg500mmnocl, 988 ADVL_MOUSE Advlllin (p92) (Actin-binding prol<>in OOC6) jmfag5minlgg200mmnacl, 1234 jmfag1tnnacl0minigg, 1438 JMF AGNACL 10 _2B21E3, 1782 JMFAGNACL 10_.1B21E3, 2464 jmfag5minigg250mmMc I, 2694 ARP8 &et in-.rclated protein 8 homolog; actin ..rel&ted protein 8 homolog jmfag1 mnacl5minigg, 2762 rawphag2007chffsol1; 1302 rawsuclfp~300phagigg_Mar04, 1121 rawsucrfp_ _1000phagtgg_Mar04, 1213-1215 rawsucrfpJOOphagigg_Mar04, 1429 phagrawF600_dec20, 2440 phagrawF150_dec22, 2684 ARP1 actin-related protein 1 homolog A, centractln zlpha; AR1'1 (actln-r jmfag5mincon250mmnacl. 828 jmbeads150rawphag3007, 1280-1282 rawsucrfp_chlfphagigg_Mar04. 654 rawsuclfp_chlfphagigg_Mar04, 1806 phagrawF350 _dec20. 2424 phagrawF200_dec22, 2987 ARP1 octln-related J>roteln 1 homolog B (Mus musculus) phagrawFsuc60M60H_dec23, 1348 rawsucrfp_350phag lgg_Mar04, 1524 phagrawFchlf_dec23, 2092 jmbaads150rawphag3007, 1080 jmfag5mincont400_030531151834, 1358 &etin relatfld ptf?re;n 2/3 comple"-, subunit 3; actin rela.ted prote;~ln 213 JMMAGNEGB16D3, 170·172 jmfag5minigg200mmnac I, 452 capping protein (actin fi!Amenl) nu:scle Z-line, alpha 2; capping protei JMFAGNACL 15B21E3, 1228 simihar.to cortaetin·isoform .b; onco~ene EMS1; cort&c:Un [Mus musculus jmfag5minigg150mmnac I, 686 JMFAGNACL15S21E3, 946 JMFAGNACL 15B21E3. 1472 cortactin, p80/p85 [mice, BALB/c 3T3 cells, Peptide, 548 aa) JMMAGTube1B16E3, 1474 Jmfag1mnacl5mirn:on. 1916 A54728 actin alpha, cardiac - mouM (fragment) jmfag1mnacl2.5minigg, 2134 TRIO and F·actlll bltlding 1>rotein !Mus musculus) X& jmfag1 mnacl2,5minigg, 264 jmfag1 mnaol5mitw.On, 440 jmfag5miniggbead_030528200105, 1335 jmfag5mini gg250mmnac I, ·1772 JMMAGTube1B16E3, 2048 similar tQ ARP1 actJnarelated protein 1 homolog A; actin-rel&ted prote jmfag5minigg350mmnacl, 885 JMFAGNACL5B21E3. 2868 rawextr_150baadigg2_Mar04, 326 &Ciin-relat.od protein T1 [Mus musculus) jmfag5mini99150mmnacl, 676 SWI/SNF related, matrix aasociated, actin dependent r&gubtor of chrom rawextr_350bead_Mar04. 344 rawextr_200bead_Mar04, 1130 rawextr_150bead_Mar04, 2553 jmbeads250rawpt\ag3007, 274 jmfagtimeconl10min_030601202502,1406-140S jmbeads150rawphag3007, 1620 jmbaads500rawphag3007, 2556 rawphag2007chfoead2 , 94 rawphag2007chfbsad3, 973

-.EGAIGKYWFGQHVK.-.TLOTISLLGYMK.-.KWVPTLRSVCLIGDK. -.TLQTISLLGYMKHYRNIPGPHMVLVPK.-.EGVSFAISKR.-.EKFLVFAHHKVILDAVAK.-.MWVNPGRISSR. -.QSISDSFYVLGGI\.-.WLPSLSPENINWVTGK. -.QSISDSFYVLGGKTPRTEGR.-.VLGEAGLSETNFSEMTEA TDYVHKAPKOK.-.FLVFAHHKVILDAVAK.-.OLKTPFKVVIIDESHFLK.-.RLKSDVLSQLPAK .-.QVOLDPLPK.-.LKADVPEADLSGVDAKLVSSLM PFQR.-.FEVOIGYSEAVIGLFK.-.VLGEAGLSETNFSEMTEATDYVHKAPKOK.-.LSTVSLKPLDEAGGSVGGQTSL PSAPSL TFVTGI<.-.AAIGRYFTEGTVLAHYADVLGLLLR-.WEDSKFALTFFASATOR.-.INALMHAUELR.-.SEVHLNFYVYYGPDRIRDSAWLSK.-.LROICCHTHLL TNGMSSSGPSRSDTPEELR.-.QEVIITK.-.DSVEENMLKIONTK.· .IILSSGSDEECAICLDSL TFPVITHCAHVFCK. -.KGMSMMECSEACDTGER.-.GAIEMASRVEOSYOK· -.HQGGSSSGKSSLLCAEPKVDLK.-.EAIIRINVGGKLLTNHLK.-.EAtiRINVGGKLLTNHLK. -.GALSTAQEYLVTHPSGR.-.TQAEHYLWYGKGSSGDER.-.GATI<VEKOAAMSK.-.QGIIYKKGGVASGMK.-.DELAASAYRAVEVOOQFDRAPVQVR.-.HPDSPALLYQFRLGDEf<.-.YYRCILLIPDIYNK.-.CILUPDIYNKQHW.-.YYRCILLIPDIYNK.-.RGOLNIHPGPGGSL TAVLADIEVIWSHAIQK.-.LIAWKGGAVLACLDTTOELWIYQR.-.CILLIPDIYNKOHVK-.EYEEDGAR.· -.AEEHRGLLS IRYPMEHGIVK.-.LAPKDVKIR.· -.KEGYDFHSSSEFEIVK.-.EGYOFHSSSEFEIVKAIK.-.EYEEDGARSIHRK.-.EYEEDGSRAIHR.-.TLFSNIVLSGGSTLFI\.-.EYEEDGSR.A.IHR.-.LLLRKEGADFHTSAEFEVVR.-.DQLOTFSEEHPVLL TEAPLNPSK.· -.SQFKGPAPR-.QFMNKSLSGPGQ.-.LLLNNDNLLR.-.YAVGIEYQSK.-.VOKMAKESQEXEIC-.ASAGHAVSITQDDR.-.ELETGPKASHGYGGKFGVEQDR.-.TVPIEAVTSKTSNIRANFENLAK.-.DDEETTAL VCDNGSGL VK.-.DELQVIQKDK.-.KWFESTOGR.-.PTI<OEDLERDLAQR.-.LAMAALQEKEAVRNSLAE.-.IGEQRTGSEVIGRGGPR.-.HPVLL TEALLSPR.-.MRSVAFAANRAGISFLGGK.-.LSEVI(I(LVPK.· -.LDNPAVIFDNGSGLCK.-.TSNVCVR-.TIGYKVPRNPEIPNPAIAQR.-.DDKOSLISVGDYR.-.MVNMPLKADP-AK-.VSEPKIPK.· -.LGTVEWIEPPK.-.EEGAAAAATEGTTA TEKGEK.-.SEKEMDPEYEEK.-.EMDPEYEEI<.-

1620.84 1363.67 1716.03 3108.76 1094.25 2066.48 1315. 57 1401.55 1854.14 2199.41 3182.51 1809.19 2143.56 1455.73 1036.22 2788.21 1788.03 3182.51 3303.71 2721.15 2047.30 1394.71 2917.23 3327. 72 830.99 1649.85 3454.02 1866.13 1697.90 2229.50 1990.38 1990.38 1787.96 2085. 18 1349.58 1537.85 2835.08 1987.21 1788.15 1798.19 1788.15 3279.74 2750.21 1798.19 968.95 2336.70 1040.29 1903.04 2087.27 1590.68 '1462.51 1684.96 1462.51 2318.62 2594.86 988.13 1294.46 1198.40 1158.29 1548.79 1428.49 2353;53 2504.83 1866.98 1216.37 1126.20 1699.35 1945.23 1769.94 1446.72 1954.29 1141.43 1663.88 778.90 2235.58 1496.61 1374.70 898.03 1269.47 1922.96 1514.59 1170.23

2 68.09 3 763.00 2 192.00 2 146.06 2 3 2 2 3 3 3 2 3 3 2 3 2 2 2 365.81 406.03 492.83 509.72 501.77 627.04 348.35 631 .52 467.72 482.84 786.49 382.66 431.19 72.73 177.48

2 142.71 3 820.94 2 1487.96 214M9 2 195.94 1 714.62 2 307.30 2 24.45 2 120.23 3 1247.88 3 1120.69 3 1542. 16 3 753.52 2 3 2 2 3 1 3 2 3 3 2 2 3 3 2 2 3 2 2 2 2 3 3 648.64 243.41 139.25 239.70 963.82 1736.05 1014.79 206.09 627.80 482.07 219.14 833.32 550.42 315.38 130.92 440.17 220.63 191 .67 339.18 765.82 361.75 929.24 365.95

3 454.08 3 1171.45 2 1515.36 2 743.58 2 523.38 2 245.25 2 694.27 3 749.12 2 1299.18 3 2 2 3 2 240.99 143.65 361 .10 358.21 88.21

1.28 1101.05 1.62 1.09 0.98 6684.24 1.60 1.36 1.22 1.33 1.45 1.42 1.20 2. 38 1.11 1.78 1.33 1.59 1.32 0.84 1.00 3960.73 0.97 1.78 1.50 0.90 1.14 1.22 1.13 0.72 1.16 2368.57 2.17 1.29 2295.68 2.04 1.29 2234.82 1.50 1.16 0.80 0.87 1.53 5119.25 1.21 1.51 1.13 1.80 1.56 0.87 1.59 1849.20 1.32 2.19 0.78 1.56 1.36 0.82 2781.93 1.03 1.41 1.62 1.60 1.60 1625.53 1.27 1.65

0.0 40254124.0 0.1 0.0 0.1

41 371 163 44 18 212 282 164 316 320 179 140 260 409 220 456 240 149 74 90 79 461 316 39 19 118 259 34 104 526

3113 17144 5114 7/52 11/18 9/ 34

9055348.0
0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 34785644.0 0.1 0.0 0.3 0.1 0.1 0.2 0.0 0.0

7122
11/24 9/32 4/19 15/112 11/30 21/68 5116 5/8 19/100 4/15 1/7 3122 3/16 21/68 5111 3123 7/58 112 9/26 3/31 7/32

0.0
7513586.0 0.1 0.2 21313172.0 0.1 0.1 14547908.0 0.2 0.1 0.0 0.1 0.2

608
711 541

19/56 1/4
13/34 21/68

13
191 167 169 161 232 165 470 177 319 236 80 285 360 93 169 269 152 11 /32 3117 113

217
19/96 511 6 17152 91 28

13937369.0
0.4 0.1 0.0 0.1 0,1 0.1 0.2 5031569.0 0.1 0.1 0.0 0.0 0.0 0.0 22122615.0 0.1 0.2 0.1 0.1 0.0 9790141.0 0.1 0.1 6671672.0 0.2 33034311 .0 0.1 0.1 0.1 489821.0 0.2 0.0 627834.0 0.3 27503073.0 0.0 0.0 0.1 0.0

9/26
3120 4/23 317 1/2 7138 7116 11/30 7!34 3/8 10 1/2 11130 9/22 6/19 15188 11/32 17/44 5/9

234
287 314 165 507 241

237
603
423

1515.38
1.90 1512.21 1.65 1.61 1.03 1443.39 1.30 1.77 1299.18 1.40 1192.17 1.60 1.20 1.31 1.08 1.27 2101!.25 1.37 0.88 1.82 1319.87 2.00 4437.08 1.04 1.71 1.24 1.61 1.16 0.99 0.91 1.07 1.11

285
191 184 11

112
3/8 4/13 13142 19188 11/34 12 7118 112 7/26 15/68 9/32 1/3 1/4 2/3 1/3 12 112 1/4 5112 7/22 5/7 3/10 4/19 1/4 7116

144
413 149 149 110 103 331 70 414 98 507 611 171 297 340 182 251 34 123 220 192

0 .0
38080491.0 0.2 0.0 0.1 13386313.0 0.1 30578300.0 0.0 0.0 0.1 0.0

3 987.86 1 97.30 2 1024.09 3 1319.87 2 178.41 3 533.04 2 553:44 3 295,89 2 634.89 1 128.64 2 185.85 3236', 17 2 225.51

0.2
0.1 0.1 0.0 0.0

98

Table 2 continued

phagrawF60MeOH_dec23. 2372 rawsucrfp_800phagigg_Mar04, 826 phagrawFsuc450_ dec20. 1492

phagrawFsuc350_dec20, 1860 rawsucrfpJOOphagigg_Mar04, 2569 825819 actin, felll l skeleiaUadu lt c ardiac muscle. mouse (!rogrmml) j mfag5miniggbaad,943-945 jmfag5miniggbead, 949 jmfag5minigg350mmnacl .1 037-1039 jmfag5mimgg600mmnacl, 1054-1056 jmfag5minlgg600mmnacl , 1060-1062 JMFAGNACL10_2B21E3, 1062 JMFAGNACL10.2B21E3, 1074 jrnfag1mnacl0 mlnigg, 1078-1080 )mfag5minigg 150mmnacl , 1114·1116 jmtag5mlnigg150mmnacl, 1128 )mfag1mnacl2,5n11nigg, 1142 Jmfag5mlniggbead __030528200105, 1143 JMMAGNEGB16D3, 1146-1148 jmfag5minlggbead _0305282001 05, 114 7 JMFAGNACL5B21E3, 1150·1152 jmfag5miniggbead_030528200105, 1153 JMMAGTube1816E3, 1168 JMMAGTube1616E3, 1172 jmfag5minigg400mmnacl, 1188 jmfag5minigg1000mmnacl, 1244-1246 jmfag5minigg1 OOOmmnacl. 1250 jmfag5minigg200mmnacl, 1266-1268 JMFAGNACL10 1B21E3, 1282 jmfag1mnacl5mlr\lgg, 1308-1 31 0 jmfag1mnaol5m lncon, 1350-1352 jmfeg5mlnlgg500o'tlmnacl. 1496 jmfag5mln,gg250mmnacl, 1604 jmfag5minigg250mmnacl, 1610 jn1fag5mlnlgg450mmnacl_030527025134, 1756 jmag5mincon500mmnacl, 1804 jmag5minc6n500mmnocl, 1808 jmrmvigg5minbeadsyringdnase,897-89Q jmrawigg5min300mmnaclsyringednase,9_ 57e959 )mrawigg5min400mmnaclsd, 963 jmrawtgg5minbaadsfreezethaw, 1130 jmrawigg5min350mmnaclsyringednase, 1163 jmrawigg5min150mm nacl, 1172 jrnrawigg5mln350mm naclsyringednase, 1173 jmrawigg5min150mmnacl, 11 76 )mlgG150rawphag3007, 1526 jmlgG150rawphag3007, 1530 )mlgG300rawphag3007, 1552-1554 jmlgG250rawphag3007, 1556- 1558 jml gG350naclrawphag300 7, 1559-1561 jmrewnninigg200mmnaclsyringdnas, 1578-1580 AJRAWActinlgG_june13, 1682 jmr9weimlnigg250mmnaclsyringdnase, 1764 jm5minlggr~wlowionic, 1848 jmfreebeadsrawphag3007, 970 jmfreebeadsrawphag3007, 1032 j mir..'<ibeadsrawphag300 7, 1040 rawextr_aetlnbead_,Mar04, 1384 rawextr_200bea<I_Mar04, 1474 rawextr_150beadigg2_Mar04,624-626 rawextr_200beadigg __ Mar04, 1139 rawextr_200beadigg_MarQ4, 11 43 (QY~extr_actinbe~dlgg_Ma r04,_ 1159 rawextr_actinbeadigg_Mar04, 1163 rawextr _400beadlgg_Mar04, 1362·1364 jmrawigg5miniggfreebead, 2042 jmfagtimecon7.5mln.1720.1720.2 jmfagtimeco n2.5min.1248 .1250.3 jmbeods300rawphag3007, 1030-1032 jmfagcon5min10 OOmmnac 1_0 30601180404, 1032 jmbeads250 rawphag3007, 1036- 1038 jmfagcon5mln10 OOmm n~c 1_030601180404, 1038 jmfag5mlncont400_030531151834,1068·1070 jmfag5mincontt50mmnacl, 1095 jmfagcon5mirw>600mmnacl, 1327 jmfag5mincon450mmnacl, 1398 j mfag5mincon250mmnacl, 1550 jmfag5mincon450mmnocl, 1552 jmfag5mincon450mmnacl, 1556 jmfag5mincon250mmnacl, 1558 jmfag5mincon450mmnacl, 15tl0 jmbeads350rawphag30072nd, 1620 jmfagtilneconl0min_030001230741 , 1622·1624 jmbeads350rawphag30072nd, 1624 jmfagcont5minbead, 1632 jmfageont5minbead, 1640 jmfag5mincoli300mm nacl, 1746-17 48 jmfagtimecon10min,1834-1836 jmfagtimecant10min_030601202502, 1846 jmfagtlmeeont10min_03060 1202502, 1854 phagrawFsuc200_de<:22, 247 phagrawF200_dec22. 2631 alpha 1 actin precursor; alpha skeletal muscle actin (Homo sapi'-lllG) jmfag1mnacl0minigg, 732 jmfag5mimgg150mmnacl ,778· 780 jmlag5miniggbead_030528200·105, 837 jmfag5minigg1 000mrnnacl,894-896 jmfag5minigg200mmnacl, 928 jmfag1 mnaci5minigg, 952 jmfag5minigg450mmnaci_030527025134. 1350

· .LGTVEWIEPPKRER.· -.EEGAAAAATEGTTATEK GEK.· ·.SPTSPLNMKLAR.· -.EVEGKSPEEVMEYSAVFWER.· · .AAFIRDE MMPGEWDVCVTSYEMVIKEK.· -.YPIEHGIITNWDDM EK .· -.YPIEHGIITNWDDMEK.· ·.YPIEHGII TNWDDMEK.· -.YPIEHGIITNWDDMEK.· · .YPI EHGIITNWDDMEK.· -.YPIEHGIITNWDDMEK.· -.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·,YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· -.YPIEH GII TNWDDM EK.· - .YPIEHGI ITNWDDMEK. · -.YPIEHGIITNWDDMEK.· ·.YPIEI-iGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· · .YPIEHGIITNWODMEK.· - .YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK.· -.YPIEHGI!TNWDDMEK.· -.YPIEHGIITNWDDMEK.· ·.YPI EHGIITNWDDMEK.-.YPIEHGII TNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDM EK.· ·.YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK .-.YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK.· ·.YPI EH GIITNWDDMEK.· -.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· -.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWODMEK.· -.YPIEHGIITNWDDMEK.· · .YPIEH GIITNWDDMEK.· -.YPI EHGIITNWDDMEK.· -.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· .YPIEH GIITNWDDMEK.· -.YPIEHGIITNWDDMEK.·.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· - .YPIGHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·. YPIEHGIITNWDDMEK.· .YPIEHGIITNWDDMEK.· -.YPIEHGIITNWDDM EK.· -.YPI EHGIITNW DDMEK.· · .YPIEHGIITNWDDMEK.· ·.YPIEt!GIITNWDDMEK.· -.YPI EHGIITNWDDMEK.· · .YPIEHGtiTNWDDMEK.· -.YPIEHGI ITNWDDMEK- .YPIEHGIITNWDDMEK.' ·.YPIEHGI ITNW DDMEK.· -.FRCPETLFQPSFIGM ESAGIHETTYNSIMK.· - .YPIEHGI I'fNW DDMEK.·. YPIEHGIITNWDDMEK.· -.YPI EHGI.I TNWDDMEI\. · .YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·. YPIEHGIITNWDDMEK.· · .YPIEHGI ITN WDDMEK. -.YPIEHGJ ITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· -.VAPEEHPTlL TEAPLNPK.· -.YPIEHGIITNWDDMEK.· ·.YPIHtGIITNWDDMEK· - .YPIEHGIITNWDDMEK.· · .YPIEHGIITNWDDMEK. -.YPIEHGI ITNWDDMEK.·.YPIEHGIITNWDDMEK.· ·.YPIEHGIITNWDDMEK.· ·.YPIEHG. I ITNWDDMEK.· · .YPII:HGIITNWDDMEK.-.YPIEHGIITNWDDMEK.· -.YPIEHGIITNWDDM E"K.· ·.YPIEHGIITNW DOMEK.-.YPIEHGIITNWDDMEK.· ·.YPIEH GIITNWDOM EK.· ·.PRAVFPSIVGRPR.· -.LCYVALDFENEMAT AASSSSLEK.· -.QEYDEAGPSIVHR.· · .QEYDEAGPSIVHR.· - .QEYDEAGPSIVHR.· ·.QEYDEAGPSIVHR. · .QEYDEAGPSIVHR.· - .QEYDEAGPSIVHR.· .QEYDEAGPSIVHR.·

1710.96 1922.98 1315.57 2402.62 3179.70 1962.17 1962.17 1962.17 1982.17 1962.17 1962.17 1962.1 7 1962.1 7 1962. 17 1962. 17 1962. 17 1962.17 1962.17 1962.17 1962.17 1962.17 1962 .17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 " 1962.17 1962. 17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962. 17 1962. 17 1962.17 1962. 17 1962. 17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962. 17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 3436.93 1962.17 1962.17 1962.17 1962.17 1962.17 1962.17 1962 17 1962.17 1962.17 1957.22 1962.17 1962.17 1962 .17 1962.17 1962.17 1962.1 7 1962.17 1962.17 1962.17 1962.1 7 1962.17 1962 .17 1962.17 1962.1 7 1452.73 2480.75 1501.58 1501.58 150 1.58 1501.58 1501.58 1501 .58 1501.58

85.57 54.25 472.20 712.31 2 140.90 3 2 3 3 2 3 3 3 3 2 2 3 3 3 3 2 2 2 3 2 3 3 3 2 2 2 2 3 3 3 3 3 3 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 2 3 3 3 3 3 3 3 3 2 0 0 3 3 3 3 2 2 3 3 3 3 3 2 2 3 3 3 3 3 3 3 3 2 3 3 10029.44 5488.19 11 77 3.73 8115.00 10030.71 3007.84 2836.80 7747.41 10918.86 7245.02 12357.51 10977.74 2730.27 4730.39 10189.47 6949.96 7973.36 655ti.08 12166.31 10699.08 15327.59 2022.03 8460.62 10987.87 10558.34 5197.36 7744.79 6620.92 3070 .10 5605.85 9787.95 4647.28 1962.31 71 90.53 3083.59 2941.31 6413.94 7776.51 3689.10 7041 .73 8771.33 6475.44 6145.59 2197.39 2382.72 5263.06 439L90 9768.94 8008.57 3032.31 2504.30 4637.01 9320.18 8742.20 10126.04 10978.69 7446.91 8066.30 788.25 661 6.43 8350.07 9425.79 4628 .57 6010.45 1304.68 13444,85 2730.78 6321.00 1910.42 8051.07 4096.74 2859.03 6323.09 4950.69 3309.53 6754.34 9232.00 6018.36 5144.18 8183.97 6"303.28 2884.45 5504.71 291.47 807.99

2 2 2 3

0.89 0.83 1.33 1.51 0.89 560477.27 4.22 3.88 3.95 3. 70 3.93 2.02 2.61 3.72 4.70 3.58

4.49
3.58 2.82 2.86 3.49 2.89 3.14 3.69 3.95 3.42 3.60 4.25 1.84 3.44 4.42 3.47 3.11 3. 16

3 7230.19

0.0 85 0.0 63 0.0 349 0 .1 384 84 0.1 90263.0 0.4 1144 0.3 785 0.4 1538 0.3 1204 0.4 712 0.3 61 1 0.2 471 0 .3 1030 0.3 1237 0.3 836 0.4 854 0.4 1159 0.1 922 0.2 1341 0.4 1156 0.4 622 0.4 803 0.4 551 0.4 15tl8 0.3 1377 0.4 1279 0.5 1535 0.2 .· 523 0.4 1034

3/13 7/38 5/11 5119 2/13 13130 17/30 9/20 9/20 17/30 1/3 17/60 9120 9/20 8/15 3/5 7/15

7120
9120 2/5 8/15 17130 1/2 7115 13130 191 30 291 00 19/00 23100 8115 8/15 7/15 8115 13/30 11130 13/30 9/20 23100
1~100

0.4
0.5

825

0.3

2.82 1.98 2.61 3.56 2.83 2.18 3.43 2.67 2.28 2.88 3.75 2.91 .2.91 3.24 2.95 2.91 2.44

2.51
2.58 2.86 3.32 3.33 2.55 2.52 2.82 3.62 3.41 3.83 4.21 3.04 3.26 1.21

792 635 0.4 636 0.4 1080 0.3 778 0.3 1213 0.4 1378 0.3 997 0.2 586 0.4 763 0.2 81 5 0.2 930 0.4 809 0.31140 0.2 693 0.3 1721 0.3 2023 0.3 1095 0.3 1163 0.1 .· 803 0 ..1 171 0.3 893 0.1 1311 0.4 .1036 0.4 . 575 0.3 436 0.2 448 0.2 1333 0.3 1514 0.4 1121 0.4 863 0 .4 1298 0.4 1003 0 .4 1288

8115

7120
23/00 23/60 13130 11130 29/60 29/60 215 2/5 11130 23/60 23/60 5112 215 7/15 13130 3110 9120 7115 5112 215 9120 13/30 7/15

0..2

94

9/58
1/2 9/20 215 3/10

3.08
3.29 3.47

2.9$
3.34 2.62 4.29 2.49 2.98 1.77 3.53 3.02 2.45

3.34 2.79
2.16 3.41

3.40
3.20 2.86 3.95 2.98 2.8 1 3.0 5 1.08 1.90

0.4 648 0.3 . 1486 0.4 898 0.3 481 0.3 841 0.0 498 0.5 1060 0.3 ·. 347 0.3 925 0.3 412 0.3 1202 0.2 974 0.2 6 15 0.4 630 0.3 593 0.3 631 0.3 817 0.4 890

23/60
19160

3/5 13/30
215 19/68 215 23100

7120
112 7115 19100

7120
5i12

0.2

~28 1

13/30

0.3 792 0.3 954 0.3 1461 0.2 552 0.3 631 0.0 269 0.1 367

11 130 215
13130 1/3 1/2 1/4 1/4

5700.05

45013a1.0
0.1 0.0 0.1 0.2 0.1 0.1 0.1 270 319 415 320 291 340 401

2 553.00
2 2 2 2 2 2 55i.57 764.23 981.11 781.86 571 .5tl 933.75

1.72 1.68 1.46 1.72 1.64 1.47 1.65

318
5/12 11124 5112 318 318 11/24

99

Table 2 continued

j mag5m incon500m mnacl, 1390 $im ilar to actin, gamma, cytop lao.mic (Mus musculus] Jmfag1mnael2.5minigg, 148 jmfag1mnacl7,5minigg, 1832 rawextr _ 300beadigg_Mar4, 924

-.QEYDEAGPSIVHR. · -.AGFAGDDAPR.· .HQDVMVGMGQ KDSYVGDK.· .GYSFTTTAKR.-.VLTDYLMI<ILTER. ·.AGFAGDDAPR.-.AGFAGDOAPR.·.AGFAGDDAPR.·.AGFAGDDAPR.·.AGFAGDDAPR.-.AGFAGDDAPR.·.GYSFTTTAKR.-.KDL Y ANTVLSGGT TMYPGLADR.·.KDLY ANTVLSGGT TMYPGLADR.· .KDL Y ANTVLSGGT TMYPGLADR.· .KDL Y ANTVLSGGT TMYPGLADR.·.KDLY ANTVLSGGT TMYPGLADR.·.KDLY ANT VLSGGT TMYPGLADR.· ·.KDL YANT VLSGGT TMYPC-LADR.· -.KDL YANTVLSGGT TMYPGLADR.·.KDLY ANTVLSGGT TMYPGLADR.·.KDLY ANTVLSGGT TMYPGLADR.· -.CDVDIRKDL Y ANTVLSGGT TMYPGLADR. · -.VILSIERQK.·.NLHSILSSA TYVSOR.-.WNLLLDTLLHSGGLIPRILLKSSK.-. WNLLLDT LLHS GGLIPRILLKSSK.-.GAVHALVSP ECSQ KERR .-.LQNVQIALDFLKQR .· -.RWTDLLSK.· -.LETVALPLQGLEDLAADRMNR.·. IHQQHRHKALNEEIINR.-.EALAGLLK.· -.WDTVCGK.·.DODGKIT RQEFIDG ILASK.· .PSSRAASPTR.· .ALERHQGGASR.·.IAEOEHTQ EDLQHLR.·.ALERHQGGASR. - .ALERHQGGASR.·.LAELSQRFQQLQ LQOQEKESNLK.· .FQNLSCSLDER.-.ELEEAVT SALQQET EK.·.VDEIDAAIQRSQQYEQAADAELA WVAETKR.· .NLNAIVQK.· .NLNAIVQK.· -.LDRLEETVOAK.· ·.NLNAIVQK.-.YFEI TSEAPFLHYLSMFSSK.-.KCEPIVMTVPRK.· .DLKVSRR.-.RCSLIKW HPLASNVI LSCG VDLK.-.PHEGARPLRAVFTADG K.-.PVHAVFVSEGKIL TTGFSR. -.MQEITIIAPPERK.·.VAPEEHLVLLT KVPL SPK.-.ASGRGLQPK.· -.ASGRGLQPI\.· -.ASGRGLQPK.·.FNGSHWGSPFKVR.-.VIVLFAGQHISKSPFEVNVDK.·.VHAQGPGLK· ·.CLATG PGIAPTVKT GEEVGFVVDAKTAGK.·.ASGRGLQPK.-.ETADFKVDT KAAGSGELGVT VK.· ·.FADEHVPGSPFTVKISGEG R.· -. YSVAVTWGGHHIPKSPFEVQVGPEAGMQK.·.VKVFGPGVERSGLK.-.ANEPTHFT VDCT EAGEGDVSVGIKCDAR.· .EAFTNKSNVFT WTRG AGIGGLG ITVEGPSESK.·.VMYTPMAPGNYLIGVKYGGPNHISRSPFK.-.RCSQVKLGSAADFLLDISETD LSTLT ASIK.· -.HLWDYTFGPEK.· -.RKHMVFLGGAVLADIMK.· .HLWDYTFGPEK.· .RLDIAGRDIT R.· .DLMVGDEASELR.·.MSDQOLDCALDLM R. ·.MSDQOLDCALDLMR.- .SPWSNKYDPPL EDGAMPSAR.·.AVFPSIVGRPR.·.AVFPSIVGRPR.-.AVFPSIVGRPR.· .AVFPSIVGRPR.-.AVFPSIVGRPR. -

1501.58 977.01 1995.23 1132.25 1595.93 977.01 977.01

2 564.99

2 8847.26
1 92.08

2 2311 .12
3 302.92 2 2198.65 2 2945.27 2 2056,46 2 1547.29 2 3211.06 2 6702.89 2 231 1.12 3 3 3 3 3 6610.63 539.76 6303.52 0084.02 14322.25

1.53 32326.12 2.96 0.98 2.16

0.0

370

11/24

33089775.0
0.4 1432 0.0 89 0.2 584 0.0 176 0.2 878 0.2 968 0.3 582 0.1 792 0.3 939 0.3 1092 0.2 584

8/9
7/34 213 5/16

jmfagSm incont350, 434 jmfagtimecont0min_030601230741 , 918 jmfagtim econtOm in_030601230741, 924 jmfagtim econ10tn in, 992 jmfagtim econt10m ln__030601202502, 1008 jmfagtim econt10m in_030601202502, 1012 rawsuerfp _60MeOHphagigg __MAr04,361-383 rawextr_300bsadigg_Mar4, 924 actin-like [Mus musculus] jmfag5m i n1gg~ead, 1009 jmfag5minigg350m mnacl, 1103 jmfag1m nac l2,5minigg, 1204-1206 jmfag5m lnlggbead_0305282001 05, 1209-1211 JMMAGT ubs1 B16E3,1228-1230 JMMAGTube1B16E3, 1238-1240 jmfag1mnael5mlncon, 1418-1420 j mfag5minlgg450m mnaei_030527025134, 1872 jmfag5minigg450m mnaci_030527025134, 1878 jmag5inincon500m mnacl, 1886 )mfag1mnac17,5mimgg, 2514 s imilar to KIAA0825 protein [Mu· m usculus) acti n jmfag1mnacl5mincon, 1430 JMFAGNACL5B21E3, 1490 jmfag5minigg200m nmacl, 1826 jmfag1mnacl5minigg, 1900 jmfag5m~nigg500m mnacl, 1994
miCrotubule-ec:tln Cro3sUnkin g factor 1 [Mus musculus] jmfag5m inigg350m mnacl, 473

1.72
1.65 2.17

m

977.01
977. 01 977.01 977.0 1 1132.25 2344.63 2344.63 2344.63 2344. 63 2344.63 2344.63 2344.63 2344.63 2344.63 2344.63 3046.43 1086.31 1676.86 2689.24 2689.24 1868.11 1686.98 1019.18 2326.66

1.63 1.62
1.84 2.97 2.16 102395.17

719 213 2!3 2/3

8/9
2/3 23/34 3114

2.77
1.87
3.1 9

8850200.0 0.4
0.0

2.69
3.86

0.4 0.4 0.5
0.7 0.4 0.3 0.4

2 37139.96
3 4855.45 3 4642.09 3 6470.44 3 15301.57 2 225.49 2 304.07

5.37
2.76 2.56 2.92

4.26
1.03

0.5
0.1

445 287 470 478 910 2347 501 755 774 590 96

217
5121 9/28 9/14 23184 13142

9/28
25/84 5/27

11085.52

38075392.0
0.1 0.1 0.5 0.2 0.0 140

13 363
429 314 9/16 19/56

3 737.88 3 8238.55
3 1524.88 3 260.14

jmfag5m lriigg350m mnacl, 491 jmfag1mnacl0minigg, 498 jmfag5m inigg600m mnacl, 672 JMMAGNEG B1603, 842 jmfag5m lnigg250m mnacL 900 jmfag5moniggbead, 1021 JMMAGTube1816E3, 1370 jmfag1mnael0mlnigg, 1386 jmfag5m iniggbead_0305282001 05. 1431 JMFAGNACL5B21E3. 1442-1444 JMMAGT uba1816E3, 1464 jmfag5minigg1000m mnacl, 2028 j mf2gSm inigg400m mnacl, 2284 jmag5mincon500m mnacl, 2374 j mfag1 m nael7,5minigg, 2768 Coronin, actin binding protein 1A [ Mus m usculus]] JMFAG NACL5B21 E3, 164 jmfag1mnacl2,5minigg, 186 JMFAGNAC L582 1E3, 422 jmfagtimecont10min_030601202502, 1076 coronin, &etln bin ding prot&ln 1A; coroni,....llke actin binding protein; jmfag!imecont10m in~03060 1 202502 , 2948 coronln, actin bindbl9 protein1B; coionin ib; coronln 2 [Mus muscuk.w] j mMads300rawphag3007, 151 jmfag5mlneont350, 764
coronln ·(Hemlce:ntrotus tMJicherrimu&] ing proten 1 jmfag!im econ2.5m in.1962,1962.3 coronin, actin··bin ding protein 6 leoform A; coronin 6; cllpin E [Mus m jmfagtimecont10m in_030601202502. 2072 p57 coronln (Mus musculus) s) jmbeads250rawphag3Q07, 906 similar to actin, ~m ma, Cytoplasmic: (Mus musculus] rawaxtr_250beadigg_Mar04, 1180 FPbeado 1coQ Dec19, 1219 FLNI3_M OUSE Fllam In B (FLN-B) (Beta-fllamln) (Actln,bin!'ling like protein) (ABP j mfag5m lnigg200m mnacl, 432 jmfag1m nac 15m inoon,432-434 jmfag5minigg1000m mnacl, 436 jmfag5minigg600m mnacl, 006 JMFAGNACL 10_2821E3, 696 jmfag5minigg250m mnacl, 702 jmfag5minigg350m mnacl, 909 jmfag5minigg250m mnacl, 960 jmfag1m nocl2,5minigg, 1250-1252 jmfag5m lniggbead, 1369 jmfag 1mnacl0minigg, 1726 jmfag1mnael7,5mimgg, 1732 jmmg5mlnigg300m mnael,2040-2042 jmfag5minigg150m mnacl, 2108 jmfag5m inigg400m mnacl, 2744 jmfag5minigg400mmnacl, 3064 octln-related protein 2; ARP2 (actin-related protein 2, yeaut) homolog jmfag5m inigg350m mnacl. 355 jmfag1mnael0minigg, 874 jmfag1mnael7,5minigg, 1158 jmfag5mlnlgg500m mnacl, 1492 jmfag5m inigg250m mnacl, 1560 CAPB_MOUSE F-actin c&pping protein beill5u b<mlt (CopZ beto) JMFAGNACL5821E3, 006 jmfag1 mnael2.5m inigg, 670 JMFAGNACL5B21 E3, 1014 553793 actin -mouse (fragments) A14; EST AI449046 [M us muse JMFAGNACL 10 282 1E3, 678 JMFAGNACL 10=1821E3. 836 j mfag5mlnigg500m mnacl, 1098 jmfagtimecon7.5mtn.1230.1232.3 AJRAWSolute.Contrjune1 3, 572

2226.57 814.99
808.93 2135.36 1030.12 1182.28 1847.97 1182.28 11 82. 28 27881 1 1312.44 1605.92 3406.68 900.06 900.06 1302.46 900.06 2398.72 1401 .77 874.02 2554.08 1823.05 2046.36 1526.83 1971.37 914.05 914.05 914.05 1531.74 2328.70 907.05 2818.24 9 '14.05

3 927. 78 2 188.43 3 1030.50 3 668.27 2 081.34 2 233.36 3 455.11 2 233.62 2 509.16 2 197.06 2 1607.35 2 .1074.76 3 617.90 2 329,04 2 94.47 2 468.82
2 3115.91 2 3090.69

1.01 1.73 3.16 2.08 1.16 9636.96 1.63

25192
11/41l 15i64

225

25021541l.O

o. 1

71
390 195 4/13

0.95
1.55 1.84 1.95 0.95 1.25 0.87 1.20 1.19 1.61 1.72 1.68 1.24 1.01 0.89 10210.14 2.24 2.21 2.79 2.06 6077.20 2.99 12011.04 1.60 1.23

0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.2 0.0

3/7
9/40 9134 11114 7/ 12

324 357 494 238 276 241 169 137 247

5124
1/2

9/20
114 11/20 315 19/88 3110 4/15 9/58

335
350 165 89 70

0.1
0.0

0.2
31418362.0 0. 3 0.3 0.2 0. 1

10
494 414 617 525 11114 517 19140 11/14 11138 4111 7112

3 2674.63
2 1328.90 36077.20

6753492.0
0.4

488
41 9

6753494.0
0.0 0.1 11463876.0 0.1 41281697,0 0.1 3642629.0 0.0

3 677.97
2 528.08 0 680.53

348
339 127 305

680.53
1.65

9144
114 17172

509.32 2 509.32
3 457.26 2 580.62 3 452.81 1.45

457.26
1.42 1033.44 1.61 1.35

30090438.0
0.1

6656.56

0.1 33257404.0
0.1 0.1 0.2 0 .0 0. 0 0.1

326 306

11/24
19168

31
450 302

2 640.01

2 503.63
2 1473.04
3 672.57

1.19 1.42

5/8 5/8
11/16 15152

1.79
1.72 1.46 0.85 0.96 1.76

534
373 168 229 43 627 657

3 276.17 2 369.51 2 164.41
2 11 50.10 3 1789.23

17180
7/16 1/S 3/4 25184 5119 1/7 1/4 191108 9/84 3128 11/58 17/40 11/32

0.1
0. 1

2224.45
2'131.33

2.61
1.07 1.05 1.08 1.79 0.95 0.79 0.75

3138.55
1473.75 2\)23.14 3324.69 3196.74 3184.61 1393.53 1887.35 1393.53 1286.47 1335.47 1639.90 1639.90 2219.42 1199.43 1199.43 1199.43 1199.43

3 477.69 2 328.67
3 215.65 3 351 .21

o.o
0.2 0.0

0.1

448

76
196 191

2 9i.88
2 42.70 2 104.10 3 2552.49 3 4293.32 2 740.95 2 97.61 2 401.41 3 289.06 3 430.93 3 6007.66

0.0 0.1
0.0

o.o
5031571.0

77 34 138 677
644 383

8085.78
2.14 2.36 1.32 0.91 1.09 6727.65 1.28 1.56 2.76 27264.26 1.85 1.78 1.25 1.25 1.49

0.2
0.3 0.1 0.0 0.1 1345668.0 0.0 0.0 0.4 1363149.0 0.4 0.2 0.1 0.1 0.1

3!5
3/10 5111 1/4 4113 13138 3/5 1/2 1S/40 3110 3/5

107
288 213

271
829 431 359 150 149 536

2 3626.53
2 3 0 2 1206.91 407.52 220.49 867.94

1199.43

100

Tab]e 2 continued

r,JRAWSoluteContr_june13, 580 jmfagtimecont10min_030601202502, 1372-1374 rawphag2007chfbead3, 615 rawsucrfp_60MaOHphagigg_MAr04, 746 rawsucrfp_60Me0Hphagigg _MAr04, 750 rawsucrfp_60Me0Hphagigg_MAr04, 754 rawsucrfp_300phagigg_Mar04, 822 rawsucrfp __900phagogg_Mar04, 835 rawsucr(p_600phagigg_Mar04, 958 rawsucrfp_700phagigg_Manl4, 980 actin related protein 213 complex subunit 4; Arp213 protein complex sub JMMAGNEGB16D3, '1168 JMMAGTube1816E3, 1198 JMMAGNEGB1 6D3, 1738·1740 similar to actin relsted protein 2/3 complex, subunit 5; tactln related rawsucrfp_450phagigg_Mar04, 1364 cytoGkcletal actin·modulaiing protein [Mus muse ulus) jmfa~1mnacl5minigg, 262 JMMAGNEGB16D3. 660 JMFAGNACL 1<i_1B21E3, 774 JMFAGNACL 15821 E3,806·808 jmag5mincon500mmnacl , 908 JMMAGTubs1B16E3, 1460 JMFAGNACL10_1621E3, 1638 rawextr_400bead_Martl4,761-763 rawextr_900bead_Martl4,780-782 rawextr_150bead_Martl4, 1551 rawextr_300bead_ Martl4, 1820

· .AVFPSIVGRPR.· ·.AVFPSIVGRPR.· ·.PRVAPEEHPVSYIOLP.· · .AVFPSIVGRPR.· ·.AVFPSIVGRPR.· ·.AVFPSIVGRPR.· · .AVFPSIVGRPR.· · .AVFPSIVGRPR.· ·.AVFPSIVGRPR.· · .AVFPSIVGRPR.· - .ELLLQPVTISR.· ·.ELLLQPVTISR.· ·.EISEMK.· ·.VLISFKANDIEKAVQSLDK..· ·.NQEESIDAR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· - .TDQMKADLTALFLPR.· · .LFRCSNEK.· ·.PKVELMPGMRLLQSLLDTR.· ·.ACSAIHAVNLR.· - .ACSAIHAVNLR.· ·.VGLGLGYLELPQINYKLSVEHKK.· -. GGYFPENVKAMTSLR.· · .LYKVGL GLGYLELPQINYI<LSVEHK.· · .ACSAI HAVNLR.· · .ACSAIHAVNLR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· · .KNIKLEPVPLK.· -.AFTRCFHAWSTFR.·.ACSAIHAVNLR.· -.FKNWDDVL TVDYTR.· ·.ACSAIHAVNLR.· ·.NQL TSLPSAICK.· .CSN EKGYFAVTEK.· ·.ACSAIHAVNlR.· ·.ACSAIHAVNLR.· · .PYDDDAEYMK.· ·.QLPAMMALQTLHLR.· -.NTQRTQSNLPTSLEGLSNLSDVDLSCNDLTR.· ·.QLPAMMALQTLHLR.· ·.ACSAIHAVNLR.' -.ACSAIHAVNLR.· ·.AC$ AIHAVNLR.· -.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· -.TDQM KADL TALFLPR.· · .ACSAIHAVNLR· · .ACSAI HAVNLR.· · .ACSAIHAVNLR.· ·.ACSAIHAVNLR.· ·.ACSAIHAVNLR.· · .ACSAIHAVNLR. · ·.LAGASPATVA-AJ>.AAVGSGSK.·.ACSAIHAVNLR.· ·.IWHHTFYNELR.· ·.IWHHTFYNELR.· -.IWHHTFYNELR.· ·.IWHHTFYNELR.· -.IWHHTFYNELR.· ·.IWHHTFYNEL R.· -.IWHHTFYNELR· · IWHHTFYNELR.· ·.IWHHTFYNEL R.· · .IWHHTFYNELR.· -.IWHHTFYNELR.· ·.IWHHTFYNELR.· · .IWHHTFYNELR.· ·.MXKEIAALAPSTMKIK.· ·.ALESDGGCGSDGLLHGDEAQSKRGIPTLK.· ·.AELINIHHLMVELKKHK.· ·.LMKVOYEEVAEK.· · AELINIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK.· · .AEL.I NiHHLMVELKKHK.· ·.AELlNIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK.· · .AELiNIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK.· · .AELINIHHLMVELKKHK.· · .AELINIHHLMVELKKHK.· · .AELINIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK· · .AELINIHHLMVELKKHK .· · .AELINIHHLMVELKKHK..· ·.VLSQPQLRALPAR.· · .AELINIHHLMVELKKHK.· ·.AEL INIHHLMVELKKHK.· ·.DEYVETLSK.·.AELINIHHLMVELKKHK.·

1199.43 1199.43 1720.91 1199.43 1199.43 1199.43 1199.43 1100.43 1199.43 1199.43 1269.52 1269.52 736.86 2119.45 1062.07 1155.36 1155.36 1155.36 1721.02 997.15 219&.6& 1155.J6

3 2 3 3 2

2
2 2 2 2

170.07 4839.96 328.55 1626.74 3036.57 5686.91 1097.82 1277.29 2321.00 549.98

2 2742.43 2 1744.83 1 188.08 3 1185.88 2 425.91 2 535.37 2 763.70 2 989 .81'i 3 275.08 1 944.02 3 500.23

2 766.42
2 3 2 3 2 2 2 1216 .19 128.14 560.56 791.32 1108.66 1096.15 495.78 746.25 612.76 1390.79 97.37 320.61 1262 .07 1173.53 416.82 180.70 259.64 1384.77 531.03 281.41 930.92 58.55 232.75 752.29 872.54

1155.36
2600.05 1670.92 2876.38 1155.36 1155.36 1155 .36 1155.36 1155,36 1155.36 1279.60 1630.86 1155,36 1772.94 1155.36 1275.50 1476.64 1155.36 1155.36 1247.31 1624.01 3393.64 1624.01 1155.36 1155.36 1155.36 1155.36 1155.36 1721.02 1155.36 1155.36 1155.36 11 55.36 1155.36 1155.36 1657.85

1.32 2.48 1.37 1.55 2.12 2.62 1.39 1.51 1.81 1.05 4675.33 2.11 1.47 1.26 1185.88 1.49 30920.50 1.12 1.76 1.57 1.65 1.34 1.47 1.29 1.74 2.19

rawoxtr_450bead_Mar04, 1950 rowextr _ 500beadigg_Mar04. 782-784 rawextr_,1000 _beadigg_Mar04, 796 rawextr_900beadigg_Mar04,804·806 rowextr_900beadigg_Mar04. 824 rawextr_450beadigg_Mar04,874·8 76 raw<>xtr_250beadigg_Mar04, 892 FPbeads150.:_Dee19, 975 rawextr_60Me01ibeadlgg~M·r04. 982 jmfagtimecon7.5min.716.716.2 jmlagthnecon7.5mn1.3158.3158.2 jmfagcon5minn600mmnsel, 717 AJRAWActinContr_june13 , 732 jmlagcon5min1000mmnac 1_030601180404, 792 jmbeads500rawphag3007, 814 jmbeads500rawphag3007, 828 jmlog5mincon450mmnacl, S98 jmbeads150rawphag3007, 1968 jmfagtimecon10mln, 3080 rawphag2007chfbood2, 304 rawphag2007chfbead2. 528 RawPhg2007Etsolutiondigest, 605 rawphag2007chlfsol1, 1138 rawphag2007chfbead1, 1176 rawph·g2007chlfsol2, 1286·128 8 phograwFsuc150_dec22, 48 phagrawFAetin_!lec23, 814 rawsucrfp_300phagigg _ _ Mar04, 816 rawsucrfp_150phagigg_Mar04.935-937 rawsucrfp_450phagigg_M2r04,946-948 raw-oucrfp_700phag igg_Mar04, 966 raw-.ucrfp _700phagigg_Mar04, 968 rawsucrfp_800phagigg_Mar04, 974 rawsucr(p_400phagigg_Mar04, 985
similar to be tl!l s·ctin [Mus musculus·) usculus] X&

2
2 2 1 2 0 0 2

2
2 2 2 2 2 2 2 2 2

1.45 1.27 1.99 1.91 1.82 1.42 1.45 1.53 1.74 0.88 1.32 1.77 1.36 1.46 1.08 1.27 1.79 1.59 1.15 1.61 0.84 1.01 1.86

0.0 0.3 0.0 0.3 0.3 0 .4 0.2 0.2 0.3 0.2 5031595.0 0.3 0.2 0.0 38049444.0 0 .2 17222137,0 0.0 0,0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.2 0.2 0.0 0.1 0.0

113

768
230 202 512 670 335 312 358

114 13/20 1/4 13/40 13/20 7/10

1/2
1/2 1/2 1/2 7110

226
526 760 149 465

13/20
3/5 1/4

20
362 287 269 800 195 582 309 440 329 518 1/2 912.0 13/20 1/4 9/14 17,72

3/5
1/2 2/11 217 17/96 11/20

83
104 258 335 238 348 434

9!20
11/20

315
315 11120

398
390 110 218 343 261 203 167 203 449 252 236 178 60

Q:2
0:0 0.0 0,2

7120
318 11120 9/26 9/20

0.2
0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0,1 0.0 0:0 0,0 0.1 0.0 0.1 0.3 38085870.0 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.2 0.3 0.2 0.4 0.4 0.2 0.0 0.0

7122
113 315 9/20

419
4113

7160
9/26 11/20 13120 112 315 13120 13158 3/5 9120 11120 11/20 11120 9/20 9/38 11/20

218
322 543

1:5·7
1.66 1.83 2.11 1.13 1.48 1.47 1.73 1.71 1.71 1.32 0.99 1.88

2 2 2 3

2
2 2 2 2 1

2
2 3 3 3 3 3 0 0 0 3 3 3 3 2 2

1155.3&
151 6.69 1516.69 1516.69 1516.69 1516.69 1516.69 1516,69 15'16.69 1516.69 1516.69 1516.69 1516.69 1516 .69 1746.22 2913.17 2054.49 1467.71 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49

662,86 979.88 1384A9 142.05 803.71 350.09 619.46 655.06 696,20 278,30 236.16 2040.02
7343.21 10871.40 7194.25 8261.02 10458.41 7198.13 8065.55 4403.97 1640.96 7961.70 4822.87 1704.35 394.02 75.16

279
399 446 126 473 234 358 378 363 211 138 356 1525 1090 . 627 1048 1140 995 932 979 728 433 1283 840 633 212 74

6514&.65
3.48 3.53 3.15 3.02 2.97 2.84 3.34 3.00 2.43 2.15 3.10 2. 17 1.67 1.74 1.01 493B4.57 1.63 1.26 1.77 2.35 1.86 2.22 1.45 2.27 1.52 1.50 1.82 2.07 1.55 1.33 1.39 1.74 1.46 1..24 1.50 1.15 1.58

jmfag5mlnigg350mmnacl ,569-571 jmfao)5minlgg600mmnacl ,586-588 JMFAGNACL5621 E3, 624

5/f!
23i40 19140 3/5

jmfag5mm!gg400mmnacl; 694
jmfag5minlgg400mmnacl, 704
jmfagtlm~co n2 .5 min.724724.3

315
11120 11120 21i40 112 7120 3/5 21/40 9120 3/10

jmfagtimacon7.5mln.947.949.3 jmf3gtimecon7.5min.852.854.3 jmlagtimecon2.5min. 738.738,3 jmfag5mincont150mmnacl, 611 jmfagc.>n5mim600mmnacl, 791 jmfsgcon5minn600mmnacl, 795 jmfagtimacont0min.,030601230741, 1084 jmfagcon5minn600mmnacl, 1947-1949 jmfsgcon5minn600mmnac I, 2643 SAC2 (sup<esoor of actin mutatl.,. 2, homolog)-llke [Mus musculus) jmfag5mil'ligg350onmnacl ,495-497 jmfsg5minigg600mmnacl, 502 JMFAGNACL5B21 E3,504·506 jmfag5minigg600mmnacl ,506·508 JMFAGNACL 10_2621 E3, 508

0 4753.65

5128 24
19164 4/11 17164 21/64 19/64 5!16 5116 11132 9132 15/64 19/64 19164 11132 7132 17164 19164 17/48 21164 17164 3/8 5!16

28499084.0
0.2 0.1 0.1 0.1 0.3 351 427 237 361 250 321 336 258 222 396 323 471 177 240 313 489 429 216 119 449

3 980.45
3 717.24 3 801.19 3 1116.61 3 2227.18 3 1682.43 3 438.89 33980.17 3 556.65 3 352.41 3 1195.38 32216.74 3 882 .32 3 278.21 3 364.46 3 1387.26 3 695.11 3 565.15 3517.04 2 137.32 3 770.32

jmrswigg5minbeadsfreezethaw,512-514 jmrawigg5mh1150mmnacl, 514 jmfag5minlgg150mmnacl ,518-520 jmlag1mnacl2,5mlnigg,554·556 jmfag1mnacl7,5minigg,558-560 jmfag5minigg400mmnacr, 576 jmfag5min igg400mmllacl , 580 jmfag5minigg200mmnacl, 606 jmfag5minigg1000mmnacl, 606 jmfsg5minigg1000mmnacl, 610 JMFAGNACL 15B21E3, 628 jmfag5minigg600mmnacl, 770 jmfag5minigg500mmnacl, 972 jmfag5mlnigg500mmnacl, 978 jmfag1mnacl5minigg, 1036 jmlgG400rawphag3007, 1040

0.2
0.0 0.1 0:0 0.2 0.3 0.1 0.1 0.0 0.2 0,0 0. 1 0.1 0.0 0.1

0.4 498

2054.49
2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 1449.73 2054.49 2054.49 1084.16 2054.49

101

Table 2 continued

jmlgG350naelrawphag3007, 1041-1043 jmfag5minigg300m mnael, 1178-1180 jm5miniggrawlowion_ ic,1228·1230 jmfagfrench20mlnigg1mnacldtt, 1524 jrnraVI:Iigg5m in1m nacl, 2015 jmfag5minlgg150mmnacl, 2698 Jmfag5minigg150m mnacl, 2912 JMMAGTube1616E3, 264 jmfag5miniggbead ,441-443 JMMAGNEGB16D3, 484 JMMAGTuba1616E3, 502 JMMAGTuba1616E3, 506 jmfag5miniggbaad_030528200105, 603 jmfag1mnacl5mincon,632-634 jmag5mincon500mmnacl, 1200-1202 jmfagtimecon2,5m in.604.606. 3 jmfagtimecon7.5m in.436.436. 3 jmfagcon5m inn600mmnacl, 425 jmfag5mincont400 _030531151834, 466 Jtnbaads400rawphag3007, 468 jmbeads400rawphag300 7, 476 jmfag5mincoot150mmnacl,495-497 jmfag5mincont350 ,538-540 jmfag5m incont200 mmnacl ,620-62 2 jmfag5mincon450mmnacl, 916 jmfag5mincoo250mmnacl, 996-998 jmfagtimecontOm in_0306012 30741.1056-1058 jmbaads350rawphag300 72nd, 1128 -1130 jmfag5mincon300mmnacl, 1164-1166 jmfagtimecont10m in_030001 202502,1224-1226 phagrawF350_dee20, 1018 phag<awFsue600_dec20 , 1574 phagrawFs<Jc150_dec22, 1610 nex:ilin; ·nF. actin binding protein [Mus musculus] rawextr 600baad MarO 4, 696 rawextr)OObead=MarO 4, 1234 rawextr_200bead_Mal{)4.1396·1398 FPbeads150_Dec19, 697 rawextr_400beadigg_Mar04, 123C rawextr_350beadigg2_Manl4, 1818 jmfag5mincont350, 448 jmfag5mincont200mmnacl , 1154 jmt»..ads300rawphag3007, 181 2 jmfag5mincont200mmnacl, 1940 phagrawF150_dee22. 516 phagrowF ~;Uc600.~dec20 , 1716 phagrawF800_Dec23, 2240 phagrawFSOO_Dec23 , 2244 fa~inhomolog 2, :~ctin-bundltng protein, retinol (Strongylocentrotuo '""'"xtr 60Me0Hbea d Mal{)4, 506 rawextr)00bead_Mar04, 1125 raw~xtr 600bead MarO 4, 2086 rawex!r=450beadigg_Manl4, 610 BRG1/brm-assoclaled factor 53A; aclin-llko 6 [Mus musculus] rawextr_150beadigg2_M3r04, 550 kaptin; actinoobindlng protein (Mus n1usculus] jmfag5mincon300mmnacl, 268 ~ctin, gemma 2·propsptido; actin, alpha.. 3 [Homo sepiem] AJRA.W ActinContrjune13, 696 simllartoactln-12[Mus musculus]) phagrawFsucchlfbead_dec23, 1020-102 2 rawphag2007chfbead2. 1418 phagr·wFouc60MeOH_dec23, 1808 RawPhag2007E;t Beadsdigest_030 718152 503, 2454 Anxs5 protein (M\Js museu Ius] d domain protein 1 [M jmfag 1mnocl5mincon, 116 jmfag1mnacl0minigg, .248 jmfag1mnac10minlgg, 260 jmfag1mnaol5minlgg, 264 jmfag 1mnaciSmincon,- 270 jmfag1mnacl5minigg. 270 jmfag1mnacl5mincon, 284 jmfag1 m nael2, 5m inigg, 376-378 jmfag1mnocl7,5minigg, 384 jmfag1mnacl7,5minigg, 542 jmfag1mnacl2,5minigg,546-548 jmlag1mnacl7,5mirJgg, 548 jmfag5minigg400m mnacl,564-566 jmfag1ml1®15mincon, 596 jmfag5minigg200m mneol, 614 jmfag1mnacl5mlnigg, 618 jmfag1mnacl5minigg, 622 jmfag1mn..1CI0minigg. 724 jmfag1mnacl0minigg, 728 jmfag 1mnaciOminigg, 778-780 jmfag5minigg600m mnacl, 792 j!11fag1mnacl2,5minigg,848-850 jmfag1mnscl5minigg, 934 jmfag1mnac15minigg,992-994 jmfag1mnacl5m!llcon, 1016 jmfag1mnacl0minigg,1016-1018 jmfag1mnacl5mincon, 1020 jmfag1mnac!Omlni99, 1066-1066 jmlag1mnael2,5m inigg, 1072-1074 jnifag1mnacl7,5minigg, 1086-1088 jmfag5mtniggbead _03052820010 5, 1087 jmfag5minigg500m mnacl, 1124 jmfag1mnacl 2,5minigg, 1124-1 126 jmfag1mnacl7,5minigg, 1154 jmfag5mfnigg1000mmnact, 1160

·.AELINIHHLMVELKKHK.· .AE.LI NIHHLMVELKKHK.· ·.AELI NIHHLMVELKKHK.· -.YAEFSSALVSI NQTIPNER.·.RYAEFSSALVSI NQTI PNER.· · .GKLGELVDGLW PSALIITAI LEAP\IT EPR.· -.HLESYL ADCYDAIAVFLCIHIYLRFR.·.LGGLDTR.· ·.AELINIHHLMVELKKHK.·.AELINIHHLMVELKKHK. · -.AEUNIHHLMVELKKHK. · ·.AELINIHHLMVELKKHK. -.AELINIHHLMVELKKHK.·.AELINIHHLMVELI\KHK. ·.AELI NIHHLMVELKKHK.· -.AELINIHHLMVELKKHK.·.AELINIHHLMVELKKHK.·.AELINIHHLMVELKKHK. ·.AELINIHHLMVElKKHK.· · .AELINIHHlMVELKKHK· ,AELINIHHLMVELKKHK.· ·.AELINIHHLMVELKKHK·.AELI NIHHLMVELKKHK.·.AELINIHHLMVELKKHK.-.AELINIHHLMVELK.· .AELINIHHLMYELKKI'iK· ·.AELI NIHHLMVELKKHK.·.AELINIHHLMVELKKHK.-.AELI NIHI-iLMVELKKHK.· -.AELINIHHLMVELKKHK.·.KPM TNYQI PQAAlLK.· -.SFTNFP.NG TSIIQGAL TQLIOL YHR.·.PSLRSRNTI FTLGTR.· -.KSE $PFTHK.·.EEEENESFGLSR.·.MRYEEECRVLI< .· -.KSESPFTHK.· .QKMEEERR.-.CLSLVMDDETE AK.·.RSGSIQAKNLK.-.RTEEERR.·.FE;I<IGQLSEKEVQK.· -. EDEEE EEGSI VNGST TEDEE OTR.· .KSESPFT HK.· · .EDEEE EEGS. I VNGSTTEDEE QTR.· .EDEEEEEGSIVNGSTTEDEEQTR.· · .EDEEEEEGSIVNGSTTEDEEQTR· .DGA YQIRGR.·.STYDVFHLSFRDG AYQI R.·.GLDGFVCPRRGS NQLDTNR.· .PLLVlRGLOOF VCPR.· -.AGYAGEDCPKVDFPT AJGWLER.· · .GKVLGFR. -.PEYDEAGPSI VHR.· · .DMWITNHEYLEIG PSVIFRR.· ·.EMAKWSPDF CVK. ·.TELNMYYPISRGAITNWDNVEK.-.ANPGIHMLTLESIMSCEK.· -.GAGTDDHTLIR.· · .OEIAQEFK.· · .QEIAQEFK.· ·.QEIAQEFK.·.OEIAOEFK.-.QEIAQ EFK. - .QEIAQEFK.· ·.OEIAQEFK. ·.OEIAOEFK.·.TPEELSAIK .-. TPEELSAIK .-.TPEELSAIK .·.TPEELSAIK.· .TPEELSAIK .· .TPEElSA IK .· -. TPEELSAIK .· ·.TPEELSA IK.·.LYDAYELK.· .L YDAYELK. - .VL TEIIASR.· · .VLTEIIASR.·.VLTEIIASR.-.L YDAYELK. ·.VL TE IIASR.· · .VLTEIIASR.·.GTVTDFPGFDGR.-.VLTEIIASR.· ,FITIFGTR.· -.GTVTDFPGFDGR.·.GTVTDFPGFOOR.-.GlVTDFPGFDGR.· · .LYDAYELK.-.FITIFGTR.· .FITIFGTR.-.GTVTDFPGFDGR.·

2054.49 2054.49 2054.49 2140.34 2296.53 2945.44 3062.63 731.82 2054.49 2054A9 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 2054.49 2054. 49 2054.49 2054.49 2054.49 2054.49 1661.01 2054.49 2054.49 2054.49 2054.49 2054.49 1717.07 2880.25 1719.97 1061.17 1426.43 1456.72 106 1.17 1106.24 1454.65 1202.39 976.03 1663.90 2613.51 1061.17 2613.51 2613.51 2613.51 1036.13 2176.36 2106.31 1656.03 2408.72 776.95 1470.57 2477.83 1453.75 2615.90 1975.34 1156.23 003.10 993. 10 993.10 993.10 993.10 993.10 993.10 993.10 988.12 988.12 988.12 988. 12 988.12 988.12 988.12 968.12 1015.14 1015.14 1002.19 1002.1 9 1002.19 1015. 14 1002.19 1002. 19 1269.35 1002.19 955.14 1269.35 1269.35 1269.35 1015.14 955. 14 955.14 1269.35

3 542.46 3 560.25 3 365.69 3 1282 .10 3 513.68 2 132.67 2 187.42 2 670.31 3 882.20 3 359.04 3 1898. 31 3 807.19 3 2024.14 3 1095.66 3 1045.14 0 348.42 0 581.45 3 274.14 3 1525.47 3 810.08 3 3C7.60 3 1626.29 3 587.32 3 2804.58 3 604.82 3 1001.56 3 965.68 3 579.88 3 1124.06 3 978.78 3 397.26 3 303.51 2 214.68

1.61 1.69 1.53 1.70 1.53 0.91 1.03 1.25 1.86

1.35
1.55 1.74 2.05 1. 71 1.68 1.83 1.61 1.35 1.55 1.69 1.26 1.96 1.71 2.05 1.53 1.59 2.03 1.62 2.07 1.93 1.69 1.44 1.01 9702.61 1.37 1.00 1.37 1.55 1.21 1.07 1.66 1.27 1.33 2.07 1.09 1.84 2.16 2.28

0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0. 1 0.1

329 281 185 276 231 88 91 529
261 265 403 287 257 316 256 155 358 198 173 216 148

19/64 5/16 15/64 17!72 17176 117 9150 3/4 9/32 19/64 9132 19/64

19/64
19/64 19164 15164 5/16 15/64 7132 17164 15164 5/16 9/32 19/64 17/52 21164 19/64 21/64 191 64 17/64 13156 1/6 2/7
7116 4/11 2/5

352
250 258 395 382 321 357 357 247 213 160 164 319 167 256 319 354 306 714 224 344 348 100 263 283 416
86 284 223 513

41054994.0
0.0 0.1 0.0

3 437.04
2 2 3 2 2 210.72 356.72 501.48 434.45 432.82 1309.47 300.48 487.64 761.99 202.34 671.38 1897.97 1698.11

0.0
0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.2

112
911 4 11/24 19/40 213 11/26 19/88 114 9144 5122 114

3
2 2 3 3

3
3

3

2028.94

273701112 .0
0.1 0.0 0.1 0.1 9789893 .0 0.1

2 135.54
3 470.22 3 370.35 3 1052.82

0.88 1.65 1.25 1.88

318
114 5124 19156 21/88 112 11/24 17fl6 113 19184 7134

846.!14 3 846.94
2 1006 .15
1.88

420 178 302 148 149 357 73

1006.15
1.02

19520016.0
0.3 4501889.0 0.1 38087599.0 0.0 0.2 0.1 0.1 13277612.0 0.0 0.2 0.2 0.3 0.1 0.1 0.3 0.3 0.2 0.3 0.4 0.2 0.3 0.2 0.4 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.5 0.4 0.2 0.5 0.5 0.0 0.1 0.2 0.3 0.3

575.15 2 575.15 3 315.09 2 815.73
3 633.73 1 155.52 2 1120.12 2 1321.94 2 984.19 2 2273.65 2 558.44 2 838.93 2 1595 .60 1.41

1920.07
2.12 1.05 1.36

0.00

2008443.14 1.83 1.86 1.62 2.22 1.68 1.64 1.72 1.95 2 2088 .94 1.58 2 1078.34 1.78 2 1946.24 2.94 2 8275.82 2.62 2 4101.95 2 3809.54 2.3C 2.00 2 3672 .58 2.37 2 5343.84 2.92 2 5382.52 2.11 2 2575.43 2 1063.95 1.98 1.87 2 1752.85 3.37 2 5094.25 1.60 2 1006.49 2 4306 ,91 2.86 1.66 2 1915.11 2.88 2 5034.44 2.58 2 5250.08 2 13380.3() 3.57 2.50 2 6104.49 1.92 2 1667.53 2 10548.58 2.93 2.72 2 8453.62 1.15 2 348.75 2 740.50 1.52 2.18 2 2468.73 1.60 2 2524.50 1.75 2 2837.83

18
612 265 240 305 280 321 246 375 285 357 1124 1082 73C 1223 655 1044 544 507 629 950 300 946 448 896 964 986 903 416 1058 818 291 363 510 416 551 13120

517
9114 5/7 9114 11114 9/14

517
5fl 11116 15/16 15/16 13116 15116 13116 718 3/4 13114

6/7 15116
9/16 7/8 11114 13116

718
9/11 15/16 11114 17/22 17122 9/22 9/14

617
11114 7111

102

Table 2 continued

jmfag5minigg450m mnaci_030527025134, 1138 jmfag1mnac l5mtnigg,1236-1238 jmfag5m inigg600m mnacl, 1256 jmf ag1mnacl5mincon, 1274-1276 jmfag 1mnacl0minigg, 1292-1294 jmfag1mnacl5minlgg, 1296-1298 jmfag1 mnacl 2,5mi nigg, 1348-1350 jmfag1mnac l7,5minigg, 1370 jmfag1mnacl7.5minigg, 1374 jmfag1mnacl0mini gg, 138Q-1382 jmfag5minigg450m m nacl_03052 7025134, 1420 jmfag5m inigg300m mnacl, 1426 j mfag5m inigg300m mnacl, 1434 jmag5mincon500m m nac l,1458- 1460 jmfag1mnacl2,5minigg, 1520 jmfeg1mnacl7,5minigg, 1530 j mfag1 mnacl5minlgg, 1530-1532 jmfag5minigg250m m nacl, 1544 j mfag5m inlgg250mmnacl, 1548 jmfag5m inigg400mmnacl, 1552 jmfag1mnacl5m incon, 1564 jmfag5m inlgg350mmnacl, 1635 jmfag5minigg250m mnacl, 1656 jmfag1mnacl5minigg,1704-1706 jmfag5minigg450mmnacl_030527025134.1 706-1708 jmfag5minigg300mmnacl , 1724 jmfag 1mnac l0mlnigg, 1732 jmfag5minigg300mmnacl. 1736 jmag5mincon500tl1 mnacl, 1742 jmag5mincon500mm nacl, 1750 jmfag5minigg350mmnacl, 1763 jmfag5minigg350m mnacl. 1767 jmfag 1mnac l2,5mimgg, 1774 jmfag5m inlgg500m mnacl , 1776- 1778 Jmfag5in lnlgg600m mnacl, 1794 Jmfag5m inigg600m mnacl, 1800 jmfag1mnac l0in inigg,181 8-1820 jmfag5mlniggbead_0305282 00105, 1833 jmag5mlncon500m mnacl, 1836-1838 jmfag1m nacl0m ini gg.1858-1860 jmfag1mnacl2.5minigg, 1864 j m fag 1m nacl2,5minigg, 1872 jmfag1mnacl2, 5minigg, 1904-1906 jmfag1mnacl 7,5minigg, 1926 jmfag5minigg400mmnacl, 1926 jmfag1mnacl7,5minigg, 1930 jmfog5mlnigg400m mnacl, 1932 jmfag1mnacl0minigg, 1936 jmfag1mnacl0minigg, 1940 JMFAGNACL5B21E 3, 1950 JMMAGTube1B16E3, ·1952 JMMAGTube1B16E3, 1958 jmfag1mnacl5minigg, 1960 j mfag1mnacl5m inlgg, 1964

-.TPEELSAIK.·.GTVTDFPGFDGR.-.SEIDLFNIR· .GTVrDFPG FDGR.-.S EIDLFNIR.· -.F ITI FG TR.· .S EIDLFNIR.-.SEIDLFNIR.· -.SEIDLFNIR.·.NFATSLYSMIK.· ·.VLTEIIASR.· -.VLTEIIASR.·.VLTEIIASR. -.VLTE IIASR·
- . YMTISGFQIEETIDI~ .-

jmfag1mnacl2,5minigg, 1968
Jmfag1mnac l5minlgg, 1970 Jrnfag 1m nacl2.5minigg, 1972 jmfag5minigg1000inmnael ; 1972 jinfag1m nacl2,5minigg. 1974 jmfag1mnac l7,5mfnigg,2002-2004 Jmfag5minigg1000in mnac1 ,2004-2006 jmfag1mnacl5m injgg, 2050 jmfag1mnacl5minigg. 2058 j mfag5mlnigg450m mnaci_030527025134. 2068 jmag5m incon500m mnac 1,2070-2072 jmfag5minigg 1000mmnacl , 2074 jmfag1mnacl5minigg, 2074 Jmfag1 n,nac15m inlgg,2098-2100 jmfag1mnacl5mlncon,2122-2124 Jmfag 1m nacl5m incon, 2150-2152 jmfag1mnacl5minigg,2168-2170 jmfag1mnacl5minigg,2172-2174

jmag5m incon500m mnaci, 2180
jmfag 1mnac l5m incon,2224-2226 jmfag5minigg500m mnacl , 2382 jmfag5minigg500mmnacl, 2444 jmfag5min!gg500m mnacl , 2498 jmfag5mimgg250m mnacl ,2508-2510 jmfag5minigg250m rnnacl, 2564 jmfag5minigg250m mnacl, 2618 jmfag5m inigg450m mnaci_030527025134, 2648

jmag5mincon500m mnacl, 2698 jmag5inincon500m mn~cl, 2702 jmfag5minigg450m mnacl_030527025134, 2718 jmfag5mlnigg450m mnaci_030527025134. 2726 jmfag5minigg300mmnacl, 2754 j mag5m incon500m mnacl,2760-2762 jmfag5mlntgg450m mnaci_030527025134,2772-2774 jmfag1 mnacl 0m lnigg, 3379 jmr<iiwrh1inigg200mmnaclsyringdnas , 1016 jmrawigg5minba~sfreazethaw, 1064 jml gG250rawphag3007, 1238 jmtgG150rawphag3007, 1464-1466 jmlgG250rawphag3007, 1496- 1498 jmlgG300rawphag300i, 1506 jmrawrminigg200m mnaclsytingdnas , 1514 jmrawrminigg200m mnaclsyringdnas. 1524 j mrewrminigg200m mnaclsyringdnas , 1742 jmrawigg5minbeadsfreeze.thaw, 1888 jm lgG350naclrawphag3007, 2163

· .YMTI SGFQIEETIDR.-.SEIDLf'NIR. · .GTVTDFPGFDGR · -.GTVTDFPG FDGR.· ·YMTISG FQI EETIDR.· ·.SEIDLFNIR.· -.DLVDDLKSELTGK.· -.FITIFGTR.· .YMTISG FQIEETIDR .· · .G TVTDFPG FDGR. ·.GTVTDFPG FDGR.-.DLV DDLKSELTG K. ·.GTVTDFPGFDGR.· - .G TVTDFPG FDGR.· ·.GTVTDFPGFDGR.·.GLGTDEDSILNLLT SR.· - .GLGTDEDSILNLL T SR. · - .DLVDDLKSE LTGK.· .S!OIDLFNIR.-.G LGTDEDSILNLLT SR. ·.GI;GTDEDSILNLLTSR.-.S IPAYLAETLYYAMK.· .SIPAYLAETI.YYAMK.· -.FITIFGTR.· .GLGTDEDSILNLLT SR.·.SIPAYLAETLYYAMK.· -.SIPAYLAETLYYAMK· -.GLGTOE DSILNLLT SR. · -.GLGTDEDSILNLLTS R.· -.GLGTOEDSILNLLT SR.· · .GLGTOEDSILNLLTS R.· .GLG TDEDSILNLLT SR.· .ETSGNLE QLLLA WK.·.ETSGNLE QLLLA WK.· .GLGTDEDSILNLLTS R.· -.GLGTDE DSILNLLTS R· -.GLGTDEDSILNLLTS R.· .DLVDDLKSE LTGK.· .DLV DDLKSELTGK.· -.ETSGNLEOLLLAWK.· -.DLVDDLKSELTGK.· -.ETS GNLEQLLLAVVK. ·.SIPA YLAE Tl YYAM K.· · .ETSGNLE.QLLLAWK.· .ETSGNLEOLLLA WK. · -.GLGTDEDSILNLlTSR.·.SIPA YLA ETLYYA MK. · - .SIPAYLAE'ftYYAMI<.· -.SEIDLFNIR.· .SEIDLFNIR. - .E TSGNLE QLLLA WK. · - .YMTISGFQIEET IDR.·.GLGTDEDSIL NLLT SR.· .SIPAYLAETLYYAMK.-.GLGTDEOSILNLLT SR. · .ETSGNLE OLLLAWK.-.ETSGNLEQLLLA WK.·.NFATSLYSMIK-.ETS GNLEOL.LLA WK.· -.SIPA YLAE TL YYAMK· - .GLGTDEDSILNLLTSR.· .ETSGNLEOLLLAWK.-.SIPA YLAE TL YYAM K.· .GLG TDEDSILNLLT SR. · .ETSGNLE QLLLA WK.· -.SIPAYLAETLYYAMK.· .GLG TDEDSILNLLTS R· ·.GLGTDEDSILNLLTS R.·.GLGTDEDSILNLLTS R.·.GLGTDEDSILNLL TS R.·.GLGTDEDSILNLLT SR.· -.ETSGNLEQLLLAWK.·.ETSGNLEQLLLAWK. -.DPDT AIDDAQVELDAQALFQAGELI< .· ·.TPEELSAIK.· -.GTVTDFPG FDGR. · .VLTEIIASR. -.GTVTDFPGFDGR.·.GTVTOFPGFDGR. · ·.GTVTOFPGFDGR · .GTVTOFPGFDGR.-.GTVTDFPGFDGR. ·. WGTDEEKF ITIFGTRSVSHLR.-.GLG TDEDSILNLLTS R.·.DLVODLKSE LTGKFEI< .·

988.12 1269.35 11 07.24 1269.35 1107.24 955. 14 1107 .24 1107.24 1107.24 1275.50 1002.19 1002 .19 1002 .19 1002. 19 1804.02 1804.02 1107 .24 1269 .35 1269.35 1804.02 1107 .24 1433.59 955.1 4 1804.02 1269.35 1269 .35 1433.59 1269 .35 1269.35 1269.35 1704 .86 1704.86 1433.59 1107.24 '1704 .86 1704.86 1735.04 1735.04 955.14 1704.86 1735.04 1735.04 1704 .86 1704.86 1704.66 1704.86 1704 .86 1614.87 1614.87 1704.86 1704.86 1704.86 1433.59 1433.59 1614.87 1433 .59 1614.87 1735.04 1614.87 1614 .87 1704.86 1735.04 1735.04 1107 .24 11 07.24 1614.87 1804.02 1704.86 1735.04 1704.86 1614.87 1614.87 1275.50 1614 .67 1735.04 1704 .86 1614.87 1735.04 1704 .86 1614.87 1735.04 1704.86 1704.86 1704.86 1704.86 1704.86 1614.87 1614.87 2674.86 988.12 1269.35 1002.19 1269.35 1269.35 1269.35 1269.35 1269.35 2480.76 1704.86 1838.05

2 2509.41 2 5296.22 2 7218.06 2 6350.65 2 9954.04 2 2668.67 2 10469.92 2 9773.66 2 8 115.10 2 6406.62 2 3268.30 2 2 163.22 2 2304.85 2 3410.06 2 387.04 2 4794.91 2 7152.98 2 1883.75 2 2220.37 2 798.36 2 8970.16 2 8634.28 2 2128.45 2 371.57 2 4081.94 2 5010.49 2 14564.66 2 602.99 2 1478.44 2 5207.15 2 13079.66 2 8348.76 3 1732.18 2 9639.09 2 10777.82 2 3497.96 2 16228.78 2 7546.66 2 3048.77 2 19359.88 2 10598.04 2 12033. 18 2 14929.15 2 15427. 15 2 12383.09 2 11386.43 2 10715.94 2 14333.34 2 17175.77 2 13121.38 2 11376.02 2 11676. 86 3 1165.05 2 15354.49 2 1620.53 2 595e.93 2 11183.21 2 4769.71 3 8782.85 2 11831 .31 2 17404.44 2 835.02 2 14481.70 2 7978.37 2 6729.14 2 8097.53 2 1005.12 2 11028.34 2 2418.08 2 14978.98 2 12640.40 3 10247.98 2 1773.15 2 12510.59 2 746.38 2 3579.14 2 6113.81 2 305.16 2 7486.10 2 11145.04 2 9811.92 2 4623.39 2 4859.37 2 '13260. 09 2 9232.80 2 10351.10 2 10991.41 2 8645.71 2 5256.28 2 1974.58 2 3679.35 2 11 75.03 2 506.32 2 2135.06 2 5127.95 2 1388.77 2 2721.60 3 485.99 2 11388.10 3 4017.43

1.93 2.28 2.69 2.11 3.37 2.51 3.54 3.29 3.26 2.57 2.32 2.09 2.00

2.49
1.61 2.15

3.38
1.45 1.29 1.56 3.05 2.55 1.89 1.85 2.21 1.90 3.34 1.50 1.43 2.09 3.91 3.62 1.86 3.25

0.2 586 0.3 1119 0.4 1124 0.5 780 0.4 1238 0:2 567 0.4 1310 0.4 1245 0.4 1228 0.4 10SO 0.2 832 0.2 650 0.2 631 0 .2 983 0.1 169 0.4 462 0.3 1067 0.3 621 0. 3 697 0.2 170 0.4 1196 0.5 1250 0.3 299 0.1 140 0.4 598 0.4 797 0.5 2173 0. 1 348 0.2 587 0.4 861

13/16

17/22
718 17122

718
6/7

7!8
718

718
415

7!8
13116

3/4
7/B 5/14 13/28 7/8 7/11 13/22

217
7/8 17/24 9114 5/ 14 7/ 11 8/1 1 718

112
13122 8/11 8115 19130 113

0.5

876

3.70
1.80 4. 13 2.97 2.28 4.85 3.01 2.99 4.32 4.66 3.58 3.81 3.87 3.63 4.00 4.38 3.90

3.38
1.91

3.77
2.22 2.18 3.62 2.50 3.54 3.54 4.78 1.52 3.15 2.56 3.05

0.3 1202 0.3 209 0.4 1260 0.3 1925 0.4 559 0.5 978 0.5 449 0.3 346 0.5 1587 0.5 636 0.6 524 0.5 1063 0. 4 1358 0.5 1021 0.5 958 0.4 1269 0. 5 999 0.6 1173 0.4 1217 0.4 1014 0.5 1254 0.2 301 0.5 1546 0.2 422 0.4 959 0.5 895 0.4 55il 0.4 1198

7!8
7110 112 9/14

1/2
9114 7110 17128 417 1\l/30 19/30 17/30 17130 2/3 17128 19128 3/5 8/15 315 318 19/24 3/7 2/3 417

417
27/56 17/28

o:s

869

0.5 1120 0.2 237 0.6 914 0.4 1425
0.4
0.4 0.1 0.4 0.3 0.5 0.5 0.4 02 0.5 0.1 0 .3 0.4 0.0 0.4 0.5 0.5 0. 3 0.3 0.5 0.4 04 0.5 0.5 0.4 0.2

213
3/7 17128 7/8 13116 417 5114 315 317 19/30 17128 3/7 3/5 19/28 1/2 13130 112

933
827 377 1002 408 1427 909 953 631 1201 484 647 643 172 1292 1144 647 905 988 946 709 1292 568 623

2.90
1.70 4.43 1.86 4.22 3.92

3.63
1.75 3.81 1.12 2.14 2.66 1.77 2.94 3.35 2.78

217
17130 9/14 17128 8115 811'5 8115 7/15 19/30

2.37
2.78 4.02

3.43
3.77

3.32
3.07 2. 22 1.76 1.67 1.36 1.39 1.87 2.36 1.63 1.92 1.66 3.61 2.53

4/7
15/28 17148 13115 13122 13116 51'11 6111 13/22 1/2 1/2 17/80 8115 1/3

740
680 461 693 296 425 598 488 368 292 844 278

OA
0. 1 0.1 0.3 0.4 0.2 0.3 0.0 0.5 0:4

103

Table 2 continued

jmlgG300rawphag3007, 2194 jmlgG250rawphag3007, 2214 jmravvrminigg200mmnaclsyringdnas. 2250 jmrawrmini99200mmnaclsyringdnas,2450-2452 jm5miniggrawlowionic, 2736 jm5miniggrawlowionic, 2740 rawextr_400bead_Mar04, 705 rawextr_actinbead_Mar04, 876 rawextr_actlnbead_Mar04, 882 rawextr_actinbead_Mar04, 1092 rawextr_actinbead_Mar04, 1336-1338 rawextr_200bead...:Mar04.1414·1416 rawextr_800bead_Mar04; 1662 rawextr_800be.,d_Mar04, 1666 rawextr_actinbead...:Mar04, 1764 rawextr_450bead_Mar04. 1860 rawextr_450bead~Mar04, 1864 rawextr_350bead_Mar04, 1918 rawaxtr 600bead Mar04. 1974 rawextr)50baad=Mar04. 1980 rawextr _250bead_Mar04, 1986 rawextr_ehlfbead __Mar04, 1996 rawsxtr_chlfbead_Mar04, 2006 rawextr_a.,tinbead_Mar04, 2068 rawextr_actinbead_Mar04,2122-2124 rawextr_200bead_Mar04, 2130 rawextr_200bead_Mar04, 2134 rawextr actinbead Mar04, 2138 rawextr)00bead_r;;tar04,215S·2160 rawextr_200bead_Mar04,·2164 rawextr 200baad Mar04. 2460 rawextr=actinbaad_Mar04, 2642 rawextr_200beadigg_Mar04, 603 rawextr _actinbeadigg_Mar04, 611 FPbeads150_Dec19, 873 rawextr_actinbeadlgg_Mar04.673-675 rawextr_300tleadigg_Mar4 , 664 rawextr.·200beadlgg_Mar04,843-S45 rawextr_actlnbeadigg_ Mar04,863-865 ra;vextr_200beadigg_Mar04, 1083·1085 raw<>xtr_actinbe3di99_Mar04,1121-1123 rawsxtr_250beadigg_Mar04, 1250-1252 rawextr_200beadi99_Mar04, 1337 rawextr_200beadigg_Mar04, 1341 rawextr_actinbeadlgg_Mar04, 1365 rawextr_aotinbeadigg_Mar04, 1371 rawextr_200baadigg_Mar04, 1417 rawextr_200beadig9_Mar04 , 1501 rawextr_200beadigg_Mar04 , 1709 rawextr__200baadigg_Mar04, 1711-1713 rawaxtr_200beadigg_Mar04, 1717 FPbeads150 Doc19, 1721 rawextr_500beadi99_Mar04 , 1740
1745 rawextr_500beadigg_Mar04 , 1748 raw~xtr__ac tinbe adigg_Mar04, 1751 rawextr_actlnbeadigg_Mar04, 1755-1757 rowextr_actinbeadlgg_Mar04, 1783 rawextr _700beadi99_Mar04, 1788-1790 rawextr_actinbeadigg_Mar04, 1789 rawextr_20Qbeadigg_Mar04,1795-1797 rawextr ·.actinbaadigg_Mar04,1833-1835 rawextr_200beadigg_Mar04,1837-1839 rawaxtr_200beadigg_Mar04 , 1861 rawextr_actinbaadlgg_Msr04,1881 - 1683 rawextr_200beadigg_Mar04,1889-1891 rawextr_actinbaadi99_Mar04, 1903 rawextr_actinpeadigg_Mar04, 1905 rawextr __actinboadigg_Mar04, 1929··1931 rawextr_450beadigg_Mar04,1966-1968 rawextr_250baadlgg_Mar04, 1990 ra.,.;extr_250beadigg _Mar04 . 1994 rawextr_actinbeadigg_Mar04, 2007 rawextr_400beadigg_Mar04,2016-2018 rawextr_350beadi992_Mar04,2114-2116 rawextr_300baadi99_Mar4,213Q-2132 rawaxtr_350beadigg_Mar04,2187-2191 FPbeads450_Dec19, 2384 FPbeads250 Dec19, 2806 FPbeads300=Dec19, 2946 FPbeads300_Dec19, 2952 jmfagb!llecon2.5mil1.185.185.3 jmfagtimecon7.5mln.2406.2408.2 jmfagtimecon7.5min.2412.2412.3 jmfagtimecon2.5min.2030 .2030.3 jmfagtimecol\2.5mi n.2024.2026 .2 jmfagtimecon2.5mln.1996.1996.2 jmfagtimecon2.5mi n.189. 189.3 Jmfagtimecon2.5min.1660.1882.3 jmfagtimecon2.5min.938 .938.2 jmfagtimecon7.5mln.2434.2436.2 jmfagtimecon2.5min.1178.1180.2 jmfagtimecon7.5mln.2504.2506.2 jmfagtimecon2.5mln.668 .668.3 jmfagtimacon2.5min,672 .672.3 jmfagtimecon7.5ml n.2304.2304.3 jmfagtimecon7.5m in.536.536 .3 jlllfBgtlmecon2.5min.322.322.2 jmfagtimacon7.5min.1650. 1650.2 jmfagtimecon2. 5min.952 .952.2
rawextr_actin0..~00tgg_Mar04,

·.DLVDDLKSELTGKF EK.· ·.Dl.VDDLKSELTGKF EK.· ·.DlVDDLI<SEL TGKF EK.· ·.GLGTDEDSILN LLTSR.·.GLGTDEDSILNLLTSR.· ·.GLGTDEDSILNLLTSR.· ·.TPEELSAIK.· · .Q EIAQEFK· -.QEIAQEFK.·.VLTEIIASR.· -.GTVTDFPGFDGR.· .GTVTDFPGFDGR.·.GLGTDEDSILNLLTSR.· -.GLGTDEDSILNLLTSR.-.WGTDEEKFITIFGTR· ·,GLGTDEDSILNLLTSR.·.GLGTDEDSILNLLTSR.·.GLGTDEDSILNLL TSR. ·.GLGTDEDSILNLLTSR.· -.GLGTDEDSILNLLTSR.· ·.GLGTDEDSILNLLTSR.· ·.GLGT DEDSILNLLTSR. ·.GLGTDEDSILNLLTSR.· ·.SIPAYLAETLYYAM K.· .GLGTDEDSILNLLTSR. -.SIPAYLAETLY'(AM K. -.SIPAYLAETLYYAM K.·.ETSGNLEQLLLAWK.· -.GLGTDEDSILNLLTSR.· ·.GLGTDEDSILNLL TSR.-.YM TISGFQIEETIDRETSGNLEQL LLAWK.· .GlGTDEDSILNll TSR.· · .QEIAQEFK.· -.QEIAQEFK.· ·. TPEELSAIK.· · .TPEELSAII<.· ·.GDTSGDYKKALLLLCGGEDD.· · .VLTEilASR.· ·.VLTEIIASR.· · .GTVTDFPGFDGR.· .GTVTDFPGF DGR.· -.GTVTDFPGFDGR·.SEIDLFNIR· ·.SEIDLFNIR.· -.SEIDLFNIR· ·. SEIDLFNIR.· ·.NFATSLYSMIK.-.WGTDEEKFITI FGTR.· · .DlVDDLKS!OLTGKFEK.· ·.DLVDDLKSEL TGKF EK.· .DLVDDLKSELTGKF EK.· · .DLVDDLI<SELTGK. · -.GLGTDEDSILNLLTSR.·.DLVDDLKSEL TGKFEK.· -.GLGTDEDSILNLLTSR.· ·. DL VDDL!<SEL T GKFEK. · -.DLVDDLKSEL TGKFEK.·.DLVDDLKSEL TGK.· .GLGTDEDSILNLL TSR. ·.Dl VDDLKSEL TGK.· · .SIPAYLAETL YYAM K.· -.SIPAYLAETLYYAMK.·.GLGTDEDSILNLLTSR. · ·.GLGTDEDSILNLLTSR.· · .GlGTDEDSILNLLTSR.· -.ETSGNLEQLLLAVVK.-.GLGTDEDSILNLL TSR.·.GLGTDEDSILNLLTSR.· ·.ETSGNLEQLLLAWK.· .GLGTDEOSILNLLTSR.·.GLGTDEDSILNLLTSR.· · .GLGTDEDSILNLLTSR.· .GLGTDE.D SILNLLTSR.·.GLGTDEDSILNLLTSR.· ·.GLGTDEDSILNLLTSR·.GLGTDEDSILNLLTSR.· · .GLGTDEDSILNLLTSR.· .GLGTDEDSILNLL TSR .· -.GLGTDEDSILNLLTSR. · .GLGTDEDSILNLLTSR.·.GLGT DEDSILN LLTSR .· -.SNAQRQEIAQEFK. ·.SIPAYLAETLYYAM K.· -.SIPAYLAETL YYAM K.· -.GLGTDEDSILNLLTSR.·.GLGTDEDSILNLLTSR.·.SIPAYLAETLYYAM K.· ·.SNAQRQEIAQEFK. · .DLVDDLKSEL TGKF EK.· -.\1\.TEIIASR.· · .GLGTDEDSILN LLTSR.· · .GTVTDFPGF DGR.-.ETSGNLEQLLLAWK.-.LIVAMMKPSR .·.LIVAMMKPSR. · · .DlVDDlKSEL TGKF EK.·.LIVAMMKPSR .· · .QEIAQEFK.-.GTVTDFPGF DGR.· ·.Vl TEIIASR·

1838.05 1838.05 1838.05 1704.86 1704.86 1704.86 988.12 993.10 993.10 1002.19 1269.35 1269. 35 1704.86 1704.66 1800.99 1704.86 1704.86 1704.86 1704.86 1704.66 1704.86 1704.86 1704.86 1735.04 1704.66 1735.04 1735.04 1614.87 1704.86 1704.86 3399.66 1704.86 993.10 993.10 988.12 988.12 2071.25 1002.19 1002.19 1269.35 1269.35 1269.35 1107.24 1107.24 1107.24 1107.24 1275.50 1800.99 1838.05 1838.05 1838.05 1433.59 1704.86 1838.05 1704.86 1838.05 1838.05 1433.59 170·.86 1433.59 1735.04 1735.04 1704.86 1704.86 1704.86 1614.87 1704.86 1704.86 1614.87 1704.86 1704.86 1704.86 1704.86 1704.86 1704.66 1704.86 1704.86 1704.66 1704.86 1704.86 1704.86 1549.67 1735.04 1735.04 1704.86 1704.86 1ns.o4 1549.67 1838.05 1002.19 1704.86 1269.35 1614.87 1146.50 1146.50 1838.05 1146.50 993.10 1269.35 1002.19

3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 3 2 2 2 2 2 2

318.29 2900.88 1722.25 6955.12 7691.0d 10919.93 3103.03 661.32 2061 .08 4629.91 7150.89 5833.09 5268.70 15579.89 4903.30 6880.80 4686.91 7781.25 13669.76 6375.16 1496.84 658.75 2940.47 11429.34 8671.46 12630.13 6605.01 2123.24 12179.42 12399.78 145$.42 1776.18 638.54 1516.05 841.82 5771.22 475.66 5534.56 3123.77 9441.75 5290.75 6730.31 7817.06 2 5946 .88 2 6821.80 2 6055.15 2 1768.63 2 7619.44 3 6042.04 2 1881661 3 4573.17 2 10360.54 2 13672.34 3 7639.44 2 3742.11 3 8840.43 2 1965$.69 2 11675.24 2 10916.16 2 11525.97 2 1531 9.76 2 2512.55 2 17476.27 3 2169.92 2 16143.29 2 10208.38 1 455.82 3 2G19.82 2 7285.13 2 10058.61 2 16862.93 2 24558.30 2 1829.61 2 10408.47 2 13534.72 2 13573.59 2 23062.70 2 12049.01 2 4747.14 2 7495.76 2 5942.81 0 8847.31 0 1321 6.10 0 2689.21 0 9084.10 0 17476.05 0 6063.46 0 5887.88 0 8775.46 0 6164.25 0 17406.96 0 8505.31 0 10799.49 0 3774.72 0 3S75.31 0 907.19 0 2952.82 0 912.85 0 7166.57 0 2558.91

1.50 2.01 2.11 3.41 2.91 3.76 1.86 1.87 1.67 2.49 2.68 1.91 3.32 4.33 2.23 3.63 2.93 3.72 4.07 3.12 2.09 1.63 2.44 3.03 3.56 3.06 2.40 2.35 4.24 4.09 1.67 1.74 1.36 1.77 1.53 2.70 1.86 2.68 2.24 2.72 2.91 2.64 2.72 3.16 2.91 3.03 1.61 2.82 3.33 4.44 2.88 3.01 4.27 2.61 2.53 3.28 4 .. 61 3.25 3.78 3.43 3.66 2.20 4.88 2.69 4.52 3.41 1.41 2.66 3.32 3.89 4.68 5.32 2.02 4:14 4.22 4.72 5.47 3.70 2.78 3.24 2.51 3.38 3.75 1.99 3.85 4.73 2.17 2.77 3.26 2.53 5.07 3.25 3.50 2.17 2. 16 2.23 2.33 1.58 2.40 2.44

0.1 0.3 0.2 0.3 0.4 0.4 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.4

103

488
275 1281 826 1490 925 283 476 1137 775 1039 690 1638 349 1253 608 1221 1001 787 607 403 276 749 943 609 891 326 1146 900 444 415 164 276 393 874 254 971 999 933 950 761 1138 1061 1269 1067 989 485 470 1041 376 1458 1025 257 793 555 1134 1732 1543 1294 1154 396 1251 512 1246 824 162 707 755 1351 1267 2018 651 998 1511 1550 1268 1165 929 930 1034 1066 674

11160 215 3110 315 315 213 718 517

617
15116 17/22 9/11 8115 2/3 11128

0.4
0.3 0.3 0.3 0.5 0.4 0.1 0.0 0. 3 0.6 0.4 0.6 0.4 0.2 0.4 0.5 0.2 0.2 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.5 0.3 0.4

3/5
7115 315 17130 1/2

7115
215 7115 9/14 17130

417
17128
11128 315

3/5
251116 11/30 4/7 11/14 5/8 7/8 5119 15116 15/16 9/11 17122 8/11

0.4
0.3 0.3 0.3 0.1 0.5 0.4 0.6 0.3 0.4 0.5 0.5 0.3 0.5 0.6

718
13116
15/16

13116 7110 13128 5112 213 7/20 3/4 17/30 1/3 1/2 9/20 2/3

0.4
0.4 0.5 0.6 0.3 0.5 0.2 0.5 0.5 0.1 0.2 0.4 0.4 0.5 0.5 0.2 0.4 0.4 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.5 0.4 0.5 0.4 0.5 0.4 0.4 0.1 0.3 0:2 0.4 0.2

5/6
7110 314 517 1/2 19130 17/60 19130 17128 3/10 11/30 17128 19/30 2/3 11/15

7115 3/5
7/10 2/3 19/30 17/30 1/2 3/5

8/15
1/2 17!28 318 9120 213 15!28 23148 23160 718

308
1380 1186 578 697 482 907 1290

2/3
15122

898
754 257

417
5/12 112 113 19/36 9114 9111 13116

276
327 320 220 1151 709

104

Table 2 continued

jmfagtimecon7.5m in. 386.386.2 jmfagtlmecon7.5m in.1380.1382.2 jmfagtlmecon7.5min.1642.1642.2 jmfagtim<>con7.5m in.1700.1700.2 jmfagtimecon7.5m in.1914.1916.2 jmlagtimecon7.5m in. 544.544.3 jmfagtimecon7.5m in. 394.394.2 jmfagcon5m inn600m mnacl. 373 jmbeads250rawpha g3007, 448 jmfag5mincont400_030531151834, 478 Jmlag5mmcont400_030531151834, 484 jmfagcon5m in1000m mnaci_030601180404, 534 jmfag5mincont350, 5e2 jmfag5m incont400__030531151834, 778-780 Jmbead$250rawpha g3007, 974 Jmla>g5mincont400_030531151834, 1010 jmfagcon5minn600mmnacl, 1027 jmiag5mincon450m mnacl, 1080 jmfag5mincon300m mnacl, 1096 )tnfagtimecon10m in, 1138 jmfagtimecori10tnin, 1146 jmbeads300rawphag3007, 1150 jmfagtimecont10min_Q30601202502, 1156 )mfagtimecont10m in_030601202502, 1164

Jmfag5mincon300m mnacl, 1180 jmfag5mincon250mmnacl, 1220 jmfagtimecont0min_030601230741, 1240 jmfagcon5m inn600m mnacl.1267-1269
jmfag5mlncon450m mnacl, 1276 Jmfagtimecont0min_0306012307 41,1286-1288 jmfag5mincon300m mnacl, 1400

jmbeadsactlnrawpheg3007, 1417 jmfagtimecon10min, 1418-1420 jmfagtimecont10min 030601202502,1434-1438 jmfagtlmecon10min,-1474 jmfagttmecont10min_030601202 502,1492- 1494 jmfag5mlncon450m mnacl, 1504 jmfag5mincon450rn mnac!, 1512 jmfagtimecontOm ln_030601230741,1558-1560 jml::eads300rawphag3007, 1582-1534 jmbeads250rawpha g3007, 1594-1596 jmlagtlmecontOmln_030601230741, 1664 jm!agccn5m in1000m mnacl __030601180404, 1708 jmfagcon5m in1000m mnaci_030601180404, 1744-'1746 jmfagtimecont10m in~030601202502, 1786 jmfagtimecont10m in_030601202502, 1792 jmfagcon5m in 1000m mnacl_030601180404. 1802 jmfagcon5m in1000m mnaci __030601180404, 1808 jmfag5minconl400_030531151834, 1814 jmfag5mincont400_030531151834, 1818 Jll1fag5mincont350, 1830
jtnfag5mincon450m mnacl, 1832 jmfag5mincon!400_030531151834, 1892 jmfagtimecont0min_030601230741, 1898 Jrnfagcon5m inn600m mn~cl, 2023 jmlagcon5m inn600m mnacl, 2059 jmfagcon5m inn600m mnacl, 2111 jmfagtimecon10min, 2122 Jmlagtimecont10min_030601202502. 2140 Jmfagtim~con10m in, 2214 jmfagtimecont0mln_030601230741, 2342 jmfagllm~cont0min_030601230741, 2346 jmfagtimecont0min_030601230741, 2350 jmlag5mincon450m moacl,2458-2460 jmfag5mincon250m mnacl, 2474 jmfagtimecont0mtn_030601230741, 2482 jmfag5mlncon250m mnacl, 2486 Jmfag5mincon450m mnacl, 2526 Jmfagtimecont0min__ 030601230741, 2550 jmfagtimecon10m in, 255e jmfagtimecont0min __030601230741, 2558 jmfagtimecon10m in, 2562 JmfagtimecontOm ln_030601230741, 2572 jmfagtimecont10m in_030601202502, 2598 jmfagtlmecont10m in_030601202502, 2606 jmlagtimecont10min_030601202502, 2610 Jmfagtimeoont10m in_030601202502, 2614 jmfag5mincon300m mnacl, 2668 jmfag5mincon300m mnscl, 2674 jmfsgtimecon10m in,2696·2698 )mfagtimecont10m in_030601202502.2752·2754 Jmfagtilnecon10m in,2776-2778 jmfagtimecont10m in_030601202502, 2818 jmfagtimecont10min 030601202502, 2822 jmfagtimecon10m in,--2844 rawphag2007chf bead1, 1562 RawPhag2007E tBeadadi gest__ 030718152503, 1782 rawsucrfp_ 350phagi gg_M ar04, 1404-1406 ANXS,MO USE Anne~ln A8 (Annexl n VIII) phagrawFsuc400_dec 20, 3678 MOES_MOUSE Moesln (Membrane·organizing extension .spike protein) rawextr__?OObead1 gg_Mar04, 1868 rawexlr_350beadi gg2_Mar04, 2316 ezrin, pp81.,1yrosine·phosphorylated band 4.1 cytosolic prol~in homolog [mi phagrawF300 __dec20, 13~5 erythrocyte protein band 4.1·1ike 2; generally ·~pressed protein 4.1[ rawextr_300beadi gg_Mar4, 185e erythrocyte protein band 4.1·11ke 4a; erythrocyte protein bond 4.1·1ike jmfag5minigg200m mnacl, 860 jmlag5miniggbead_030528200105, 2039

-. TPEELS AIK. ·.VLTEIIASR.-.GTVTDFPGFDGR.-.FITIFGTR.-.SEIDLFNIR.·.UVAMMKPSR.-.TPEELSAIK.· .TPEELSAIK.-.TPEELSAIK.·.TPEELSAIK.· -.TPEELSAIK.· -.TPEELSAIK.·.TPEELSAIK.-.VLTEIIASR.· .GTVTDFPGFDGR· -.GTVTDFPGFDGR·,VLTEIIASR. -.TPEELSAIK.-.QEIAQEFK.·.QEIAQEFK.·.QEIAQEFK -. GTVTDFPGFDG RADA EVLR.-.QEIAQEFK.· .OEIAQEFK.-.TPEELSAIK.·.VLTEIIASR.-.LYDAYELK.· .GTVTDFPGFDGR· ·.VLTEIIASR.·.VLTEIIASR.· -.VLTEIIASR.·.ALLlLCG GEDD.· ·.LYDAYELK.·.LYDAYELK.-.VLTEIIASR.·VLTEIIASR.-.GTVTDFPGFDGR·.GTVTDFPGFDGR-.GTVTDFPGFDGR.·.DLVDDLKSELTGKFEK.·.DLVDOLKSELTGKFEK.·.FITIFGTR.-.SIPAYLAETLYYAMK·-GLGTDEDSI LNLLTS R.·.GTVTDFPGFDGR.-.GTVTDFPGFDGR.·.ETSGNLEOLLLAVV K.· .ETsGNLEOLLLAVV K.· -.GLGTDEDSI trJLL TS R.· -.GLGTDEDSI LNLLTS R.·.GLGTDEDSILNLLTSR.-.SEIDLFN IR.·.ETSGNLEOLLLAVVK.-.SEI DLFN IR.·.SIPAYLAETLYYAMK.·.GLGTDEDSI LNLL TSR.·.ETsGNLEOLLLAVVK.-.SEIDLFNIR.-.SEIDLFN IR.-.NFATSL YSM IK.·.DLVDDLKSELTGKFEK.-.DLVDDLKsELTGKFEK.·.DLVDDLKSELTGKFEK.-.GLGTDEDSI LNLLTs R·.GLGTDEDSILNLLTSR -.SIPAYLAETLYYAMK. · -.GLGTDED$1 LNLLTSR.-. ET SG NLEQ LLLAVV K. · - .GLGTDEDSILNLLTSR·.DLVDDLKSEL TGKFEK.·.GLGTDEDSILNLLTSR.-.DLVDDLK SEL T GKFEK.· .GLGTDEDSI LNLL TSR.·.DLVDDLK SELTGKFEK.·.DLVDDLJ< SELTGKFEK.·.DLVDDLKSELTGKFEK.-.DLVDDLKSEL TGKFEK.·.GLGTDEDSILNLLTSR- .GLGTDEOSILNLLTSR. ·.SIPAYLAETLYYAMK.·.SIPAYLAETLYYAMK.·.GLGTDEDSILNLLTSR-.GLGTDEDSI LNLLTSR.· .GLGTDEDSILNLLTSR-..ETSGNLEQLLLAVV K.·.GTVTDFPGFDGR.-.SIRSIPAYLAETLYYAMKGAGTDOHTLIR.·.SEIDLFNIRK -.CIEDSFKSETHGSLEEAMLTVVKCTR.-.TISVRVTTMDAELEF AIQPNTTGK.· .TISVRVTTMDAELEFAIOPNTTGK.-.KQLFDOVE.· -.VTPLPFQPQASSHETLNVVEEKK.-.IIAPSPVKSFKK.·.LPCPVN!AAQMGAYAIQAELGDHDPYK.-

988.12 1002.19 1269.35 955.14 1107.24 1146.50

0 285770
6370.46 5551.97 1150.01 7641.15 0 2281.&8 0 2928.45 2 2678.33 2 3206.31 2 2042.85 2 3921.21 2 1066.09

2.32
2.87

0.2
0.4 0.4

0 0 0 0

2.45 1.81 3.13
2.04 1.99 2.43 2.03 2.11 2.58 1.29 1.78 2.74 2.19 1.46

851 904 496

0.2 384 0.4 1023 0.3 0.3 132 762 747

718 15116 7111 5/7

718
113

988.12 988.12
988.12

718
13116

988.12 988.12 988.12
988.12

0.2 0.3 0.2 0.3 0.1

848 517 602 685

13/16
3/4 3/4 11116

2 1645.45
2 6724.56

0.2

489

11116
15/16 3111 13122 718 314 9114 517

1002.19
1269.35 1269.35 1002.19 988.12 993.10 993.10 993.10 2024.18 993.10 993.10

2 6514.03 2 1314.24
2 3535.86

0.5

0.4 1197 883 0.2 495 0.2

2 2133.51
2 211.32 2 494.56

2.15 1.98
1.02

0.3
0.0

920 707
207

1.66
1.45 1.76 1.52

0.0

292
210 601 236' 250

2 810.61
3 1164.20 2 1677.61 2 661.99 2 1780.17 2 1693.75

0.2
0.1

417
11136 417 517 3/4 11116 517 8111 13116 15116 15116

0.3
0.1

1.60
2.17

988.12
1002.19 1015.14 1269.35 1002.19 1002.19 1002.19 '1119.27 1015.14 1015.14 1002.19 1002.19 1269.35

0.2

529
630

1.59
1.45

2 603.02 2 6313.64
2 1718.27 2 4885.66

2.20
1.91 2.78

0.2 0.0 0.5

404 757

0.1 726 0.2 1135

2 4883.96 2 30U33 2 2879.39

2.19
1.13

0.3 1052
0.1

178
758

215
13114 13114 13116 15116 17122 112 7/11 13/30 5/12 112

2 3436.01
2 1371.59

2.56 3.05
1.93 3.01

0,2 0.2

637

1269.35
1269.35 1838.05 1838.05 955.14

2 2 2 2 3 3

4653;58
8841.47 1323.44

0.1 640 0.2 1078

2.67
1.41

0.5 1024

3049.77
10886.27

8539.90

1735.04
1704.86 1269.35 1269.35 1614.87 1614.87 1704.86 1704.86 1704.86 1107.24 1614.87 1107.24 1735.04 1704.86 1614.87 1107.24 1107.24 1275.50 1838.05 1838.05

2 599.42 2 11337.77 2 13798.67 2 2020.53 2 2541.98 2 10407.33 2 8127.00 2 9530.93 2 12662.39
2 11277.75
2 7668.05 2 2860.37

3.02 1.50 3.11 4.44 1.57

17128
19/30 15122 7111

1.55 2.94

2.90
3.79 4.26 3.74

15/28 15128 19/30
7/10

315
7/8 13128 718 112 8/15 15/28 11/16 7/8 13120

3.07 2.38
2.76 2.57

2 7720.03
2 8194.88 2 7963.41 2 5302.77

3.24
2.46 2.61 2.86

0.4 0.4
0.3

835 577
695 1173 609 357 285 110 ·1317

1838.05
1704.86

2 2 2 3 3 2

2
2

1704.86 1735.04 1704.86 1614.87 1704.86 1838.05 1704.86 1838.05 1704.86 1838.05 1838.05 1838.05 1838.05 1704.86 1704.86 1735.04 1735.04 1704.86 1704.86 1704.86 1614.87 1269.35 3228.67

2
2

2 2 7446.86 3 3052.43

4006.19 4744.34 1847.17 1307.15 4893.51 107.02 1445e.55 127.34 517.12 7761 . 78 3958.91

0.2

1.94
2.06 2.51 0.97 4.54 1.09 1.11 2. 73 2.17 2.95 1.95 3.96 2.24 1.93 1.68 2.20 1.83 1.12 4.02 3.35 3.76 3.04 3.54 3.71 2.21

0.2
0.2
0.4 0.0

2/5
113 3/10

OA
0.0 0.0 0.5 0.4 0.4 0.4

104
465 722 579 846

213 1/5 3!7

2 13061.42

3 4827.05 1 3222.96
3 1223.75 2 5391.40 3 1009.98 2 443.51 2 11654.12 2 9003.97 2 16206.84 2 7874.30

204 OA 1422 0.4 435
0.4 242

0.2

294

0.4 545 0.2 211 0.2 148 0.4 1407 0.4 1014

19130 23/60 113 3!10 13130

1/4
3110 19130

315
19/28

0.6

960

2 9034.20
2 9168.30

2 2607. 82 2 5778.92

0.5 510 0.4 854 0.4 1012 0.2 636

15128
17130

3/5

8115
15/28 5/11 1/8 113

2.29
1.32 0.85 1.39

2 45e.75
2 206.03 2 347.82
2 97.47 3 469.72 3 529.34 2 430.79 3 790.76

0.4 0.1
0.1

604 286
59

1235.42
2915.31

0.1

97

97.47 0.97
999.05
1.81 1.67 430.79 1.12

12585137.0 0.0
46260&.0
0.1 0.0 255111.0 0.1

86
105 308 325

4/25
15192 17192 417

2623.97
2623.97
1007.12 2579.89 1315.63 2887. 28

790.76 1.98 3136.09
1.40 0.94

29789052.0 0.1 7305033.0
0.1 0.1

286
303

2/11
17/44 2/13

3 466.89
2 124.62

67

105

Table 2 continued

phagrawFsuc150_dec22, 40 phagrawF350_dec20, 714 phagraw F suc800 _dec 23, 1164 jmfagfrench5m inigg1m nacldtt. 51 7 rawextr 600baad Mar04, 972 jmfagti.;;econ10,;in, 1584 RawPhag2007E tBeadsdigest_030718152503, 1214 oimll2.r to erythrocyte membrane protein bond 4.11ike 46; EHM2 gano; F rawphag2007chf bead3, 503 rawphag2007chl fsol2, 746 phagrawFchlfbead_dec23, 1815 AJRAWActinContr.June13, 474 Snx27 protein [Mus mu sculus] rane protein band 4. i rawsucrfp_600phagi gg_Mar04, 2000 rawsucrfp_400phagi gg_Martl4, 2155 erylluocyte pro tein band 4.1 -llke 4b ; expr"""ed in high-metast atic ce ll )mlggactinrawphag3007, 904 jmrawigg5m inbeads yrlngdnass, 1429 jmraw5minigg500m mnaclsd, 1560 jmraw5mlnigg600m mnaelsd, 1720 jmrawigg5minbaadsfreezethaw, 2788 orythrocyte pro tein band 4. 1-lik~ 1 [Mu" tnuoculus) phagraw F250_dec22, 1295 jmfag1mnacl2,5minigg. 646 AJRAWSoluteContrjune13, 746 jmbaads600nacl rawphage3007, 1579 jm lgG 350nac lrawphag3007, 1269 E4L2..;MOUSE Band 4.1-likG p rotein 2 (Generally expressed protein 4.1) (4.1G) AJRAWActilllgGjune13. 2638 ery1hrocyto protein b2nd 4.1-llke 3; DAL 1P [Mue muoculus] rawex tr 60Me0 Hooad Mar 04. 854 rawextr- 1000baad Ma;M, 1628 jmbe3d;400rawp ~g3007. 1249 FPbeads 150_Dec19, 751 phagrawF450 _dec20. 1202 jmfag5minigg350mmnacl, 435 jmrawigg5m in 350m mnac lsyringednas e. 1043 ajrawphog1MNaCI 20. 1272 jmfagfrench5m tnigg1m nacldtt, 1571 jmrawrminigg200n1mnaclsyringdnas, 2974 erythrocyte protein b~nd 4.1 (Mus musculus) phagrawFsucchlfbaad_dec23. 678 jmooads250rawphag3007. 662 jmfagcon5m inn600m mnacl , 3" 147 FPbeads250_Dec1 9, 1560 FPbeads700 Dec19. 1619 rawextr_60M;O Hbaadlgg__M ar04. 1832 rawextr_700beadi gg_M arQ4, 2402 FPbaads 1000 Dsc 19. 3218 ajrawphagj unioactinDPI .648-650 jmraw5mlnigg600mmnaclsd, 1330 ajrawphag1MNaCI20, 1732 phagrawFsuc150_dec 22. 606 rawsucrfp_500phagi gg_M ar04. 1584 JMFAGNACL 15S21E 3, 124 jmfag5m inigg350m mnacl .283·285 JMFAGNACL5S21E3, 1636 similar to Ccfilin, no n-muscle lsoform [Mus musculus] r.wextr_800baad:._Martl4. 562 cofilin 1, non-muscle [Mus musculus] jmfag1mnacl5m incon.482-484 jmfag1mnacl2,5minigg. 1102 JMFAGNACL5B21E 3, 1106 jmfag1 mnac l2. 5minigg, 1108 jmlag5minigg400m mnael, 1152 jmfag5minigg1000m mnacl . 1198 jmf ag1 mnac l5mini gg. 1264·1266 jrnfagtim ocont0min_030601230741, 1612 jmfB(ltimecon5min. 1682 ~ofilln 2, mu.Mic [Mt.is nmsculus] rawextr_1000_baadlgg_M ar04. 1550 FERM, Rf>oGEF 2nd plockstrin domain protein 2 [Mus museu Ius] FPbaads350 Dec19, 715 rawex tr_200beadi gg_Milr04.847·849 rawextr_450baad_Mar04. 896 rawextr_chlfbeadl gG_M artl4. 990 rawextr_700beadi gg_Martl4. 1620 rawextr_600bead__Mar04. 1792·1794 FPbeads250 Doc19, 1878 phagrawF350_dec20,634-636 phagrawF500_dec20, 735 phagrawFsuc450_dec 20.1332·1334 rawsucrfp_chlfphagigg_Msr04, 1336 rawsucrfp_300phagi gg_Martl4. 1529 rawsucrfp_600phagi gg_Martl4. 1716-1718 phagr·wFsuc400_dec 20, 2768 JMMAG Tuba1816E3, 384 jmfag5minigg250m mnacl ,854·856 JMFAGNACL 10 2B21E3, 2946 jm5mini ggrawlo;;;onic. 890 jmlgG1000ru.cl rawphag3007, 2468 jmrawigg5minbeadsfr..,zell1aw . 2518 jmraw5minigglowionic:2597·2599 jmfagtimecon5min, 137 jmfag5mincont350, 1448 jmbeads250rawphag3007. 1746 jmfag5minconl400_0305311518 34. 2066 jmfagtlmecont0min~030601230741, 2146 FERM domain containing 3 [Mus musculus] jm fag5m~ncon450m mnacl . 1982

· .FGSISYK .· ·IHKTLMGQAPSEAELNYLR.· ·.AHNSG EDS DLKQ RR.· · ETQ FELR. · · .IHI<T LMGQAPSEAELNYLR.· ·. FGSISYKHRYR .· · .IIAPSPVK.· · .KPVSLATSEF YDLR.· · .ALTTAFER.· ·.SCCANDPA SILPGLTDECCA PIIK.· ·.PSQYLALKA KDAS YR.·

801.91 2172.49 1613.68 923.01 2172.49 1414.60 825.03 1626.84 909.02 2435.85 1711.94

1 481.33 3 437.05 2 87.13 2 517.11 3 267.76 2 634.1 5 2 120. 02

2 445.96
3 146.33
3 772.89 2 294.41
2 513.67 2 160.08

·.GIHPSAPHRNGGGGGGSGLHCAGNG GGGGGGPRVVR.· 3175.42 · .GDRILEVNGVNVEGATHK.· 1909.09 ·.GAAGLGDERDGG PR. · · .EYRG KSPAQAE LSYLNK .· ·.ASNPIIAAQLCS K.· ·.ASNPIIAAQLCSK.· · .TSASGDGSHFD YVODQNQRNLGGAYSVTYR · ·.GACSTPEMPOFESVK.· · .APESDT GDEDO DOER.· ·.APESDT GOEDQ DOER.· · .SLDGAEFSRPASVSENHDA GPOGOK .· · .IIITGDEOVDODOALALAI K· ·.ATPLPAE GKKNTLR.· ·.KAEEATPVT ALR.· ·VIELHKSHRG MTPAEAEMHFLENAK.· · .RI\1TGDADI DHDOALAQ Ali<.· ·.PKSMQCK.· · .SGAWHFSFNVKFYPPDP AQ LSEDITR.· ·. LLL PEAP PKK FLTLGSK. · · .AEEATPVT ALRHE GKTOSER. · ·.LMDGSEILSLLESAR.· ·.DSVSMEVG TGQYATTKGISQTNLITT VTPEK· ·.QQPALEOFPEMAHSTPVKREI GDK.· · .ASNGDTPTHEDLTK· · .DVPIVHTETI\.· · .QVRGVPWNFTFNVKFYPPDPAQLTEDITR.· ·.THTEVTVPTSNGDQ TQK.· ·.SPRPTSAPAIAQSQVTEGPGRP IK.· ·.AKDLE GVDIILG VCSSGLLVYKDK · ~. TQTVTi SDT ANAV KSE IPTKDVPIVHTETK.· · .LDGENIYIRHSNLM LEDLDKS QEEIK.· ·.PKSQVSEEEGR.· · .LDGENIYI R· · .TLNINGQVPTGDGPPLVK.· · .ERLOG ENIYIRHSNLMLEDLD K.· ·.EVESEKEKGEGGQK.· ·.LRiNRFPWPK .· · .ISSK.RSS FFIK.· · .RVCEH LNLLEE DYFGLALWDSA TSK· ·. NWSGNMASGVADSDDVI K.· ·.HELOANCYEEIIK. · ·.LGGSAVISLEGKPL.· · .LGGSAVISLEGKPL.· · .LGGSAVISLEGKPL. · ·.LGGSAVISLEGI<PL.· ·.LGGSAVISLEGKPL.· ·.LGGSA VIS LEGKPL. · ·.LGGSAVISLEGKPL.· ·.LGGSAVISLEGKPL.· ·.KAVLFCLSDDI<.· · .TRTSLHALTVDLPK.· ·.HDEVLTELEKATKHCK.· ·.MFFLFSDMLLY TSK.· · .OLV DYVKDGGMKR.· · .l TELORDLVGVENLIAPGREFIR.· · .LTELQ RDlVGVENLIAPGREFIR.· ·.OLVOYVKDGGMKR.· ·.VCYLP LNTF LLK. · · .YLFA LOLKR.· -.VCYLPLNTFLLK.· · .GLQORMFFLFSDMLLYTSK. · ·.LTELQ RDL VGVENLIA PGREF IR.· ·.LTELORDLVGVENUAPGREFIR· · .VKLLDS TVELFDIEPK.· '.NSNGWOK.· · .KLEMYGIR.· · .LLLSRLCAHY SPG HRDYA OCH EAlK. · ·.YSGRTQK.· ·.LTELORDLVGVENLIAPGREFiR· ·.LEAVYKEFELOKVCYLPLNT FLLK.· ·.PKAKAVFFSR.· ·.GDHORIGDI LLRNM R.· · .MFFLFSDMLLY TSKSVTGASHFR· · .EFELQKVCYLP LNTFLLKPVQR.· ·.STAAER SSGPSS SDGPS TQSAHLPG PPVLR.· · .LLDSTV ELFDIEPKCDGQVLLTOVWK· · .EARQALSWSYSILTGHIWVNPLVK.· 1328.37 1955.16 1316. 55 1316.55 3295.40 1611.82 1692.59 1692.59 2559.60 2142.39 1496.74 1286.46 2877.29 2264.52 822.03 3011.29 1853.28 2198.34 1634.68 3269.56 2749.03 1486. 52

3 1530.85 3 142.44 2 174 .72
2 515.53 2 72. 67

0.91 1.58 0.99 1.40 1.48 1.06 0.93 1659.59 1.14 1. 10 1.53 1.06 673.74 1.05 0.95 2436.21 1.57 1.09 1.23 1.32 0.85

0.1 0.1 0.1 0.0 0.0 0.1 0.0 38076458.0 0.1 0.0 0.0 0.1 32425866.0 0.2 0.0 9506567.0 0. 1 0.0 0.0 0.1 0.0

31 2 203 43 368 173 378 119 327 131 485 105 63 168 331 130 141 188

7/12 19/72 7/26 3/4

219
1/2 317 5113 1/4 21 /92 11 4 4135 9/34 21/52 11 /64 7124 3/8 9156

65
387 380 406 257 346 118 573 266 231 159 146 187 307 271 47 145 414 136 113

2792.94 3 501.50
3 3 3 3 829.61 561,87 445.68 434.27 1.29 1.74 1.43 1.32 1.24 124.36 1.05 5942.45 1.85 1.45 1.48 1,14 1.00 1.18 1.81 1.33 0.64 1.18 5978.14 1.17 0.80 0.88

7305029.0
0.0 0. 1 0.0 0.1 0.0 17432986.0 0.0 7305031.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1

217 9/28 9/28 3/16 1/4
5113 17/44 11/48 17/80 5/12 11/50 15/64 21 / 76 2/7 7/62 3/16 15152

2 124.36 3 3 3 1 2 3 3 3 1061. " 1 9 469.55 363.26 219.75 1056.00 220.29 872.56 465.14

2 29.95
2 1184.75 3 2 2 3 2 3 2 571.59 137.59 118.43 247.17 57.60 11 34.57 60.78 2 164.66 2 252.30

0.0
0.3 38570129.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1

1139.28
3437.85 1843.93 2446.75 2536.97 3225.59 3104.44 1248.31 1093.22 1821.07 2674.97 1534.61 1327.61 1300.53 2911.24 1866.00 1463.60 1341.58 1341.58 1341.56 1341.58 1341.58 1341.58 1341.58 1341. 56 1239.47 1552.80 1882. 13 1744.1 1 1509.76 2640.03 2640.03 1509.76 1424.78 1152.41 1424.78 2326.77 2640.03 2640.03 1847.14 833.87 1010.24 2870. 26 839.92 2640.03 2903.47 11 51.39 1795. 06 2687.13 2680.20 2935.11 2001 .45 2770.18

1/3
9/55 7/32 7/46 17/ 92 4/29 4125 9/20 1/2 4/17 4/21 9/26

1.15
0.72 1.53 0. 81 1.00

209
62 303 63 67 89 254 205 214 66 129 448 229

1.03
1.1 3 1.57 1.26 1.61 1.20 'i. 42 1.93 1078.04 1.87 34282.87 4.43

189.51 2 233.95 3 637.71 3 442.77

2 3 3 2

290.14 649.93 789.43

0.0
0.1

0.2
0.1 0.1 0.0

1/3 318
17/96
19168

0.0

3 1078.04 2 19696.62 2 1593. 75 2 349.78 2 572.02 2 3039.24 2 784.81 2 5166.49 2 17'17. 76 2 1362.41 2 135.49 2 3 2 2 3 3 2 2 1 2 3 3 3 2 2 3 3 2 2 2 2 3 3 2 323. 84 359.90 206.93 268.35 2822.38 1463.96 79.53

31!050273.0 0.1 356 6000924.0 0.5 1476

19/22
15126 11/26 9/26 7/13 6/13 8/13 15/26 15/26 1/4 29 11/ 26 1/5 4/13 3/8 23188 19/88 5/24

1.63
1.10 1.39 2.05

0.2
0.1 0. 1 0.3 0.1

548
240 195 478 406 728

1.57
2.60 1.64 1.49 135.49 0.90

0.3 0.2
0.2 6671746.0 0.1 21704022.0 0.0 0.0 0, 1 0.1 0.3

504
485
86

13282.41
1.10

2.00
1. 11 1.17 2.30 2.48

0.2
0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2

0.88
1. 55 0.96 1.38 1.38 2.10 1.85 1.41 1.42 1.08 1. 10 0. 72 1. 75 0.92 0.92

365.12
264;06 354.85 315.51 1138.66 592.54 573.98 630.54 283.24 262.45 71 .68

0.0
0.1

0.0

o.o
0.2
0.1 0.0

3 1282. 23
131.68 141.67 208.32 50'1.64 455.21 109.03 2 74.72 3 451.01

1.02
1.66 1.67 0.87 0.68

0.0
0;0 0. 1 0.0 0.1 273703111.0 0.0

291 157 95 157 523 252 84 210 276 253 227 330 242 175 429 69 235 81 274 64 136 204 297 241 111 43 283

9/22
9/16 9/22

1/4
19/88 9144 3/10 314 9/28 17/96 5/12 9/44 9/46 1/3 9/28 17/88 17184 5129

4125
9/46

846.11
1.56

106

Table 2 continued
jmfag5mincon250mmnacl, 2758 capping protein (s.ciin filament), gelsolin-like [Mus musculus] jmfag1 mnac10minigg, 266 jmf~g1 mnG'!cl5mincon, 302 jmfag1mnacl5mincon, 316 jmfag1mnacl5minigg, 326 JMMAGNEGB16D3, 352 JMMAGTube1B16E3 , 362 jmfag5minigg600mmnacl, 398 jmfag1mnacl2,5minigg, 406 jmfag1mnacl2,5mmlgg, 410 jmlag1 mnacl7,5minlgg, 414 jmfag5minigg350mmnacl. 1003 jmfag1mnacl7,5minigg, 1142 jmfag1mnacl5minlgg, 1276 jmfag5minigg400mmnacl, 1320 jmfag1mnacl5mincon. 1326 jmiag5minigg500mmnacl, 1494 jmlag5minlgg300mrnnacl, 1776-1778 JMFAGNACL 5621 E3, 2938 profilin 1; actin binding protein {Mus musculus] JMFAGNACL5B21E3, 994 jmfag5minigg150mmnacl, 1014 jmfagSminigg600mmnacl, 1172 jmfag1 mnact5minigg, 1ns jmfag5minigg350mrnnacl, 1413 JMFAGNAC L5821E3, 1424 jmfag5minigg250mmnacl,1482-1484 jmfag1 mnaciOminigg, 1496 jmfag5minigg200mmnacl, 1516 jmfag5minigg450mmnac1 __o30527025134, 1632 JMMAGTube1B16E3, 1818 jmrawigg5minbsadsfreszethaw,1390-1392 jmrawigg5minbeadsfreezethaw, 1516 jmra\wminigg200mmnaclsyringdnas, 1854 jmrawrminigg200mmnedsyringdnas, 2002 Jm5mil1iggrawlowionic.2132-2134 jmlreebeadsrawphag3007, 1122 jmlagtimecon2.5min.1368.1368.2 Jmfagti mecon2.5min.1658.1658.2 jmfagtimecon7.5min.1824.1826.2 jmfagtimecon7.5min. 1506.1506.2 ;mfagtimecon2.5min.2000.2000.2 jmfagtimecon2.5min.1664.1664.2 jmfagtimecon2.5min.1364.1364.2 ;mfag5mincont350, 122 jmbeads500rawphag3007, 1246 jmbeads600naclr.owphage3007, 1273-1275 jmfag5mincont400_030531151834, 1456·1458 ;mfag5mincon450mmnacl, 1470 jmfag5mincont150mmnacl, 1473 jmfag5mincont350. 1494 ;mfagtimecon5min, 1593 jmfag5mincon300mmnacl, 1640-1642 jmfagtimecont10min_030601202502, 1692-1694 jmfag5mincont200mmnacl, 1704 jmfagcon5minn600mmnacl, 1713 jmfag5mincont200mmnacl, 1714 jmfagtim econtOmin_030601230 741 , 1798·1800 ;mfagtimecont0min_030601230741, 1802 jmfagtimecon5min, 1860 jmfagtimecont0min_030601230741. ·1946 Jmfagtimecont10mih_030601202502, 2026 jmfagtimecont10min_030601202502, 2030 jmfag5mincon450mmnacl,2042-2044 jmbeads250rawphag3007, 2062 ;mtagtimecont0min_030601230741, 2106 jmfagtlmecont0min_030601230741, 2114 phagrawFs"c60MeOH._dec23, 1168-1170 rawphag2007chib~sd3, 2239 phagrawF300_dec20, 1295 Wiskott-Aidrich syndrome protein interacting protein; WASP Interacting JMFAGNAC L 10_2621 E3 ,436-438 jmfag5minlggbead, 1865 jmfag5minigg200rnmnacl, 2286 JMMAGTube1816E3, 2294 jrnrowigg5m inbeadstreezethaw, 778-780 rawextr_150bead_Mar04, 625 rawextr_200bead_Mar04, 1090 rawextr_60Me0Hbead_Mar04, 1542 rawaxtr...,_350beadigg2~Mar04, 1064 rawextr_chlfbeadlgG_Mar04, 1592 rawextr __1000_beadlgg_Mar04, 2067 rawphag2007chfbead2.470-472 phagrawFsucchlfbead_dec23, 1628 jmfag5mincon450mmnacl, 1772 phsgrawF250_doc22,17HJ-1721 phsgrawF200_dec22,2009-2011 phagrawFsuc450_dec20, 2694 Wasp-binding protein [Mus musculus! rawsuclfp_actinphagigg_Msr04, 1324 rawsucrfp_chlfphagigg_Mar04, 1370 FPbeads600_Dect9, 696 FPbeads800 _Dec19, 2024 jmlgG150rawphag3007, 1148 jmlgG400rawphag3007, 1596 JMMAGNEGB16D3, 1520 jmfag5minigg1000mmnacl, 1702 jmfag5m·nigg1000mmnacl. 2078 JM FAGNACL 15621 E3,211 0-2112
- .t:WVAGKVNIVL YMLGCS.-.VSDATGQMNL TK.-.VSDATGQMNL TK.-.VSDATGQMNL TK. -.VSDATGQMNL Tl\.-.VSDATGQMNL TK.-.VSDATGQMNL TK.-.VSDATGQMNL TK.-.VSOATGQMNL TK.-.VSDATGQMNL TK.-.VSOATGQMNL TK.-.QMLQVADGFISR. -.EGNPEEDITAOQTNAQAAALYK.-.QMLQVADGFISR-.ELQGNESD LFMSYFPRGL K. -.EGNPEED ITADQTNAQAAALYK.-.QAALQVADGFISR.- .QAALQVAOGFISR.-.DEQGACAVL AVHLNTLLGERPVQHR. -.TLVLLMGK.-.DSPSVW AAVPGK.-.SSFFVNGL TLGGQK.- .STGGAPTFNVTVTMTAK.-.TFVSITPAEI!GVL VGK.-.TFI!SITPAEVGVL VGKDR.· -.DSPSVW AAVPGK.-.TFVSITPAEVGVL VGK.- .SSFFVNGLTLGGQK.-.TLVLLMGK. -.DSLLQDGEFTMDLR .-.TFVSITPAEVGVL VGKDR.-.TFVSITPAEVGVL VGK. -.TFVSITPAEVGVL VGKOR.- .TFVSITPAEVGVL VGK.-.TFVS1TPAEVGVL VGKDR.-.SSFFVNGLTLGGQK.-.SSFFVNGLTLGGQK.- .TFVSITPAEVGVL VGI<.-.SSFFVNGL TLGGQK.-.TLVLLMGK.-.DSLLODGEFTMDLR .-.TFVSITPAEVGVL VGK.-.SSFFVNGLTLGGQK.- .EGVHGGLINK.· -.TFVSITPAEVGVL VGKDR.-.TFVSITPAEVGVL VGKDR.-.TFVSITPAEVGVL VGK.-.DSPSVWAAVPGK-.TFVSITPAt:VGVL VGK. -. TFVSITPAEVGVL VGK.-.STGGAPTFNVTVTMTAK.-.DSPSVWAAVPGK.-.TLVLLMGK. -.TFVSITPAEVGI!L VGK.-.TFVSITPAEVGVL VGK. -.TFVSITPAEVGVL VGK.- .SSFFVNGLTLGGQK.- .SSFFVNGL TLGGQK.-.STGGAPTFNVTVTMTAK.- TFVS1TPAEVGVL VGKDR.- .SSFFVNGLTLGGQK.-.SSFFVNGLTLGGQK.-.TFVS1TPAEVGVL VGK.- .DSLLODGEFTMOLR .-.TF'v'SITPAEVGVL VGK.·.TFVSITPAEVGVLVGK-.TFVSITPAEVGVL VGKDR.-.05LLQDGEFTMDLR .-.TFI!SITPAEVGVL VGKDR.-.SGPLPPPPS ER.-.PVPSSL HNRGSPAGLGAPRPPFPGNR .-.POSLPPPVPNTPR .· .GSPAGLGAPRPPFPGN RGMFGAGSAR.· -.DNDSGGSRPPILPPGGR.·.DNDSGGSRPPILPPGGR.-.DNDSGGSRPPILPPGGR.-.PPFPGNRGAAFGAGSAR.-.DNDSGGSRPP1LPPGGR .· -.MPVPPPPAP PPPPTF ALANTEKPTLN K.- .QNPSGS$SPFPRP PLPPTPSRA LOOK. -.GSPAGLGAPR· -.PPVPSTPRP GLGSOAPPPPPPPS R.-.PDSLPPPVPNTPR .- .PPFPGNRGAAFGAGSARQN PSGSSSPFPR.-.PPFPGNRGAAFGAGSARQN PSGSSSPFPR.-.QNPSGSSSPFPR.-PPGSAASGRPHDOTDSNR.-.TPAGPPPPPPPPL RNGHR.-,DAPPPP PPYR.- .YSFHPVED FPAPEEYKHL OR.-.SAPVIEKPRGSSGGYGPGAAALQPK.-.GLAPPPPTSATPSL LSNR.-.GSSGG YGPGAAAL QPK.- .GSSGGYGPGAAAL QPK.-.PPPPAREPPSRGAAPPPP PPMIR.·.ASLPEL PRMQR.1883.27 1265.42 1265.42 1265.42 1265.42 1265.42 1265.42 1265.42 1265.42 1265.42 1265.42 1376.54 2350.44 1376.54 2232.50 2350.44 1376.54 1376.54 2728.09 875.16 2 195.11 2 1325.09 2 5754.67 2 6448.84 2 3397.37 2 3238.32 2 3535.89 2 5050.06 2 4891.13 2 4174.01 2 4861.48 2 7861.09 3 934.34 2 6901.22 3 288.83 2 12680.59 2 7143.35 2 1695.43 3 295.35 2 257.29 1.21 80477.06 1.49 2.66 2.90 1.91 201 0.0 157 679 925 9132

001.10842.0
0.1

0.4

2A2
2.48 2.05 2.34 2.38 2.42 1.62

2.28
1.24 3.43 2.31 1.94 1.32

0.4 999 0 .2 1483 0.3 978 0.2 1210 0.3 1080 0.4 984 0.3 996 0.3 1395 0.5 765 0.1 549 0.5 773 0.1 201 06 607 0.5 653 0.2 457 0.0 223

17/22 9111 15/22 9/11 15122 8111 8/11 9111

518
11142

213
5124 17142

518
7112 17196

232299.93 1214.35
1455.64

6755040.0 232 0.3 1209 0.5 1005 0.0 139 0.5 753 0.0 178
0.0

10
1/2 15122 9113 9132 3/5 9134 8111 1'1115

2 3869.69
2 2 2 3 2 2 2 2 2 3 2 3 2 3 2 0 0 0 0 0 0 0 2 3 3 2 2 2 1 2 2 2 2 2 1 2 1 2 3 2 2 2 2 2 2 3 2 3 2 3 2 3 3 3 3 2 3 3 2 2 3 2 3 3 2 2 2 2 2 3 2 1 2 10560.62 211.48 7830.80 283.92 3567.48 10209.61 4722.71 1771 .10 3159.92 603.95 14304.61 1841.32 1814.70 1469.58 10519,74 10259.25 8100.41 13415.62 3611.23 1002.09 9892.53 12248.09 753.98 709.51 610.66 14117.92 612.42 4007 35 487.66 1970.97 265793 2435.40 10262.00 3941.40 218.35 4945.55 857.33 417.82 304.71 12075.82 8053.42 9531.98 1886.13 12432.22 1445.42 647.05 321.22 1067 53 820.74 1045.54 65.43 1293.26 1052.39 203.42 488.05 378.9!\ 481.59 413.14 292.33 176.70 233.86 500.44 229.66 618.33 725.72 144.76 211.64 32147 193.81 342.33 358.51 392.17 270.73

1.07 1.68 3.11 1.52

2.63
1.57 1.89 2.81

1389.19 1214.35 1617.91 1455.64 875.16 1640.80

0.3 1037
0.5 0.4 0.2 0.3

941
425

212

e113
11i14 5113 114 315 15/68 13130 9/34

449 326
254 604 175

1889.19 1617.91 1889.19 1617.91 1889.19 1455.64 1455.64 1617.91 1455.64 875.16 1640.80 1617.91 1455.64 1024.16 1889.19 1889.19 1617.91 1214.35 1617.91 1617.91 1683.91 1214.35 875.16 1617.91 1617.91 1617.91 1455.64 1455.64 1683.9'1 1889.19 1455.64 1455.64 1617.91 1640.80 1617.91 1617.91 1889.19 1640.80 1889.19
1134.27 2636.96 1387.57 2494.76 1692.82 1692.82 1692.82 1630.79 1692.82 2821.33 2747.02

0.1 0.6
0.3 2.10

0.2
0.2

2.09 3.24 3.21

336 209
814

0.5 0.5
0.5 0,5

662
658 792 545

2.50 3.54
2.06
1.65

0.3

1.59 1.43 1.40 3.33 1.38 2.43 1.30

0.0 594 0.5 653 0.5 1344 0.1 420 0.0 474 0.1 406

0.6 0.1

970 327
386 302

0.4
0.1

2J2 1.83
2.06
3.22 1.86

0.2
0.2 0.3

370
982 308 762 507 169

1.29
2.11

0.5 0.4 0.0
0.4

19130

112 4/15
8113 9/26 11132 114 19126

885
166 143

1.49

0.2
0.1

0.0

237

0.5 1182 Q.5 969 0.5 679 0.3 205
0.6'

574
265 307 206
382 215 9134 4/13 9134

0.2

0.1
1.10 1.70

0.1
0.2 23346579.0

9019.5.4
1.17

13
205 357

0.2
0 ,2

1.55 0.80

0.0
0.1

1.78
1.79 1.29

65 695

0.2
0.0 0.1

272
153

3113 19/64

114
15164

1.69
1.47

6S
115 240

0.1
0.1

0.1
0.2

224 88
142 114 1$8 122 175 313 67 73

882.99
2384.72 1387.57 2873.10 2873.10 1261.33 1837.85 1856.12 1107.24 2490.71

0.0
0.1 1.11

0.2
0.1

1.87
2.25 1.33

o,o

9/32 5116 5126 9150 419 4123 112

3892.96
1.04 1.45 1.05 1.09 1.62 1.22 1.39 1.37

0.2 37537556.0
0.1 0.1

2396.69 1777.02 1418.54 1418.54 2383.80 1298.54

3 408.47
2 242.48

1.37
1.09

0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1

225
40

205
293 258 184

227
181

419 4119 3116 11/34 1/3 113 5122 215

107

Table 2 continued
1768. 08 1220.40 2512.89 1329. 62 1491.64 2280.44 714.88 2425.71 1643.90 3024.29 876.00 3229.65 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540. 54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540. 54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540. 54
1540.54

jmfagtlmecon2.5m in.1826.1826.2 jmfagtimecon5m '"· 717 jmfagcon5m in1000m mnaci_030601180404,1876-1878 RawPhg2007M eEthmeth3di ges~ 3474 WASP family 1 [Mus musculus] jmfag1mnacl0minigg, 634 AJRAWActinlgGjune13, 984
rawextr actinbead -M ar04, 480

·EPPSRGAAPPPPPPMIR.·.EKPLPPTPGQR.-.KTPGPVRGLAPPPPTSATPSLLSN R.·.AARGAPPLPP ILR.· ·.QKNLDRPHE PEK.·.YAEDIFGELFNEAHSFSFR.· -.KGIQLR.· ·.PTPTCISSATGLIENRPQSPAAGR.· · .NIDPRHLCHTA LPR.· ·.QLSSLSKYAEDIFGELFNEAHSFSFR.·.GAPPPPPSR.· -.QAPPPPPPSRGGPPPPPPPPHSSGPPPPPARGR. ·. GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR. · -.GGGGGGGGGGGGGGGGGGQPLR. ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.-.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.· ·. GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGOPLR.-.GGGGGGGGGGGGGGGGGGQPLR.· .GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.-.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.·. GGGGGGGGGGGGGGGGGGQPLR.· .GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.· .GGGGGGGGGGGGGGGGGGQPLRPPWGSNI<GR. · ·.GG GGGGGGGGGGGGGGGGQPLR. · ·.GGGGGGGGGGGGGGGGGGQPLR.· -.RSRVIH.SSDEGEOOTGEDEEDDEWDD.·.GGGGGGGGGGGGGGGGGGQPLR. · ·.GGGGGGGGGGGGGGGGGGQPLR.·.VIHSSOEGEDQTGEDEEDDEW DD.· ·.GGPPPPP PPATGR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· ·.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· .GGGGGGGGGGGGGGGGGGQPLR. · -.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· ·.GG GGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· -.GGGGGGGGGGGGGGGGGGQPLR.· -. GGGGGGGGGGGGGGGGGGQPLR.· ·.YRG LPAP GPGPTDKK.· ·.GGGGGGGGGGGGGGGGGGQPLR.·.GGGGGGGGGGGGGGGGGGQPLR.-.NELRRQAPPPPPPSR.· ·.TGGVEAVK.· ·.GRGAAPPPPXR. · -.TG GVEAVI<.· -.TGGVEAVK.·.RAAPTIPPPPVKR.· ·.AAPTIPPPPVK.· -.RQGPEHSPTLRQVCHDQQR.· .NTGLSHELCRV AIASWWVTSR.·.LQGMEQDVLQAIDRAIEAVHNT AMRDGGK.' ·.AAPTIPPPPVK.·.DMQTDTQDHQK.-.DREALVISGSGGR.· -. VAIASWWVTS RPPCSQLTYHG AGPPLAGR.·.AIEAVHNTAMR.· ·.LLLLLNRGD DPVRI FR.-.PPCSQLTYHGAGPPLAGRRQGPEHS PTLR.· · .RAAPTIPPPPVKR.·.SAVGHEYVADVEK· .SAVGHEYVA DVEK.· ·.I<TTPIEAASSGARGLK .· -. EEE EKAQQMARQQQER.-. DRVDKSAVGFNEMEAPTTAYK.· ·.ELESGPKASHGYGGR.·

0 2 3 2

301 .99 78.10 564.15 62.35

rawextr-900bead Mar04, 1316·1318 jmfagc.;;,5m iml600m mnacl. 729 jmfagcon5m in1000m mnacl_030601180404. 1084 N-WASP protein [Mus musculus] uaculus]6 jmfag5mincon300m mnacl . 774 phagrawFsuc500 __dec 20, 1690 Wlskoii-Aidrich syndrome homolog; Wlskott-Aidrlch syndrome protein [Mus jmra.VIgg5min300m mnaclsyring'>dnase, 557 jfnrawlgg5m in400m mnaclsd, 583 jmfag1m nacl0minigg,646- 648 jmfag5ininigg350mmnacl,651-653 jmfag5m il\igg600m mnacl, 658 jmfag5mlnigg000m mnacl. 662 jmra\\4gg5m in beads freezethaw ,69&698 JMFAGNACL5B21E 3,712·714 jmfaglmnacl2,5minigg, 724 jmrawlgg5m in 150m mnac I,750-752 jmfag5minigg400mmnacl,772-774 jmfag1mnacl5minigg,858-860 jmrewrminigg200m mnaclsyri ngdnas , 1032 jmrawrminlgg200m mnaclsyrlngdnas , 1086 jmraw5minigg250m mnaclsyringdnase,12G6-1268 jmlag5m inigg450m nmoci_030527025134, 1292 jm5miniggrawlowionic, 1338-1340 jmfreebeadsrawpllag3007, 356 jmfreabsadsrawphag3007, 494 jmfreabeadsraw phag3007. 588 rawextr 700beacl Mar04. 685 rawextr)00bead)Aar04, 768-770 rawextr_900bead_Mar04, 788 ravrextr_350bead_Mar04 , 846-848 rawextr_250bead_M~r04, 928-930 rawextr chlfbead Mar04. 942 nw.'extr:chllbead=M ar04, 94e rawextr_actinbead_M ar04, 974 rawextr 60M&O Hbead Mar 04,976-978 rawextr:actinbead_M ar04, 978 rawextr _200bead_Mar04. 1022 rawextr 200bead Mar04, 1028 rawextr-300boad-Mar04, 1764

2 740.94 3 979.81 2 266.41 2 217.23 3 1396.37 3 152.26

2 448.41 3 124.82
3 4979.03 3 5236.90 3 5998.14 3 5855.63 3 5500.02 3 5680.34 3 7264.94 3 4936.15 3 1639.17 3 3815.18 3 8578.55 3 5907.74 3 4956.37 3 3578.67 3 5648.67 3 2804. 15 3 7624.63 3 6249.47 3 2260.95 3 2575.40 3 4800.83 3 4714.35 3 4446.21 3 8798.44 3 2836.50 3 4786.44 3 2826.89 3 5813.03 3 6676.43 3 6579.79 3 4615.15 3 3445.63 3 666.41 3 4016.42 3 3985.43 2 95.22 3 10557. 28 3 3112.43 2 120.94 2 340.48 3 7383.37 3 5869.50 3 5951.18 3 55S6.35 0 2232.31 0 5868.55 3 452o.62 3 3660.39 3 3580.35 3 2572.03 3 423530 3 2829.06 3 6246.99 3 11584.63 3 4488.56 3 521 .68 3 3774.22 3 2501.76 3 1819.22

1.07 0.85 1.89 0.70 3755.01 1.66 1.69 1.06 1.29 1.62 1.01 573.23 1.21 1.16 267733.21 2.27 2.13 2.77 2.43 2.27 2.22 2.30 1.79 1.52 2.07 2.49 2.57 2.24 1.98

0.0 0.0 0.0

2.21
1.66 2.65 2.48 1.47 1.90 2.07 2.44 21 2 2.83 1.51 2.26 1.75 2.51 2.46 2.53 2.45 1.91 1.70 2.38 1.67 0.81 2.69 1.74 1.02 1.23 2.68 2.67 2.30 2.10 1.91 2.43 2.03 1.99

JMMAG~NEGB16D3,686-688

jmfag5minlggbesd_030528200105.755-?57 jmfag5minlggbead_030528200105, 2377 rawphag2007chf bead2, 592 rawphag2007chf bead2, 606 rawsucrfp_chlfphagigg_M ar04, 2092 rawsucrfp__ 150phagi gg_Mar04, 1092 rswextr _chlfbeadl gG_M ar04, 754-756 rawextr~60M e0Hbeadlgg_M ar04,922-924 rawex tr_400beadi gg~Mar04, 996 jmrawigg5minlggfreebead, 618 jmfagtiillecon7.5m in.1162.1162.3 Jmfagtimecon7.5min.1158.1158.3 jmbeads250rawphag3007.616·618 jmbead~300rawpha g3007, 636 jmbeads300rawphag3007, &40 jmfag5mincont400_030531151834, 646 jmfag5mincont150mmnacl,667-669 jmfag5mincont350,696-698 jmfag5mincont200mmnacl,836·838 jmfagcon5m inr.tlOOm mnacl,897·899 )mfag5mlncon250m mnacl , 11 10 AJRAWAc!inContrjune13, 11 50 jmbsads350rawphag30072nd, 1230 jmfag5mincon300m mnacl. 1294 Wiskott-Aiclrich syndromo· like [Mus onusculus) Squ jrnfag5minigg150m innael, 438 JMFAGNACL5B21E 3, 494 JMMAGTube1B16E3, 766 jmfsg5mincont350, 528 jmfag5mincont200mmnacl, 641) Wiskott-Aidrlch syndrome homolog (human) binding protein [Mus museu Ius ra\Nphag2007chf bead1 , 1004 rawextr_200bead_Mar04, 158 rawextr_250bead_Marb4, 1938 phagrawF300_dec20, 1293 phagrawFsuc'l50_dec 22, 2582 jmfagc·oosrn~n"OOOmmm~cl-, 261 jmbeads150rawphag3007, 1680 JMFAGNACL5821E 3, 658 jmrawigg5m in 350m mnae lsynngednas e. 1361 JMFAGNACL 15821E 3, 1468 JMFAGNACL15B21E3, 1648 jmfag5minigg350mmnacl. 2287 jmfag5m iniggbead, ·1315 Heillatopoietlc cell specific Lyn substrate 1 [Mus musculus] jmfag1mnacl5minigg, 354 jmfag1mnacl5m incon, 378 jmfag1mnacl0m inigg, 696 jmfag1mnacl5minigg, 2740 jmlgG300rawphag3007, 1214 )mraw5minigg1000m msd, 1356

1540.54 1540.54 1540.54 1540.54 2532.68 1540.54 1540.54 3051.91 1540.54 1540.54 2652.46 1198. 36 1540. 54 '1540.54 1540. 54 1540. 54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540.54 1540. 54 1540. 54 1554.78 1540.54 1540.54 1712.94 760.88 1089.28 760.86 760.86 1388.64 1076.27 2273.48 2387.71 3168.55 1076.27 1347.40 1317.44 3080.51 1213. 39 1911.28 3082.45 1338.64 1404.51 1404.51 1587.80 2019.14 2330.58 1545.64

1.68
1.88 2.05 1.55 2.46 2.87 2.22 1.26

2.03
1.79 <1401.95 1.73 1.42 1.13 1.54 1.33 5671.46 1.22 1.28 1.37 1.54 0.91 1.40 1.02 1.41 0.90 1.31 0.85 0.95 0.93 15588.70 1.94 2.53 1.89 2.08 1.20 1.18

2 358.90
2 292.63 2 1156.53 2 77468 3 489.15 3 1440.90 3 498.18

3 228.38
2 3 2 3 2 2 239.40 446.89 572.90 657.85 74.45 380.26 3 145.06 2 371.95 2 146.12

3 720.98
3 2 3 3 2 4792.17 1478.87 1205.68 231.35 311.51

0.0 13994209.0 0.1 0.1 0.0 0.1 0.0 0.1 15706272.0 0.0 0.0 6578581,0 0.3 0.3 0.1 0.2 0.2 0.3 0.2 0.2 0.1 0.1 0.3 0.3 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0,1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.3 0.1 0.2 0.4 0.1 0.0 0.2 0.1 33083702.0 0.2 0.0 0.0 0.2 0.1 13507686.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13S38627 .0 0.1 0.4 0.0 0.0 0.0 0.1

276 83 288 89 343 377
2~·2

11 /32 31"10 7/32 5/24 1/2 17/72 315 4/23

56 840 110 362 102 1358 1525 2065 1891 1875 1848 2667 2431 1019 1655 2528 1269 2035 1613 2118 1681 2087 2489 1535 1336 1997 1731 1521 2444 1857 1648 1570 1732 2314 1817 1300 1589 361 1673 2350 62 2473 1772 90 185 2345 1662 1770 2367 1087 1909 1$09 1729 1958 1306 1423 1749 2165 2707 1811
~1 1

1'1126
131100 5/8 171128 5112 37/84 19/42 19/42 37/64 317 11/21 41184 31/84 3/ 7 13128 31184 19/42 317 37/84 3/7 13128 37/84 11/28

8/21
19142 19/42 5/12 10121 317 37/84 19142 19/42 10121

1397 1336 525

13/28 17142 5!12 13/62 5/12 13128 7/50 112 5/12 2/11 1/3 1/2 19/42 37/84 41 / 84 8121 19/42 5/12 37/84 19/42 5112 5112 37184 10/21 10/21 19/42 19/56 5/12 17142
19156 9/14 1/2 517 517 1/3 17/40

252
251 458 391 354 712 364 146 9!; 316 541 456 80 290 153 123 143 11 335 631 780 578 191 208

1/4
17180 9/58 318 1/2 318 9/56 11/ 20 115 5!28 7/24 318 1/2 17/ 30 7120 17180 5114

108

Table 2 continued

jmlgG250rawphag3007,2318-2320 jmfreebeadsrawphag3007, 1212·1214

jmrawigg5m;niggfreebead, 880 FPbeads300 Dec19, 1510 AJRAWSolut;,Contrjune 13, 736 jmfag5mincon250mmnacl, 1324 hematopoietic ce II specific lyn substrole 1 [Mus musculus] rawextr_450beadigg_Mar04, 864 rawsucrfp_350phagigg_Mar04, 1428 rawsucrfp_600phagigg_Mar04, 1450-1452 phagrawF200_dec22, 1617 phagrawFsuc450_dec20, 2178 Similar to cytopl<tsmic bets ..actin (Mus musculus] rawsucrfp_500phagigg_Mar04, 1648 similar to cytoplasmic b<tta-actin [Mus musculus] jmfag1mnacl2,5minigg, 1256 JMFAGNAC L 10_1 621 E3, 2618 rawextr_actinbead_Mar04, 986 rawextr 150bead Mar04, 1059-1061 FPbead-;;1000 D_;c19, 2864 similar to mul;,nt bela-actin (beta-actin) [Mus musculus) jmfag5minigg1000mmnacl.·l52·154 jmlag5minigg600mmnacl, 164-166 jmlag1mnacl5mincon, 608 jmfag5m inigg450mmnacl_030527025134,1000-1 002 AnXA1 protein ajmembphaglgGDPIJune16, 962 ajmembphaglgGDPIPJune19, 1214-1216 ajmembphaglgGDPIPJune19, 1786 ajmembphagiGGPJune19, 2522 ajmembphaglgGDPIPJune19, 1954-1956 ajmembphaglgGDPIPJune19, 2008 aJmembphagiGGPJune19, 2326 AnXJ\2 protein rawextr_250beadigg_Mar04, 1156 AnXA4 protein rawextr_250beadigg_Mar04, 1962 fMS-11 ke tyroslno kinss e 1 rawextr chlfbead Mar04, 70$ rawextr)50beadigg2_Mar04, 1056 FPbeads600_Dec19, 1124 rawexlr_150bead __Mar04, 1325 rawexlr_300baad_Mar04, 1658 rawextr_actmbaad_Mar04, 2000 ra&·GTPase-4!:1ctlvating protein SH3 domain binding protein rawextr_200bead_Mar04. 1516 rawextr_60Me0Hbeadlgg_Mar04, 1632 FPbeads150 Dec19, 1677 rawextr_350bead_Mar04, 1830 rawextr~actinbead_Mar04, 2106 rawextr_actinbead_Mar04. 2604 Rho GTPase-activating protein FPbeads400_Dec19, 1178 rawextr 200bead Mar{l4, 1194 rawextr=60Me0Hbeadlgg_Mar04, 2334 rawextr 700bead. Mar04, 2564 rawextr=chlfbeadi;,G_Mar04, 2698 RAB25, member RAS oncoiJGno family jmraw5minigglowionic, 513 FK506 binding protein 12-rapamycin associated protein 1 jmlagfrench5minigg1mnacidtt, 1123 jmigg450rawphag3007, 1472 jrnraw5minigg500mmnae:lsd. 2098 jmrgg600rawphage3007, 2276 jmfagfrench20minigg1mnacldtt, 2618 jmlgG300rawphag3007, 2780
ajrawphagactin20, 2966

-.HSSQTDMRGFGGKYGVER .· .KTTPIEMSSGARGLK .·.SAVGFNEMEAPTTAYK.- .KTTPI EMS$GARGLK · -.TTPIEMSSGARGLK.·.QSPLQN HLEDNEEPPAL PPR.-.ELEsGPKAsHGYGGQFGVER.-.KTTPI EMSSGARGLK .·.KTTPI EMSSGARGLK .· -.lsSEVW PPAEs HLPPESQPVRS RR.· -.KTTPI EMSsGARGLK .-.EITALAP5 TMKIKIITPPER.·.YGSARRSMTSSTPPTSTAN ASR.-. ELAD!TLDS PQNCS PGTKVDNLSEYR.· ·.EITVLVPSTMK. · ·.AEHDRMTROWTK.· -.RSMTSSTPPTSTANASR WTEQQTAK.· .RGILTLK.·.RGILTLK.· -.LCYVALDFK.· ·.RGILTLK.· -.GGPGSAVSPYP TFNPSSDV MLHK.·.DLAKDITSD TSGDFR.· -.GVDEATIIDILTKR·.GVDEA TIIDILTKR.· ·.GVDEATIIDILTK.· -.GLGTDEDTLIEILASR.·.GTDVNVFNTILTTR.· WISIMTER SETSGSFED ALLAIVK -.PQIYEKSVSSLP5PPL YPLGSR.·.QPVQETTAGRR.-.MATTQDYSITLN LVIKNVSLEDSGTYACRAR.·.LGKSL GRGAFGK.· · .VQMSWNYPGKATKR.· -.MPAEGED LKLSCWNKFLYR.- .FMQTFVLAPEGSVANK.·.PESKPDSOIPPORPQR .·.LPNFGFWFDDSEPVOK.-.DFFQNFGNV VELR.· ·.GGPSGGMRGPPR GGMVOK.· ·.EFVRQYY TLLNQAPDML HRFYGK.· -.KSPVGSW RSFFNL GK. · -.NESEPSEMK.· -.PHHSSEL TDKSPMPSTLPRDK.· ·.ELPNPLLTYOL YEK FSDAVSAATDEERLIK. ·.SVPISRTEVPPD DEPAYCPRPVYQYK.-.WLIGESGVGKTN LLSRFTR.· -.PQWYRHTFEEAEK.· -.YCKDLMGFGTKPR.·.ETSFNQAYGR DLMEAQEWCRK.·.VYLPRVL DIIRAAL PPK.· ·.LHEWEDALVAYDI<.-. KYPTL LEVL LNFLKTEQNQGTR.· -.LIHQLL TDIGR.· -.SSQGDAL ASGPVETGPMKK LHVSTI NLQK.·.YHPQALIYPLTVAS K.· -.VTEDLSKTLLLYTVPAVQGFFRSISLSR.· -.PLVGRLIHQLLTDIGR.· -.GFDETLAKEKGMN R. · .STAMDTLSSLVFQLGK.-.KAGTTVPESIHSFIGDGL VKPEALNK.·.EQSARMLGHLVSNAPR.- .NIDPRHLCHTALPR.· - .QLSSLSKYAEDIFGELFN EAHSFSFR .· -.QKNLDRPHEPEK.·.YAEDIFGELFNEAHSFSFR.-.KGIQLR.·.PTPTCISSATGL IENRPQSPMGR.-.VSIAVKQADEIEKILCHK.· -.PYLSAVRATLQMLCLENFSSQWERHNK.· ·.ELLLQPVTISR.· -.EISEMK.·.PVEGYDISFLITNFHTEQMYK.-.HNKPEVEV RSSK.·.LVDFVIHFMEEIDK .· · .LVDFVIHFMEEIDKEISEMK.· -.QGNMTAAL QMLKNPPINTK. · -.ALMGGVGSIVR.· · .IGQGASGTVYTAMD VATGQEVAIKQMNLQQQPK.·.KRYTVVGNPYWMAPEMINGR .·.FDEETQRTFLKEVK.-.SELDMLDIREIFR.·.DAISGIGTDEKC LIEILAS R. ·.TNAEIRAINEAYI<EDYHK.-.FMTVLCTRSYPHLR.· -.GSVHDFPEFDANQDAEAL YTAMK.·.QTFKSHFGR.-.VELKGTVCAANDFNPDADAK.· -.GSVHDFPEFDANQDAEALYTAM K.-. EEGGENRDOAOEDAQVM EILEIADTP5GDK.-

2024.14 1587.80 1716.89 1587.80 1459.63 2282.46 2106 .24 1587.80 1587.80 2743.03 1587.80 2210.67

3 593.03 2 1821.17 2 2714.07 2 576.32 2 482.59 3 660.97

1.56 2.19 2.22 1.43

00 0.1 0.3

379 629

5118

7i15
112

545
398 265 416

0.0
0.0
0.0

2/5
5/14 9/38 9/36 215 113

1.70
1.56

3 664.90 2 617.64 2 500 69 3 371.74
2 2001 .81

4156.79 1.59
1.44 148

6660187,0 0.1 0.1
0.0 0.0

325
309 335

1.45 1.67 493.52
1.48

240
643 261 360 373 306

9!46
13130 114

0.2 38061104,0
0.1

3 493.52
3 548.09
3 537.29

1725,40
1.44 1.44

38082980.0 0.0
0.0

114
115 1/2 13/44 11196 11112 314 13!32 11112 514 730

1218.49

2 357.75

1559.74 2725.93
801.01

3 175.43
3 106.84
2 2250.90

1.16 1.37
1.03

4912.95 2.12
2.26 '1.30 1.98

0.0 0.0 0.0 38085842.0 0.2
0.1 0.0 0.1
~502101

108 95 673 367
298 522

801.01
1072.30 801.01 2357.56 1641.72 1544.78

2 1177.67 3 400.49 2 1083.88
3 7670.87
3 2978.07 2 7913.82

56217.77
170233.20

3.42

170233.20
170233.20 170233.20 170233.20 170233.20 170233.20 10.1 10.2

2.60
3.09 2.31

1544.78
1388.59

3 1843.39 2 13791.86
2 13229.97

1703.87
1551.73 1036.23

2 8789.79
1.64

4.22 3.66 0.4 3 03 0.4 13435564 1.639 0.26 33416530
3.676 0.48

0.4 0.2 0.5 0.2 0.4

518
246 1477 2007 1120

365.4
1852.6
204 107

1667.34
2416.76

3.68

3622.36 1243.36 3435.88
1191.41 1666.93 2313.73

3 312.66 2 211.06
3 2 2 3 993.86
128.48 190.57

3622.37

34 328180 1.50
1.10

0.0

3622.37
3622.37 3622,37

3622.37
3622.37

1.67 0.88 1.15
2.47

1785.74

0.1 0.2 0.1 0.1 0.2
0.2
0.1

183
103 104 459 317

26117.S3 1740.02
1861.05 1939.16 1565.75 1727.01

7 305 075
2.34 1.3 1

2 2199.74 2 237.63 2 18803.69 2 4439.27
2 328.15

41199.84 41199.84

131
1249

41199.84 41199.84
41199.84

4.18 2.52
1.35

0.6
0.3

2891.30
1710.96 1051.11 2361.62 3455.86 3008.35 2147.51 1721.85

2 109.06
2 2 3 2
559.97

41199.84 2417,66
2417.66

0.96

0.1 0.0

964 197
108

28 893 539
1.52 1.06

97
384 147

553.94 193.42

2417.66 2417.66
2417.66

1.32
0.82

59.87 2 1050.46

2417.66 781.41
781.41

3 781.41
2 343.30 2 190.36 3 528.44
2 987.09 2 810.13 2 159.46 2 112.19

6210.96 3541.04
3541.04

1.31 31980338 1.75 9 910 228
1.37
0.98

0.1 0.3
0.0
0.0

39 132
426
237

1516.81 2563.81
1935.39

0.0
0.0

1589.73
2607.00

3541.04 3541.04 3541c04
354t.04 3541.04

1.81
2.08

0.2
0.2 0.1 0.1

jmrawrminigg200mm naclsyringdnas, 3376 FPbeado600 Dec19, 652
FPbeads500=dec19, 1340 FPbeads400 Dec19, 1396 rawextr aoob;,ad Mar04, 1876 rawextr-60Me0Hbead Mar04, 2124 rawextr=chlfbeadlgGJ~ar04, 2690

1279.51 2995.40
170'1.99

1.16 1.06 0.79
1.04

192 288 185 245
121

117
81

3142.64 1802.16 1596.79
1698.96 2710.08

2 3 2 2

240.73
1114,90

143.28 290.53

3541:04 2837.35 2837.35
2837.35 28$7.35 2837.35 2837.35

0.1
0.1 0.0

1.&6 1.02
1.07

2339.15 2 284.41

jmrawigg5minbeadsfreezethaw, 996 WAVE (WASp family protein member 1) jtnfagcon5mi nn600mmnacl, 729 jmlagcon5mi n1000mmnaci_030601180404, 1084 jmlag1mnacl0minigg, 634 AJRAWActinlgGjune13, 984 rawextr actinbead M ar04, 480 rawextr-900bead Mar04, 1316-1318 Arp213 ~ompl ex FPbeads150_Dec19, 1767 FPbeads300 Dec19, 3958 JMMAGNEGB16D3. 1168 JMMAGNEGB16D3, 1738-1740

1767.01
1643.90

3 497.65 3 169.35
3 1396.37 3 152.26

3024.29 1491.64 2280.44 714.88 2425.71

2 740.94 3 979.81
2 268.41 2 217.23

1269.52 736.36

3 333.84 3 140.21 2 2742.43 1 188.08
3 1250.34

3541.04 3755.01 1548,63 1548.63 740.94 1720.75 485.64 485.64 289l12.90 474.05 474.05
4675.33

0.82 1.18 1.69 1.22 13 994 209 1.62 1.01 1.66 1.69 1.06
1.29

0.1 0.1 0.0
0.1 0.0

655 130 182 219 237
230 131 840 110

0.0 0.1 01
0.1

343 377
252 56

0.0

0.1
0.1 0.1

5031595
1.02

300
93

4675.33
11268.94

jmbeads250rawphag3007, 1548 jm5mtniggrawiowionic, 3162
AJRAWSoluteContrjune13, 1034 jmfag5mincon250mmnecl, 3160 ajmembphagiGGDPIRJUne192nd_030622052702, 1078 ajmembphaglgGDPIPJune19, 798

2533.84
1410.56 1736,03

2453.86 2082.41
1071.26 3464.92

2 3 3 3 2

344.58
535.42 9483.18

3'153.52
11268.94 11268.94

3463.05 10421.79

42493.42
42493.42 396.42 396.42 1083.84 1433.95 1433.95 10383.01
1.74

PAK (p21 (CDKN1A)-sctivated kinsse 1 jmfag1 mnacl5rninigg, 2626 UM kinase
rawextr__200bead_Mar04, 76 FPbeads400_Dec19, 2114 Anxs6 protein [Mus muscuiua]Gin [Mus musculus] X& JMFAGNACL15B21E3, 1026 jmfag5minlgg500mmnaci, 1444 jmbeads250rawphag3007, 1172 jmbeads150rawphag3007, 1932 jmfagtimecon!Omin_030601230741, 2122 RawPhg2007MeEthrneth3drgest, 1206 rawextr 150bead Mar04, 1635 rawextr)50beadlgg_Mar04, 1694 ANX6_MOUSE Annaxin A6 (Annex In VI) (Lipooortin VI) (P68) (P70) (Protein Ill) (C rawextr_200beadigg_Mar04, 751

2 396.42

2383.78
1770.97

3 691.05 2 372.78 3 565.68 3 495.94 3 738.30
2 306.27 3 6334,53

1.15 2.1 1 1.26 2.17 0.94 1.36 3.55 2.44 2.98 6754973 0.93 6754 548 1.20
1.16

0.3 0.0 0.2 0.2 0.1 0.5
0;3
0.5

526
149

278
135

370 532
715
909

0.2
0.2 0.1

84

162 245

135427&2.0
0.0 311

12
'113

1637.88
2105.40

2166.34
1725.08 2557.73 1108.24
2079.28 2557.73

1.41 1.46 1 08 2.82
0.82

0,1 0.2 0.1 0.4
0.0 0.0 0.1

2 130.87 3 481.15 3 1330.26
3 1325.93

1.21
1.87

211 236 134 605 142 399
515

7138 4117
9126

1

23188 112 114
23/88

1325.93

3287.36

1.79

113963.0 0.2

317

115

109


